DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	2q36.3	2	226146604	NYAP2							rs13422522-C	rs13422522	0	13422522.0	intergenic_variant	1.0	0.77	9e-11	10.045757490560677		0.005674	[0.0014-0.01] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	16p12.3	16	20308765	GP2	SNRPEP3 - GP2	ENSG00000227624	ENSG00000169347		69518.0	809.0	rs4078023-T	rs4078023	0	4078023.0	intergenic_variant	1.0	0.98	3e-07	6.522878745280337		0.03292	[0.02-0.045] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	8q12.1	8	59061616	TOX	TOX			ENSG00000198846			rs16924527-A	rs16924527	0	16924527.0	intron_variant	0.0	0.02	4e-06	5.3979400086720375		0.007825	[-0.00229-0.01794] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	20q11.23	20	38655427	ARHGAP40	ARHGAP40 - Metazoa_SRP	ENSG00000124143	ENSG00000276525		4392.0	56394.0	rs6027072-A	rs6027072	0	6027072.0	intergenic_variant	1.0	0.03	4e-09	8.397940008672037		0.0184	[0.0095-0.0273] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	18q21.33	18	63178651	BCL2	BCL2			ENSG00000171791			rs12454712-T	rs12454712	0	12454712.0	intron_variant	0.0	0.58	3e-08	7.522878745280337		0.00336	[-0.00081-0.00753] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	12q14.1	12	61094991	FAM19A2							rs10506418-A	rs10506418	0	10506418.0	intergenic_variant	1.0	0.03	2e-08	7.698970004336019		0.0261	[0.016-0.036] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	1p31.1	1	79780335	ELTD1							rs1857095-T	rs1857095	0	1857095.0	intergenic_variant	1.0	0.98	8e-09	8.096910013008056		0.000282	[-0.00881-0.00938] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	13q12.11	13	21758683	FGF9	FGF9 - RN7SL766P	ENSG00000102678	ENSG00000244197		54185.0	31854.0	rs12583553-A	rs12583553	0	12583553.0	intergenic_variant	1.0	0.97	4e-09	8.397940008672037		0.02395	[0.015-0.033] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	22q12.3	22	34739115	ISX	NA - LINC02885		ENSG00000286592			17561.0	rs10483182-A	rs10483182	0	10483182.0	intergenic_variant	1.0	0.01	8e-12	11.096910013008056		0.04803	[0.034-0.062] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	15q25.3	15	86710303	AGBL1	AGBL1			ENSG00000273540			rs10520638-T	rs10520638	0	10520638.0	intron_variant	0.0	0.01	1e-07	7.0		0.03605	[0.023-0.049] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	20q13.2	20	54193838	PFDN4	CYP24A1 - PFDN4	ENSG00000019186	ENSG00000101132		19852.0	14249.0	rs6013915-A	rs6013915	0	6013915.0	intergenic_variant	1.0	0.03	2e-09	8.698970004336019		0.03705	[0.023-0.051] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (BMI interaction)	16,753 European ancestry individuals	13,354 European ancestry individuals	14q13.1	14	33300706	NPAS3	NPAS3			ENSG00000151322			rs11627967-T	rs11627967	0	11627967.0	intron_variant	0.0	0.016	2e-07	6.698970004336019		0.0396	[0.024-0.055] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2018-01-22	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index	16,753 European ancestry individuals	13,354 European ancestry individuals	3q22.3	3	138278900	TXNDC6	NME9, ARMC8			ENSG00000181322, ENSG00000114098			rs13059110-?	rs13059110	0	13059110.0	intron_variant	0.0	NR	2e-06	5.698970004336019		0.1	[0.061-0.139] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	16,753 European ancestry individuals	13,354 European ancestry individuals	3p25.2	3	12348985	PPARG	PPARG			ENSG00000132170			rs17036328-T	rs17036328	0	17036328.0	intron_variant	0.0	NR	1e-06	6.0		0.07	[0.050-0.090] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	16,753 European ancestry individuals	13,354 European ancestry individuals	2q36.3	2	226146604	NYAP2							rs13422522-C	rs13422522	0	13422522.0	intergenic_variant	1.0	0.77	1e-11	11.0		0.06	[0.040-0.080] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	16,753 European ancestry individuals	13,354 European ancestry individuals	18q21.33	18	63178651	BCL2	BCL2			ENSG00000171791			rs12454712-T	rs12454712	0	12454712.0	intron_variant	0.0	0.58	2e-08	7.698970004336019		0.05	[0.030-0.070] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2017-02-24	27416945	Walford GA	2016-07-14	Diabetes	www.ncbi.nlm.nih.gov/pubmed/27416945	Genome-Wide Association Study of the Modified Stumvoll Insulin Sensitivity Index Identifies BCL2 and FAM19A2 as Novel Insulin Sensitivity Loci.	Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)	16,753 European ancestry individuals	13,354 European ancestry individuals	2q36.3	2	226155937	IRS1	NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		501919.0	502773.0	rs7578326-A	rs7578326	0	7578326.0	TF_binding_site_variant	1.0	NR	7e-09	8.154901959985743		0.06	[0.040-0.080] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	7,572 South Asian ancestry individuals		17q25.3	17	82727657	FN3KRP	FN3KRP			ENSG00000141560			rs1046896-T	rs1046896	0	1046896.0	3_prime_UTR_variant	0.0	0.3677	7e-07	6.154901959985743		0.0517	[0.031-0.072] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		10q22.1	10	69330087	HK1	HK1			ENSG00000156515			rs4745982-T	rs4745982	0	4745982.0	intron_variant	0.0	0.8726	3e-65	64.52287874528034		0.0954	[0.084-0.106] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		17q25.3	17	82727657	FN3KRP	FN3KRP			ENSG00000141560			rs1046896-T	rs1046896	0	1046896.0	3_prime_UTR_variant	0.0	0.3162	4e-64	63.39794000867204		0.028	[0.025-0.031] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		2q31.1	2	168906638	G6PC2	SPC25, SPC25, G6PC2, G6PC2			ENSG00000152253, ENSG00000277909, ENSG00000152254, ENSG00000278373			rs560887-C	rs560887	0	560887.0	intron_variant	0.0	0.6843	1e-58	58.0		0.0284	[0.025-0.032] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		10q22.1	10	69331257	HK1	HK1			ENSG00000156515			rs10823343-A	rs10823343	0	10823343.0	intron_variant	0.0	0.7223	2e-55	54.69897000433602		0.0325	[0.028-0.037] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		7p13	7	44196069	GCK	GCK			ENSG00000106633			rs4607517-A	rs4607517	0	4607517.0	intron_variant	0.0	0.2017	9e-38	37.04575749056068		0.0306	[0.026-0.035] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		7p13	7	44207659	GCK	YKT6			ENSG00000106636			rs3824065-C	rs3824065	0	3824065.0	intron_variant	0.0	0.5557	4e-35	34.39794000867204		0.0192	[0.016-0.022] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		16q24.3	16	88787321	CDT1	PIEZO1 - CDT1	ENSG00000103335	ENSG00000167513		2101.0	16468.0	rs837763-T	rs837763	0	837763.0	upstream_gene_variant	1.0	0.5548	2.0000000000000002e-28	27.69897000433602		0.0172	[0.014-0.02] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		6p22.2	6	26092913	HFE	HFE			ENSG00000010704			rs1800562-G	rs1800562	0	1800562.0	missense_variant	0.0	0.9279	5e-28	27.30102999566398		0.0398	[0.033-0.047] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		8p11.21	8	41772887	ANK1	ANK1			ENSG00000029534			rs4737009-A	rs4737009	0	4737009.0	intron_variant	0.0	0.2531	4e-27	26.39794000867204		0.0212	[0.017-0.025] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		1q23.1	1	158656588	SPTA1	SPTA1			ENSG00000163554			rs857691-T	rs857691	0	857691.0	synonymous_variant	0.0	0.2715	3.9999999999999997e-25	24.39794000867204		0.0193	[0.016-0.023] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		6p22.2	6	26107235	HFE	H4C3 - H1-6	ENSG00000197061	ENSG00000187475		2898.0	177.0	rs198846-G	rs198846	0	198846.0	intergenic_variant	1.0	0.8293	1.0000000000000001e-23	23.0		0.0218	[0.017-0.026] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	0.2938	2.0000000000000002e-23	22.69897000433602		0.0196	[0.016-0.024] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		22q12.3	22	37073551	TMPRSS6	TMPRSS6			ENSG00000187045			rs4820268-G	rs4820268	0	4820268.0	missense_variant	0.0	0.4606	1e-22	22.0		0.0162	[0.013-0.02] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		8q24.11	8	117173494	SLC30A8	SLC30A8			ENSG00000164756			rs11558471-A	rs11558471	0	11558471.0	3_prime_UTR_variant	0.0	0.6745	1e-19	19.0		0.015	[0.012-0.018] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		6q23.3	6	135110502	MYB	HBS1L - MYB	ENSG00000112339	ENSG00000118513		7446.0	70806.0	rs11154792-T	rs11154792	1	9494142.0	TF_binding_site_variant	1.0	0.7415	7e-18	17.154901959985743		0.0205	[0.016-0.025] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		8p11.21	8	41691676	ANK1	ANK1			ENSG00000029534			rs6474359-T	rs6474359	0	6474359.0	intron_variant	0.0	0.953	2e-16	15.69897000433602		0.0436	[0.033-0.054] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		12q13.11	12	48105348	SENP1	PFKM, SENP1			ENSG00000152556, ENSG00000079387			rs2408955-T	rs2408955	0	2408955.0	5_prime_UTR_variant	0.0	0.5039	1e-15	15.0		0.0124	[0.0093-0.0155] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		2p24.1	2	23798361	ATAD2B	ATAD2B			ENSG00000119778			rs17509001-C	rs17509001	0	17509001.0	intron_variant	0.0	0.1576	2e-15	14.69897000433602		0.0181	[0.014-0.023] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		4q31.21	4	143738642	FREM3	FREM3 - NA	ENSG00000183090			37967.0		rs13134327-A	rs13134327	0	13134327.0	intron_variant	1.0	0.3335	3e-15	14.522878745280336		0.0131	[0.0098-0.0164] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		3q21.1	3	123346931	ADCY5	ADCY5			ENSG00000173175			rs11708067-A	rs11708067	0	11708067.0	intron_variant	0.0	0.7542	1e-12	12.0		0.0132	[0.0095-0.0169] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		9q22.1	9	88888321	C9orf47	NA - PCNPP2		ENSG00000225856			82566.0	rs7040409-C	rs7040409	0	7040409.0	intergenic_variant	1.0	0.8953	3e-14	13.522878745280336		0.0284	[0.021-0.036] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		16p13.3	16	243563	ITFG3	FAM234A			ENSG00000167930			rs11248914-T	rs11248914	0	11248914.0	intron_variant	0.0	0.647	3e-14	13.522878745280336		0.0142	[0.01-0.018] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		13q34	13	112697348	ATP11A	ATP11A			ENSG00000068650			rs282587-G	rs282587	0	282587.0	intron_variant	0.0	0.1513	2e-12	11.69897000433602		0.019	[0.014-0.024] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		6p22.3	6	20679478	CDKAL1	CDKAL1			ENSG00000145996			rs7756992-G	rs7756992	0	7756992.0	intron_variant	0.0	0.2862	3e-12	11.522878745280336		0.0123	[0.0088-0.0158] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		19p13.11	19	17145713	MYO9B	MYO9B			ENSG00000099331			rs17533903-A	rs17533903	0	17533903.0	intron_variant	0.0	0.2428	5e-12	11.30102999566398		0.015	[0.011-0.019] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		9p21.3	9	22132077	MTAP	CDKN2B-AS1 - NA	ENSG00000240498			3974.0		rs2383208-A	rs2383208	0	2383208.0	intergenic_variant	1.0	0.7992	7e-12	11.154901959985745		0.0142	[0.01-0.018] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		3q26.2	3	171007094	SLC2A2	SLC2A2			ENSG00000163581			rs8192675-T	rs8192675	0	8192675.0	intron_variant	0.0	0.6906	1e-11	11.0		0.0112	[0.0079-0.0145] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		17q11.2	17	28856086	ERAL1	ERAL1			ENSG00000132591			rs9914988-A	rs9914988	0	9914988.0	intron_variant	0.0	0.7877	3e-11	10.522878745280336		0.0131	[0.0092-0.017] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		10q25.2	10	112992744	TCF7L2	TCF7L2			ENSG00000148737			rs17747324-C	rs17747324	0	17747324.0	intron_variant	0.0	0.2489	6e-11	10.221848749616356		0.0149	[0.01-0.019] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		11p15.5	11	205198	BET1L	BET1L			ENSG00000177951			rs3782123-C	rs3782123	0	3782123.0	3_prime_UTR_variant	0.0	0.3205	2e-10	9.69897000433602		0.0126	[0.0087-0.0165] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		3p25.2	3	12226148	SYN2	SYN2 - GSTM5P1	ENSG00000157152	ENSG00000236062		34116.0	31653.0	rs7616006-A	rs7616006	0	7616006.0	intergenic_variant	1.0	0.5744	5e-10	9.30102999566398		0.0103	[0.007-0.0136] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		6q21	6	109240832	C6orf183	CCDC162P			ENSG00000203799			rs11964178-A	rs11964178	0	11964178.0	intron_variant	0.0	0.5666	6e-10	9.221848749616356		0.0096	[0.0065-0.0127] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		3p21.31	3	49345492	USP4	USP4 - GPX1	ENSG00000114316	ENSG00000233276		4780.0	11684.0	rs9818758-A	rs9818758	0	9818758.0	regulatory_region_variant	1.0	0.2028	8e-10	9.096910013008056		0.0121	[0.0082-0.016] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		1q21.3	1	150968149	CERS2	CERS2			ENSG00000143418			rs267738-T	rs267738	0	267738.0	missense_variant	0.0	0.7701	3e-09	8.522878745280337		0.0111	[0.0074-0.0148] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		11q13.4	11	72721940	ARAP1	ARAP1			ENSG00000186635			rs11603334-G	rs11603334	0	11603334.0	5_prime_UTR_variant	0.0	0.815	7e-09	8.154901959985743		0.012	[0.0079-0.0161] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		9q34.2	9	133278724	ABO	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		2700.0	59004.0	rs579459-C	rs579459	0	579459.0	upstream_gene_variant	1.0	0.2389	9e-09	8.045757490560675		0.0107	[0.007-0.0144] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		13q34	13	113839885	GAS6	GAS6, GAS6-AS1			ENSG00000183087, ENSG00000233695			rs9604573-T	rs9604573	0	9604573.0	non_coding_transcript_exon_variant	0.0	0.2738	1e-08	8.0		0.0101	[0.0066-0.0136] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		12q24.12	12	111472415	ATXN2	ATXN2			ENSG00000204842			rs10774625-G	rs10774625	0	10774625.0	intron_variant	0.0	0.5056	1e-08	8.0		0.0088	[0.0057-0.0119] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		2p16.3	2	48187596	FOXN2	NA - RN7SKP224		ENSG00000201010			29979.0	rs12621844-T	rs12621844	0	12621844.0	intron_variant	1.0	0.5999	2e-08	7.698970004336019		0.0099	[0.0064-0.0134] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		16q12.2	16	53769662	FTO	FTO			ENSG00000140718			rs1558902-A	rs1558902	0	1558902.0	intron_variant	0.0	0.4128	3e-08	7.522878745280337		0.0103	[0.0066-0.014] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		8p11.21	8	42527944	SLC20A2	SLC20A2			ENSG00000168575			rs6980507-A	rs6980507	0	6980507.0	intron_variant	0.0	0.4014	4e-08	7.397940008672037		0.0097	[0.0062-0.0132] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		6q24.1	6	139519556	CITED2	LINC01625 - ATP5PBP6	ENSG00000238099	ENSG00000219806		44898.0	94882.0	rs592423-A	rs592423	0	592423.0	intron_variant	1.0	0.4566	4e-08	7.397940008672037		0.0091	[0.0058-0.0124] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		12p13.31	12	6966719	PHB2	PHB2			ENSG00000215021			rs2110073-T	rs2110073	0	2110073.0	intron_variant	0.0	0.1097	4e-08	7.397940008672037		0.0153	[0.0098-0.0208] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		16q22.1	16	68716287	CDH3	CDH3			ENSG00000062038			rs4783565-A	rs4783565	0	4783565.0	intron_variant	0.0	0.2941	2e-07	6.698970004336019		0.0092	[0.0057-0.0127] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		1p36.11	1	25202547	SYF2	IFITM3P7 - SYF2	ENSG00000233419	ENSG00000117614		77093.0	19729.0	rs2375278-A	rs2375278	0	2375278.0	intergenic_variant	1.0	0.1888	2e-07	6.698970004336019		0.0113	[0.007-0.0156] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		7p21.2	7	15024684	DGKB	GTF3AP5 - NA	ENSG00000225816			38610.0		rs2191349-T	rs2191349	0	2191349.0	intergenic_variant	1.0	0.532	2e-07	6.698970004336019		0.0086	[0.0053-0.0119] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		9q31.2	9	107774651	KLF4	NA - RNU6-1064P		ENSG00000222558			23093.0	rs1467311-G	rs1467311	0	1467311.0	regulatory_region_variant	1.0	0.3508	2e-07	6.698970004336019		0.0086	[0.0053-0.0119] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		13q12.2	13	27913462	PDX1	PLUT			ENSG00000247381			rs11619319-G	rs11619319	0	11619319.0	intron_variant	0.0	0.2327	5e-07	6.301029995663981		0.0094	[0.0057-0.0131] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		11q22.1	11	100585873	CNTN5	NA - RN7SL222P		ENSG00000242165			56102.0	rs11224302-C	rs11224302	0	11224302.0	intergenic_variant	1.0	0.869	5e-07	6.301029995663981		0.0146	[0.0089-0.0203] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		11q12.2	11	61837342	FADS2	FADS2			ENSG00000134824			rs174577-C	rs174577	0	174577.0	intron_variant	0.0	0.6485	5e-07	6.301029995663981		0.0083	[0.005-0.0116] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		3q26.31	3	172077750	FNDC3B	FNDC3B			ENSG00000075420			rs4894799-A	rs4894799	0	4894799.0	intron_variant	0.0	0.6214	2e-06	5.698970004336019		0.0089	[0.0052-0.0126] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	88,355 European ancestry individuals		19p13.11	19	17135927	MYO9B	MYO9B			ENSG00000099331			rs11086054-A	rs11086054	0	11086054.0	intron_variant	0.0	0.6753	8e-06	5.096910013008056		0.0097	[0.0054-0.014] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	7,564 African American individuals		Xq28	X	154536002	G6PD	G6PD			ENSG00000160211			rs1050828-T	rs1050828	0	1050828.0	missense_variant	0.0	0.116	8e-135	134.09691001300806		0.3819	[0.35-0.41] unit decrease	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	7,564 African American individuals		5q33.3	5	157628483	SOX30	SOX30			ENSG00000039600			rs11954649-G	rs11954649	0	11954649.0	intron_variant	0.0	0.045	4e-08	7.397940008672037		0.1191	[0.077-0.161] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		1q22	1	156348350	TMEM79	CCT3			ENSG00000163468			rs12132919-A	rs12132919	0	12132919.0	intron_variant	0.0	0.2803	3e-11	10.522878745280336		0.0289	[0.02-0.038] unit decrease	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		8p11.21	8	41772887	ANK1	ANK1			ENSG00000029534			rs4737009-A	rs4737009	0	4737009.0	intron_variant	0.0	0.4977	1e-10	10.0		0.0255	[0.018-0.033] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		17q25.3	17	82727657	FN3KRP	FN3KRP			ENSG00000141560			rs1046896-T	rs1046896	0	1046896.0	3_prime_UTR_variant	0.0	0.5008	7e-10	9.154901959985745		0.0225	[0.015-0.03] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		19p13.11	19	17135927	MYO9B	MYO9B			ENSG00000099331			rs11086054-A	rs11086054	0	11086054.0	intron_variant	0.0	0.5685	2e-09	8.698970004336019		0.0236	[0.016-0.031] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	0.4542	7e-09	8.154901959985743		0.0223	[0.015-0.03] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		8q24.11	8	117173494	SLC30A8	SLC30A8			ENSG00000164756			rs11558471-A	rs11558471	0	11558471.0	3_prime_UTR_variant	0.0	0.5391	1e-08	8.0		0.0213	[0.014-0.029] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		9q31.2	9	107774651	KLF4	NA - RNU6-1064P		ENSG00000222558			23093.0	rs1467311-G	rs1467311	0	1467311.0	regulatory_region_variant	1.0	0.2582	1e-07	7.0		0.0236	[0.015-0.032] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		2q24.3	2	168898336	G6PC2	SPC25, SPC25			ENSG00000152253, ENSG00000277909			rs13387347-T	rs13387347	0	13387347.0	intron_variant	0.0	0.541	1e-07	7.0		0.0203	[0.013-0.028] unit decrease	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		6p22.3	6	20679478	CDKAL1	CDKAL1			ENSG00000145996			rs7756992-G	rs7756992	0	7756992.0	intron_variant	0.0	0.5103	1e-07	7.0		0.0192	[0.012-0.026] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		11p15.4	11	2837210	KCNQ1	KCNQ1, KCNQ1			ENSG00000282076, ENSG00000053918			rs2237896-G	rs2237896	0	2237896.0	intron_variant	0.0	0.6145	2e-07	6.698970004336019		0.0251	[0.015-0.035] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		2q31.1	2	174427636	SCRN3	SCRN3			ENSG00000144306			rs17256082-C	rs17256082	0	17256082.0	intron_variant	0.0	0.2581	4e-07	6.3979400086720375		0.0227	[0.014-0.032] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		16q24.3	16	88787321	CDT1	PIEZO1 - CDT1	ENSG00000103335	ENSG00000167513		2101.0	16468.0	rs837763-T	rs837763	0	837763.0	upstream_gene_variant	1.0	0.5987	6e-06	5.221848749616356		0.022	[0.012-0.032] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		11q12.2	11	61837342	FADS2	FADS2			ENSG00000134824			rs174577-C	rs174577	0	174577.0	intron_variant	0.0	0.5111	8e-06	5.096910013008056		0.0177	[0.0099-0.0255] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2019-06-21	28898252	Wheeler E	2017-09-12	PLoS Med	www.ncbi.nlm.nih.gov/pubmed/28898252	Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.	Glycated hemoglobin levels	18,472 East Asian ancestry individuals		7p13	7	44196069	GCK	GCK			ENSG00000106633			rs4607517-A	rs4607517	0	4607517.0	intron_variant	0.0	0.2492	9e-15	14.045757490560677		0.0377	[0.028-0.047] unit increase	Affymetrix, Illumina, Perlegen [~ 2500000] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		1p22.1	1	91758510	TGFBR3	TGFBR3			ENSG00000069702			rs3738441-?	rs3738441	0	3738441.0	intron_variant	0.0	NR	9e-07	6.045757490560675	(AA)	0.039	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		2p23.3	2	25175973	intergenic	POMC - LINC01381	ENSG00000115138	ENSG00000230452		7070.0	28340.0	rs2028196-?	rs2028196	0	2028196.0	intergenic_variant	1.0	NR	9e-07	6.045757490560675		0.013	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		2q22.3	2	147192553	LOC105373670							rs1597595-?	rs1597595	0	1597595.0	intergenic_variant	1.0	NR	7e-07	6.154901959985743	(AA)	0.025	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		5q14.1	5	80705351	MSH3	MSH3			ENSG00000113318			rs7709909-?	rs7709909	0	7709909.0	intron_variant	0.0	NR	1e-08	8.0	(AA)	0.045	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		17p13.1	17	9445693	STX8	STX8			ENSG00000170310			rs7214842-?	rs7214842	0	7214842.0	intron_variant	0.0	NR	1e-06	6.0	(AA)	0.024	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		22q13.31	22	46458337	CELSR1	CELSR1			ENSG00000075275			rs71313049-?	rs71313049	0	71313049.0	intron_variant	0.0	NR	7e-07	6.154901959985743	(AA)	0.043	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		1p21.3	1	98677991	SNX7	SNX7			ENSG00000162627			rs9285630-?	rs9285630	0	9285630.0	intron_variant	0.0	NR	8e-07	6.096910013008056	(EA)	0.022	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		3p13	3	71282213	FOXP1	FOXP1			ENSG00000114861			rs1653969-?	rs1653969	0	1653969.0	intron_variant	0.0	NR	9e-07	6.045757490560675	(AA)	0.037	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		3q26.33	3	179850308	PEX5L	PEX5L			ENSG00000114757			rs112284299-?	rs112284299	0	112284299.0	intron_variant	0.0	NR	7e-07	6.154901959985743	(AA)	0.107	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		10q21.1	10	58827232	BICC1	BICC1			ENSG00000122870			rs72804453-?	rs72804453	0	72804453.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(AA)	0.111	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		13q33.1	13	102066314	FGF14	FGF14			ENSG00000102466			rs2607653-?	rs2607653	0	2607653.0	intron_variant	0.0	NR	4e-07	6.3979400086720375		0.038	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		17q25.3	17	81706393	MRPL12	MRPL12			ENSG00000262814			rs73354145-?	rs73354145	0	73354145.0	intron_variant	0.0	NR	2e-07	6.698970004336019		0.032	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	LDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		19p13.11	19	19383674	PBX4, MAU2	MAU2 - GATAD2A	ENSG00000129933	ENSG00000167491		24920.0	2152.0	rs150268548-?	rs150268548	0	150268548.0	upstream_gene_variant	1.0	NR	9e-08	7.045757490560675	(EA)	0.028	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		1p31.1	1	76128101	ST6GALNAC3	ST6GALNAC3			ENSG00000184005			rs2631781-?	rs2631781	0	2631781.0	intron_variant	0.0	NR	1e-06	6.0	(AA)	0.051	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		1q43	1	236495210	intergenic	EDARADD			ENSG00000186197			rs181126208-?	rs181126208	0	181126208.0	intron_variant	0.0	NR	7e-08	7.154901959985743	(AA)	0.066	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		6p22.2	6	25667803	SCGN	SCGN			ENSG00000079689			rs75639901-?	rs75639901	0	75639901.0	intron_variant	0.0	NR	5e-07	6.301029995663981	(AA)	0.039	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		6p21.1	6	46183649	intergenic	ENPP5 - ACTG1P9	ENSG00000112796	ENSG00000229349		12669.0	21080.0	rs9472719-?	rs9472719	0	9472719.0	intergenic_variant	1.0	NR	9e-07	6.045757490560675		0.008	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		7q36.1	7	150387372	ZNF775	ZNF775			ENSG00000196456			rs7810240-?	rs7810240	0	7810240.0	intron_variant	0.0	NR	2e-07	6.698970004336019		0.015	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		8p23.3	8	1771328	CLN8	KBTBD11-OT1, CLN8, CLN8			ENSG00000283239, ENSG00000182372, ENSG00000278220			rs34030778-?	rs34030778	0	34030778.0	missense_variant	0.0	NR	4e-08	7.397940008672037	(AA)	0.124	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		8q12.3	8	63563681	intergenic	NA - RN7SKP135		ENSG00000252358			45673.0	rs114007472-?	rs114007472	0	114007472.0	intergenic_variant	1.0	NR	8e-07	6.096910013008056	(AA)	0.071	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		2q21.3	2	135861240	MCM6	MCM6			ENSG00000076003			rs4988198-?	rs4988198	0	4988198.0	intron_variant	0.0	NR	9e-07	6.045757490560675	(AA)	0.058	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		2p16.3	2	50971652	NRXN1	NRXN1			ENSG00000179915			rs141864436-?	rs141864436	0	141864436.0	intron_variant	0.0	NR	1e-07	7.0	(AA)	0.062	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		2q21.3	2	135975206	DARS	DARS1			ENSG00000115866			rs145010525-?	rs145010525	0	145010525.0	intron_variant	0.0	NR	8e-07	6.096910013008056	(AA)	0.058	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		3p24.3	3	19055898	intergenic	NA - KCNH8		ENSG00000183960			92612.0	rs115990514-?	rs115990514	0	115990514.0	intergenic_variant	1.0	NR	5e-07	6.301029995663981	(AA)	0.065	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		3q26.31	3	174201323	NLGN1	NLGN1			ENSG00000169760			rs115092681-?	rs115092681	0	115092681.0	intron_variant	0.0	NR	1e-06	6.0	(AA)	0.061	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		3q26.33	3	179850308	PEX5L	PEX5L			ENSG00000114757			rs112284299-?	rs112284299	0	112284299.0	intron_variant	0.0	NR	1e-07	7.0	(AA)	0.065	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		4p15.1	4	34193882	LOC105374394	LINC02484			ENSG00000248685			rs10034465-?	rs10034465	0	10034465.0	intron_variant	0.0	NR	1e-07	7.0	(AA)	0.053	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		4q21.21	4	81419698	intergenic	RNU5A-2P - RASGEF1B	ENSG00000207065	ENSG00000138670		85280.0	6695.0	rs6847878-?	rs6847878	0	6847878.0	intergenic_variant	1.0	NR	1e-06	6.0	(AA)	0.062	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		5p15.1	5	15524361	FBXL7	FBXL7			ENSG00000183580			rs80333777-?	rs80333777	0	80333777.0	intron_variant	0.0	NR	5e-07	6.301029995663981		0.02	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		5p14.1	5	28184372	intergenic							rs75298135-?	rs75298135	0	75298135.0	intergenic_variant	1.0	NR	4e-07	6.3979400086720375	(AA)	0.065	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		5q21.1	5	99159794	intergenic	HSPB3 - NA	ENSG00000169271			44703417.0		rs113816795-?	rs113816795	0	113816795.0	intergenic_variant	1.0	NR	2e-07	6.698970004336019	(AA)	0.072	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		6p25.2	6	3904005	intergenic	FAM50B - TDGF1P4	ENSG00000145945	ENSG00000217566		52685.0	37277.0	rs146807753-?	rs146807753	0	146807753.0	intergenic_variant	1.0	NR	7e-07	6.154901959985743	(AA)	0.06	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		10q21.1	10	58827232	BICC1	BICC1			ENSG00000122870			rs72804453-?	rs72804453	0	72804453.0	intron_variant	0.0	NR	8e-11	10.096910013008056	(AA)	0.078	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		12q14.1	12	58041829	intergenic	RN7SKP65 - LINC02403	ENSG00000262776	ENSG00000257541		63552.0	46063.0	rs116616455-?	rs116616455	0	116616455.0	intergenic_variant	1.0	NR	7e-07	6.154901959985743	(AA)	0.047	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		12q21.31	12	84947358	LOC102724680	SLC6A15 - TSPAN19	ENSG00000072041	ENSG00000231738		33729.0	66953.0	rs112209655-?	rs112209655	0	112209655.0	intergenic_variant	1.0	NR	2e-07	6.698970004336019	(AA)	0.066	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		12q24.21	12	113940539	RBM19	RBM19			ENSG00000122965			rs143838781-?	rs143838781	0	143838781.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(AA)	0.061	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		13q12.12	13	22791997	intergenic	DDX39AP1 - SNORD36	ENSG00000225777	ENSG00000253094		85791.0	11148.0	rs138270994-?	rs138270994	0	138270994.0	intergenic_variant	1.0	NR	6e-07	6.221848749616356	(AA)	0.045	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		13q33.1	13	102066314	FGF14	FGF14			ENSG00000102466			rs2607653-?	rs2607653	0	2607653.0	intron_variant	0.0	NR	1e-07	7.0		0.023	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		15q13.2	15	30060226	intergenic	SYNGR2P1 - GOLGA8J	ENSG00000260174	ENSG00000278119		14930.0	22827.0	rs76043556-?	rs76043556	0	76043556.0	intron_variant	1.0	NR	7e-07	6.154901959985743	(AA)	0.058	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		15q26.3	15	101854599	intergenic	OR4F13P - OR4F28P	ENSG00000214344	ENSG00000257109		4275.0	21365.0	rs117168171-?	rs117168171	0	117168171.0	intergenic_variant	1.0	NR	2e-07	6.698970004336019	(AA)	0.066	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		16p12.2	16	23383078	intergenic	SCNN1B - COG7	ENSG00000168447	ENSG00000168434		1784.0	5415.0	rs250567-?	rs250567	0	250567.0	intergenic_variant	1.0	NR	1e-07	7.0	(AA)	0.072	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		16q12.1	16	47050042	intergenic	DNAJA2-DT - NETO2	ENSG00000261173	ENSG00000171208		71059.0	27661.0	rs80147136-?	rs80147136	0	80147136.0	intergenic_variant	1.0	NR	2e-08	7.698970004336019	(AA)	0.071	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		17q25.3	17	81706393	MRPL12	MRPL12			ENSG00000262814			rs73354145-?	rs73354145	0	73354145.0	intron_variant	0.0	NR	3e-07	6.522878745280337		0.018	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		19p13.11	19	19609590	PBX4	PBX4			ENSG00000105717			rs57504626-?	rs57504626	0	57504626.0	intron_variant	0.0	NR	6e-07	6.221848749616356	(EA)	0.014	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		21q21.1	21	15497529	intergenic	CYCSP42 - NA	ENSG00000224524			6762.0		rs2823310-?	rs2823310	0	2823310.0	intron_variant	1.0	NR	3e-07	6.522878745280337	(AA)	0.043	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		21q21.1	21	19649854	LOC105372744	NIPA2P3 - SREK1IP1P1	ENSG00000271486	ENSG00000229336		28309.0	89855.0	rs62210650-?	rs62210650	0	62210650.0	intergenic_variant	1.0	NR	7e-07	6.154901959985743	(AA)	0.064	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		22q13.1	22	37736644	TRIOBP	TRIOBP			ENSG00000100106			rs58847779-?	rs58847779	0	58847779.0	intron_variant	0.0	NR	7e-07	6.154901959985743	(AA)	0.039	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Total cholesterol change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		1q24.2	1	170674137	PRRX1	PRRX1			ENSG00000116132			rs6693796-?	rs6693796	0	6693796.0	intron_variant	0.0	NR	6e-08	7.221848749616356		0.019	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		1q21.2	1	147605222	BCL9	BCL9			ENSG00000116128			rs79128089-?	rs79128089	0	79128089.0	intron_variant	0.0	NR	3e-08	7.522878745280337	(AA)	0.108	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		1q42.13	1	227908878	intergenic	PRSS38 - WNT9A	ENSG00000185888	ENSG00000143816		62408.0	9778.0	rs2185774-?	rs2185774	0	2185774.0	intergenic_variant	1.0	NR	3e-07	6.522878745280337	(AA)	0.159	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		2p16.2	2	53557787	intergenic	ASB3			ENSG00000115239			rs73934724-?	rs73934724	0	73934724.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(AA)	0.174	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		3q24	3	146921799	LOC101927866	LINC02010			ENSG00000242671			rs200803778-?	rs200803778	0	200803778.0	non_coding_transcript_exon_variant	0.0	NR	7e-07	6.154901959985743	(AA)	0.152	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		4p16.1	4	9112775	intergenic	ENPP7P10			ENSG00000249767			rs138945390-?	rs138945390	0	138945390.0	intron_variant	0.0	NR	2e-07	6.698970004336019	(AA)	0.167	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		4p15.2	4	24942593	CCDC149	CCDC149			ENSG00000181982			rs137945355-?	rs137945355	0	137945355.0	intron_variant	0.0	NR	3e-07	6.522878745280337	(AA)	0.127	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		4q32.1	4	156252512	intergenic							rs7657890-?	rs7657890	0	7657890.0	intergenic_variant	1.0	NR	5e-07	6.301029995663981		0.019	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		5q31.3	5	143951835	intergenic							rs116116673-?	rs116116673	0	116116673.0	intergenic_variant	1.0	NR	3e-07	6.522878745280337	(AA)	0.147	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		6p21.2	6	40416077	LRFN2	LRFN2			ENSG00000156564			rs148347825-?	rs148347825	0	148347825.0	intron_variant	0.0	NR	2e-08	7.698970004336019	(AA)	0.166	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		6q23.2	6	134370090	intergenic	LINC01010			ENSG00000236700			rs114176593-?	rs114176593	0	114176593.0	intron_variant	0.0	NR	5e-08	7.301029995663981	(AA)	0.153	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		9p24.2	9	3948365	GLIS3	GLIS3			ENSG00000107249			rs1017568-?	rs1017568	0	1017568.0	intron_variant	0.0	NR	3e-07	6.522878745280337	(AA)	0.265	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		9p21.1	9	28227169	LINGO2	LINGO2			ENSG00000174482			rs7357773-?	rs7357773	0	7357773.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(AA)	0.114	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		10q21.2	10	60978985	RHOBTB1	RHOBTB1			ENSG00000072422			rs77972797-?	rs77972797	0	77972797.0	intron_variant	0.0	NR	8e-07	6.096910013008056	(AA)	0.111	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		12q15	12	69694564	BEST3	BEST3			ENSG00000127325			rs75229567-?	rs75229567	0	75229567.0	intron_variant	0.0	NR	9e-07	6.045757490560675		0.041	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		12q21.31	12	84532353	intergenic							rs201486960-?	rs201486960	0	201486960.0	intergenic_variant	1.0	NR	2e-07	6.698970004336019	(AA)	0.124	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		12q24.22	12	116481563	intergenic	MIR4472-2 - LINC02457	ENSG00000264037	ENSG00000258018		53245.0	510.0	rs116517707-?	rs116517707	0	116517707.0	intergenic_variant	1.0	NR	1e-07	7.0	(AA)	0.147	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		13q13.3	13	36601856	intergenic	NA - SERTM1		ENSG00000180440			72164.0	rs11619726-?	rs11619726	0	11619726.0	intergenic_variant	1.0	NR	6e-08	7.221848749616356	(AA)	0.173	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		13q31.1	13	84421272	LINC00333	NA - MTND4P1		ENSG00000228597			98831.0	rs61960346-?	rs61960346	0	61960346.0	intron_variant	1.0	NR	5e-08	7.301029995663981	(AA)	0.162	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		15q14	15	38887084	LOC105370782	LINC02694			ENSG00000175779			rs11636249-?	rs11636249	0	11636249.0	intron_variant	0.0	NR	5e-07	6.301029995663981	(AA)	0.153	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		16q12.2	16	53634741	RPGRIP1L	RPGRIP1L			ENSG00000103494			rs73607972-?	rs73607972	0	73607972.0	intron_variant	0.0	NR	2e-07	6.698970004336019	(EA)	0.026	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		16q24.2	16	87822832	intergenic	KLHDC4 - SLC7A5	ENSG00000104731	ENSG00000103257		56840.0	7191.0	rs76069656-?	rs76069656	0	76069656.0	TF_binding_site_variant	1.0	NR	5e-07	6.301029995663981	(AA)	0.103	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		20q11.23	20	38421365	SNHG17	SNHG17			ENSG00000196756			rs41308713-?	rs41308713	0	41308713.0	non_coding_transcript_exon_variant	0.0	NR	2e-07	6.698970004336019	(AA)	0.114	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		21q21.1	21	15497529	intergenic	CYCSP42 - NA	ENSG00000224524			6762.0		rs2823310-?	rs2823310	0	2823310.0	intron_variant	1.0	NR	7e-08	7.154901959985743	(AA)	0.109	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		16q12.2	16	53564398	LOC105371270	AKTIP - RPGRIP1L	ENSG00000166971	ENSG00000103494		59987.0	33755.0	rs111886096-?	rs111886096	0	111886096.0	intergenic_variant	1.0	NR	3e-07	6.522878745280337		0.022	unit decrease	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		17q12	17	34342002	intergenic	CCL8 - CCL13	ENSG00000108700	ENSG00000181374		20600.0	14478.0	rs62056376-?	rs62056376	0	62056376.0	intergenic_variant	1.0	NR	5e-07	6.301029995663981	(AA)	0.244	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-09-21	28736931	Rotroff DM	2017-07-24	Clin Pharmacol Ther	www.ncbi.nlm.nih.gov/pubmed/28736931	Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes.	Triglyceride change in response to fenofibrate in statin-treated type 2 diabetes	781 European ancestry individuals, 138 African American ancestry individuals, 345 unknown ancestry individuals		22q13.33	22	50032791	TTLL8	TTLL8			ENSG00000138892			rs115025532-?	rs115025532	0	115025532.0	intron_variant	0.0	NR	8e-07	6.096910013008056	(AA)	0.103	unit increase	Affymetrix, Illumina [8129838] (imputed)	N
2017-08-16	27500523	Zhou K	2016-09-01	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/27500523	Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.	Response to metformin in type 2 diabetes (HbA1c reduction)	1,372 European ancestry individuals	9,184 European ancestry individuals, 1,196 African American ancestry individuals, 627 Asian American individuals, 743 Latino individuals	3q26.2	3	171007094	SLC2A2, GLUT2	SLC2A2			ENSG00000163581			rs8192675-C	rs8192675	0	8192675.0	intron_variant	0.0	NR	7e-14	13.154901959985745	(EA)	0.17	[0.13-0.21] unit increase	NR [705124]	N
2009-01-07	19060909	Bouatia-Naji N	2008-12-07	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/19060909	A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk.	Fasting plasma glucose	2,151 European ancestry individuals	16,094 European ancestry individuals	11q14.3	11	92940662	MTNR1B	SNRPGP16 - MTNR1B	ENSG00000255287	ENSG00000134640		2996.0	28989.0	rs1387153-T	rs1387153	0	1387153.0	downstream_gene_variant	1.0	0.29	2e-36	35.69897000433602		0.07	[0.05-0.08] mmol/l increase	Illumina [308846]	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	11q13.4	11	72721940	ARAP1	ARAP1			ENSG00000186635			rs11603334-A	rs11603334	0	11603334.0	5_prime_UTR_variant	0.0	0.15	3e-102	101.52287874528034				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	5q15	5	96393194	PCSK1	PCSK1			ENSG00000175426			rs6235-G	rs6235	0	6235.0	missense_variant	0.0	0.28	9.999999999999999e-27	26.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	10q25.2	10	112998590	TCF7L2	TCF7L2			ENSG00000148737			rs7903146-T	rs7903146	0	7903146.0	intron_variant	0.0	0.30	2e-20	19.69897000433602				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	15q22.2	15	62090956	C2CD4B, C2CD4A, VPS13C	NPM1P47 - C2CD4B	ENSG00000259466	ENSG00000205502		7651.0	72579.0	rs4502156-T	rs4502156	0	4502156.0	intergenic_variant	1.0	0.58	4e-20	19.39794000867204				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	8q24.11	8	117173494	SLC30A8	SLC30A8			ENSG00000164756			rs11558471-A	rs11558471	0	11558471.0	3_prime_UTR_variant	0.0	0.69	3e-18	17.522878745280337				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	15q23	15	70816808	LARP6	RPL29P30 - LARP6	ENSG00000235420	ENSG00000166173		14120.0	12322.0	rs1549318-T	rs1549318	0	1549318.0	intergenic_variant	1.0	0.61	2e-10	9.69897000433602				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	17p13.3	17	2359409	SGSM2	SGSM2			ENSG00000141258			rs4790333-T	rs4790333	0	4790333.0	intron_variant	0.0	0.45	3e-09	8.522878745280337				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	1p21.3	1	98711697	SNX7	SNX7			ENSG00000162627			rs9727115-G	rs9727115	0	9727115.0	intron_variant	0.0	0.64	2e-07	6.698970004336019				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	11p11.2	11	47291341	MADD	MADD			ENSG00000110514			rs10838687-T	rs10838687	0	10838687.0	intron_variant	0.0	0.80	7e-12	11.154901959985745				Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-09-27	21873549	Strawbridge RJ	2011-08-26	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21873549	Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.	Proinsulin levels	10,701 European ancestry individuals	16,378 European ancestry individuals	11p11.2	11	47272248	MADD	MADD			ENSG00000110514			rs10501320-G	rs10501320	0	10501320.0	5_prime_UTR_variant	0.0	0.72	1.0000000000000001e-88	88.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	NR	1.0000000000000001e-24	24.0		0.235	[0.19-0.28] pmol/l decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	12q24.31	12	120989098	HNF1A	HNF1A			ENSG00000135100			rs12427353-G	rs12427353	0	12427353.0	intron_variant	0.0	NR	1e-06	6.0		0.141	[0.084-0.198] pmol/l decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	3q27.2	3	185793899	IGF2BP2	IGF2BP2			ENSG00000073792			rs4402960-T	rs4402960	0	4402960.0	intron_variant	0.0	NR	5e-06	5.301029995663981		0.101	[0.058-0.144] pmol/l decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	13q12.2	13	27913462	PDX1	PLUT			ENSG00000247381			rs11619319-G	rs11619319	0	11619319.0	intron_variant	0.0	NR	3e-06	5.522878745280337		0.106	[0.061-0.151] pmol/l decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	10q25.2	10	112998590	TCF7L2	TCF7L2			ENSG00000148737			rs7903146-T	rs7903146	0	7903146.0	intron_variant	0.0	NR	7e-06	5.154901959985743		0.105	[0.058-0.152] pmol/l decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	6p22.3	6	20686765	CDKAL1	CDKAL1			ENSG00000145996			rs9368222-A	rs9368222	0	9368222.0	intron_variant	0.0	NR	9e-16	15.045757490560677		0.178	[0.13-0.22] pmol/l decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	7p13	7	43819817	LOC102724946, BLVRA, URGCP-MRPS24	BLVRA - MRPS24	ENSG00000106605	ENSG00000062582		12475.0	46741.0	rs56379725-?	rs56379725	0	56379725.0	regulatory_region_variant	1.0	NR	4e-08	7.397940008672037	(BMI adjusted)	0.176	[0.11-0.24] pmol/l increase	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	7p13	7	43893384	URGCP, MRPS24, URGCP-MRPS24	URGCP, URGCP-MRPS24			ENSG00000106608, ENSG00000270617			rs576416681-?	rs576416681	0	576416681.0	intron_variant	0.0	NR	4e-08	7.397940008672037	(BMI adjusted)	0.172	[0.11-0.23] pmol/l increase	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	11p11.2	11	45566848	CHST1	NA - CHST1		ENSG00000175264			80841.0	rs10577852-?	rs10577852	0	10577852.0	intergenic_variant	1.0	NR	4e-09	8.397940008672037	(Non Europeans, BMI adjusted)	0.226	[0.14-0.3] pmol/l decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-21	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	13q12.2	13	27913462	PDX1	PLUT			ENSG00000247381			rs11619319-G	rs11619319	0	11619319.0	intron_variant	0.0	NR	4e-07	6.3979400086720375		0.115	[0.07-0.16] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-21	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	NR	4e-21	20.39794000867204		0.218	[0.17-0.26] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-21	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	12q24.31	12	120989098	HNF1A	HNF1A			ENSG00000135100			rs12427353-G	rs12427353	0	12427353.0	intron_variant	0.0	NR	3e-06	5.522878745280337		0.136	[0.079-0.193] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-21	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	11q13.4	11	72722053	ARAP1, CENTD2, STARD10	ARAP1			ENSG00000186635			rs1552224-A	rs1552224	0	1552224.0	5_prime_UTR_variant	0.0	NR	4e-06	5.3979400086720375		0.14	[0.081-0.199] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-21	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	2p12	2	78632958	REG3G	GPN1 - UGT1A8	ENSG00000198522	ENSG00000242366		50981447.0	154984675.0	rs1401735-T	rs1401735	0	1401735.0	intergenic_variant	1.0	0.011	3e-08	7.522878745280337	(EA)	1.773	[1.15-2.4] unit increase	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-21	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	11p11.2	11	45566848	CHST1	NA - CHST1		ENSG00000175264			80841.0	rs10577852-?	rs10577852	0	10577852.0	intergenic_variant	1.0	0.44	4e-09	8.397940008672037	(Non Europeans, adjusted for BMI)	0.226	[0.15-0.3] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-21	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	6p22.3	6	20686765	CDKAL1	CDKAL1			ENSG00000145996			rs9368222-A	rs9368222	0	9368222.0	intron_variant	0.0	NR	4e-12	11.397940008672036		0.154	[0.11-0.2] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-21	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	3q27.2	3	185795604	IGF2BP2	IGF2BP2			ENSG00000073792			rs7651090-G	rs7651090	0	7651090.0	intron_variant	0.0	NR	8e-06	5.096910013008056	(Adjusted for BMI)	0.099	[0.056-0.142] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Insulin secretion rate	527 European ancestry individuals		6p22.3	6	20679478	CDKAL1	CDKAL1			ENSG00000145996			rs7756992-G	rs7756992	0	7756992.0	intron_variant	0.0	NR	2e-07	6.698970004336019		0.232	[0.14-0.32] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Insulin secretion rate	527 European ancestry individuals		11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	NR	9e-08	7.045757490560675		0.232	[0.15-0.32] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-10	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Insulin disposition index	2,345 Hispanic individuals, 2,042 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	NR	3e-17	16.522878745280337		0.195	[0.15-0.24] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2018-12-06	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response (BMI and insulin secretion adjusted)	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals				KCNK13, PSCM1							chr14:89741552-?	chr14:89741552	0			1.0	NR	4e-08	7.397940008672037		0.366	[0.23-0.50] pmol/l increase	Affymetrix, Illumina [~ 39000000] (imputed)	N
2018-12-06	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Peak insulin response (insulin secretion adjusted)	2,337 Hispanic individuals, 2,159 European ancestry individuals, 332 Pima Indian ancestry individuals	739 European ancestry individuals	9q34.3	9	136362314	DNLZ	CARD9, DNLZ			ENSG00000187796, ENSG00000213221			rs3829109-?	rs3829109	0	3829109.0	intron_variant	0.0	NR	3e-06	5.522878745280337		0.103	[0.060-0.146] pmol/l increase	Affymetrix, Illumina [~ 39000000] (imputed)	N
2018-12-06	28490609	Wood AR	2017-05-10	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28490609	A Genome-Wide Association Study of IVGTT-Based Measures of First-Phase Insulin Secretion Refines the Underlying Physiology of Type 2 Diabetes Variants.	Acute insulin response (insulin secretion adjusted)	2,346 Hispanic individuals, 2,087 European ancestry individuals, 332 Pima Indian ancestry individuals	741 European ancestry individuals	9q34.3	9	136364010	GPSM1, DNLZ1, CARD9	CARD9			ENSG00000187796			rs1135314-A	rs1135314	0	1135314.0	3_prime_UTR_variant	0.0	0.597	4e-08	7.397940008672037		0.126	[0.081-0.171] unit decrease	Affymetrix, Illumina [~ 39000000] (imputed)	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		13q32.1	13	97364129	MBNL2	MBNL2			ENSG00000139793			rs144506210-C	rs144506210	0	144506210.0	intron_variant	0.0	0.13	6e-07	6.221848749616356		77.91416	[47.29-108.53] kcal/day decrease	Affymetrix [491265]	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		6q26	6	161144609	AGPAT4	AGPAT4			ENSG00000026652			rs73015431-T	rs73015431	0	73015431.0	intron_variant	0.0	0.6	1e-06	6.0		50.57351	[30.04-71.11] kcal/day decrease	Affymetrix [491265]	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		7q36.3	7	155280487	HTR5A, INSIG1	RN7SKP280 - INSIG1-DT	ENSG00000201066	ENSG00000273117		98303.0	15431.0	rs62471607-T	rs62471607	0	62471607.0	intergenic_variant	1.0	0.34	3e-06	5.522878745280337		53.02256	[30.9-75.15] kcal/day decrease	Affymetrix [491265]	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		13q32.1	13	97202346	OXGR1, MBNL2	LINC00456 - MBNL2	ENSG00000233124	ENSG00000139793		14768.0	19088.0	rs72637434-A	rs72637434	0	72637434.0	intergenic_variant	1.0	0.15	4e-06	5.3979400086720375		69.783646	[40.28-99.29] kcal/day decrease	Affymetrix [491265]	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		7q21.11	7	82517986	CACNA2D1, PCLO	CACNA2D1 - MTHFD2P5	ENSG00000153956	ENSG00000213530		74209.0	71862.0	rs10486963-T	rs10486963	0	10486963.0	intergenic_variant	1.0	0.87	6e-06	5.221848749616356		66.71365	[37.93-95.49] kcal/day decrease	Affymetrix [491265]	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		16q22.3	16	73962708	LOC100506172, LOC101928035	PSMD7-DT			ENSG00000261404			rs2189609-C	rs2189609	0	2189609.0	intron_variant	0.0	0.65	6e-06	5.221848749616356		51.241184	[29.12-73.36] kcal/day decrease	Affymetrix [491265]	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		6q26	6	161137004	AGPAT4	AGPAT4			ENSG00000026652			rs7768457-G	rs7768457	0	7768457.0	intron_variant	0.0	0.69	6e-06	5.221848749616356		49.021145	[27.76-70.28] kcal/day decrease	Affymetrix [491265]	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		10p12.1	10	25448453	GPR158	GPR158			ENSG00000151025			rs4747521-C	rs4747521	0	4747521.0	intron_variant	0.0	0.72	7e-06	5.154901959985743		48.283463	[27.29-69.28] kcal/day decrease	Affymetrix [491265]	N
2017-08-16	28476931	Piaggi P	2017-05-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/28476931	A Genome-Wide Association Study Using a Custom Genotyping Array Identifies Variants in GPR158 Associated With Reduced Energy Expenditure in American Indians.	Energy expenditure (24h)	419 Pima Indian ancestry individuals		1q41	1	217178064	ESRRG, GPATCH2	ESRRG - NA	ENSG00000196482			40309.0		rs11117784-C	rs11117784	0	11117784.0	intergenic_variant	1.0	0.69	8e-06	5.096910013008056		47.787292	[26.79-68.79] kcal/day decrease	Affymetrix [491265]	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Macroalbuminuria in type 1 diabetes	2,751 European ancestry cases, 12,124 European ancestry controls		2q36.3	2	227256385	COL4A3	MFF-DT, COL4A3			ENSG00000236432, ENSG00000169031			rs55703767-G	rs55703767	0	55703767.0	missense_variant	0.0	0.794	9e-09	8.045757490560675		1.2820514	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Macroalbuminuria in type 1 diabetes	2,751 European ancestry cases, 12,124 European ancestry controls		14q24.2	14	73273542	PAPLN	PAPLN			ENSG00000100767			rs113554206-A	rs113554206	0	113554206.0	3_prime_UTR_variant	0.0	0.012	5e-07	6.301029995663981		4.6	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Kidney disease (end stage renal disease vs macroalbuminuria) in type 1 diabetes	2,187 European ancestry cases, 2,725 European ancestry controls		8q24.21	8	127087785	PRNCR1	PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs551191707-CA	rs551191707	1	57532727.0	non_coding_transcript_exon_variant	0.0	0.122	4e-08	7.397940008672037		1.7	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Microalbuminuria in type 1 diabetes	2,447 European ancestry cases, 12,113 European ancestry controls		3p25.2	3	11869161	TAMM41	FANCD2P2			ENSG00000230342			rs142823282-G	rs142823282	0	142823282.0	intron_variant	0.0	0.011	8e-10	9.096910013008056		6.73	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Microalbuminuria in type 1 diabetes	2,447 European ancestry cases, 12,113 European ancestry controls		4q34.1	4	173579655	HAND2-AS1	HAND2-AS1			ENSG00000237125			rs145681168-G	rs145681168	0	145681168.0	intron_variant	0.0	0.014	2e-07	6.698970004336019		5.53	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Microalbuminuria in type 1 diabetes	2,447 European ancestry cases, 12,113 European ancestry controls		6p21.33	6	30919688	DDR1, VARS2	VARS2, VARS2, VARS2, VARS2, VARS2, VARS2			ENSG00000236178, ENSG00000234032, ENSG00000230985, ENSG00000206476, ENSG00000137411, ENSG00000223494			rs118124843-T	rs118124843	0	118124843.0	non_coding_transcript_exon_variant	0.0	0.011	4e-08	7.397940008672037		3.79	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Microalbuminuria in type 1 diabetes	2,447 European ancestry cases, 12,113 European ancestry controls		14q12	14	25535506	STXBP6							rs61983410-C	rs61983410	0	61983410.0	intergenic_variant	1.0	0.787	1e-07	7.0		1.2658228	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Microalbuminuria in type 1 diabetes	2,447 European ancestry cases, 12,113 European ancestry controls		20q13.31	20	57262207	BMP7	BMP7			ENSG00000101144			rs144434404-T	rs144434404	0	144434404.0	intron_variant	0.0	0.011	3e-09	8.522878745280337		6.78	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Microalbuminuria in type 1 diabetes	2,447 European ancestry cases, 12,113 European ancestry controls		7q22.1	7	100130923	MBLAC1	MBLAC1 - RPL7P60	ENSG00000214309	ENSG00000214142		2428.0	8706.0	rs77273076-T	rs77273076	0	77273076.0	upstream_gene_variant	1.0	0.008	1e-08	8.0		9.16	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Microalbuminuria in type 1 diabetes	2,447 European ancestry cases, 12,113 European ancestry controls		11p15.1	11	16916299	PLEKHA7	PLEKHA7			ENSG00000166689			rs183937294-G	rs183937294	0	183937294.0	intron_variant	0.0	0.007	2e-08	7.698970004336019		17.22	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in type 1 diabetes	2,987 European ancestry cases, 11,766 European ancestry controls		2q36.3	2	227256385	COL4A3	MFF-DT, COL4A3			ENSG00000236432, ENSG00000169031			rs55703767-G	rs55703767	0	55703767.0	missense_variant	0.0	0.794	5e-09	8.301029995663981		1.2987013	[NR]	Illumina [up to 49000000] (imputed)	N
2019-12-16	31537649	Salem RM	2019-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/31537649	Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.	Kidney disease (end stage renal disease or albuminuria) in type 1 diabetes	7,247 European ancestry cases, 12,053 European ancestry controls		2q36.3	2	227256385	COL4A3	MFF-DT, COL4A3			ENSG00000236432, ENSG00000169031			rs55703767-G	rs55703767	0	55703767.0	missense_variant	0.0	0.794	4e-10	9.397940008672036		1.2048193	[NR]	Illumina [up to 49000000] (imputed)	N
2019-10-01	31511532	Teumer A	2019-09-11	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31511532	Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.	Urinary albumin-to-creatinine ratio in diabetes	51,541 European, African American, East Asian, South Asian or Hispanic ancestry individuals		1p36.21	1	14806568	KAZN	KAZN			ENSG00000189337			rs59825600-A	rs59825600	0	59825600.0	intron_variant	0.0	0.0905	4e-08	7.397940008672037		0.0751	[0.048-0.102] unit decrease	Affymetrix, Illumina [8034757] (imputed)	N
2019-10-01	31511532	Teumer A	2019-09-11	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31511532	Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.	Urinary albumin-to-creatinine ratio in diabetes	51,541 European, African American, East Asian, South Asian or Hispanic ancestry individuals		1p33	1	47530532	FOXD2	RPL21P24 - ATP6V0E1P4	ENSG00000229554	ENSG00000227883		32191.0	19664.0	rs6688849-A	rs6688849	0	6688849.0	intergenic_variant	1.0	0.8195	4e-09	8.397940008672037		0.0485	[0.032-0.065] unit decrease	Affymetrix, Illumina [8034757] (imputed)	N
2019-10-01	31511532	Teumer A	2019-09-11	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31511532	Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.	Urinary albumin-to-creatinine ratio in diabetes	51,541 European, African American, East Asian, South Asian or Hispanic ancestry individuals		2p23.3	2	27519736	GCKR	GCKR			ENSG00000084734			rs780093-T	rs780093	0	780093.0	intron_variant	0.0	0.373	1e-13	13.0		0.0485	[0.036-0.061] unit increase	Affymetrix, Illumina [8034757] (imputed)	N
2019-10-01	31511532	Teumer A	2019-09-11	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31511532	Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.	Urinary albumin-to-creatinine ratio in diabetes	51,541 European, African American, East Asian, South Asian or Hispanic ancestry individuals		2p16.1	2	60311754	MIR4432HG, BCL11A	NA - MIR4432HG		ENSG00000228590			24692.0	rs6706313-A	rs6706313	0	6706313.0	regulatory_region_variant	1.0	0.7416	3e-08	7.522878745280337		0.0408	[0.026-0.055] unit decrease	Affymetrix, Illumina [8034757] (imputed)	N
2019-10-01	31511532	Teumer A	2019-09-11	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31511532	Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.	Urinary albumin-to-creatinine ratio in diabetes	51,541 European, African American, East Asian, South Asian or Hispanic ancestry individuals		7q31.1	7	114389196	FOXP2	FOXP2			ENSG00000128573			rs17137004-A	rs17137004	0	17137004.0	intron_variant	0.0	0.6176	3e-08	7.522878745280337		0.0364	[0.024-0.049] unit decrease	Affymetrix, Illumina [8034757] (imputed)	N
2019-10-01	31511532	Teumer A	2019-09-11	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31511532	Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.	Urinary albumin-to-creatinine ratio in diabetes	51,541 European, African American, East Asian, South Asian or Hispanic ancestry individuals		10p13	10	16905665	CUBN	CUBN			ENSG00000107611			rs74375025-A	rs74375025	0	74375025.0	intron_variant	0.0	0.1071	1.0000000000000001e-24	24.0		0.1064	[0.086-0.127] unit increase	Affymetrix, Illumina [8034757] (imputed)	N
2019-10-01	31511532	Teumer A	2019-09-11	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31511532	Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.	Urinary albumin-to-creatinine ratio in diabetes	51,541 European, African American, East Asian, South Asian or Hispanic ancestry individuals		18q12.1	18	27895834	CDH2	NA - CDH2		ENSG00000170558			37045.0	rs4258701-T	rs4258701	0	4258701.0	intergenic_variant	1.0	0.3272	1e-08	8.0		0.0385	[0.025-0.052] unit increase	Affymetrix, Illumina [8034757] (imputed)	N
2019-10-01	31511532	Teumer A	2019-09-11	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/31511532	Genome-wide association meta-analyses and fine-mapping elucidate pathways influencing albuminuria.	Urinary albumin-to-creatinine ratio in diabetes	51,541 European, African American, East Asian, South Asian or Hispanic ancestry individuals		19q13.11	19	35058218	HPN	HPN-AS1, HPN			ENSG00000227392, ENSG00000105707			rs149131600-T	rs149131600	0	149131600.0	intron_variant	0.0	0.1614	3e-08	7.522878745280337		0.0501	[0.032-0.068] unit increase	Affymetrix, Illumina [8034757] (imputed)	N
2019-04-30	25043022	Moltke I	2014-06-18	Nature	www.ncbi.nlm.nih.gov/pubmed/25043022	A common Greenlandic TBC1D4 variant confers muscle insulin resistance and type 2 diabetes.	Two-hour glucose	2,540 Greenlandic ancestry individuals	845 Greenlandic ancestry individuals	13q22.2	13	75324027	TBC1D4	TBC1D4			ENSG00000136111			rs7330796-?	rs7330796	0	7330796.0	intron_variant	0.0	NR	4e-17	16.397940008672037				Illumina [up to 196725]	N
2020-07-21	32341051	Wang X	2020-04-01	BMJ Open Diabetes Res Care	www.ncbi.nlm.nih.gov/pubmed/32341051	Shared genetic architecture and casual relationship between leptin levels and type 2 diabetes: large-scale cross-trait meta-analysis and Mendelian randomization analysis.	Circulating leptin levels or fasting insulin levels	254,263 individuals		2p23.3	2	27518370	GCKR	GCKR			ENSG00000084734			rs780094-?	rs780094	0	780094.0	intron_variant	0.0	NR	2e-09	8.698970004336019				NR [NR]	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	2q31.1	2	172681585	PDK1, RAPGEF4	RAPGEF4-AS1			ENSG00000228016			rs733331-?	rs733331	0	733331.0	intron_variant	0.0	NR	7e-11	10.154901959985745		0.036	[0.024-0.048] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	9p24.3	9	622523	KANK1	KANK1			ENSG00000107104			rs10815355-?	rs10815355	0	10815355.0	intron_variant	0.0	NR	1e-09	9.0		0.045	[0.031-0.059] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	15q26.3	15	98715481	IGF1R	IGF1R			ENSG00000140443			rs2018860-?	rs2018860	0	2018860.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.031	[0.019-0.043] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	2p23.3	2	27518370	GCKR	GCKR			ENSG00000084734			rs780094-?	rs780094	0	780094.0	intron_variant	0.0	NR	4e-09	8.397940008672037		0.052	[0.034-0.070] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	2p21	2	44961214	SIX2, SIX3	SIX3 - KRTCAP2P1	ENSG00000138083	ENSG00000231848		15143.0	35199.0	rs895636-?	rs895636	0	895636.0	non_coding_transcript_exon_variant	1.0	NR	3e-13	12.522878745280336		0.069	[0.049-0.089] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	2q24.3	2	168898336	G6PC2, ABCC11	SPC25, SPC25			ENSG00000152253, ENSG00000277909			rs13387347-?	rs13387347	0	13387347.0	intron_variant	0.0	NR	2e-36	35.69897000433602		0.114	[0.096-0.132] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	6p22.3	6	20685255	CDKAL1	CDKAL1			ENSG00000145996			rs9356744-?	rs9356744	0	9356744.0	intron_variant	0.0	NR	9e-10	9.045757490560677		0.057	[0.039-0.075] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	7p21.2	7	15025842	TMEM195, DGKB	GTF3AP5 - AGMO	ENSG00000225816	ENSG00000187546		39768.0	174475.0	rs1974620-?	rs1974620	0	1974620.0	intergenic_variant	1.0	NR	3e-11	10.522878745280336		0.063	[0.045-0.081] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	7p13	7	44184122	GCK	GCK			ENSG00000106633			rs730497-?	rs730497	0	730497.0	intron_variant	0.0	NR	8e-27	26.096910013008056		0.121	[0.099-0.143] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	8q24.11	8	117172786	SLC30A8	SLC30A8			ENSG00000164756			rs3802177-?	rs3802177	0	3802177.0	3_prime_UTR_variant	0.0	NR	5e-12	11.30102999566398		0.063	[0.045-0.081] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	9p24.2	9	4290085	GLIS3	GLIS3			ENSG00000107249			rs4237150-?	rs4237150	0	4237150.0	intron_variant	0.0	NR	4e-09	8.397940008672037		0.053	[0.035-0.071] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	9p21.3	9	22134095	CDKN2A, CDKN2B	CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		5992.0	312729.0	rs10811661-?	rs10811661	0	10811661.0	intergenic_variant	1.0	NR	9e-12	11.045757490560677		0.062	[0.044-0.080] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	11q14.3	11	92935660	MTNR1B	LINC02746 - SNRPGP16	ENSG00000282916	ENSG00000255287		20016.0	1781.0	rs3847554-?	rs3847554	0	3847554.0	intergenic_variant	1.0	NR	2e-11	10.69897000433602		0.059	[0.041-0.077] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2015-04-24	25187374	Hwang JY	2014-09-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25187374	Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians.	Fasting plasma glucose	24,740 East Asian ancestry individuals	21,345 East Asian ancestry individuals	20p11.21	20	22600630	FOXA2	LNCNEF			ENSG00000237396			rs6048216-?	rs6048216	0	6048216.0	intron_variant	0.0	NR	2e-12	11.69897000433602		0.095	[0.070-0.120] unit increase	Affymetrix, Illumina [up to 2315813] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	1q22	1	156285665	CCT3, TMEM79, c1orf85	TMEM79			ENSG00000163472			rs6684514-G	rs6684514	0	6684514.0	missense_variant	0.0	0.76	1.0000000000000001e-23	23.0		0.09	[0.070-0.110] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	6q23.3	6	135097880	HBS1L, MYB	HBS1L			ENSG00000112339			rs9399137-T	rs9399137	0	9399137.0	intron_variant	0.0	0.69	9e-15	14.045757490560677		0.07	[0.050-0.090] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	9q31.2	9	107774651	intergenic	NA - RNU6-1064P		ENSG00000222558			23093.0	rs1467311-G	rs1467311	0	1467311.0	regulatory_region_variant	1.0	0.23	1e-06	6.0		0.04	[0.020-0.060] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	11q12.2	11	61829740	FADS2	FADS2			ENSG00000134824			rs174570-C	rs174570	0	174570.0	intron_variant	0.0	0.55	2e-07	6.698970004336019		0.04	[0.020-0.060] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	16q24.3	16	88778524	CYBA	PIEZO1			ENSG00000103335			rs9933309-C	rs9933309	0	9933309.0	intron_variant	0.0	0.63	1e-08	8.0		0.07	[0.050-0.090] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	19p13.11	19	17121689	MYO9B	MYO9B			ENSG00000099331			rs11667918-C	rs11667918	0	11667918.0	intron_variant	0.0	0.62	9e-12	11.045757490560677		0.06	[0.040-0.080] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	8p11.21	8	41772887	ANK1	ANK1			ENSG00000029534			rs4737009-A	rs4737009	0	4737009.0	intron_variant	0.0	0.51	1e-15	15.0		0.08	[0.060-0.100] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	17q25.3	17	82727550	FN3K	FN3KRP			ENSG00000141560			rs1046875-A	rs1046875	0	1046875.0	3_prime_UTR_variant	0.0	0.49	4e-17	16.397940008672037		0.08	[0.060-0.100] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	2q31.1	2	168935661	G6PC2, ABCB11	ABCB11, ABCB11			ENSG00000073734, ENSG00000276582			rs3755157-T	rs3755157	0	3755157.0	intron_variant	0.0	0.34	3e-11	10.522878745280336		0.07	[0.050-0.090] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	6p22.3	6	20665715	CDKAL1	CDKAL1			ENSG00000145996			rs7772603-C	rs7772603	0	7772603.0	intron_variant	0.0	0.42	4e-08	7.397940008672037		0.06	[0.040-0.080] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	7p13	7	44189469	GCK	GCK			ENSG00000106633			rs1799884-T	rs1799884	0	1799884.0	intron_variant	0.0	0.19	2e-22	21.69897000433602		0.12	[0.10-0.14] unit increase	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24647736	Chen P	2014-03-19	Diabetes	www.ncbi.nlm.nih.gov/pubmed/24647736	Multiple nonglycemic genomic loci are newly associated with blood level of glycated hemoglobin in East Asians.	Glycated hemoglobin levels	17,290 East Asian ancestry individuals, 1,727 Malay ancestry individuals	up to 13,585 East Asian ancestry individuals	8q24.11	8	117172544	SLC30A8	SLC30A8			ENSG00000164756			rs13266634-A	rs13266634	0	13266634.0	missense_variant	0.0	0.46	2e-07	6.698970004336019		0.05	[NR] unit decrease	Affymetrix, Illumina [up to 2400000] (imputed)	N
2014-11-01	24595857	Sandholm N	2014-03-05	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/24595857	Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes.	Urinary albumin excretion rate in type 1 diabetes	1,925 European ancestry cases	3,750 European ancestry cases	4q34.1	4	174721548	GLRA3	GLRA3			ENSG00000145451			rs11725853-A	rs11725853	0	11725853.0	intron_variant	0.0	0.15	8e-07	6.096910013008056		0.11	[0.07-0.16] unit increase	Illumina [2400000] (imputed)	N
2014-11-01	24595857	Sandholm N	2014-03-05	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/24595857	Genome-wide association study of urinary albumin excretion rate in patients with type 1 diabetes.	Urinary albumin excretion rate in type 1 diabetes	1,925 European ancestry cases	3,750 European ancestry cases	8p22	8	19065067	SH2D4A, PSD3	PSD3			ENSG00000156011			rs2410601-G	rs2410601	0	2410601.0	intron_variant	0.0	0.47	4e-06	5.3979400086720375		0.08	[0.04-0.11] unit increase	Illumina [2400000] (imputed)	N
2010-08-30	20045101	Ferreira MA	2009-12-31	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/20045101	Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.	CD4:CD8 lymphocyte ratio	2,538 European ancestry twins from 1,089 families	988 individuals from 550 families	6p21.33	6	31284619	HLA-B	RPL3P2 - WASF5P	ENSG00000227672	ENSG00000234980		3100.0	2891.0	rs2524054-A	rs2524054	0	2524054.0	intron_variant	1.0	0.32	2.0000000000000002e-28	27.69897000433602		0.37	[0.31-0.43] SD increase	Illumina [529721]	N
2019-09-10	20045101	Ferreira MA	2009-12-31	Am J Hum Genet	www.ncbi.nlm.nih.gov/pubmed/20045101	Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.	CD8-positive T-lymphocyte count	2,538 European ancestry twins from 1,089 families	988 individuals from 550 families	6p21.33	6	31284619	HLA-B	RPL3P2 - WASF5P	ENSG00000227672	ENSG00000234980		3100.0	2891.0	rs2524054-A	rs2524054	0	2524054.0	intron_variant	1.0	0.32	6e-21	20.22184874961636		0.37	[0.31-0.43] SD increase	Illumina [529721]	N
2017-03-31	27647854	Sandholm N	2016-09-19	J Am Soc Nephrol	www.ncbi.nlm.nih.gov/pubmed/27647854	The Genetic Landscape of Renal Complications in Type 1 Diabetes.	Kidney disease (end stage renal disease vs normoalbuminuria) in type 1 diabetes	729 European ancestry cases, 84 cases, 1,903 European ancestry controls, 491 controls	94 European ancestry cases, 964 cases, 627 European ancestry controls, 3187 controls	4q21.3	4	86607925	PTPN13	PTPN13			ENSG00000163629			rs61277444-G	rs61277444	0	61277444.0	intron_variant	0.0	0.08	6e-06	5.221848749616356		1.42	[1.20-1.67]	Illumina [NR] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065414401	9e-10	9.045757490560677		0.268785	[0.18-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	1.0000000000000001e-23	23.0		0.288119	[0.23-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081321371	2e-57	56.69897000433602		0.629339	[0.55-0.71] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014114907	1e-09	9.0		0.554503	[0.38-0.73] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762438463	3e-12	11.522878745280336		0.174003	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	5e-13	12.30102999566398		0.164813	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	5e-14	13.30102999566398		0.239037	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065414401	2e-09	8.698970004336019		0.265452	[0.18-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	3e-23	22.522878745280337		0.285996	[0.23-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081321371	2e-59	58.69897000433602		0.639746	[0.56-0.72] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014114907	2e-09	8.698970004336019		0.546709	[0.37-0.72] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762438463	1e-11	11.0		0.170148	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	4e-11	10.397940008672036		0.150981	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	1e-11	11.0		0.214872	[0.15-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065414401	1e-10	10.0		0.281888	[0.2-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	4.0000000000000004e-24	23.39794000867204		0.291267	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081321371	1e-47	47.0		0.572838	[0.5-0.65] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small LDL	4,348 individuals		8q24.13	8	125487789		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-G	rs28601761	0	28601761.0	intron_variant	1.0	0.45	7e-08	7.154901959985743		0.12	[0.081-0.159] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small LDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.129349137	7e-11	10.154901959985745		0.215928	[0.15-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small LDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866280193	2e-15	14.69897000433602		0.250429	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small LDL	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299439844	7e-15	14.154901959985745		0.180295	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small LDL	4,348 individuals		15q21.3	15	58435126		ALDH1A2, LIPC-AS1, LIPC			ENSG00000128918, ENSG00000259293, ENSG00000166035			rs261332-G	rs261332	0	261332.0	non_coding_transcript_exon_variant	0.0	0.797935358	7e-12	11.154901959985745		0.184467	[0.13-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small LDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.073269151	2e-13	12.69897000433602		0.299346	[0.22-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	4e-11	10.397940008672036		0.190428	[0.13-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in chylomicrons and extremely large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866050551	1e-14	14.0		0.248589	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in chylomicrons and extremely large VLDL	4,348 individuals		19p13.11	19	19277691		SUGP1			ENSG00000105705			rs8107974-T	rs8107974	0	8107974.0	intron_variant	0.0	0.073091519	1e-09	9.0		0.255464	[0.17-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in chylomicrons and extremely large VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.165453761	7e-09	8.154901959985743		0.169466	[0.11-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in chylomicrons and extremely large VLDL	4,348 individuals		6q24.1	6	139638205		ATP5PBP6 - FILNC1	ENSG00000219806	ENSG00000231426		23001.0	39434.0	rs75860909-G	rs75860909	0	75860909.0	intron_variant	1.0	0.016123143	5e-08	7.301029995663981		0.48503	[0.31-0.66] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in chylomicrons and extremely large VLDL	4,348 individuals		8p21.3	8	19967052		LPL			ENSG00000175445			rs1059611-C	rs1059611	0	1059611.0	3_prime_UTR_variant	0.0	0.116917705	8e-15	14.096910013008056		0.266622	[0.2-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in chylomicrons and extremely large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866050551	2e-15	14.69897000433602		0.254853	[0.19-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in chylomicrons and extremely large VLDL	4,348 individuals		6q24.1	6	139638205		ATP5PBP6 - FILNC1	ENSG00000219806	ENSG00000231426		23001.0	39434.0	rs75860909-G	rs75860909	0	75860909.0	intron_variant	1.0	0.016123143	5e-08	7.301029995663981		0.485405	[0.31-0.66] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in chylomicrons and extremely large VLDL	4,348 individuals		8p21.3	8	19967052		LPL			ENSG00000175445			rs1059611-C	rs1059611	0	1059611.0	3_prime_UTR_variant	0.0	0.116917705	4e-14	13.397940008672036		0.259446	[0.19-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in chylomicrons and extremely large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866050551	4e-15	14.397940008672036		0.252809	[0.19-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Free cholesterol meal response (OrNLSr)	4,292 individuals												chr16:82387230-T	chr16:82387230	0			1.0	0.01554446	2e-08	7.698970004336019		0.643117	[0.42-0.87] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Glucose meal response (OrNLSr)	4,292 individuals		11q14.3	11	92975544		MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	0.259063683	2e-19	18.69897000433602		0.227764	[0.18-0.28] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Triglycerides levels in IDL meal response (﻿OrNLSr)	4,292 individuals		10q23.2	10	86906307		BMPR1A			ENSG00000107779			rs71473282-A	rs71473282	0	71473282.0	intron_variant	0.0	0.022752595	5e-08	7.301029995663981		0.397299	[0.25-0.54] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Triglycerides levels in IDL meal response (﻿OrNLSr)	4,292 individuals		12q23.2	12	101410028		ARL1 - RNU6-1068P	ENSG00000120805	ENSG00000222890		2256.0	1329.0	rs118039629-A	rs118039629	0	118039629.0	upstream_gene_variant	1.0	0.023132849	5e-08	7.301029995663981		0.440365	[0.28-0.6] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Triglycerides in LDL meal response (OrNLSr)	4,292 individuals		12q23.2	12	101253018		SLC5A8 - UTP20	ENSG00000256870	ENSG00000120800		42780.0	27087.0	rs2037053-G	rs2037053	0	2037053.0	intergenic_variant	1.0	0.039062586	4e-08	7.397940008672037		0.32504	[0.21-0.44] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Triglycerides levels in medium LDL meal response (﻿OrNLSr)	4,292 individuals		12q23.2	12	101253018		SLC5A8 - UTP20	ENSG00000256870	ENSG00000120800		42780.0	27087.0	rs2037053-G	rs2037053	0	2037053.0	intergenic_variant	1.0	0.039080604	4e-08	7.397940008672037		0.323833	[0.21-0.44] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Free cholesterol in small HDL meal response (﻿OrNLSr)	4,292 individuals		5q21.3	5	106570679		RNA5SP189 - LINC01950	ENSG00000201790	ENSG00000251027		647571.0	244518.0	rs114652642-C	rs114652642	0	114652642.0	intergenic_variant	1.0	0.024749166	1e-08	8.0		0.425044	[0.28-0.57] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Free cholesterol in small HDL meal response (﻿OrNLSr)	4,292 individuals		13q32.3	13	99532537		TM9SF2			ENSG00000125304			rs150441681-G	rs150441681	0	150441681.0	intron_variant	0.0	0.036989919	4e-08	7.397940008672037		0.322863	[0.21-0.44] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Total cholesterol in small LDL meal response (﻿OrNLSr)	4,292 individuals		4p15.1	4	31250592		LINC02497 - LINC02501	ENSG00000251182	ENSG00000249882		38914.0	255830.0	rs28855728-A	rs28855728	0	28855728.0	intergenic_variant	1.0	0.137089273	4e-08	7.397940008672037		0.171076	[0.11-0.23] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Cholesterol esters in small LDL meal response (﻿OrNLSr)	4,292 individuals		4p15.1	4	31250592		LINC02497 - LINC02501	ENSG00000251182	ENSG00000249882		38914.0	255830.0	rs28855728-A	rs28855728	0	28855728.0	intergenic_variant	1.0	0.137183056	3e-08	7.522878745280337		0.173564	[0.11-0.23] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Free cholesterol in very large HDL meal response (﻿OrNLSr)	4,292 individuals		5q35.1	5	169331487		SLIT3 - RNU6-477P	ENSG00000184347	ENSG00000206614		30348.0	220962.0	rs116717021-T	rs116717021	0	116717021.0	regulatory_region_variant	1.0	0.028546879	4e-08	7.397940008672037		0.396513	[0.25-0.54] unit decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Total cholesterol in very large VLDL meal response (﻿OrNLSr)	4,292 individuals		5q11.2	5	56513638		C5orf67			ENSG00000225940			rs173964-G	rs173964	0	173964.0	intron_variant	0.0	0.771823014	1e-08	8.0		0.155968	[0.1-0.21] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Cholesterol esters in very large VLDL meal response (﻿OrNLSr)	4,292 individuals		5q11.2	5	56509812		RPL26P19 - C5orf67	ENSG00000226221	ENSG00000225940		4740.0	1755.0	rs467022-T	rs467022	0	467022.0	upstream_gene_variant	1.0	0.768960659	7e-09	8.154901959985743		0.157321	[0.1-0.21] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Free cholesterol in very large VLDL meal response (﻿OrNLSr)	4,292 individuals		5q11.2	5	56513638		C5orf67			ENSG00000225940			rs173964-G	rs173964	0	173964.0	intron_variant	0.0	0.771823014	2e-08	7.698970004336019		0.153228	[0.1-0.207] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Total cholesterol in chylomicron and extremely large VLDL meal response (﻿OrNLSr)	4,292 individuals		5q11.2	5	56512010		C5orf67			ENSG00000225940			rs458741-C	rs458741	0	458741.0	intron_variant	0.0	0.768329167	6e-10	9.221848749616356		0.172648	[0.12-0.23] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Cholesterol esters in chylomicron and extremely large VLDL meal response (﻿OrNLSr)	4,292 individuals		5q11.2	5	56512010		C5orf67			ENSG00000225940			rs458741-C	rs458741	0	458741.0	intron_variant	0.0	0.768329167	1e-09	9.0		0.170343	[0.12-0.22] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Free cholesterol in chylomicron and extremely large VLDL meal response (﻿OrNLSr)	4,292 individuals		5q11.2	5	56513638		C5orf67			ENSG00000225940			rs173964-G	rs173964	0	173964.0	intron_variant	0.0	0.773034722	4e-09	8.397940008672037		0.16392	[0.11-0.22] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Triglycerides levels in chylomicrons and extremely large VLDL meal response (﻿OrNLSr)	4,292 individuals		5q11.2	5	56509812		RPL26P19 - C5orf67	ENSG00000226221	ENSG00000225940		4740.0	1755.0	rs467022-T	rs467022	0	467022.0	upstream_gene_variant	1.0	0.77003751	3e-09	8.522878745280337		0.165782	[0.11-0.22] unit increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Triglycerides levels in medium HDL meal response (LMM)	11,410 individuals		3p12.3	3	77262916		ROBO2			ENSG00000185008			rs66799104-G	rs66799104	0	66799104.0	intron_variant	0.0	0.109672	5e-08	7.301029995663981		0.0874972	[0.064-0.111] unit decrease	Illumina [7568622] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Triglycerides levels in small HDL meal response (LMM)	11,410 individuals		7q35	7	145961715		DPY19L4P2 - CNTNAP2	ENSG00000231839	ENSG00000174469		376898.0	154287.0	rs117796827-T	rs117796827	0	117796827.0	intergenic_variant	1.0	0.0165579	4e-08	7.397940008672037		0.221563	[0.16-0.28] unit increase	Illumina [7568622] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Total cholesterol in very large HDL meal response (LMM)	11,410 individuals		10q21.2	10	59504718		FAM13C - MRPL50P4	ENSG00000148541	ENSG00000235469		141537.0	46686.0	rs116041093-A	rs116041093	0	116041093.0	intergenic_variant	1.0	0.0260619	1e-08	8.0		0.181105	[0.14-0.23] unit decrease	Illumina [7568622] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Free cholesterol in very large HDL meal response (LMM)	11,410 individuals		10q21.2	10	59504718		FAM13C - MRPL50P4	ENSG00000148541	ENSG00000235469		141537.0	46686.0	rs116041093-A	rs116041093	0	116041093.0	intergenic_variant	1.0	0.0260619	1e-09	9.0		0.164198	[0.13-0.2] unit decrease	Illumina [7568622] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Cholesterol esters in very large HDL meal response (LMM)	11,410 individuals		10q21.2	10	59504932		FAM13C - MRPL50P4	ENSG00000148541	ENSG00000235469		141751.0	46472.0	rs147684079-T	rs147684079	0	147684079.0	intergenic_variant	1.0	0.0231715	6e-09	8.221848749616356		0.197414	[0.15-0.25] unit decrease	Illumina [7568622] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Glycoprotein acetyls (mainly a1-acid glycoprotein) meal response (LMM)	11,410 individuals		10q26.11	10	119429908		GRK5			ENSG00000198873			rs61876100-G	rs61876100	0	61876100.0	intron_variant	0.0	0.0580072	4e-08	7.397940008672037		0.128069	[0.086-0.17] unit increase	Illumina [7568622] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Glucose meal response (LMM)	11,410 individuals		11q14.3	11	92951950		SNRPGP16 - MTNR1B	ENSG00000255287	ENSG00000134640		14284.0	17701.0	rs10830959-A	rs10830959	0	10830959.0	intergenic_variant	1.0	0.267851	4e-08	7.397940008672037		0.144295	[0.1-0.19] unit decrease	Illumina [7568622] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein A-I	4,734 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.349428602	1e-08	8.0		0.127143	[0.083-0.171] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein A-I	4,734 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.355815589	1e-19	19.0		0.193087	[0.15-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein A-I	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.332185678	6e-15	14.221848749616356		0.171197	[0.13-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein A-I	4,734 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.166736586	2e-18	17.69897000433602		0.240057	[0.19-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein A-I	4,734 individuals		18q21.1	18	49579658		LIPG			ENSG00000101670			rs149615216-T	rs149615216	0	149615216.0	intron_variant	0.0	0.011231095	2e-09	8.698970004336019		0.589238	[0.4-0.78] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein A-I	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082383714	5e-12	11.30102999566398		0.261406	[0.19-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein B	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765525982	2e-08	7.698970004336019		0.135356	[0.088-0.182] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein B	4,734 individuals		8p21.3	8	19995878		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		28619.0	117465.0	rs1992442-C	rs1992442	0	1992442.0	intergenic_variant	1.0	0.27706823	5e-14	13.30102999566398		0.174539	[0.13-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein B	4,734 individuals		8q24.13	8	125494452		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56049.0	365269.0	rs112875651-A	rs112875651	0	112875651.0	intron_variant	1.0	0.413343895	2e-08	7.698970004336019		0.118333	[0.077-0.16] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein B	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867282425	3e-16	15.522878745280336		0.247034	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein B	4,734 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.074044677	2e-16	15.69897000433602		0.320244	[0.24-0.4] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein B	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	6e-26	25.22184874961636		0.290338	[0.24-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting apolipoprotein B	4,734 individuals		19q13.32	19	44912921		APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-T	rs483082	0	483082.0	non_coding_transcript_exon_variant	1.0	0.244662	2e-12	11.69897000433602	meal response (conditional)	0.26797	[0.19-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in VLDL	4,348 individuals		2p23.3	2	27519736		GCKR			ENSG00000084734			rs780093-C	rs780093	0	780093.0	intron_variant	0.0	0.645380635	6e-09	8.221848749616356		0.132198	[0.088-0.177] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	4e-18	17.397940008672037		0.216502	[0.17-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	2e-16	15.69897000433602		0.259075	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244788638	2e-08	7.698970004336019		0.140017	[0.091-0.189] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large HDL	4,348 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.345571497	2e-10	9.69897000433602		0.151235	[0.1-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large HDL	4,348 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.361858211	2e-31	30.69897000433602		0.26274	[0.22-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large HDL	4,348 individuals		15q21.3	15	58432643		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs8033940-A	rs8033940	0	8033940.0	intron_variant	0.0	0.283130938	1e-10	10.0		0.15739	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.332545696	4e-18	17.397940008672037		0.203006	[0.16-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large HDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.07716518	2e-18	17.69897000433602		0.367875	[0.29-0.45] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large HDL	4,348 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.210811671	4e-14	13.397940008672036		0.203261	[0.15-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large HDL	4,348 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.345571497	4e-10	9.397940008672036		0.149412	[0.1-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large HDL	4,348 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.361858211	5e-30	29.30102999566398		0.256749	[0.21-0.3] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large HDL	4,348 individuals		15q21.3	15	58432643		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs8033940-A	rs8033940	0	8033940.0	intron_variant	0.0	0.283130938	1e-10	10.0		0.155861	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.332545696	2e-17	16.69897000433602		0.199062	[0.15-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large HDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.07716518	3e-22	21.522878745280337		0.407295	[0.33-0.49] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large HDL	4,348 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.210811671	2e-14	13.69897000433602		0.205983	[0.15-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large HDL	4,348 individuals		16q13	16	56983750		CETP			ENSG00000087237			rs1801706-A	rs1801706	0	1801706.0	3_prime_UTR_variant	0.0	0.177069	3e-08	7.522878745280337	meal response (conditional)	0.169718	[0.11-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large HDL	4,348 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.345571497	1e-10	10.0		0.152952	[0.11-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large HDL	4,348 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.361858211	4e-33	32.39794000867204		0.270379	[0.23-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large HDL	4,348 individuals		15q21.3	15	58432643		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs8033940-A	rs8033940	0	8033940.0	intron_variant	0.0	0.283130938	8e-11	10.096910013008056		0.158201	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.332545696	7e-19	18.154901959985743		0.207757	[0.16-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large HDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.07716518	1e-09	9.0		0.255961	[0.17-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large HDL	4,348 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.210811671	6e-13	12.221848749616356		0.193542	[0.14-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very small VLDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074176036	4e-11	10.397940008672036		0.258462	[0.18-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very small VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161800085	2e-17	16.69897000433602		0.234638	[0.18-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very small VLDL	4,734 individuals		19q13.32	19	44912921		APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-T	rs483082	0	483082.0	non_coding_transcript_exon_variant	1.0	0.244656	3e-13	12.522878745280336	meal response (conditional)	0.277668	[0.2-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014010461	7e-10	9.154901959985745		0.540139	[0.37-0.71] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765532544	5e-11	10.30102999566398		0.157795	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295905748	2e-14	13.69897000433602		0.170628	[0.13-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128526416	2e-11	10.69897000433602		0.203287	[0.14-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066537489	1e-12	12.0		0.297748	[0.22-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161800085	2e-17	16.69897000433602		0.235239	[0.18-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.08231287	8e-21	20.096910013008056		0.353559	[0.28-0.43] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large HDL	4,734 individuals		16q13	16	56966973		CETP			ENSG00000087237			rs12720922-A	rs12720922	0	12720922.0	intron_variant	0.0	0.167032561	1e-14	14.0		0.215513	[0.16-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large HDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.079655704	2e-31	30.69897000433602		0.45565	[0.38-0.53] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large HDL	4,734 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.21200896	6e-16	15.221848749616356		0.205823	[0.16-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals		8p21.3	8	19958045		LPL			ENSG00000175445			rs287-G	rs287	0	287.0	intron_variant	0.0	0.261861888	1e-09	9.0		0.146342	[0.099-0.193] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals		11q12.2	11	61790331		TMEM258			ENSG00000134825			rs102275-C	rs102275	0	102275.0	non_coding_transcript_exon_variant	0.0	0.323946241	6e-10	9.221848749616356		0.140128	[0.096-0.184] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.649603365	1e-36	36.0		0.273496	[0.23-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.335678977	5e-18	17.30102999566398		0.191747	[0.15-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.165609921	2e-18	17.69897000433602		0.243696	[0.19-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals												chr17:41926126-T	chr17:41926126	0			1.0	0.041506556	4e-09	8.397940008672037		0.308223	[0.21-0.41] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.079655704	1e-14	14.0		0.302006	[0.23-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.21200896	3e-14	13.522878745280336		0.193825	[0.14-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large HDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.870130026	5e-09	8.301029995663981		0.182337	[0.12-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large HDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.298999126	4.0000000000000006e-34	33.39794000867204		0.273894	[0.23-0.32] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large VLDL	4,734 individuals		8p21.3	8	19967052		LPL			ENSG00000175445			rs1059611-C	rs1059611	0	1059611.0	3_prime_UTR_variant	0.0	0.113490644	6e-12	11.221848749616356		0.242054	[0.17-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865108141	1e-18	18.0		0.283329	[0.22-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large VLDL	4,734 individuals		8p21.3	8	19967052		LPL			ENSG00000175445			rs1059611-C	rs1059611	0	1059611.0	3_prime_UTR_variant	0.0	0.113490644	2e-12	11.69897000433602		0.248722	[0.18-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865108141	2e-18	17.69897000433602		0.282596	[0.22-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large VLDL	4,734 individuals		19q13.32	19	44912921		APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-T	rs483082	0	483082.0	non_coding_transcript_exon_variant	1.0	0.248956987	3e-08	7.522878745280337		0.142256	[0.092-0.192] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large VLDL	4,734 individuals		8p21.3	8	19967052		LPL			ENSG00000175445			rs1059611-C	rs1059611	0	1059611.0	3_prime_UTR_variant	0.0	0.113490644	2e-11	10.69897000433602		0.234938	[0.17-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865108141	2e-18	17.69897000433602		0.282737	[0.22-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very small VLDL	4,734 individuals		19p13.2	19	11077571		SMARCA4			ENSG00000127616			rs56289821-A	rs56289821	0	56289821.0	intron_variant	0.0	0.128412088	6e-12	11.221848749616356		0.209073	[0.15-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals		1p31.3	1	62568692		DOCK7			ENSG00000116641			rs7555577-C	rs7555577	0	7555577.0	intron_variant	0.0	0.64475803	4e-08	7.397940008672037		0.119419	[0.077-0.162] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very small VLDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.318095097	1e-08	8.0		0.124717	[0.082-0.167] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large VLDL	4,734 individuals		8p21.3	8	19967052		LPL			ENSG00000175445			rs1059611-C	rs1059611	0	1059611.0	3_prime_UTR_variant	0.0	0.113490644	3e-13	12.522878745280336		0.256099	[0.19-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865108141	3e-17	16.522878745280337		0.272466	[0.21-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large VLDL	4,734 individuals		19q13.32	19	44910319		APOE - APOC1	ENSG00000130203	ENSG00000130208		926.0	3928.0	rs75627662-T	rs75627662	0	75627662.0	non_coding_transcript_exon_variant	1.0	0.215231106	3e-08	7.522878745280337		0.151244	[0.098-0.204] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very small VLDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765532544	2e-10	9.69897000433602		0.152903	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very small VLDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.318095097	7e-09	8.154901959985743		0.126697	[0.084-0.169] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very small VLDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295905748	1e-14	14.0		0.172103	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very small VLDL	4,734 individuals		16q13	16	56960616		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15752.0	1307.0	rs17231506-T	rs17231506	0	17231506.0	upstream_gene_variant	1.0	0.332424556	8e-10	9.096910013008056		0.135263	[0.092-0.178] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very small VLDL	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128526416	6e-12	11.221848749616356		0.209754	[0.15-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very small VLDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066537489	2e-11	10.69897000433602		0.282147	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very small VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161800085	6e-18	17.221848749616356		0.23843	[0.18-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very small VLDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.08231287	2e-18	17.69897000433602		0.33179	[0.26-0.41] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very small VLDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765532544	9e-10	9.045757490560677		0.147377	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very small VLDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.318095097	8e-09	8.096910013008056		0.126153	[0.083-0.169] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very small VLDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295905748	3e-14	13.522878745280336		0.169186	[0.13-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very small VLDL	4,734 individuals		16q13	16	56960616		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15752.0	1307.0	rs17231506-T	rs17231506	0	17231506.0	upstream_gene_variant	1.0	0.332424556	1e-10	10.0		0.141541	[0.099-0.185] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in very large HDL	4,734 individuals		15q21.3	15	58432643		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs8033940-A	rs8033940	0	8033940.0	intron_variant	0.0	0.281375219	1e-11	11.0		0.157889	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large HDL	4,734 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.795568182	3e-20	19.522878745280337		0.240357	[0.19-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large HDL	4,734 individuals		19p13.11	19	19349732		MAU2			ENSG00000129933			rs73001065-C	rs73001065	0	73001065.0	intron_variant	0.0	0.070642745	4e-08	7.397940008672037		0.225534	[0.14-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large HDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.160012675	9e-13	12.045757490560677		0.201575	[0.15-0.26] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very large HDL	4,734 individuals		20q13.12	20	45941553		PCIF1			ENSG00000100982			rs6073966-T	rs6073966	0	6073966.0	intron_variant	0.0	0.183064685	7e-10	9.154901959985745		0.166866	[0.11-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small HDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081297048	2e-22	21.69897000433602		0.387684	[0.31-0.47] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small HDL	4,348 individuals												chr2:21263900-A	Chr2:21263900	0			1.0	0.317116236	2e-08	7.698970004336019		0.12756	[0.083-0.172] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small HDL	4,348 individuals												chr2:27730940-C	Chr2:27730940	0			1.0	0.62859548	8e-11	10.096910013008056		0.146905	[0.1-0.19] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small HDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081297048	3e-17	16.522878745280337		0.336269	[0.26-0.41] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small HDL	4,348 individuals		19q13.32	19	44918903		APOC1			ENSG00000130208			rs12721051-G	rs12721051	0	12721051.0	3_prime_UTR_variant	0.0	0.199506688	7e-14	13.154901959985745		0.199589	[0.15-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small HDL	4,348 individuals		20q13.12	20	45916409		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		4254.0	18274.0	rs4810479-T	rs4810479	0	4810479.0	upstream_gene_variant	1.0	0.732013376	1e-12	12.0		0.172419	[0.13-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small HDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.129561278	7e-17	16.154901959985743		0.276491	[0.21-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small HDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866978782	2e-15	14.69897000433602		0.251494	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small HDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244428275	8e-09	8.096910013008056		0.144653	[0.096-0.194] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014114907	1e-09	9.0		0.555096	[0.38-0.73] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762438463	4e-12	11.397940008672036		0.173656	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	1e-12	12.0		0.162526	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	1e-13	13.0		0.235299	[0.17-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial remnant cholesterol	4,348 individuals		19q13.32	19	44912921		APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-T	rs483082	0	483082.0	non_coding_transcript_exon_variant	1.0	0.244495	7e-09	8.154901959985743	meal response (conditional)	0.230277	[0.15-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial remnant cholesterol	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	1e-11	11.0		0.169803	[0.12-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial remnant cholesterol	4,348 individuals		11q23.3	11	116786845		ZPR1			ENSG00000109917			rs3741298-T	rs3741298	0	3741298.0	intron_variant	0.0	0.805661224	1e-11	11.0		0.185713	[0.13-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial remnant cholesterol	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0732523	2e-16	15.69897000433602		0.335118	[0.26-0.41] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial remnant cholesterol	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	3e-23	22.522878745280337		0.285465	[0.23-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total cholesterol	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762263109	3e-10	9.522878745280336		0.157808	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total cholesterol	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317701012	2e-11	10.69897000433602		0.152315	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total cholesterol	4,348 individuals												chr6:31487067-C	chr6:31487067	0			1.0	0.071905819	5e-08	7.301029995663981		0.228412	[0.15-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total cholesterol	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299370975	2e-10	9.69897000433602		0.147875	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total cholesterol	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127907199	1e-10	10.0		0.205084	[0.14-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total cholesterol	4,348 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.072798183	6e-13	12.221848749616356		0.294505	[0.21-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total cholesterol	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	5e-19	18.30102999566398		0.256825	[0.2-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total cholesterol	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081532659	1.0000000000000001e-39	39.0		0.519593	[0.44-0.6] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total triglycerides	4,348 individuals		2p23.3	2	27518370		GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.645464581	1e-08	8.0		0.129035	[0.085-0.173] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total triglycerides	4,348 individuals		6q24.1	6	140062487		FILNC1 - RNA5SP220	ENSG00000231426	ENSG00000252107		202011.0	96104.0	rs146782026-C	rs146782026	0	146782026.0	intron_variant	1.0	0.011914439	2e-08	7.698970004336019		0.621837	[0.4-0.84] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total triglycerides	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.129320538	7e-18	17.154901959985743		0.284783	[0.22-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total triglycerides	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	1e-16	16.0		0.261825	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total triglycerides	4,348 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.073265524	1e-08	8.0		0.232492	[0.15-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial serum total triglycerides	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244788638	1e-08	8.0		0.143338	[0.094-0.192] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small HDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081315802	1e-14	14.0		0.308243	[0.23-0.39] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small HDL	4,348 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.213103576	3e-09	8.522878745280337		0.155084	[0.1-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865620642	3e-14	13.522878745280336		0.240874	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244273129	1e-09	9.0		0.153286	[0.1-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium HDL	4,348 individuals		8p21.3	8	19967156		LPL			ENSG00000175445			rs15285-T	rs15285	0	15285.0	3_prime_UTR_variant	0.0	0.299172533	7e-15	14.154901959985745		0.183179	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium HDL	4,348 individuals		16q13	16	56968820		CETP			ENSG00000087237			rs9939224-G	rs9939224	0	9939224.0	intron_variant	0.0	0.809557166	3e-13	12.522878745280336		0.197669	[0.14-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium HDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	5e-10	9.30102999566398		0.179913	[0.12-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium HDL	4,348 individuals		8p21.3	8	19967156		LPL			ENSG00000175445			rs15285-T	rs15285	0	15285.0	3_prime_UTR_variant	0.0	0.299172533	8e-15	14.096910013008056		0.182657	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium HDL	4,348 individuals		16q13	16	56968820		CETP			ENSG00000087237			rs9939224-G	rs9939224	0	9939224.0	intron_variant	0.0	0.809557166	4e-14	13.397940008672036		0.205162	[0.15-0.26] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium HDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	2e-10	9.69897000433602		0.183513	[0.13-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium HDL	4,348 individuals		8p21.3	8	19967156		LPL			ENSG00000175445			rs15285-T	rs15285	0	15285.0	3_prime_UTR_variant	0.0	0.299172533	1e-14	14.0		0.182135	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium HDL	4,348 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.357977686	5e-08	7.301029995663981		0.121417	[0.078-0.165] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium HDL	4,348 individuals		16q13	16	56968820		CETP			ENSG00000087237			rs9939224-G	rs9939224	0	9939224.0	intron_variant	0.0	0.809557166	4e-10	9.397940008672036		0.170068	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium HDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	1e-08	8.0		0.165019	[0.11-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium HDL	4,348 individuals		2p23.3	2	27518370		GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.645498045	2e-09	8.698970004336019		0.135303	[0.091-0.18] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium HDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.129350288	5e-11	10.30102999566398		0.217357	[0.15-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium HDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866395215	4e-15	14.397940008672036		0.248309	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.330243156	2e-10	9.69897000433602		0.146173	[0.1-0.19] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium HDL	4,348 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.073282379	5e-09	8.301029995663981		0.239224	[0.16-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium HDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081551415	3e-10	9.522878745280336		0.251205	[0.17-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014114907	6e-10	9.221848749616356		0.564722	[0.39-0.74] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762438463	2e-12	11.69897000433602		0.17533	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	5e-13	12.30102999566398		0.164523	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	6e-14	13.221848749616356		0.237653	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065414401	2e-10	9.69897000433602		0.27997	[0.19-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	2.0000000000000002e-24	23.69897000433602		0.293495	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081321371	6e-57	56.22184874961636		0.626799	[0.55-0.7] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014114907	6e-10	9.221848749616356		0.564628	[0.39-0.74] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762438463	2e-12	11.69897000433602		0.175439	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	3e-13	12.522878745280336		0.165838	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	4e-14	13.397940008672036		0.239662	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065414401	2e-10	9.69897000433602		0.278971	[0.19-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	3e-24	23.522878745280337		0.292372	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081321371	2e-57	56.69897000433602		0.629306	[0.55-0.71] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014114907	7e-10	9.154901959985745		0.561558	[0.38-0.74] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762438463	3e-12	11.522878745280336		0.174707	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	3e-12	11.522878745280336		0.158775	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	6e-13	12.221848749616356		0.228293	[0.17-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065414401	1e-10	10.0		0.281511	[0.2-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	6.9999999999999995e-25	24.154901959985743		0.296131	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081321371	5.999999999999999e-54	53.22184874961636		0.609903	[0.53-0.69] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127907199	3e-14	13.522878745280336		0.240422	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065399356	4e-11	10.397940008672036		0.290287	[0.2-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	6e-24	23.22184874961636		0.290593	[0.23-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081532659	9.999999999999999e-57	56.0		0.623157	[0.55-0.7] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014111661	4e-10	9.397940008672036		0.56816	[0.39-0.75] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762263109	1e-12	12.0		0.177254	[0.13-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317701012	2e-13	12.69897000433602		0.167416	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127907199	9e-14	13.045757490560677		0.236382	[0.17-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065399356	3e-12	11.522878745280336		0.306519	[0.22-0.39] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	3e-25	24.522878745280337		0.298956	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081532659	4.9999999999999996e-54	53.30102999566398		0.608612	[0.53-0.68] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014111661	1e-08	8.0		0.51819	[0.34-0.7] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large LDL	4,348 individuals		1p13.3	1	109279544		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3793.0	12.0	rs599839-A	rs599839	0	599839.0	intergenic_variant	1.0	0.762209062	1e-11	11.0		0.170068	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317701012	3e-14	13.522878745280336		0.173449	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large LDL	4,348 individuals		11q12.2	11	61851136		FADS2			ENSG00000134824			rs174592-G	rs174592	0	174592.0	intron_variant	0.0	0.334867295	1e-08	8.0		0.131626	[0.087-0.177] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127907199	3e-14	13.522878745280336		0.240421	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	2e-19	18.69897000433602		0.259943	[0.2-0.32] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081532659	1.0000000000000001e-60	60.0		0.644641	[0.57-0.72] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium LDL	4,348 individuals		2p24.1	2	21065354		APOB - TDRD15	ENSG00000084674	ENSG00000218819		21281.0	58614.0	rs563290-A	rs563290	0	563290.0	intergenic_variant	1.0	0.832387854	1e-08	8.0		0.163636	[0.11-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium LDL	4,348 individuals												chr6:31487067-C	chr6:31487067	0			1.0	0.07192236	3e-09	8.522878745280337		0.248288	[0.17-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium LDL	4,348 individuals		15q21.3	15	58279783		ALDH1A2			ENSG00000128918			rs11854318-A	rs11854318	0	11854318.0	intron_variant	0.0	0.289429952	5e-10	9.30102999566398		0.147382	[0.1-0.19] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium LDL	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299439844	1.9999999999999998e-54	53.69897000433602		0.356686	[0.31-0.4] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium LDL	4,348 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.795333563	7e-26	25.154901959985743		0.279697	[0.23-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	1e-16	16.0		0.205866	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	3e-15	14.522878745280336		0.249463	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small VLDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0732523	3e-14	13.522878745280336		0.311159	[0.23-0.39] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in small VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	1e-16	16.0		0.238085	[0.18-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	1e-13	13.0		0.185449	[0.14-0.23] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small VLDL	4,348 individuals		11q23.3	11	116786845		ZPR1			ENSG00000109917			rs3741298-T	rs3741298	0	3741298.0	intron_variant	0.0	0.805661224	5e-12	11.30102999566398		0.188481	[0.14-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small VLDL	4,348 individuals		16q13	16	56960616		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15752.0	1307.0	rs17231506-T	rs17231506	0	17231506.0	upstream_gene_variant	1.0	0.330618445	3e-10	9.522878745280336		0.144844	[0.1-0.19] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small VLDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0732523	3e-15	14.522878745280336		0.321557	[0.24-0.4] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in small VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	4e-19	18.39794000867204		0.257337	[0.2-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	2e-18	17.69897000433602		0.218389	[0.17-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	4e-18	17.397940008672037		0.274218	[0.21-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small VLDL	4,348 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.073265524	6e-11	10.221848749616356		0.267583	[0.19-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in small VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	6e-11	10.221848749616356		0.188943	[0.13-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small VLDL	4,348 individuals		2p23.3	2	27519736		GCKR			ENSG00000084734			rs780093-C	rs780093	0	780093.0	intron_variant	0.0	0.645380635	2e-08	7.698970004336019		0.127832	[0.083-0.172] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	2e-19	18.69897000433602		0.224693	[0.18-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	2e-17	16.69897000433602		0.268125	[0.21-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in small VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244788638	1e-08	8.0		0.142394	[0.093-0.191] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	2e-17	16.69897000433602		0.211144	[0.16-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	2e-15	14.69897000433602		0.251757	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in VLDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0732523	7e-13	12.154901959985745		0.293222	[0.21-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	4e-15	14.397940008672036		0.226902	[0.17-0.28] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Cholesterol esters in chylomicron and extremely large VLDL meal response (LMM)	11,410 individuals		12p12.3	12	16759029		LMO3 - SKP1P2	ENSG00000048540	ENSG00000256211		148435.0	230097.0	rs75665264-T	rs75665264	0	75665264.0	intron_variant	1.0	0.0359685	3e-09	8.522878745280337		0.176856	[0.13-0.23] unit increase	Illumina [7568622] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium VLDL	4,348 individuals		2p23.3	2	27519736		GCKR			ENSG00000084734			rs780093-C	rs780093	0	780093.0	intron_variant	0.0	0.645380635	6e-09	8.221848749616356		0.132393	[0.088-0.177] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	2e-18	17.69897000433602		0.218673	[0.17-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	4e-16	15.397940008672036		0.256688	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244788638	4e-08	7.397940008672037		0.137505	[0.088-0.187] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium LDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.073269151	1e-09	9.0		0.248772	[0.17-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in medium LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	5e-09	8.301029995663981		0.169359	[0.11-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	4e-18	17.397940008672037		0.216396	[0.17-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	7e-16	15.154901959985745		0.254839	[0.19-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium VLDL	4,348 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.073265524	4e-10	9.397940008672036		0.255125	[0.18-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in medium VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	2e-10	9.69897000433602		0.184361	[0.13-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	1e-17	17.0		0.212493	[0.16-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	3e-15	14.522878745280336		0.249339	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium VLDL	4,348 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.073265524	5e-12	11.30102999566398		0.282861	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in medium VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	3e-13	12.522878745280336		0.210906	[0.15-0.27] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium VLDL	4,348 individuals		2p23.3	2	27519736		GCKR			ENSG00000084734			rs780093-C	rs780093	0	780093.0	intron_variant	0.0	0.645380635	9e-09	8.045757490560675		0.130666	[0.086-0.175] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium VLDL	4,348 individuals		6q24.1	6	140062487		FILNC1 - RNA5SP220	ENSG00000231426	ENSG00000252107		202011.0	96104.0	rs146782026-C	rs146782026	0	146782026.0	intron_variant	1.0	0.011914439	5e-08	7.301029995663981		0.606718	[0.39-0.82] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium VLDL	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	6e-18	17.221848749616356		0.215153	[0.17-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	3e-16	15.522878745280336		0.258074	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in medium VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244788638	3e-08	7.522878745280337		0.139192	[0.09-0.188] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL	4,348 individuals		8p21.3	8	19959850		LPL			ENSG00000175445			rs304-G	rs304	0	304.0	intron_variant	0.0	0.248567847	6e-17	16.221848749616356		0.207941	[0.16-0.26] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL	4,348 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.346976541	1e-08	8.0		0.131809	[0.086-0.177] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL	4,348 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.357895354	8e-17	16.096910013008056		0.184853	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.330282199	1e-16	16.0		0.189563	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in HDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.129320538	4e-13	12.397940008672036		0.240256	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in HDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	5e-14	13.30102999566398		0.237927	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in HDL	4,348 individuals		15q21.3	15	58388439		ALDH1A2			ENSG00000128918			rs2414577-C	rs2414577	0	2414577.0	intron_variant	0.0	0.381957222	1e-15	15.0		0.175206	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in HDL	4,348 individuals		15q21.3	15	58438954		LIPC-AS1, ALDH1A2, LIPC			ENSG00000259293, ENSG00000128918, ENSG00000166035			rs261342-C	rs261342	0	261342.0	intron_variant	0.0	0.788076127	8e-15	14.096910013008056		0.207693	[0.16-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in HDL	4,348 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.073265524	2e-09	8.698970004336019		0.245618	[0.17-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in IDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014118155	1e-09	9.0		0.550708	[0.37-0.73] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in IDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762268753	2e-12	11.69897000433602		0.175588	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in IDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317617119	3e-14	13.522878745280336		0.173174	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in IDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127851012	3e-14	13.522878745280336		0.241098	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in IDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065429452	9e-12	11.045757490560677		0.299814	[0.21-0.39] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in IDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162360792	2.0000000000000002e-23	22.69897000433602		0.287255	[0.23-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in IDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081570179	3e-50	49.52287874528034		0.586855	[0.51-0.66] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in IDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014118155	2e-09	8.698970004336019		0.548966	[0.37-0.73] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in IDL	4,348 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.768637828	3e-12	11.522878745280336		0.176315	[0.13-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014305433	7e-09	8.154901959985743		0.527407	[0.35-0.71] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.763306132	9e-10	9.045757490560677		0.154278	[0.1-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.316672651	3e-12	11.522878745280336		0.160969	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299408953	7e-15	14.154901959985745		0.181681	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127697132	1e-09	9.0		0.194655	[0.13-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065504873	1e-12	12.0		0.314044	[0.23-0.4] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162419911	5e-16	15.30102999566398		0.23526	[0.18-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081255304	6e-25	24.22184874961636		0.413311	[0.34-0.49] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial glycoprotein acetyls (mainly a1-acid glycoprotein)	4,348 individuals		2p23.3	2	27375230		SNX17			ENSG00000115234			rs4665972-C	rs4665972	0	4665972.0	intron_variant	0.0	0.625123045	2e-11	10.69897000433602		0.154103	[0.11-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial glycoprotein acetyls (mainly a1-acid glycoprotein)	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	2e-16	15.69897000433602		0.20523	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial glycoprotein acetyls (mainly a1-acid glycoprotein)	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	1e-14	14.0		0.243932	[0.18-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL2	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.12956308	3e-16	15.522878745280336		0.271101	[0.21-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL2	4,348 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.346727315	5e-08	7.301029995663981		0.127317	[0.082-0.173] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL2	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299623644	1e-14	14.0		0.179405	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL2	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.330424151	1e-16	16.0		0.189568	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL2	4,348 individuals		16q13	16	56968820		CETP			ENSG00000087237			rs9939224-G	rs9939224	0	9939224.0	intron_variant	0.0	0.808967906	2e-16	15.69897000433602		0.223523	[0.17-0.28] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL3	4,348 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.346976541	1e-10	10.0		0.149429	[0.1-0.19] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL3	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299370975	2e-31	30.69897000433602		0.269218	[0.22-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL3	4,348 individuals		15q21.3	15	58431476		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0	1800588.0	intron_variant	0.0	0.208652254	1e-10	10.0		0.170354	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL3	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.330282199	8e-14	13.096910013008056		0.171255	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in HDL3	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081532659	9e-20	19.045757490560675		0.360912	[0.28-0.44] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in IDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317617119	1e-13	13.0		0.169563	[0.13-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in IDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127851012	1e-13	13.0		0.235155	[0.17-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in IDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.072831684	2e-13	12.69897000433602		0.301513	[0.22-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in IDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162360792	9.999999999999999e-26	25.0		0.300889	[0.24-0.36] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in IDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081570179	7e-46	45.15490195998574		0.56031	[0.48-0.64] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in IDL	4,348 individuals		1p13.3	1	109279544		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3793.0	12.0	rs599839-A	rs599839	0	599839.0	intergenic_variant	1.0	0.76221468	3e-11	10.522878745280336		0.166254	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in IDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317617119	1e-14	14.0		0.175374	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in IDL	4,348 individuals		11q12.2	11	61851136		FADS2			ENSG00000134824			rs174592-G	rs174592	0	174592.0	intron_variant	0.0	0.334906351	2e-09	8.698970004336019		0.138251	[0.093-0.183] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in IDL	4,348 individuals		15q21.3	15	58387469		ALDH1A2			ENSG00000128918			rs7350789-A	rs7350789	0	7350789.0	intron_variant	0.0	0.357569489	9e-11	10.045757490560677		0.143914	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in IDL	4,348 individuals		19p13.2	19	11077571		SMARCA4			ENSG00000127616			rs56289821-A	rs56289821	0	56289821.0	intron_variant	0.0	0.127733433	6e-14	13.221848749616356		0.23819	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in IDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162360792	4e-17	16.397940008672037		0.242738	[0.19-0.3] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in IDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081570179	1.9999999999999998e-54	53.69897000433602		0.611018	[0.54-0.69] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large HDL	4,348 individuals		7p22.2	7	2903500		GNA12 - CARD11	ENSG00000146535	ENSG00000198286		59192.0	2642.0	rs7787896-T	rs7787896	0	7787896.0	downstream_gene_variant	1.0	0.115645768	3e-08	7.522878745280337		0.217217	[0.14-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large HDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.132467012	7e-09	8.154901959985743		0.194513	[0.13-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large HDL	4,348 individuals		15q21.3	15	58388439		ALDH1A2			ENSG00000128918			rs2414577-C	rs2414577	0	2414577.0	intron_variant	0.0	0.385759826	3e-24	23.522878745280337		0.227326	[0.18-0.27] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large HDL	4,348 individuals		15q21.3	15	58438954		LIPC-AS1, ALDH1A2, LIPC			ENSG00000259293, ENSG00000128918, ENSG00000166035			rs261342-C	rs261342	0	261342.0	intron_variant	0.0	0.787313721	4e-15	14.397940008672036		0.214611	[0.16-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large HDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074270798	2e-08	7.698970004336019		0.234337	[0.15-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large HDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161841572	6e-12	11.221848749616356		0.203111	[0.15-0.26] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large HDL	4,348 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.210811671	8e-09	8.096910013008056		0.155663	[0.1-0.21] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.127349429	3e-15	14.522878745280336		0.26728	[0.2-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.86539624	5e-14	13.30102999566398		0.24117	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very large VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.246502856	3e-08	7.522878745280337		0.141645	[0.092-0.191] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL2	4,734 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.166948718	7e-19	18.154901959985743		0.242821	[0.19-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL2	4,734 individuals		17q21.31	17	43797377		CFAP97D1 - MPP3	ENSG00000231256	ENSG00000161647		9757.0	3422.0	rs149580368-A	rs149580368	1	112259268.0	intergenic_variant	1.0	0.040135967	1e-08	8.0		0.309816	[0.2-0.42] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL3	4,734 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.349499261	4e-12	11.397940008672036		0.154468	[0.11-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL3	4,734 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.355890767	8e-31	30.096910013008056		0.245322	[0.2-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL3	4,734 individuals		15q21.3	15	58431476		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0	1800588.0	intron_variant	0.0	0.207945278	2e-09	8.698970004336019		0.151433	[0.1-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL3	4,734 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.166771815	1e-12	12.0		0.194748	[0.14-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL3	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082189837	5e-25	24.30102999566398		0.390335	[0.32-0.46] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL	4,734 individuals		8p21.3	8	19959850		LPL			ENSG00000175445			rs304-G	rs304	0	304.0	intron_variant	0.0	0.247824673	1e-14	14.0		0.183513	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL	4,734 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.349428602	5e-10	9.30102999566398		0.138412	[0.095-0.182] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL	4,734 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.355815589	2e-17	16.69897000433602		0.180921	[0.14-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.332185678	8e-16	15.096910013008056		0.176436	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL	4,734 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.166736586	7e-18	17.154901959985743		0.23581	[0.18-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL	4,734 individuals		17q21.31	17	43797377		CFAP97D1 - MPP3	ENSG00000231256	ENSG00000161647		9757.0	3422.0	rs149580368-A	rs149580368	1	112259268.0	intergenic_variant	1.0	0.040225735	1e-08	8.0		0.30913	[0.2-0.42] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL	4,734 individuals		19q13.32	19	44911142		APOE - APOC1	ENSG00000130203	ENSG00000130208		1749.0	3105.0	rs72654473-A	rs72654473	0	72654473.0	non_coding_transcript_exon_variant	1.0	0.112651035	2e-08	7.698970004336019		0.181916	[0.12-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in HDL	4,734 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.130039438	2e-11	10.69897000433602		0.212945	[0.15-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in HDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867282425	2e-15	14.69897000433602		0.240291	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014041667	9e-09	8.045757490560675		0.504131	[0.33-0.68] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals		1p13.3	1	109275684		CELSR2			ENSG00000143126			rs629301-T	rs629301	0	629301.0	3_prime_UTR_variant	0.0	0.765308524	4e-10	9.397940008672036		0.150275	[0.1-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.318113656	2e-09	8.698970004336019		0.131143	[0.088-0.174] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals												chr6:31459697-A	chr6:31459697	0			1.0	0.455549406	2e-08	7.698970004336019		0.114758	[0.075-0.155] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295955471	9e-10	9.045757490560677		0.136945	[0.093-0.181] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.119322646	4e-10	9.397940008672036		0.199418	[0.14-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.06665774	5e-11	10.30102999566398		0.276108	[0.19-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161711832	2e-22	21.69897000433602		0.26976	[0.22-0.32] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting esterified cholesterol	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082274067	1e-48	48.0		0.550824	[0.48-0.62] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014014921	6e-09	8.221848749616356		0.508922	[0.34-0.68] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol	4,734 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.759120635	4e-11	10.397940008672036		0.156881	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.318248466	4e-10	9.397940008672036		0.136324	[0.094-0.179] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295815026	6e-18	17.221848749616356		0.192361	[0.15-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128716825	1e-10	10.0		0.195486	[0.14-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol	4,734 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.074079894	3e-12	11.522878745280336		0.272725	[0.2-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161722328	9e-18	17.045757490560675		0.237671	[0.18-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082223175	1.9999999999999998e-30	29.69897000433602		0.432115	[0.36-0.51] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting glucose	4,734 individuals		2q31.1	2	168906638		SPC25, SPC25, G6PC2, G6PC2			ENSG00000152253, ENSG00000277909, ENSG00000152254, ENSG00000278373			rs560887-C	rs560887	0	560887.0	intron_variant	0.0	0.679018613	3e-11	10.522878745280336		0.145682	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting glucose	4,734 individuals		7p21.2	7	15020804		GTF3AP5 - AGMO	ENSG00000225816	ENSG00000187546		34730.0	179513.0	rs10231021-A	rs10231021	0	10231021.0	intergenic_variant	1.0	0.502275804	2e-08	7.698970004336019		0.117167	[0.077-0.158] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting glucose	4,734 individuals		7p13	7	44186502		GCK			ENSG00000106633			rs2971670-T	rs2971670	0	2971670.0	intron_variant	0.0	0.179481387	2e-08	7.698970004336019		0.151915	[0.099-0.205] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting glucose	4,734 individuals		11q14.3	11	92975544		MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	0.258178511	2e-15	14.69897000433602		0.193084	[0.15-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting glycoprotein acetyls (mainly a1-acid glycoprotein)	4,734 individuals		2p23.3	2	27375230		SNX17			ENSG00000115234			rs4665972-C	rs4665972	0	4665972.0	intron_variant	0.0	0.625089795	7e-13	12.154901959985745		0.157347	[0.11-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting glycoprotein acetyls (mainly a1-acid glycoprotein)	4,734 individuals		8p21.3	8	19962894		LPL			ENSG00000175445			rs331-A	rs331	0	331.0	intron_variant	0.0	0.281304035	2e-15	14.69897000433602		0.182542	[0.14-0.23] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting glycoprotein acetyls (mainly a1-acid glycoprotein)	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867254384	2e-13	12.69897000433602		0.223051	[0.16-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting glycoprotein acetyls (mainly a1-acid glycoprotein)	4,734 individuals		19p13.11	19	19277691		SUGP1			ENSG00000105705			rs8107974-T	rs8107974	0	8107974.0	intron_variant	0.0	0.075034016	4e-09	8.397940008672037		0.229342	[0.15-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL2	4,734 individuals		8p21.3	8	19959850		LPL			ENSG00000175445			rs304-G	rs304	0	304.0	intron_variant	0.0	0.248506463	1e-14	14.0		0.184202	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL2	4,734 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.349149396	2e-09	8.698970004336019		0.134117	[0.09-0.178] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL2	4,734 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.35588684	6e-16	15.221848749616356		0.17269	[0.13-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in HDL2	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.332287985	3e-16	15.522878745280336		0.179679	[0.14-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small LDL	4,734 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.130174815	6e-11	10.221848749616356		0.20786	[0.15-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small LDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867459294	2e-17	16.69897000433602		0.256992	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small LDL	4,734 individuals		12q24.33	12	131790755		SFSWAP			ENSG00000061936			rs6598156-A	rs6598156	0	6598156.0	intron_variant	0.0	0.771572214	4e-08	7.397940008672037		0.137802	[0.089-0.187] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small LDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295987735	3e-20	19.522878745280337		0.205597	[0.16-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small LDL	4,734 individuals		15q21.3	15	58435126		ALDH1A2, LIPC-AS1, LIPC			ENSG00000128918, ENSG00000259293, ENSG00000166035			rs261332-G	rs261332	0	261332.0	non_coding_transcript_exon_variant	0.0	0.798485938	1e-13	13.0		0.191671	[0.14-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small LDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074223092	5e-14	13.30102999566398		0.294503	[0.22-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161585113	4e-14	13.397940008672036		0.20887	[0.15-0.26] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small VLDL	4,734 individuals		8p21.3	8	19995878		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		28619.0	117465.0	rs1992442-C	rs1992442	0	1992442.0	intergenic_variant	1.0	0.27684853	3e-18	17.522878745280337		0.201744	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small VLDL	4,734 individuals		8q24.13	8	125494452		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56049.0	365269.0	rs112875651-A	rs112875651	0	112875651.0	intron_variant	1.0	0.413434525	2e-08	7.698970004336019		0.119751	[0.078-0.161] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867403216	4e-19	18.39794000867204		0.270622	[0.21-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small VLDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.331937169	5e-08	7.301029995663981		0.120039	[0.077-0.163] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small VLDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074254495	1e-14	14.0		0.302809	[0.23-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161548128	4e-18	17.397940008672037		0.240037	[0.19-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small VLDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765390311	2e-08	7.698970004336019		0.135144	[0.088-0.182] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small VLDL	4,734 individuals		8p21.3	8	19995878		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		28619.0	117465.0	rs1992442-C	rs1992442	0	1992442.0	intergenic_variant	1.0	0.27684853	1e-15	15.0		0.185879	[0.14-0.23] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867403216	4e-16	15.397940008672036		0.246146	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small VLDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.331937169	2e-09	8.698970004336019		0.132608	[0.09-0.176] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small VLDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074254495	2e-14	13.69897000433602		0.299788	[0.22-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161548128	7e-19	18.154901959985743		0.245388	[0.19-0.3] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small VLDL	4,734 individuals		8q24.13	8	125494452		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56049.0	365269.0	rs112875651-A	rs112875651	0	112875651.0	intron_variant	1.0	0.41	6e-08	7.221848749616356		0.12	[0.081-0.159] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small VLDL	4,734 individuals												chr7:73012042-A	chr7:73012042	0			1.0	0.133172414	3e-08	7.522878745280337		0.167749	[0.11-0.23] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small VLDL	4,734 individuals		8p21.3	8	19962894		LPL			ENSG00000175445			rs331-A	rs331	0	331.0	intron_variant	0.0	0.281026444	5e-20	19.30102999566398		0.210032	[0.17-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small VLDL	4,734 individuals		8q24.13	8	125494452		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56049.0	365269.0	rs112875651-A	rs112875651	0	112875651.0	intron_variant	1.0	0.413434525	2e-08	7.698970004336019		0.119596	[0.078-0.161] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867403216	6e-21	20.22184874961636		0.284139	[0.23-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small VLDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074254495	3e-13	12.522878745280336		0.28627	[0.21-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161548128	3e-14	13.522878745280336		0.20992	[0.16-0.26] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small VLDL	4,734 individuals		2p23.3	2	27518370		GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.645224244	3e-09	8.522878745280337		0.128588	[0.086-0.171] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small VLDL	4,734 individuals		8p21.3	8	19966981		LPL			ENSG00000175445			rs13702-C	rs13702	0	13702.0	3_prime_UTR_variant	0.0	0.299767083	3e-20	19.522878745280337		0.207239	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867403216	1e-18	18.0		0.266094	[0.21-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small VLDL	4,734 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.07426941	7e-11	10.154901959985745		0.255196	[0.18-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small VLDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244660673	6e-10	9.221848749616356		0.149059	[0.1-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in IDL	4,734 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.13017693	7e-12	11.154901959985745		0.217378	[0.16-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in IDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867670755	7e-12	11.154901959985745		0.208304	[0.15-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in IDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295670543	3e-38	37.52287874528034		0.286793	[0.24-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in IDL	4,734 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.796049905	2e-22	21.69897000433602		0.249064	[0.2-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in IDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074117361	5e-13	12.30102999566398		0.282877	[0.21-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in IDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161479805	1e-12	12.0		0.196548	[0.14-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014004542	1e-10	10.0		0.562257	[0.39-0.73] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765525982	3e-13	12.522878745280336		0.175149	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.31796071	3e-11	10.522878745280336		0.145385	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in LDL	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.119174609	2e-13	12.69897000433602		0.2354	[0.17-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066509485	1e-09	9.0		0.255349	[0.17-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large HDL	4,734 individuals		15q21.3	15	58281634		ALDH1A2			ENSG00000128918			rs28690720-G	rs28690720	0	28690720.0	intron_variant	0.0	0.148112903	1e-18	18.0		0.259445	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large HDL	4,734 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.649752541	3.0000000000000004e-75	74.52287874528034		0.395706	[0.35-0.44] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large HDL	4,734 individuals		15q21.3	15	58431476		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0	1800588.0	intron_variant	0.0	0.208285241	9.999999999999999e-31	30.0		0.297561	[0.25-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large HDL	4,734 individuals		16q13	16	56962299		CETP			ENSG00000087237			rs711752-A	rs711752	0	711752.0	splice_region_variant	0.0	0.446188909	4e-08	7.397940008672037		0.116254	[0.075-0.158] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large HDL	4,734 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.212573575	1e-14	14.0		0.197778	[0.15-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014004542	2e-10	9.69897000433602		0.561234	[0.39-0.73] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765525982	2e-13	12.69897000433602		0.17569	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.31796071	1e-11	11.0		0.148307	[0.11-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large LDL	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128788973	8e-14	13.096910013008056		0.226975	[0.17-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066509485	2e-10	9.69897000433602		0.265435	[0.18-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	5e-25	24.30102999566398		0.285202	[0.23-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082383714	2e-59	58.69897000433602		0.608555	[0.54-0.68] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014004542	1e-10	10.0		0.562122	[0.39-0.73] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765525982	2e-13	12.69897000433602		0.175883	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.31796071	2e-11	10.69897000433602		0.146805	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	9.999999999999999e-26	25.0		0.288192	[0.23-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082383714	7e-61	60.15490195998574		0.615553	[0.54-0.69] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in LDL	4,734 individuals												chr6:31457604-G	chr6:31457604	0			1.0	0.453473807	4e-08	7.397940008672037		0.112129	[0.072-0.152] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in LDL	4,734 individuals		11q23.3	11	116786845		ZPR1			ENSG00000109917			rs3741298-T	rs3741298	0	3741298.0	intron_variant	0.0	0.804907055	1e-10	10.0		0.167684	[0.12-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in LDL	4,734 individuals		15q21.3	15	58279783		ALDH1A2			ENSG00000128918			rs11854318-A	rs11854318	0	11854318.0	intron_variant	0.0	0.291483312	1e-09	9.0		0.137013	[0.093-0.181] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in LDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295780735	1e-46	46.0		0.317515	[0.27-0.36] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in LDL	4,734 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.795841783	2.0000000000000002e-23	22.69897000433602		0.25481	[0.21-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in LDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074144698	5e-12	11.30102999566398		0.2708	[0.19-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	4e-13	12.397940008672036		0.200855	[0.15-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		2q35	2	219557307		OBSL1			ENSG00000124006			rs55873563-A	rs55873563	0	55873563.0	intron_variant	0.0	0.180330093	6e-09	8.221848749616356		0.158677	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		8p21.3	8	19958045		LPL			ENSG00000175445			rs287-G	rs287	0	287.0	intron_variant	0.0	0.263755855	1e-13	13.0		0.178737	[0.13-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		11q12.2	11	61790331		TMEM258			ENSG00000134825			rs102275-C	rs102275	0	102275.0	non_coding_transcript_exon_variant	0.0	0.323547945	1e-08	8.0		0.130417	[0.086-0.175] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.358261821	3e-29	28.522878745280337		0.243795	[0.2-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.336183606	2e-14	13.69897000433602		0.170849	[0.13-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.164676536	1e-15	15.0		0.224378	[0.17-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		17q21.31	17	43797377		CFAP97D1 - MPP3	ENSG00000231256	ENSG00000161647		9757.0	3422.0	rs149580368-A	rs149580368	1	112259268.0	intergenic_variant	1.0	0.039658553	6e-09	8.221848749616356		0.323915	[0.21-0.43] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.212573575	5e-09	8.301029995663981		0.149859	[0.1-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large HDL	4,734 individuals		15q21.3	15	58432643		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs8033940-A	rs8033940	0	8033940.0	intron_variant	0.0	0.28	1e-07	7.0		0.12	[0.081-0.159] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		2q35	2	219557307		OBSL1			ENSG00000124006			rs55873563-A	rs55873563	0	55873563.0	intron_variant	0.0	0.180330093	5e-09	8.301029995663981		0.159599	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		8p21.3	8	19958045		LPL			ENSG00000175445			rs287-G	rs287	0	287.0	intron_variant	0.0	0.263755855	1e-13	13.0		0.178459	[0.13-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		11q12.2	11	61790331		TMEM258			ENSG00000134825			rs102275-C	rs102275	0	102275.0	non_coding_transcript_exon_variant	0.0	0.323547945	2e-08	7.698970004336019		0.128906	[0.084-0.173] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.358261821	7.999999999999999e-30	29.096910013008056		0.245923	[0.2-0.29] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.336183606	1e-14	14.0		0.172038	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.164676536	9e-16	15.045757490560677		0.225968	[0.17-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		17q21.31	17	43797377		CFAP97D1 - MPP3	ENSG00000231256	ENSG00000161647		9757.0	3422.0	rs149580368-A	rs149580368	1	112259268.0	intergenic_variant	1.0	0.039658553	8e-09	8.096910013008056		0.32209	[0.21-0.43] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.212573575	3e-09	8.522878745280337		0.151866	[0.1-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large HDL	4,734 individuals		15q21.3	15	58432643		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs8033940-A	rs8033940	0	8033940.0	intron_variant	0.0	0.28	1e-07	7.0		0.12	[0.081-0.159] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large HDL	4,734 individuals		2q35	2	219557307		OBSL1			ENSG00000124006			rs55873563-A	rs55873563	0	55873563.0	intron_variant	0.0	0.180330093	1e-08	8.0		0.156195	[0.1-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large HDL	4,734 individuals		8p21.3	8	19958045		LPL			ENSG00000175445			rs287-G	rs287	0	287.0	intron_variant	0.0	0.263755855	7e-14	13.154901959985745		0.179991	[0.13-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large HDL	4,734 individuals		11q12.2	11	61790331		TMEM258			ENSG00000134825			rs102275-C	rs102275	0	102275.0	non_coding_transcript_exon_variant	0.0	0.323547945	4e-09	8.397940008672037		0.134385	[0.09-0.179] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large HDL	4,734 individuals		15q21.3	15	58387985		ALDH1A2			ENSG00000128918			rs7177289-T	rs7177289	0	7177289.0	intron_variant	0.0	0.358261821	1e-27	27.0		0.236141	[0.19-0.28] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.336183606	7e-14	13.154901959985745		0.167423	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large HDL	4,734 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.164676536	9e-15	14.045757490560677		0.218004	[0.16-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large HDL	4,734 individuals		17q21.31	17	43797377		CFAP97D1 - MPP3	ENSG00000231256	ENSG00000161647		9757.0	3422.0	rs149580368-A	rs149580368	1	112259268.0	intergenic_variant	1.0	0.039658553	4e-09	8.397940008672037		0.329089	[0.22-0.44] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large HDL	4,734 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.212573575	2e-08	7.698970004336019		0.14364	[0.094-0.194] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in HDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295780735	1.0000000000000001e-23	23.0		0.223219	[0.18-0.27] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in HDL	4,734 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.795841783	4e-18	17.397940008672037		0.222061	[0.17-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in HDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074144698	4e-11	10.397940008672036		0.258223	[0.18-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in IDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013913618	4e-09	8.397940008672037		0.518852	[0.35-0.69] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in IDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765383802	8e-13	12.096910013008056		0.172154	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in IDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.31808543	1e-11	11.0		0.14828	[0.11-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in IDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295670543	2e-09	8.698970004336019		0.133955	[0.09-0.178] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in IDL	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128925143	3e-14	13.522878745280336		0.230337	[0.17-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in IDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066474075	3e-11	10.522878745280336		0.278231	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in IDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161479805	2.0000000000000002e-24	23.69897000433602		0.281504	[0.23-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in IDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082365088	9.999999999999999e-51	50.0		0.56151	[0.49-0.63] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in IDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013913618	4e-09	8.397940008672037		0.519072	[0.35-0.69] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in IDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765383802	2e-12	11.69897000433602		0.168665	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in IDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.31808543	2e-11	10.69897000433602		0.146817	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in IDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295670543	4e-08	7.397940008672037		0.122883	[0.079-0.167] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in IDL	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128925143	1e-13	13.0		0.224561	[0.17-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in IDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066474075	3e-12	11.522878745280336		0.292593	[0.21-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in IDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161479805	7.999999999999999e-26	25.096910013008056		0.290188	[0.24-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in IDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082365088	2e-46	45.69897000433602		0.537612	[0.46-0.61] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in IDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013913618	9e-09	8.045757490560675		0.505272	[0.33-0.68] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in IDL	4,734 individuals		1p13.3	1	109275684		CELSR2			ENSG00000143126			rs629301-T	rs629301	0	629301.0	3_prime_UTR_variant	0.0	0.765319306	1e-12	12.0		0.169923	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in IDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.31808543	1e-11	11.0		0.148705	[0.11-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in IDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295670543	1e-12	12.0		0.158057	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in IDL	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128925143	1e-14	14.0		0.234619	[0.18-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in IDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066474075	3e-08	7.522878745280337		0.231697	[0.15-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in IDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161479805	5e-20	19.30102999566398		0.253317	[0.2-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in IDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082365088	6e-57	56.22184874961636		0.595373	[0.52-0.67] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small HDL	4,734 individuals		2p23.3	2	27518370		GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.645453102	9e-09	8.045757490560675		0.124533	[0.082-0.167] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small HDL	4,734 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.130266504	1e-16	16.0		0.262997	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small HDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867502647	1e-15	15.0		0.243149	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.332324158	6e-09	8.221848749616356		0.127651	[0.085-0.171] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in small HDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244438492	5e-09	8.301029995663981		0.14113	[0.094-0.188] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013913618	6e-10	9.221848749616356		0.543796	[0.37-0.72] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765700994	1e-12	12.0		0.170395	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.3179797	1e-10	10.0		0.141165	[0.098-0.184] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small LDL	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.119194883	3e-13	12.522878745280336		0.233199	[0.17-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066579805	1e-08	8.0		0.240844	[0.16-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161585113	4.9999999999999996e-26	25.30102999566398		0.291323	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082153627	5.0000000000000005e-61	60.30102999566398		0.61783	[0.55-0.69] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013913618	6e-10	9.221848749616356		0.543658	[0.37-0.72] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765700994	7e-13	12.154901959985745		0.172708	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.3179797	5e-11	10.30102999566398		0.143528	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small LDL	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.119194883	9e-14	13.045757490560677		0.237468	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066579805	9e-09	8.045757490560675		0.241147	[0.16-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161585113	9.999999999999999e-26	25.0		0.289353	[0.24-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082153627	1e-62	62.0		0.626155	[0.55-0.7] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013913618	2e-09	8.698970004336019		0.531167	[0.36-0.7] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765700994	2e-11	10.69897000433602		0.161558	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.3179797	1e-09	9.0		0.132206	[0.089-0.175] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small LDL	4,734 individuals		5q21.2	5	103820137		NUDT12 - LINC02163	ENSG00000112874	ENSG00000251026		257347.0	259710.0	rs114429104-T	rs114429104	0	114429104.0	intergenic_variant	1.0	0.033180078	5e-08	7.301029995663981		0.325782	[0.21-0.44] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small LDL	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.119194883	2e-11	10.69897000433602		0.213436	[0.15-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066579805	2e-08	7.698970004336019		0.237118	[0.16-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161585113	9e-27	26.045757490560675		0.295596	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082153627	2e-52	51.69897000433602		0.57237	[0.5-0.65] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very small VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.129350288	1e-18	18.0		0.292325	[0.23-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very small VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866395215	6e-18	17.221848749616356		0.27239	[0.21-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very small VLDL	4,348 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.073282379	9e-10	9.045757490560677		0.250643	[0.17-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very small VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244729929	2e-10	9.69897000433602		0.159083	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in chylomicrons and extremely large VLDL	4,348 individuals		6q24.1	6	139638205		ATP5PBP6 - FILNC1	ENSG00000219806	ENSG00000231426		23001.0	39434.0	rs75860909-G	rs75860909	0	75860909.0	intron_variant	1.0	0.016123143	5e-08	7.301029995663981		0.484237	[0.31-0.66] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in chylomicrons and extremely large VLDL	4,348 individuals		8p21.3	8	19961817		LPL			ENSG00000175445			rs325-C	rs325	0	325.0	intron_variant	0.0	0.11277288	1e-14	14.0		0.271192	[0.2-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in chylomicrons and extremely large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866050551	3e-15	14.522878745280336		0.254212	[0.19-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in chylomicrons and extremely large VLDL	4,348 individuals		19p13.11	19	19277691		SUGP1			ENSG00000105705			rs8107974-T	rs8107974	0	8107974.0	intron_variant	0.0	0.073091519	5e-08	7.301029995663981		0.230111	[0.15-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in chylomicrons and extremely large VLDL	4,348 individuals		8p21.3	8	19961817		LPL			ENSG00000175445			rs325-C	rs325	0	325.0	intron_variant	0.0	0.11277288	3e-14	13.522878745280336		0.265847	[0.2-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.127349429	1e-15	15.0		0.271252	[0.21-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.86539624	6e-14	13.221848749616356		0.240466	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very large VLDL	4,348 individuals		19q13.32	19	44912921		APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-T	rs483082	0	483082.0	non_coding_transcript_exon_variant	1.0	0.246200619	1e-08	8.0		0.144146	[0.094-0.194] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.127349429	9e-15	14.045757490560677		0.262643	[0.2-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.86539624	5e-14	13.30102999566398		0.241258	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.127349429	3e-15	14.522878745280336		0.267229	[0.2-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in very large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.86539624	3e-14	13.522878745280336		0.243427	[0.18-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014114907	9e-09	8.045757490560675		0.524521	[0.35-0.7] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.768691051	7e-11	10.154901959985745		0.164503	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	2e-12	11.69897000433602		0.161169	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.649920635	8e-12	11.096910013008056		0.152492	[0.11-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals		16q13	16	56960616		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15752.0	1307.0	rs17231506-T	rs17231506	0	17231506.0	upstream_gene_variant	1.0	0.33057925	6e-10	9.221848749616356		0.142315	[0.097-0.187] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	1e-12	12.0		0.225398	[0.16-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.07281493	1e-12	12.0		0.291812	[0.21-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	3e-21	20.522878745280337		0.272445	[0.22-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in very small VLDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081436393	9e-24	23.045757490560675		0.398718	[0.32-0.48] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very small VLDL	4,348 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.768691051	1e-10	10.0		0.162763	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very small VLDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	2e-12	11.69897000433602		0.160291	[0.12-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very small VLDL	4,348 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.649920635	7e-11	10.154901959985745		0.14548	[0.1-0.19] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very small VLDL	4,348 individuals		16q13	16	56960616		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15752.0	1307.0	rs17231506-T	rs17231506	0	17231506.0	upstream_gene_variant	1.0	0.33057925	3e-11	10.522878745280336		0.152475	[0.11-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very small VLDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	1e-12	12.0		0.225788	[0.16-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very small VLDL	4,348 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.07281493	4e-12	11.397940008672036		0.283814	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very small VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	1e-21	21.0		0.275209	[0.22-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in very small VLDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081436393	2e-22	21.69897000433602		0.386567	[0.31-0.46] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very small VLDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014114907	1e-09	9.0		0.55361	[0.38-0.73] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very small VLDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762323441	2e-10	9.69897000433602		0.159866	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very small VLDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317774097	6e-12	11.221848749616356		0.156947	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very small VLDL	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299324822	5e-13	12.30102999566398		0.167478	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very small VLDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127936623	1e-11	11.0		0.215806	[0.15-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very small VLDL	4,348 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.07281493	3e-13	12.522878745280336		0.297741	[0.22-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very small VLDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162323441	2e-18	17.69897000433602		0.25234	[0.2-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in very small VLDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081436393	4.0000000000000004e-24	23.39794000867204		0.402175	[0.32-0.48] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.86717019	1e-16	16.0		0.251297	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium VLDL	4,734 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.074222304	3e-11	10.522878745280336		0.259982	[0.18-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium VLDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244822199	3e-09	8.522878745280337		0.142857	[0.096-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting remnant cholesterol	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.765525982	1e-08	8.0		0.13662	[0.09-0.184] mmol/l increase	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting remnant cholesterol	4,734 individuals		8p21.3	8	19995878		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		28619.0	117465.0	rs1992442-C	rs1992442	0	1992442.0	intergenic_variant	1.0	0.27706823	1e-13	13.0		0.171905	[0.13-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting remnant cholesterol	4,734 individuals		8q24.13	8	125487789		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-G	rs28601761	0	28601761.0	intron_variant	1.0	0.452801648	4e-08	7.397940008672037		0.114483	[0.074-0.155] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting remnant cholesterol	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867282425	5e-15	14.30102999566398		0.236954	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting remnant cholesterol	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074144698	3e-16	15.522878745280336		0.319125	[0.24-0.4] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting remnant cholesterol	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	2.0000000000000002e-24	23.69897000433602		0.281063	[0.23-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting remnant cholesterol	4,734 individuals		19q13.32	19	44912921		APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-T	rs483082	0	483082.0	non_coding_transcript_exon_variant	1.0	0.244662	6e-11	10.221848749616356	meal response (conditional)	0.24863	[0.17-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total cholesterol	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014004542	5e-09	8.301029995663981		0.511841	[0.34-0.68] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total cholesterol	4,734 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.759367343	2e-10	9.69897000433602		0.151829	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total cholesterol	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.31796071	7e-10	9.154901959985745		0.134665	[0.092-0.177] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total cholesterol	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295780735	6e-12	11.221848749616356		0.153688	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.86717019	5e-18	17.30102999566398		0.261839	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium VLDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0742074	3e-15	14.522878745280336		0.308388	[0.23-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161657082	9e-15	14.045757490560677		0.21437	[0.16-0.27] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium VLDL	4,734 individuals		2p23.3	2	27518370		GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.645343552	2e-09	8.698970004336019		0.129298	[0.087-0.172] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium VLDL	4,734 individuals		8p21.3	8	19962894		LPL			ENSG00000175445			rs331-A	rs331	0	331.0	intron_variant	0.0	0.281271036	1e-19	19.0		0.208032	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.86717019	3e-17	16.522878745280337		0.255072	[0.2-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium VLDL	4,734 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.074222304	1e-12	12.0		0.277646	[0.2-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161657082	4e-10	9.397940008672036		0.173567	[0.12-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium VLDL	4,734 individuals		2p23.3	2	27518370		GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.645343552	9e-10	9.045757490560677		0.132835	[0.09-0.175] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium VLDL	4,734 individuals		8p21.3	8	19967357		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		98.0	145986.0	rs3916027-A	rs3916027	0	3916027.0	intergenic_variant	1.0	0.279995772	2e-19	18.69897000433602		0.207838	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in VLDL	4,734 individuals		8q24.13	8	125494452		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56049.0	365269.0	rs112875651-A	rs112875651	0	112875651.0	intron_variant	1.0	0.413343895	5e-08	7.301029995663981		0.115763	[0.074-0.157] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867282425	8e-19	18.096910013008056		0.267582	[0.21-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in VLDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074144698	4e-15	14.397940008672036		0.307075	[0.23-0.38] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	7e-17	16.154901959985743		0.230802	[0.18-0.28] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in VLDL	4,734 individuals		2p23.3	2	27518370		GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.6455376	5e-10	9.30102999566398		0.13496	[0.093-0.177] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in VLDL	4,734 individuals		8p21.3	8	19967357		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		98.0	145986.0	rs3916027-A	rs3916027	0	3916027.0	intergenic_variant	1.0	0.279970427	2e-19	18.69897000433602		0.207064	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867282425	3e-17	16.522878745280337		0.255476	[0.2-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in VLDL	4,734 individuals		19p13.11	19	19308262		SUGP1			ENSG00000105705			rs739846-A	rs739846	0	739846.0	intron_variant	0.0	0.07415959	2e-11	10.69897000433602		0.26316	[0.19-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides in VLDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244932404	2e-09	8.698970004336019		0.144379	[0.097-0.191] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large HDL	4,734 individuals		16q13	16	56966973		CETP			ENSG00000087237			rs12720922-A	rs12720922	0	12720922.0	intron_variant	0.0	0.167032561	8e-16	15.096910013008056		0.225029	[0.17-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large HDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.079655704	9.999999999999999e-27	26.0		0.417618	[0.34-0.49] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large HDL	4,734 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.21200896	1e-15	15.0		0.203247	[0.15-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large HDL	4,734 individuals		11q12.2	11	61790331		TMEM258			ENSG00000134825			rs102275-C	rs102275	0	102275.0	non_coding_transcript_exon_variant	0.0	0.323946241	8e-10	9.096910013008056		0.139265	[0.095-0.184] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large HDL	4,734 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.649603365	1e-35	35.0		0.26935	[0.23-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large HDL	4,734 individuals		15q21.3	15	58432643		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs8033940-A	rs8033940	0	8033940.0	intron_variant	0.0	0.281375219	7e-12	11.154901959985745		0.159544	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in very large HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.335678977	2e-17	16.69897000433602		0.188105	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large HDL	4,734 individuals		11q12.2	11	61776027		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174528-C	rs174528	0	174528.0	intron_variant	0.0	0.34829611	1e-09	9.0		0.137883	[0.094-0.182] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large HDL	4,734 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.649603365	6e-34	33.22184874961636		0.26303	[0.22-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large HDL	4,734 individuals		15q21.3	15	58432643		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs8033940-A	rs8033940	0	8033940.0	intron_variant	0.0	0.281375219	1e-11	11.0		0.158102	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in very large HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.335678977	8e-17	16.096910013008056		0.184799	[0.14-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in VLDL	4,734 individuals		8p21.3	8	19962894		LPL			ENSG00000175445			rs331-A	rs331	0	331.0	intron_variant	0.0	0.281244613	5e-19	18.30102999566398		0.204137	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total cholesterol	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.119174609	1e-10	10.0		0.205258	[0.14-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total cholesterol	4,734 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.074044677	1e-11	11.0		0.264838	[0.19-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total cholesterol	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	4e-21	20.39794000867204		0.260759	[0.21-0.31] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total cholesterol	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082383714	5.999999999999999e-44	43.22184874961636		0.521783	[0.45-0.59] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total triglycerides	4,734 individuals		2p23.3	2	27518370		GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.6455376	1e-09	9.0		0.131068	[0.089-0.173] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total triglycerides	4,734 individuals		8p21.3	8	19962894		LPL			ENSG00000175445			rs331-A	rs331	0	331.0	intron_variant	0.0	0.281244613	6e-19	18.22184874961636		0.203932	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total triglycerides	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867282425	7e-18	17.154901959985743		0.26044	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total triglycerides	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074144698	8e-13	12.096910013008056		0.280464	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-10-14	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting serum total triglycerides	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244932404	8e-10	9.096910013008056		0.148094	[0.1-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small HDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082275413	3e-15	14.522878745280336		0.298507	[0.22-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in small HDL	4,734 individuals		20q13.12	20	45906012		PLTP			ENSG00000100979			rs6065904-A	rs6065904	0	6065904.0	intron_variant	0.0	0.228791825	3e-08	7.522878745280337		0.135487	[0.088-0.183] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in small HDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082257993	2.0000000000000002e-24	23.69897000433602		0.386607	[0.31-0.46] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small HDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082257993	4e-15	14.397940008672036		0.297489	[0.22-0.37] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in small HDL	4,734 individuals		20q13.12	20	45916409		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		4254.0	18274.0	rs4810479-T	rs4810479	0	4810479.0	upstream_gene_variant	1.0	0.73131696	9e-10	9.045757490560677		0.14142	[0.096-0.187] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014111661	7e-10	9.154901959985745		0.561547	[0.38-0.74] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762263109	1e-12	12.0		0.178207	[0.13-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317701012	2e-13	12.69897000433602		0.167443	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in LDL	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127907199	6e-14	13.221848749616356		0.237878	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in LDL	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065399356	1e-10	10.0		0.28241	[0.2-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	3e-24	23.522878745280337		0.291885	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in LDL	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081532659	8e-58	57.096910013008056		0.629835	[0.55-0.71] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in LDL	4,348 individuals												chr6:31487067-C	chr6:31487067	0			1.0	0.071905819	4e-09	8.397940008672037		0.246295	[0.16-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in LDL	4,348 individuals		11q23.3	11	116786845		ZPR1			ENSG00000109917			rs3741298-T	rs3741298	0	3741298.0	intron_variant	0.0	0.805661224	2e-09	8.698970004336019		0.164432	[0.11-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in LDL	4,348 individuals		15q21.3	15	58279783		ALDH1A2			ENSG00000128918			rs11854318-A	rs11854318	0	11854318.0	intron_variant	0.0	0.289478381	2e-09	8.698970004336019		0.142287	[0.096-0.189] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in LDL	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299370975	3e-45	44.52287874528034		0.324326	[0.28-0.37] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in LDL	4,348 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.795380635	9e-24	23.045757490560675		0.267312	[0.22-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in LDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0732523	1e-11	11.0		0.277179	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides in LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	4e-11	10.397940008672036		0.19086	[0.13-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large HDL	4,348 individuals		15q21.3	15	58431476		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0	1800588.0	intron_variant	0.0	0.21	8e-08	7.096910013008056		0.15	[0.091-0.209] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large HDL	4,348 individuals		8p21.3	8	19958045		LPL			ENSG00000175445			rs287-G	rs287	0	287.0	intron_variant	0.0	0.264826141	6e-14	13.221848749616356		0.191153	[0.14-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large HDL	4,348 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.644964242	2e-22	21.69897000433602		0.223863	[0.18-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.334911714	1e-12	12.0		0.168396	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large HDL	4,348 individuals		15q21.3	15	58431476		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0	1800588.0	intron_variant	0.0	0.21	6e-08	7.221848749616356		0.15	[0.091-0.209] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large HDL	4,348 individuals		8p21.3	8	19958045		LPL			ENSG00000175445			rs287-G	rs287	0	287.0	intron_variant	0.0	0.264826141	6e-14	13.221848749616356		0.191038	[0.14-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large HDL	4,348 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.644964242	7.000000000000001e-23	22.154901959985743		0.226078	[0.18-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.334911714	5e-13	12.30102999566398		0.170493	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large HDL	4,348 individuals		8p21.3	8	19958045		LPL			ENSG00000175445			rs287-G	rs287	0	287.0	intron_variant	0.0	0.264826141	5e-14	13.30102999566398		0.191966	[0.14-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large HDL	4,348 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.644964242	5e-21	20.30102999566398		0.215919	[0.17-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.334911714	7e-12	11.154901959985745		0.162226	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large HDL	4,348 individuals		15q21.3	15	58282125		ALDH1A2			ENSG00000128918			rs58038553-G	rs58038553	0	58038553.0	intron_variant	0.0	0.141273465	3e-19	18.522878745280337		0.284569	[0.22-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large HDL	4,348 individuals		15q21.3	15	58386521		ALDH1A2			ENSG00000128918			rs261290-C	rs261290	0	261290.0	intron_variant	0.0	0.644964242	6e-64	63.22184874961636		0.383171	[0.34-0.43] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large HDL	4,348 individuals		15q21.3	15	58431476		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs1800588-T	rs1800588	0	1800588.0	intron_variant	0.0	0.210628853	6e-30	29.22184874961636		0.308261	[0.26-0.36] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large HDL	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.334911714	9e-09	8.045757490560675		0.136007	[0.09-0.182] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large HDL	4,348 individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-C	rs6073958	0	6073958.0	downstream_gene_variant	1.0	0.210900863	2e-14	13.69897000433602		0.208409	[0.16-0.26] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large LDL	4,348 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014111661	7e-10	9.154901959985745		0.561258	[0.38-0.74] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large LDL	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.762263109	1e-12	12.0		0.17775	[0.13-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large LDL	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.317701012	1e-13	13.0		0.169575	[0.13-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in IDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.129345536	2e-10	9.69897000433602		0.211569	[0.15-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in IDL	4,348 individuals		11q23.3	11	116786845		ZPR1			ENSG00000109917			rs3741298-T	rs3741298	0	3741298.0	intron_variant	0.0	0.805685688	1e-11	11.0		0.184572	[0.13-0.24] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in IDL	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299278647	4e-36	35.39794000867204		0.289181	[0.24-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in IDL	4,348 individuals		15q21.3	15	58435126		ALDH1A2, LIPC-AS1, LIPC			ENSG00000128918, ENSG00000259293, ENSG00000166035			rs261332-G	rs261332	0	261332.0	non_coding_transcript_exon_variant	0.0	0.798003912	2e-22	21.69897000433602		0.260961	[0.21-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in IDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.07328601	7e-12	11.154901959985745		0.280193	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in IDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162360792	2e-12	11.69897000433602		0.203331	[0.15-0.26] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.12911046	7e-19	18.154901959985743		0.295508	[0.23-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865620642	2e-14	13.69897000433602		0.243362	[0.18-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial cholesterol esters in large VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244273129	6e-11	10.221848749616356		0.165304	[0.12-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large VLDL	4,348 individuals												chr2:27730940-C	Chr2:27730940	0			1.0	0.628333333	8e-09	8.096910013008056		0.130761	[0.086-0.175] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large VLDL	4,348 individuals		6q24.1	6	140062487		FILNC1 - RNA5SP220	ENSG00000231426	ENSG00000252107		202011.0	96104.0	rs146782026-C	rs146782026	0	146782026.0	intron_variant	1.0	0.011755841	2e-08	7.698970004336019		0.632592	[0.41-0.85] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.12911046	4e-18	17.397940008672037		0.288686	[0.22-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865620642	3e-14	13.522878745280336		0.241494	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial free cholesterol in large VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244273129	5e-10	9.30102999566398		0.1573	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large VLDL	4,348 individuals												chr2:27730940-C	Chr2:27730940	0			1.0	0.628333333	6e-09	8.221848749616356		0.132165	[0.088-0.177] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.12911046	4e-18	17.397940008672037		0.289342	[0.22-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large LDL	4,348 individuals		2p24.1	2	21160481		TDRD15 - NUTF2P8	ENSG00000218819	ENSG00000270654		16113.0	201811.0	rs34468875-T	rs34468875	0	34468875.0	intergenic_variant	1.0	0.43274425	2e-08	7.698970004336019		0.121388	[0.079-0.164] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large LDL	4,348 individuals												chr6:31487067-C	chr6:31487067	0			1.0	0.071905819	4e-09	8.397940008672037		0.245966	[0.16-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large LDL	4,348 individuals		15q21.3	15	58279783		ALDH1A2			ENSG00000128918			rs11854318-A	rs11854318	0	11854318.0	intron_variant	0.0	0.289478381	1e-10	10.0		0.151992	[0.11-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large LDL	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299370975	5.999999999999999e-54	53.22184874961636		0.354704	[0.31-0.4] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large LDL	4,348 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.795380635	9.999999999999999e-27	26.0		0.283887	[0.23-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large LDL	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0732523	7e-11	10.154901959985745		0.266822	[0.19-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial triglycerides levels in large LDL	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	5e-11	10.30102999566398		0.189325	[0.13-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large VLDL	4,348 individuals		6q24.1	6	140062487		FILNC1 - RNA5SP220	ENSG00000231426	ENSG00000252107		202011.0	96104.0	rs146782026-C	rs146782026	0	146782026.0	intron_variant	1.0	0.011755841	3e-08	7.522878745280337		0.621078	[0.4-0.84] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large VLDL	4,348 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.12911046	2e-18	17.69897000433602		0.292387	[0.23-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large VLDL	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865620642	2e-14	13.69897000433602		0.242815	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial total cholesterol in large VLDL	4,348 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244273129	2e-10	9.69897000433602		0.160921	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2018-09-13	30004843	Ge S	2018-07-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/30004843	Type 2 Diabetes Mellitus: Integrative Analysis of Multiomics Data for Biomarker Discovery.	Elevated fasting plasma glucose	76 Chinese ancestry cases, 435 Chinese ancestry controls		4q35.2	4	188663199	RPL7AP27	LINC01060, LINC01060			ENSG00000281580, ENSG00000249378			rs7686384-G	rs7686384	0	7686384.0	intron_variant	0.0	0.1424	9e-06	5.045757490560675		1.937	[1.592-2.282]	Illumina [69485]	N
2018-09-13	30004843	Ge S	2018-07-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/30004843	Type 2 Diabetes Mellitus: Integrative Analysis of Multiomics Data for Biomarker Discovery.	Elevated fasting plasma glucose	76 Chinese ancestry cases, 435 Chinese ancestry controls		9q32	9	112847661	SNX30	SNX30			ENSG00000148158			rs10817396-A	rs10817396	0	10817396.0	intron_variant	0.0	0.1367	3e-06	5.522878745280337		2.011	[1.234-2.788]	Illumina [69485]	N
2018-09-13	30004843	Ge S	2018-07-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/30004843	Type 2 Diabetes Mellitus: Integrative Analysis of Multiomics Data for Biomarker Discovery.	Elevated fasting plasma glucose	76 Chinese ancestry cases, 435 Chinese ancestry controls		10p12.33	10	18001629	SLC39A12	SLC39A12			ENSG00000148482			rs9418383-C	rs9418383	0	9418383.0	intron_variant	0.0	0.07544	8e-07	6.096910013008056		2.393	[1.957-2.829]	Illumina [69485]	N
2018-09-13	30004843	Ge S	2018-07-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/30004843	Type 2 Diabetes Mellitus: Integrative Analysis of Multiomics Data for Biomarker Discovery.	Elevated fasting plasma glucose	76 Chinese ancestry cases, 435 Chinese ancestry controls		19q13.32	19	46087217	CTCF	IGFL4 - IGFL3	ENSG00000204869	ENSG00000188624		10099.0	32850.0	rs4802289-A	rs4802289	0	4802289.0	intergenic_variant	1.0	0.06243	5e-06	5.301029995663981		2.377	[2.022-2.732]	Illumina [69485]	N
2018-09-13	30004843	Ge S	2018-07-01	OMICS	www.ncbi.nlm.nih.gov/pubmed/30004843	Type 2 Diabetes Mellitus: Integrative Analysis of Multiomics Data for Biomarker Discovery.	Elevated fasting plasma glucose	76 Chinese ancestry cases, 435 Chinese ancestry controls		21q22.3	21	41244078	BACE2	BACE2			ENSG00000182240			rs2837981-A	rs2837981	0	2837981.0	intron_variant	0.0	0.09043	6e-06	5.221848749616356		2.158	[1.824-2.492]	Illumina [69485]	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large LDL	4,734 individuals		11q23.3	11	116786845		ZPR1			ENSG00000109917			rs3741298-T	rs3741298	0	3741298.0	intron_variant	0.0	0.804907055	5e-09	8.301029995663981		0.152733	[0.1-0.2] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large LDL	4,734 individuals		15q21.3	15	58279783		ALDH1A2			ENSG00000128918			rs11854318-A	rs11854318	0	11854318.0	intron_variant	0.0	0.291483312	2e-10	9.69897000433602		0.144517	[0.1-0.19] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large LDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295780735	3.9999999999999995e-54	53.39794000867204		0.341996	[0.3-0.38] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large LDL	4,734 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.795841783	9.999999999999999e-26	25.0		0.26771	[0.22-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large LDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074144698	1e-11	11.0		0.265651	[0.19-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	1e-12	12.0		0.195889	[0.14-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large VLDL	4,734 individuals		8p21.3	8	19961817		LPL			ENSG00000175445			rs325-C	rs325	0	325.0	intron_variant	0.0	0.112913982	6e-16	15.221848749616356		0.271045	[0.21-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865964278	4e-15	14.397940008672036		0.24171	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large VLDL	4,734 individuals		19p13.11	19	19591575		PBX4			ENSG00000105717			rs17217098-A	rs17217098	0	17217098.0	intron_variant	0.0	0.06869176	6e-11	10.221848749616356		0.273482	[0.19-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in large VLDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.245814377	1e-08	8.0		0.140132	[0.092-0.188] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large VLDL	4,734 individuals		8p21.3	8	19961817		LPL			ENSG00000175445			rs325-C	rs325	0	325.0	intron_variant	0.0	0.112913982	2e-16	15.69897000433602		0.27554	[0.21-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865964278	1e-15	15.0		0.246669	[0.19-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large VLDL	4,734 individuals		19p13.11	19	19591575		PBX4			ENSG00000105717			rs17217098-A	rs17217098	0	17217098.0	intron_variant	0.0	0.06869176	7e-11	10.154901959985745		0.271793	[0.19-0.35] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large VLDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.245814377	6e-09	8.221848749616356		0.14265	[0.095-0.191] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large VLDL	4,734 individuals		8p21.3	8	19967052		LPL			ENSG00000175445			rs1059611-C	rs1059611	0	1059611.0	3_prime_UTR_variant	0.0	0.116812404	5e-15	14.30102999566398		0.257835	[0.19-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865964278	1e-14	14.0		0.236715	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large VLDL	4,734 individuals		19p13.11	19	19591575		PBX4			ENSG00000105717			rs17217098-A	rs17217098	0	17217098.0	intron_variant	0.0	0.06869176	2e-11	10.69897000433602		0.278478	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large VLDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.245814377	1e-08	8.0		0.139165	[0.091-0.187] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large VLDL	4,734 individuals		8p21.3	8	19967052		LPL			ENSG00000175445			rs1059611-C	rs1059611	0	1059611.0	3_prime_UTR_variant	0.0	0.116812404	3e-15	14.522878745280336		0.260197	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.865964278	4e-14	13.397940008672036		0.232621	[0.17-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large VLDL	4,734 individuals		19p13.11	19	19606247		PBX4			ENSG00000105717			rs73004967-G	rs73004967	0	73004967.0	intron_variant	0.0	0.068882095	3e-10	9.522878745280336		0.262375	[0.18-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in large VLDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.245814377	2e-08	7.698970004336019		0.138407	[0.09-0.186] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium HDL	4,734 individuals		8p21.3	8	19957745		LPL			ENSG00000175445			rs286-T	rs286	0	286.0	intron_variant	0.0	0.091241416	3e-12	11.522878745280336		0.253891	[0.18-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium HDL	4,734 individuals		16q13	16	56968820		CETP			ENSG00000087237			rs9939224-G	rs9939224	0	9939224.0	intron_variant	0.0	0.809057864	2e-14	13.69897000433602		0.198397	[0.15-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium HDL	4,734 individuals		8p21.3	8	19957745		LPL			ENSG00000175445			rs286-T	rs286	0	286.0	intron_variant	0.0	0.091241416	1e-12	12.0		0.25829	[0.19-0.33] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium HDL	4,734 individuals		16q13	16	56968820		CETP			ENSG00000087237			rs9939224-G	rs9939224	0	9939224.0	intron_variant	0.0	0.809057864	3e-15	14.522878745280336		0.204479	[0.15-0.26] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium HDL	4,734 individuals		19q13.32	19	44919689		APOC1 - APOC1P1	ENSG00000130208	ENSG00000214855		340.0	7110.0	rs4420638-G	rs4420638	0	4420638.0	downstream_gene_variant	1.0	0.198783807	4e-08	7.397940008672037		0.140446	[0.09-0.191] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium HDL	4,734 individuals		8p21.3	8	19967156		LPL			ENSG00000175445			rs15285-T	rs15285	0	15285.0	3_prime_UTR_variant	0.0	0.298856083	8e-11	10.096910013008056		0.146642	[0.1-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium HDL	4,734 individuals		16q13	16	56968820		CETP			ENSG00000087237			rs9939224-G	rs9939224	0	9939224.0	intron_variant	0.0	0.809057864	3e-11	10.522878745280336		0.173214	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium HDL	4,734 individuals		2p23.3	2	27375230		SNX17			ENSG00000115234			rs4665972-C	rs4665972	0	4665972.0	intron_variant	0.0	0.624812421	3e-09	8.522878745280337		0.12983	[0.087-0.173] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium HDL	4,734 individuals		8p21.3	8	19963914		LPL			ENSG00000175445			rs75278536-G	rs75278536	0	75278536.0	intron_variant	0.0	0.117984103	2e-10	9.69897000433602		0.204061	[0.14-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium HDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867468207	1e-17	17.0		0.25942	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium HDL	4,734 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.332570369	1e-09	9.0		0.134196	[0.091-0.177] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium HDL	4,734 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.073977851	1e-11	11.0		0.266687	[0.19-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium HDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082451145	1e-10	10.0		0.243989	[0.17-0.32] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013907736	5e-10	9.30102999566398		0.54698	[0.37-0.72] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.76558867	4e-13	12.397940008672036		0.173942	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.318056648	1e-10	10.0		0.14107	[0.098-0.184] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium LDL	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.11925018	1e-13	13.0		0.237245	[0.17-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066551659	2e-09	8.698970004336019		0.251897	[0.17-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161622913	1.9999999999999998e-26	25.69897000433602		0.29323	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082118897	2e-59	58.69897000433602		0.610309	[0.54-0.68] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013907736	5e-10	9.30102999566398		0.545852	[0.37-0.72] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.76558867	3e-13	12.522878745280336		0.175636	[0.13-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.318056648	7e-11	10.154901959985745		0.142585	[0.1-0.185] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium LDL	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.11925018	6e-14	13.221848749616356		0.239019	[0.18-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161622913	1e-11	11.0		0.18747	[0.13-0.24] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium LDL	4,734 individuals		11q23.3	11	116786845		ZPR1			ENSG00000109917			rs3741298-T	rs3741298	0	3741298.0	intron_variant	0.0	0.804994716	3e-08	7.522878745280337		0.145028	[0.094-0.196] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium LDL	4,734 individuals		15q21.3	15	58290341		ALDH1A2			ENSG00000128918			rs1973688-T	rs1973688	0	1973688.0	intron_variant	0.0	0.298355316	3e-10	9.522878745280336		0.139957	[0.096-0.183] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium LDL	4,734 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.295862608	2e-53	52.69897000433602		0.340051	[0.3-0.38] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium LDL	4,734 individuals		15q21.3	15	58434545		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs261334-C	rs261334	0	261334.0	intron_variant	0.0	0.795923695	1.0000000000000001e-24	24.0		0.261436	[0.21-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in medium LDL	4,734 individuals												chr19:19379549-T	chr19:19379549	0			1.0	0.07409163	3e-10	9.522878745280336		0.246034	[0.17-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium VLDL	4,734 individuals		8p21.3	8	19967357		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		98.0	145986.0	rs3916027-A	rs3916027	0	3916027.0	intergenic_variant	1.0	0.279995772	1e-19	19.0		0.208128	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.86717019	1e-17	17.0		0.258556	[0.2-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium VLDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0742074	2e-14	13.69897000433602		0.298238	[0.22-0.37] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in medium VLDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161657082	1e-12	12.0		0.196782	[0.14-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium VLDL	4,734 individuals		8p21.3	8	19967357		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		98.0	145986.0	rs3916027-A	rs3916027	0	3916027.0	intergenic_variant	1.0	0.279995772	2e-18	17.69897000433602		0.201382	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium VLDL	4,734 individuals		8q24.13	8	125494452		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56049.0	365269.0	rs112875651-A	rs112875651	0	112875651.0	intron_variant	1.0	0.413586681	5e-08	7.301029995663981		0.115764	[0.074-0.157] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066551659	1e-09	9.0		0.253705	[0.17-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161622913	3.9999999999999996e-26	25.39794000867204		0.291486	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in medium LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082118897	1e-59	59.0		0.61148	[0.54-0.68] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.013907736	6e-10	9.221848749616356		0.544905	[0.37-0.72] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium LDL	4,734 individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-T	rs646776	0	646776.0	downstream_gene_variant	1.0	0.76558867	1e-12	12.0		0.170207	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.318056648	4e-10	9.397940008672036		0.136432	[0.094-0.179] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium LDL	4,734 individuals		19p13.2	19	11079858		SMARCA4 - LDLR	ENSG00000127616	ENSG00000130164		432.0	9604.0	rs142158911-A	rs142158911	0	142158911.0	downstream_gene_variant	1.0	0.11925018	8e-13	12.096910013008056		0.228081	[0.17-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066551659	6e-09	8.221848749616356		0.243678	[0.16-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161622913	4e-27	26.39794000867204		0.297518	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in medium LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082118897	3e-57	56.52287874528034		0.598578	[0.53-0.67] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large LDL	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128788973	2e-13	12.69897000433602		0.224148	[0.16-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large LDL	4,734 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.066509485	4e-11	10.397940008672036		0.277447	[0.2-0.36] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	3e-26	25.522878745280337		0.29202	[0.24-0.35] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in large LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082383714	3e-57	56.52287874528034		0.596425	[0.52-0.67] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large LDL	4,734 individuals												chr1:55505647-T	chr1:55505647	0			1.0	0.014004542	6e-10	9.221848749616356		0.542068	[0.37-0.71] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large LDL	4,734 individuals		1p13.3	1	109275684		CELSR2			ENSG00000143126			rs629301-T	rs629301	0	629301.0	3_prime_UTR_variant	0.0	0.765461555	1e-12	12.0		0.170318	[0.12-0.22] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large LDL	4,734 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.31796071	4e-12	11.397940008672036		0.151244	[0.11-0.19] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large LDL	4,734 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.128788973	3e-14	13.522878745280336		0.230502	[0.17-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large LDL	4,734 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.161731728	1e-21	21.0		0.264058	[0.21-0.32] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in large LDL	4,734 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.082383714	6e-64	63.22184874961636		0.630857	[0.56-0.7] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in chylomicrons and extremely large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.862587706	7e-16	15.154901959985745		0.264063	[0.2-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in chylomicrons and extremely large VLDL	4,734 individuals		8q24.13	8	125487789		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-G	rs28601761	0	28601761.0	intron_variant	1.0	0.451058824	1e-08	8.0		0.130345	[0.086-0.175] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in chylomicrons and extremely large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.862552865	3e-16	15.522878745280336		0.267623	[0.2-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting cholesterol esters in chylomicrons and extremely large VLDL	4,734 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.124642951	2e-09	8.698970004336019		0.213694	[0.14-0.28] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in chylomicrons and extremely large VLDL	4,734 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.124635944	1e-10	10.0		0.230037	[0.16-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting free cholesterol in chylomicrons and extremely large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.862587706	5e-15	14.30102999566398		0.256669	[0.19-0.32] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in chylomicrons and extremely large VLDL	4,734 individuals		8p21.3	8	19969190		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		1931.0	144153.0	rs79108221-T	rs79108221	0	79108221.0	intergenic_variant	1.0	0.1126932	3e-10	9.522878745280336		0.226343	[0.16-0.3] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in chylomicrons and extremely large VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.8625877	9e-16	15.045757490560677		0.263235	[0.2-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein A-I	4,348 individuals		8p21.3	8	19967156		LPL			ENSG00000175445			rs15285-T	rs15285	0	15285.0	3_prime_UTR_variant	0.0	0.299103726	2e-08	7.698970004336019		0.132809	[0.087-0.179] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein A-I	4,348 individuals		15q21.3	15	58386313		ALDH1A2			ENSG00000128918			rs10468017-T	rs10468017	0	10468017.0	intron_variant	0.0	0.299370975	1e-18	18.0		0.204199	[0.16-0.25] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein A-I	4,348 individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-A	rs247617	0	247617.0	regulatory_region_variant	1.0	0.330282199	1e-16	16.0		0.18984	[0.15-0.23] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein A-I	4,348 individuals		16q13	16	56972678		CETP			ENSG00000087237			rs7499892-T	rs7499892	0	7499892.0	intron_variant	0.0	0.165212282	5e-16	15.30102999566398		0.23347	[0.18-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein A-I	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081532659	1e-08	8.0		0.228267	[0.15-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein B	4,348 individuals		19q13.32	19	44912921		APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-T	rs483082	0	483082.0	non_coding_transcript_exon_variant	1.0	0.244495	7e-09	8.154901959985743	meal response (conditional)	0.230723	[0.15-0.31] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein B	4,348 individuals		8p21.3	8	19958727		LPL			ENSG00000175445			rs295-C	rs295	0	295.0	intron_variant	0.0	0.248713431	3e-12	11.522878745280336		0.174553	[0.13-0.22] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very small VLDL	4,734 individuals		2p24.1	2	21008652		APOB			ENSG00000084674			rs676210-A	rs676210	0	676210.0	missense_variant	0.0	0.21369104	5e-08	7.301029995663981		0.136444	[0.087-0.185] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very small VLDL	4,734 individuals		8p21.3	8	19962894		LPL			ENSG00000175445			rs331-A	rs331	0	331.0	intron_variant	0.0	0.281257819	2e-19	18.69897000433602		0.206397	[0.16-0.25] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very small VLDL	4,734 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.867331995	9e-19	18.045757490560675		0.26744	[0.21-0.33] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very small VLDL	4,734 individuals		15q21.3	15	58435126		ALDH1A2, LIPC-AS1, LIPC			ENSG00000128918, ENSG00000259293, ENSG00000166035			rs261332-G	rs261332	0	261332.0	non_coding_transcript_exon_variant	0.0	0.79840448	5e-08	7.301029995663981		0.140891	[0.09-0.191] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very small VLDL	4,734 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.074176036	1e-11	11.0		0.265739	[0.19-0.34] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting triglycerides levels in very small VLDL	4,734 individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-T	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	0.244930262	3e-11	10.522878745280336		0.159502	[0.11-0.21] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in chylomicrons and extremely large VLDL	4,734 individuals		8p21.3	8	20054859		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		87600.0	58484.0	rs115849089-A	rs115849089	0	115849089.0	intergenic_variant	1.0	0.124635944	3e-10	9.522878745280336		0.223547	[0.15-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Fasting total cholesterol in chylomicrons and extremely large VLDL	4,734 individuals		8q24.13	8	125487789		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		49386.0	371932.0	rs28601761-G	rs28601761	0	28601761.0	intron_variant	1.0	0.451071229	2e-08	7.698970004336019		0.129207	[0.084-0.174] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein B	4,348 individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-C	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.866310948	1e-12	12.0		0.225239	[0.16-0.29] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein B	4,348 individuals		19p13.11	19	19296909		SUGP1			ENSG00000105705			rs10401969-C	rs10401969	0	10401969.0	intron_variant	0.0	0.0732523	3e-16	15.522878745280336		0.333647	[0.25-0.41] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial apolipoprotein B	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.162286109	9.000000000000001e-23	22.045757490560675		0.28278	[0.23-0.34] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial esterified cholesterol	4,348 individuals		1p13.3	1	109279521		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		3770.0	35.0	rs1277930-A	rs1277930	0	1277930.0	downstream_gene_variant	1.0	0.7632695	2e-09	8.698970004336019		0.150528	[0.1-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial esterified cholesterol	4,348 individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-A	rs934197	0	934197.0	upstream_gene_variant	1.0	0.316489724	3e-11	10.522878745280336		0.152964	[0.11-0.2] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial esterified cholesterol	4,348 individuals		19p13.2	19	11078223		SMARCA4			ENSG00000127616			rs112374545-T	rs112374545	0	112374545.0	intron_variant	0.0	0.127438697	2e-10	9.69897000433602		0.205029	[0.14-0.27] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial esterified cholesterol	4,348 individuals		19p13.11	19	19255823		HAPLN4			ENSG00000187664			rs72999033-T	rs72999033	0	72999033.0	3_prime_UTR_variant	0.0	0.065611957	9e-12	11.045757490560677		0.301857	[0.22-0.39] mmol/l decrease	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial esterified cholesterol	4,348 individuals		19q13.32	19	44908684		APOE			ENSG00000130203			rs429358-C	rs429358	0	429358.0	missense_variant	0.0	0.16245049	5e-19	18.30102999566398		0.258516	[0.2-0.32] mmol/l increase	Illumina [7701709] (imputed)	N
2022-03-22	34610981	Li-Gao R	2021-10-05	Diabetes	www.ncbi.nlm.nih.gov/pubmed/34610981	Genetic Studies of Metabolomics Change After a Liquid Meal Illuminate Novel Pathways for Glucose and Lipid Metabolism.	Postprandial esterified cholesterol	4,348 individuals												chr19:45412079-T	chr19:45412079	0			1.0	0.081271369	2.9999999999999997e-44	43.52287874528034		0.556775	[0.48-0.63] mmol/l decrease	Illumina [7701709] (imputed)	N
2019-04-18	30674623	Syreeni A	2019-01-23	Diabetes	www.ncbi.nlm.nih.gov/pubmed/30674623	Genetic Determinants of Glycated Hemoglobin in Type 1 Diabetes.	Glycated hemoglobin levels in type 1 diabetes	4,622 Finnish ancestry individuals	up to 3,097 individuals	13q12.3	13	31593580	RXFP2							rs2085277-T	rs2085277	0	2085277.0	intergenic_variant	1.0	0.039	4e-08	7.397940008672037		0.046	[0.030-0.062] unit increase	Illumina [8354674] (imputed)	N
2018-06-29	29650774	Rotroff DM	2018-04-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29650774	Genetic Variants in CPA6 and PRPF31 are Associated with Variation in Response to Metformin in Individuals with Type 2 Diabetes.	Change in HbA1c levels in response to metformin treatment in type 2 diabetes	845 European ancestry individuals, 222 African American individuals, 245 individuals	6,963 European ancestry individuals, 1,015 African American individuals, 4,520 individuals	19q13.42	19	54127382	PRPF31	PRPF31, PRPF31			ENSG00000275885, ENSG00000105618			rs254271-?	rs254271	0	254271.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(EA)			Affymetrix, Illumina [26000000] (imputed)	N
2019-02-01	30566433	Taira M	2018-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30566433	A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.	Type 2 diabetes nephropathy including microalbuminuria	at least 2,809 Japanese ancestry cases, 5,592 Japanese ancestry controls	at least 2,115 Japanese ancestry cases, 2,519 Japanese ancestry controls	16q12.2	16	53772541	FTO	FTO			ENSG00000140718			rs56094641-G	rs56094641	0	56094641.0	intron_variant	0.0	NR	2e-09	8.698970004336019		1.18	[1.12-1.24]	Illumina [NR]	N
2019-02-01	30566433	Taira M	2018-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30566433	A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.	Type 2 diabetes nephropathy including microalbuminuria	at least 2,809 Japanese ancestry cases, 5,592 Japanese ancestry controls	at least 2,115 Japanese ancestry cases, 2,519 Japanese ancestry controls	5q34	5	168365677	WWC1	WWC1			ENSG00000113645			rs78954674-A	rs78954674	0	78954674.0	intron_variant	0.0	NR	1e-06	6.0		1.17	[1.10-1.25]	Illumina [NR]	N
2019-02-01	30566433	Taira M	2018-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30566433	A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.	Type 2 diabetes nephropathy including microalbuminuria	at least 2,809 Japanese ancestry cases, 5,592 Japanese ancestry controls	at least 2,115 Japanese ancestry cases, 2,519 Japanese ancestry controls	15q21.3	15	57404428	CGNL1	CGNL1			ENSG00000128849			rs16977473-G	rs16977473	0	16977473.0	intron_variant	0.0	NR	2e-07	6.698970004336019		1.27	[1.15-1.39]	Illumina [NR]	N
2019-02-01	30566433	Taira M	2018-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30566433	A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.	Type 2 diabetes nephropathy including microalbuminuria	at least 2,809 Japanese ancestry cases, 5,592 Japanese ancestry controls	at least 2,115 Japanese ancestry cases, 2,519 Japanese ancestry controls	17q25.1	17	76544835	PRCD	PRCD, CYGB			ENSG00000214140, ENSG00000161544			rs895157-G	rs895157	0	895157.0	3_prime_UTR_variant	0.0	NR	1e-06	6.0		1.2	[1.11-1.29]	Illumina [NR]	N
2019-02-01	30566433	Taira M	2018-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30566433	A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.	Type 2 diabetes nephropathy including microalbuminuria	at least 2,809 Japanese ancestry cases, 5,592 Japanese ancestry controls	at least 2,115 Japanese ancestry cases, 2,519 Japanese ancestry controls	18q11.2	18	24102336	TTC39C	TTC39C			ENSG00000168234			rs16940484-T	rs16940484	0	16940484.0	intron_variant	0.0	NR	6e-07	6.221848749616356		1.13	[1.08-1.19]	Illumina [NR]	N
2019-02-01	30566433	Taira M	2018-12-19	PLoS One	www.ncbi.nlm.nih.gov/pubmed/30566433	A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.	Type 2 diabetes nephropathy including microalbuminuria	at least 2,809 Japanese ancestry cases, 5,592 Japanese ancestry controls	at least 2,115 Japanese ancestry cases, 2,519 Japanese ancestry controls	5p15.32	5	4741874	LOC107986400	NA - LINC02114		ENSG00000249521			31607.0	rs73048515-C	rs73048515	0	73048515.0	intron_variant	1.0	NR	5e-07	6.301029995663981		1.52	[1.28-1.79]	Illumina [NR]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12q12	12	40027315	NR	SLC2A13			ENSG00000151229			rs10877955-G	rs10877955	0	10877955.0	intron_variant	0.0	0.936511	5e-13	12.30102999566398		0.028411	[0.021-0.036] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		16q24.2	16	88502880	NR	ZFPM1			ENSG00000179588			rs139829677-G	rs139829677	0	139829677.0	intron_variant	0.0	0.958903	1e-13	13.0		0.0365414	[0.027-0.046] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		3q25.33	3	160324671	NR	IFT80			ENSG00000068885			rs4616688-G	rs4616688	0	4616688.0	intron_variant	0.0	0.470985	5e-13	12.30102999566398		0.013898	[0.01-0.018] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		21q22.11	21	31733452	NR	SCAF4 - NA	ENSG00000156304			1334.0		rs73201545-G	rs73201545	0	73201545.0	regulatory_region_variant	1.0	0.955521	8e-13	12.096910013008056		0.0333784	[0.024-0.043] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11p13	11	32131922	NR	THEM7P			ENSG00000227160			rs79953563-T	rs79953563	0	79953563.0	intron_variant	0.0	0.849602	9e-13	12.045757490560677		0.0191638	[0.014-0.024] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		14q32.33	14	103866422	NR	LINC00637		ENSG00000156411			45866.0	rs12891477-C	rs12891477	0	12891477.0	intron_variant	0.0	0.631191	3e-12	11.522878745280336		0.0139634	[0.01-0.018] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		4p14	4	40416653	NR	RNU7-74P - RBM47	ENSG00000239010	ENSG00000163694		39140.0	6614.0	rs203273-C	rs203273	0	203273.0	intergenic_variant	1.0	0.343941	5e-12	11.30102999566398		0.0139005	[0.01-0.0178] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		18q21.31	18	57651800	NR	ATP8B1			ENSG00000081923			rs369298568-T	rs369298568	0	369298568.0	intron_variant	0.0	0.876157	5e-12	11.30102999566398		0.020139	[0.014-0.026] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7q36.3	7	155235097	NR	RN7SKP280 - INSIG1-DT	ENSG00000201066	ENSG00000273117		52913.0	60821.0	rs4374942-T	rs4374942	0	4374942.0	regulatory_region_variant	1.0	0.925872	1e-12	12.0		0.0259845	[0.019-0.033] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		1p36.33	1	2235046	NR	SKI			ENSG00000157933			rs560221037-A	rs560221037	1	34974355.0	intron_variant	0.0	0.619607	6e-12	11.221848749616356		0.0135788	[0.0097-0.0174] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q21.2	15	49550054	NR	FAM227B			ENSG00000166262			rs566865466-T	rs566865466	0	566865466.0	intron_variant	0.0	0.636004	6e-12	11.221848749616356		0.0137315	[0.0098-0.0176] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		21q21.1	21	15210560	NR							rs62219001-G	rs62219001	0	62219001.0	intron_variant	1.0	0.982845	1e-12	12.0		0.0530653	[0.038-0.068] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p12.1	12	25254792	NR	KRAS - RNU4-67P	ENSG00000133703	ENSG00000201439		3856.0	149496.0	rs12318598-A	rs12318598	0	12318598.0	regulatory_region_variant	1.0	0.915758	3e-11	10.522878745280336		0.0229614	[0.016-0.03] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		13q12.3	13	30442842	NR	UBE2L5 - HMGB1	ENSG00000236444	ENSG00000189403		13084.0	13862.0	rs1331698-C	rs1331698	0	1331698.0	intergenic_variant	1.0	0.284514	8e-11	10.096910013008056		0.0139899	[0.0098-0.0182] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		19p13.3	19	2803229	NR	THOP1			ENSG00000172009			rs1640273-C	rs1640273	0	1640273.0	intron_variant	0.0	0.712177	4e-11	10.397940008672036		0.0134802	[0.0095-0.0175] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		16q23.2	16	79470160	NR	RNA5SP431 - MAF	ENSG00000222244	ENSG00000178573		205587.0	115683.0	rs1862719-A	rs1862719	0	1862719.0	regulatory_region_variant	1.0	0.246309	8e-11	10.096910013008056		0.0147549	[0.01-0.019] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		8p23.1	8	6707055	NR	MCPH1-AS1, MCPH1-AS1			ENSG00000249898, ENSG00000285400			rs2911987-A	rs2911987	0	2911987.0	intron_variant	0.0	0.320055	3e-11	10.522878745280336		0.0136165	[0.0096-0.0176] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20q13.2	20	53918861	NR	SUMO1P1 - BCAS1	ENSG00000241721	ENSG00000064787		43304.0	17916.0	rs6022850-C	rs6022850	0	6022850.0	intergenic_variant	1.0	0.552785	9e-11	10.045757490560677		0.0125912	[0.0088-0.0164] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20p13	20	409666	NR	RBCK1			ENSG00000125826			rs6139104-A	rs6139104	0	6139104.0	intron_variant	0.0	0.907226	2e-11	10.69897000433602		0.0221474	[0.016-0.029] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11p15.4	11	2977392	NR	NAP1L4, NAP1L4			ENSG00000273562, ENSG00000205531			rs61871243-G	rs61871243	0	61871243.0	intron_variant	0.0	0.875298	7e-11	10.154901959985745		0.018856	[0.013-0.025] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10q11.21	10	45458319	NR	MARCHF8, MARCHF8			ENSG00000165406, ENSG00000278545			rs7908745-A	rs7908745	0	7908745.0	missense_variant	0.0	0.685035	6e-11	10.221848749616356		0.0134821	[0.0094-0.0175] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q21.3	15	53447229	NR	LINC02490 - WDR72	ENSG00000259237	ENSG00000166415		316885.0	66512.0	rs79391862-A	rs79391862	0	79391862.0	intron_variant	1.0	0.986175	9e-11	10.045757490560677		0.0542363	[0.038-0.071] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q24.1	15	74888551	NR	SCAMP2 - MPI	ENSG00000140497	ENSG00000178802		15186.0	1454.0	rs9673065-T	rs9673065	0	9673065.0	intergenic_variant	1.0	0.426014	2e-11	10.69897000433602		0.0130176	[0.0092-0.0168] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		19p13.3	19	4492942	NR	HDGFL2			ENSG00000167674			rs111174163-T	rs111174163	0	111174163.0	intron_variant	0.0	0.888589	9e-10	9.045757490560677		0.0190674	[0.013-0.025] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		13q22.1	13	74132814	NR	KLF12			ENSG00000118922			rs112679104-C	rs112679104	0	112679104.0	intron_variant	0.0	0.981785	6e-10	9.221848749616356		0.0475502	[0.032-0.063] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7p14.2	7	36129593	NR	MARK2P13 - EEPD1	ENSG00000228815	ENSG00000122547		18721.0	23661.0	rs67050321-T	rs67050321	0	67050321.0	regulatory_region_variant	1.0	0.696262	5e-20	19.30102999566398		0.0191502	[0.015-0.023] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		3q23	3	142930268	NR	PCOLCE2 - PAQR9	ENSG00000163710	ENSG00000188582		41062.0	18896.0	rs9832727-C	rs9832727	0	9832727.0	intron_variant	1.0	0.660225	3e-20	19.522878745280337		0.0186298	[0.015-0.023] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7p22.3	7	1007979	NR	C7orf50			ENSG00000146540			rs10272002-A	rs10272002	0	10272002.0	intron_variant	0.0	0.787524	3e-19	18.522878745280337		0.0210319	[0.016-0.026] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		2q37.1	2	233756852	NR	UGT1A4, UGT1A3, UGT1A10, UGT1A8, UGT1A5, UGT1A9, UGT1A7, UGT1A6			ENSG00000244474, ENSG00000288702, ENSG00000242515, ENSG00000242366, ENSG00000288705, ENSG00000241119, ENSG00000244122, ENSG00000167165			rs11568318-C	rs11568318	0	11568318.0	intron_variant	0.0	0.93368	7e-19	18.154901959985743		0.0336663	[0.026-0.041] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20q13.33	20	64060707	NR	TCEA2			ENSG00000171703			rs6090040-A	rs6090040	0	6090040.0	intron_variant	0.0	0.478913	8e-19	18.096910013008056		0.0170833	[0.013-0.021] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p13.33	12	513963	NR	B4GALNT3			ENSG00000139044			rs35882350-A	rs35882350	0	35882350.0	intron_variant	0.0	0.738696	2e-18	17.69897000433602		0.0191123	[0.015-0.023] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		Xp22.12	X	20136228	NR	EIF1AX			ENSG00000173674			rs73447108-C	rs73447108	0	73447108.0	intron_variant	0.0	0.801919	8e-18	17.096910013008056		0.0172508	[0.013-0.021] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		6p24.1	6	11868281	NR	AMD1P4 - NA	ENSG00000215124			5311.0		rs9470298-T	rs9470298	0	9470298.0	intergenic_variant	1.0	0.908377	5e-18	17.30102999566398		0.0285705	[0.022-0.035] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals					NR							chr14:64236436-TA	chr14:64236436	0			1.0	0.14174	4e-17	16.397940008672037		0.0237405	[0.018-0.029] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q22.31	15	63496068	NR	LINC02568 - USP3	ENSG00000259459	ENSG00000140455		57748.0	8443.0	rs11636087-T	rs11636087	0	11636087.0	downstream_gene_variant	1.0	0.705945	2e-17	16.69897000433602		0.0181098	[0.014-0.022] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		1p36.12	1	23468691	NR	ASAP3, ASAP3			ENSG00000088280, ENSG00000282854			rs375390883-TAG	rs375390883	0	375390883.0	intron_variant	0.0	0.124841	3e-17	16.522878745280337		0.0240988	[0.019-0.03] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10q25.3	10	116638383	NR	PNLIPRP2			ENSG00000266200			rs4751996-A	rs4751996	0	4751996.0	missense_variant	0.0	0.480843	1e-17	17.0		0.0164643	[0.013-0.02] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		9q34.3	9	136425617	NR	PMPCA - INPP5E	ENSG00000165688	ENSG00000148384		1856.0	3002.0	rs10448340-T	rs10448340	0	10448340.0	intergenic_variant	1.0	0.679777	6e-16	15.221848749616356		0.0166194	[0.013-0.021] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q13.2	22	40872921	NR	XPNPEP3			ENSG00000196236			rs138352-T	rs138352	0	138352.0	intron_variant	0.0	0.341431	8e-16	15.096910013008056		0.0163988	[0.012-0.02] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20p12.1	20	12978039	NR	LINC01723			ENSG00000234265			rs438568-A	rs438568	0	438568.0	intron_variant	0.0	0.391162	7e-16	15.154901959985745		0.0158686	[0.012-0.02] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20p12.3	20	5600143	NR	GPCPD1			ENSG00000125772			rs73075609-C	rs73075609	0	73075609.0	intron_variant	0.0	0.973118	2e-16	15.69897000433602		0.0490853	[0.037-0.061] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20q13.33	20	62710120	NR	NTSR1			ENSG00000101188			rs3746778-G	rs3746778	0	3746778.0	intron_variant	0.0	0.579511	1e-15	15.0		0.0159772	[0.012-0.02] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		3q26.2	3	171039196	NR	SLC2A2 - TNIK	ENSG00000163581	ENSG00000154310		12453.0	19218.0	rs6785233-T	rs6785233	0	6785233.0	intron_variant	1.0	0.920413	4e-15	14.397940008672036		0.0277941	[0.021-0.035] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q13.33	22	50402144	NR	PPP6R2			ENSG00000100239			rs9616822-G	rs9616822	0	9616822.0	intron_variant	0.0	0.64845	4e-15	14.397940008672036		0.0158614	[0.012-0.02] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q13.31	22	45600418	NR	FBLN1			ENSG00000077942			rs13268-A	rs13268	0	13268.0	missense_variant	0.0	0.97457	9e-14	13.045757490560677		0.0455362	[0.034-0.058] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		2p25.3	2	3594771	NR	RPS7 - COLEC11	ENSG00000171863	ENSG00000118004		13851.0	61.0	rs3820897-T	rs3820897	0	3820897.0	upstream_gene_variant	1.0	0.180112	2e-14	13.69897000433602		0.0189654	[0.014-0.024] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		4p16.1	4	7221592	NR	SORCS2			ENSG00000184985			rs4689653-T	rs4689653	0	4689653.0	intron_variant	0.0	0.378108	6e-14	13.221848749616356		0.0148487	[0.011-0.019] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		13q34	13	110385979	NR	COL4A2			ENSG00000134871			rs75816352-C	rs75816352	0	75816352.0	intron_variant	0.0	0.364969	7e-14	13.154901959985745		0.0151199	[0.011-0.019] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20p11.21	20	25226018	NR	ENTPD6			ENSG00000197586			rs1044573-A	rs1044573	0	1044573.0	3_prime_UTR_variant	0.0	0.506977	4e-13	12.397940008672036		0.0139532	[0.01-0.018] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10p13	10	17213096	NR	TRDMT1 - VIM-AS1	ENSG00000107614	ENSG00000229124		11042.0	1143.0	rs10795464-G	rs10795464	0	10795464.0	downstream_gene_variant	1.0	0.578732	3e-13	12.522878745280336		0.0144189	[0.011-0.018] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		17q25.3	17	82572553	NR	FOXK2			ENSG00000141568			rs3736206-T	rs3736206	0	3736206.0	intron_variant	0.0	0.364379	2e-09	8.698970004336019		0.0119093	[0.008-0.0158] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7q31.2	7	116845966	NR	CAPZA2			ENSG00000198898			rs41785-C	rs41785	0	41785.0	intron_variant	0.0	0.582682	9e-09	8.045757490560675		0.0111724	[0.0074-0.015] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		2q37.3	2	241431336	NR	FARP2			ENSG00000006607			rs59916403-G	rs59916403	0	59916403.0	intron_variant	0.0	0.64831	4e-09	8.397940008672037		0.0116418	[0.0078-0.0155] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q26.1	15	90566379	NR	CRTC3			ENSG00000140577			rs6496691-G	rs6496691	0	6496691.0	intron_variant	0.0	0.150168	2e-09	8.698970004336019		0.016099	[0.011-0.021] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		13q14.3	13	50471162	NR	DLEU1			ENSG00000176124			rs67854369-G	rs67854369	0	67854369.0	intron_variant	0.0	0.303242	4e-09	8.397940008672037		0.0124182	[0.0083-0.0166] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		2p25.1	2	8580520	NR	LINC01814			ENSG00000236008			rs72784625-T	rs72784625	0	72784625.0	intron_variant	0.0	0.7389	6e-09	8.221848749616356		0.0125258	[0.0083-0.0167] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p11.22	12	29355709	NR	ERGIC2			ENSG00000087502			rs10843391-A	rs10843391	0	10843391.0	intron_variant	0.0	0.715098	3e-08	7.522878745280337		0.0117868	[0.0076-0.016] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		17q25.3	17	83051228	NR	B3GNTL1, B3GNTL1			ENSG00000175711, ENSG00000277033			rs111571253-C	rs111571253	0	111571253.0	intron_variant	0.0	0.853646	1e-08	8.0		0.0154801	[0.01-0.021] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p11.23	12	26681872	NR	ITPR2			ENSG00000123104			rs111626763-T	rs111626763	0	111626763.0	splice_region_variant	0.0	0.412167	2e-08	7.698970004336019		0.010901	[0.0071-0.0147] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		1p36.22	1	11829758	NR	CLCN6			ENSG00000011021			rs112521149-G	rs112521149	0	112521149.0	intron_variant	0.0	0.890774	4e-08	7.397940008672037		0.0169696	[0.011-0.023] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		3q24	3	147316110	NR	RPL21P71 - ZIC4	ENSG00000239412	ENSG00000174963		38858.0	69936.0	rs113270900-C	rs113270900	0	113270900.0	intron_variant	1.0	0.753478	1e-08	8.0		0.0127604	[0.0084-0.0171] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		13q14.2	13	49474266	NR	SETDB2			ENSG00000136169			rs11386165-C	rs11386165	0	11386165.0	intron_variant	0.0	0.898916	5e-08	7.301029995663981		0.0177064	[0.011-0.024] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p13.31	12	7472418	NR	CD163L1, CD163			ENSG00000177675, ENSG00000177575			rs117692263-T	rs117692263	0	117692263.0	intron_variant	0.0	0.917178	2e-08	7.698970004336019		0.0194479	[0.013-0.026] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p13.2	12	11744963	NR	ETV6			ENSG00000139083			rs117864888-T	rs117864888	0	117864888.0	intron_variant	0.0	0.968293	3e-08	7.522878745280337		0.0303073	[0.02-0.041] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		8q24.3	8	140728488	NR	PTK2			ENSG00000169398			rs11997161-T	rs11997161	0	11997161.0	intron_variant	0.0	0.482346	3e-08	7.522878745280337		0.0106387	[0.0069-0.0144] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		14q12	14	31255905	NR	Y_RNA - Y_RNA	ENSG00000264495	ENSG00000264495		11044.0	2703.0	rs139262716-G	rs139262716	0	139262716.0	intron_variant	1.0	0.982544	1e-08	8.0		0.0420476	[0.028-0.056] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7p14.1	7	41710893	NR	INHBA-AS1			ENSG00000224116			rs142220572-T	rs142220572	0	142220572.0	non_coding_transcript_exon_variant	0.0	0.821606	2e-08	7.698970004336019		0.0142998	[0.0093-0.0193] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		Xq23	X	110662875	NR	M6PRP1 - CHRDL1	ENSG00000228042	ENSG00000101938		25203.0	10981.0	rs144832584-C	rs144832584	0	144832584.0	intergenic_variant	1.0	0.966073	2e-08	7.698970004336019		0.0259675	[0.017-0.035] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10p12.33	10	18217497	NR	CACNB2			ENSG00000165995			rs1757216-G	rs1757216	0	1757216.0	intron_variant	0.0	0.152589	1e-08	8.0		0.0154368	[0.01-0.021] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		Xq28	X	154443984	NR	GDI1 - FAM50A	ENSG00000203879	ENSG00000071859		517.0	157.0	rs188437955-G	rs188437955	0	188437955.0	TF_binding_site_variant	1.0	0.887524	1e-08	8.0		0.0145092	[0.0096-0.0195] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7q33	7	134706212	NR	BPGM - TUBB3P2	ENSG00000172331	ENSG00000230101		26396.0	28686.0	rs2347699-T	rs2347699	0	2347699.0	intergenic_variant	1.0	0.720851	3e-08	7.522878745280337		0.0121069	[0.0079-0.0164] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10p14	10	8058162	NR	GATA3			ENSG00000107485			rs3824667-A	rs3824667	0	3824667.0	intron_variant	0.0	0.172864	3e-08	7.522878745280337		0.0141513	[0.0092-0.0192] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p11.21	12	31992066	NR	RESF1			ENSG00000174718			rs4931005-A	rs4931005	0	4931005.0	intron_variant	0.0	0.213317	2e-08	7.698970004336019		0.0130497	[0.0085-0.0176] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q11.21	22	21561983	NR	UBE2L3			ENSG00000185651			rs5754102-C	rs5754102	0	5754102.0	intron_variant	0.0	0.817884	2e-08	7.698970004336019		0.0141391	[0.0092-0.0191] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7q31.33	7	127375029	NR	ZNF800			ENSG00000048405			rs62621812-G	rs62621812	0	62621812.0	missense_variant	0.0	0.979683	3e-08	7.522878745280337		0.0386871	[0.025-0.052] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		5p13.2	5	35885880	NR	IL7R - CAPSL	ENSG00000168685	ENSG00000152611		6277.0	18408.0	rs6871748-T	rs6871748	0	6871748.0	intergenic_variant	1.0	0.725289	5e-08	7.301029995663981		0.0117199	[0.0075-0.0159] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10p15.1	10	6087347	NR	RPL32P23 - RBM17	ENSG00000214015	ENSG00000134453		15429.0	1687.0	rs75641219-T	rs75641219	0	75641219.0	intergenic_variant	1.0	0.994972	3e-08	7.522878745280337		0.0769511	[0.05-0.104] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q22.2	15	63036763	NR	NA - TPM1		ENSG00000140416			5869.0	rs76162994-A	rs76162994	0	76162994.0	intergenic_variant	1.0	0.845697	4e-08	7.397940008672037		0.0146184	[0.0094-0.0198] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		3q25.1	3	149406996	NR	TM4SF1-AS1 - RPL32P8	ENSG00000240541	ENSG00000240246		20413.0	26048.0	rs7645585-C	rs7645585	0	7645585.0	intergenic_variant	1.0	0.253335	1e-08	8.0		0.0126101	[0.0082-0.017] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11p15.2	11	14477390	NR	COPB1			ENSG00000129083			rs769117329-CA	rs769117329	0	769117329.0	intron_variant	0.0	0.404225	2e-08	7.698970004336019		0.0114474	[0.0075-0.0154] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		5q11.2	5	54014309	NR	ARL15			ENSG00000185305			rs7735249-C	rs7735249	0	7735249.0	intron_variant	0.0	0.887265	2e-08	7.698970004336019		0.0171391	[0.011-0.023] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		6p25.1	6	6972360	NR	RN7SL554P - RREB1	ENSG00000240936	ENSG00000124782		33463.0	135237.0	rs942922-G	rs942922	0	942922.0	intergenic_variant	1.0	0.67878	2e-08	7.698970004336019		0.0116349	[0.0076-0.0157] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		17p13.3	17	1719561	NR	WDR81, WDR81			ENSG00000167716, ENSG00000276021			rs11431553-A	rs11431553	0	11431553.0	intron_variant	0.0	0.701037	3e-10	9.522878745280336		0.0138204	[0.0095-0.0181] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		21q22.12	21	36180834	NR	DOP1B			ENSG00000142197			rs11911615-T	rs11911615	0	11911615.0	intron_variant	0.0	0.671868	5e-10	9.30102999566398		0.0127873	[0.0088-0.0168] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q13.33	22	49674346	NR	MIR3667HG - RN7SKP252	ENSG00000188511	ENSG00000223142		16804.0	64331.0	rs1807675-T	rs1807675	0	1807675.0	intergenic_variant	1.0	0.362062	7e-10	9.154901959985745		0.0124787	[0.0085-0.0165] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11q24.2	11	126357131	NR	ST3GAL4			ENSG00000110080			rs1893351-C	rs1893351	0	1893351.0	intron_variant	0.0	0.971758	4e-10	9.397940008672036		0.0371287	[0.026-0.049] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q13.31	22	43945024	NR	PNPLA3			ENSG00000100344			rs2294915-C	rs2294915	0	2294915.0	intron_variant	0.0	0.768407	6e-10	9.221848749616356		0.0141373	[0.0097-0.0186] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q12.3	22	35280146	NR	HMGXB4			ENSG00000100281			rs35288294-C	rs35288294	0	35288294.0	intron_variant	0.0	0.347458	7e-10	9.154901959985745		0.012491	[0.0085-0.0165] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11p15.5	11	778857	NR	GATD1 - CEND1	ENSG00000177225	ENSG00000184524		1369.0	8258.0	rs61876729-A	rs61876729	0	61876729.0	intron_variant	1.0	0.906038	6e-10	9.221848749616356		0.020453	[0.014-0.027] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		1p36.22	1	10738495	NR	CASZ1			ENSG00000130940			rs682178-T	rs682178	0	682178.0	intron_variant	0.0	0.631643	5e-10	9.30102999566398		0.0122107	[0.0084-0.0161] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7p21.1	7	17247645	NR	AHR			ENSG00000106546			rs6968865-A	rs6968865	0	6968865.0	5_prime_UTR_variant	0.0	0.372116	4e-10	9.397940008672036		0.0122478	[0.0084-0.0161] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		17p13.3	17	2039567	NR	DPH1			ENSG00000108963			rs7207466-C	rs7207466	0	7207466.0	non_coding_transcript_exon_variant	0.0	0.270168	6e-10	9.221848749616356		0.0134091	[0.0092-0.0176] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q22.2	15	62073266	NR	C2CD4A - NPM1P47	ENSG00000198535	ENSG00000259466		2349.0	9184.0	rs72749770-C	rs72749770	0	72749770.0	intergenic_variant	1.0	0.547299	9e-10	9.045757490560677		0.011851	[0.0081-0.0156] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10q25.3	10	114026474	NR	NHLRC2 - ADRB1	ENSG00000196865	ENSG00000043591		109280.0	17392.0	rs72823013-G	rs72823013	0	72823013.0	intergenic_variant	1.0	0.873563	2e-10	9.69897000433602		0.0184463	[0.013-0.024] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10p11.22	10	31957010	NR	ARHGAP12 - RPL34P19	ENSG00000165322	ENSG00000230240		28134.0	26875.0	rs796526078-TA	rs796526078	1	201700897.0	intergenic_variant	1.0	0.554468	1e-10	10.0		0.0132548	[0.0092-0.0173] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		14q13.1	14	34717488	NR	CFL2 - RPL12P6	ENSG00000165410	ENSG00000243824		2665.0	22848.0	rs11846704-C	rs11846704	0	11846704.0	upstream_gene_variant	1.0	0.73116	3e-09	8.522878745280337		0.0128621	[0.0086-0.0171] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7p15.1	7	28152174	NR	JAZF1			ENSG00000153814			rs12055996-T	rs12055996	0	12055996.0	intron_variant	0.0	0.91827	4e-09	8.397940008672037		0.0204948	[0.014-0.027] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		3q25.31	3	155828335	NR	SLC33A1			ENSG00000169359			rs138283229-C	rs138283229	1	76440173.0	missense_variant	0.0	0.995046	5e-09	8.301029995663981		0.0795274	[0.053-0.106] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		5p13.2	5	34713687	NR	RAI14			ENSG00000039560			rs146433259-C	rs146433259	0	146433259.0	intron_variant	0.0	0.988308	1e-09	9.0		0.0577472	[0.039-0.076] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11p14.3	11	26061460	NR							rs1489502-C	rs1489502	0	1489502.0	intergenic_variant	1.0	0.120095	3e-09	8.522878745280337		0.0173801	[0.012-0.023] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q11.21	22	19961490	NR	COMT			ENSG00000093010			rs165722-C	rs165722	0	165722.0	intron_variant	0.0	0.484285	3e-09	8.522878745280337		0.0114996	[0.0077-0.0153] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		22q12.2	22	30221596	NR	HORMAD2 - LIF-AS1	ENSG00000176635	ENSG00000232530		44521.0	17598.0	rs16988410-T	rs16988410	0	16988410.0	TF_binding_site_variant	1.0	0.953773	7e-09	8.154901959985743		0.0265452	[0.018-0.036] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		4p16.1	4	8222549	NR	SH3TC1			ENSG00000125089			rs2002574-T	rs2002574	0	2002574.0	intron_variant	0.0	0.73602	2e-09	8.698970004336019		0.0130536	[0.0088-0.0173] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		16p13.12	16	14287318	NR	Y_RNA - MIR193BHG	ENSG00000264495	ENSG00000262454		11718.0	14071.0	rs246179-G	rs246179	0	246179.0	intergenic_variant	1.0	0.616282	8e-09	8.096910013008056		0.011403	[0.0075-0.0153] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		18q11.2	18	23533321	NR	NPC1			ENSG00000141458			rs2510344-T	rs2510344	0	2510344.0	non_coding_transcript_exon_variant	0.0	0.509842	2e-09	8.698970004336019		0.0116266	[0.0079-0.0154] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7q22.3	7	107160643	NR	PRKAR2B			ENSG00000005249			rs257377-G	rs257377	0	257377.0	3_prime_UTR_variant	0.0	0.79674	2e-09	8.698970004336019		0.0143025	[0.0096-0.019] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q26.3	15	101305277	NR	PCSK6, SNRPA1-DT			ENSG00000140479, ENSG00000259172			rs34631529-G	rs34631529	0	34631529.0	missense_variant	0.0	0.99483	6e-09	8.221848749616356		0.0777648	[0.052-0.104] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7p15.2	7	25952206	NR	MIR148A - NFE2L3	ENSG00000199085	ENSG00000050344		2220.0	199992.0	rs4722551-T	rs4722551	0	4722551.0	upstream_gene_variant	1.0	0.841323	6e-37	36.22184874961636		0.0332192	[0.028-0.038] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		19q13.43	19	58150868	NR	ZNF329			ENSG00000181894			rs35081008-C	rs35081008	0	35081008.0	intron_variant	0.0	0.852153	9e-35	34.045757490560675		0.0322757	[0.027-0.037] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		8q24.3	8	143977246	NR	PARP10			ENSG00000178685			rs1134027-G	rs1134027	0	1134027.0	3_prime_UTR_variant	0.0	0.630063	2.0000000000000003e-34	33.69897000433602		0.0243881	[0.02-0.028] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		5q11.2	5	56561722	NR	C5orf67			ENSG00000225940			rs547065676-A	rs547065676	1	11450869.0	intron_variant	0.0	0.809433	2e-31	30.69897000433602		0.0286141	[0.024-0.033] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		14q32.13	14	94380925	NR	SERPINA1, SERPINA1			ENSG00000197249, ENSG00000277377			rs17580-T	rs17580	0	17580.0	missense_variant	0.0	0.952305	3.9999999999999996e-30	29.39794000867204		0.0514106	[0.043-0.06] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		5q11.2	5	52787392	NR	MFSD4BP1 - ITGA1	ENSG00000250827	ENSG00000213949		206286.0	524.0	rs115421711-A	rs115421711	0	115421711.0	intron_variant	1.0	0.959036	2.0000000000000002e-29	28.69897000433602		0.0544016	[0.045-0.064] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11p15.1	11	18617165	NR	SPTY2D1			ENSG00000179119			rs10500834-A	rs10500834	0	10500834.0	intron_variant	0.0	0.260904	1.0000000000000001e-28	28.0		0.0241684	[0.02-0.028] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		4q31.3	4	154568456	NR	FGB			ENSG00000171564			rs6054-C	rs6054	0	6054.0	missense_variant	0.0	0.994312	6e-26	25.22184874961636		0.138318	[0.11-0.16] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10q26.13	10	122927140	NR	FAM24A - C10orf88	ENSG00000203795	ENSG00000119965		14029.0	3761.0	rs10794579-T	rs10794579	0	10794579.0	intergenic_variant	1.0	0.42467	1.9999999999999998e-25	24.69897000433602		0.0201777	[0.016-0.024] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		17q25.3	17	78386710	NR	PGS1			ENSG00000087157			rs12948394-C	rs12948394	0	12948394.0	intron_variant	0.0	0.51766	1.9999999999999998e-25	24.69897000433602		0.0202562	[0.016-0.024] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		Xp22.33	X	2938114	NR	ARSL			ENSG00000157399			rs35143646-C	rs35143646	0	35143646.0	missense_variant	0.0	0.339396	1.9999999999999998e-25	24.69897000433602		0.0175742	[0.014-0.021] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		14q24.2	14	70304150	NR	ADAM21P1 - COX16	ENSG00000235812	ENSG00000133983		56349.0	20931.0	rs8005362-A	rs8005362	0	8005362.0	intron_variant	1.0	0.527696	1.9999999999999998e-25	24.69897000433602		0.0201149	[0.016-0.024] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		1p36.13	1	16186091	NR	EPHA2 - ARHGEF19-AS1	ENSG00000142627	ENSG00000234166		30022.0	11763.0	rs12078100-C	rs12078100	0	12078100.0	intergenic_variant	1.0	0.376535	2.0000000000000002e-24	23.69897000433602		0.0199294	[0.016-0.024] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		14q24.3	14	73783423	NR	MIDEAS			ENSG00000156030			rs13379043-T	rs13379043	0	13379043.0	intron_variant	0.0	0.720018	8.000000000000001e-24	23.096910013008056		0.0219466	[0.018-0.026] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		16q23.3	16	83946924	NR	OSGIN1, MLYCD			ENSG00000140961, ENSG00000103150			rs4782568-C	rs4782568	0	4782568.0	intron_variant	0.0	0.548655	1.0000000000000001e-24	24.0		0.0198789	[0.016-0.024] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		18q21.1	18	49583585	NR	LIPG			ENSG00000101670			rs77960347-A	rs77960347	0	77960347.0	missense_variant	0.0	0.986653	3e-24	23.522878745280337		0.0851286	[0.069-0.102] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		16p13.13	16	11612244	NR	LITAF			ENSG00000189067			rs12445804-G	rs12445804	0	12445804.0	intron_variant	0.0	0.925127	5e-23	22.30102999566398		0.0363752	[0.029-0.044] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		9p24.2	9	2640759	NR	VLDLR			ENSG00000147852			rs3780181-A	rs3780181	0	3780181.0	non_coding_transcript_exon_variant	0.0	0.932446	1.0000000000000001e-23	23.0		0.0385591	[0.031-0.046] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		17q25.1	17	75882573	NR	TRIM65			ENSG00000141569			rs56000661-A	rs56000661	0	56000661.0	intron_variant	0.0	0.688336	1.0000000000000001e-23	23.0		0.0207389	[0.017-0.025] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		21q22.2	21	39338034	NR	BRWD1-AS1 - HMGN1	ENSG00000238141	ENSG00000205581		14816.0	4281.0	rs1963676-C	rs1963676	0	1963676.0	downstream_gene_variant	1.0	0.435396	2e-22	21.69897000433602		0.0189758	[0.015-0.023] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7q32.2	7	130760670	NR	KLF14 - H4P1	ENSG00000266265	ENSG00000240680		26463.0	62535.0	rs35363532-C	rs35363532	0	35363532.0	intergenic_variant	1.0	0.508297	3e-22	21.522878745280337		0.0186209	[0.015-0.022] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		5q13.2	5	72714474	NR	LINC02056 - RPL7P22	ENSG00000248371	ENSG00000226544		53805.0	10945.0	rs3010239-G	rs3010239	0	3010239.0	intron_variant	1.0	0.790123	2e-21	20.69897000433602		0.022256	[0.018-0.027] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p13.32	12	4275678	NR	CCND2, CCND2-AS1			ENSG00000118971, ENSG00000255920			rs76895963-T	rs76895963	0	76895963.0	non_coding_transcript_exon_variant	0.0	0.979288	1e-21	21.0		0.0709513	[0.056-0.085] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		9p22.2	9	16884588	NR	BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		13745.0	169313.0	rs10810657-T	rs10810657	0	10810657.0	regulatory_region_variant	1.0	0.375323	5e-20	19.30102999566398		0.0182458	[0.014-0.022] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12p13.31	12	9053207	NR	VDAC2P2 - LINC00612	ENSG00000255776	ENSG00000214851		15963.0	2382.0	rs201319146-CG	rs201319146	0	201319146.0	intergenic_variant	1.0	0.643581	2e-20	19.69897000433602		0.0186527	[0.015-0.023] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals					NR							chr8:126504383-CCACCAT	chr8:126504383	0			1.0	0.40301	5e-324	323.30102999566395		0.0807714	[0.077-0.085] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		2p24.1	2	21152474	NR	TDRD15 - NA	ENSG00000218819			8106.0		rs312976-G	rs312976	0	312976.0	intergenic_variant	1.0	0.298952	5e-324	323.30102999566395		0.0794248	[0.075-0.083] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		19q13.32	19	44918393	NR	APOC1			ENSG00000130208			rs140480140-G	rs140480140	0	140480140.0	intron_variant	0.0	0.97168	4e-323	322.39794000867204		0.216585	[0.21-0.23] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		6q25.3	6	160589086	NR	LPA			ENSG00000198670			rs10455872-A	rs10455872	0	10455872.0	intron_variant	0.0	0.920929	3e-321	320.5228787452804		0.135534	[0.13-0.14] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		5q13.3	5	75307654	NR	ANKRD31 - HMGCR	ENSG00000145700	ENSG00000113161		70743.0	28675.0	rs2335418-G	rs2335418	0	2335418.0	intergenic_variant	1.0	0.579942	5e-321	320.30102999566395		0.074248	[0.07-0.078] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11q23.3	11	116778201	NR	ZPR1			ENSG00000109917			rs964184-G	rs964184	0	964184.0	3_prime_UTR_variant	0.0	0.133391	2e-316	315.69897000433605		0.106826	[0.1-0.11] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		1p13.3	1	109233663	NR	SARS1			ENSG00000031698			rs35271870-T	rs35271870	0	35271870.0	intron_variant	0.0	0.912531	8e-304	303.0969100130081		0.124867	[0.12-0.13] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		9q34.2	9	133266456	NR	ABO, ABO			ENSG00000175164, ENSG00000281879			rs2519093-C	rs2519093	0	2519093.0	intron_variant	0.0	0.815454	2e-228	227.698970004336		0.079807	[0.075-0.085] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		16q22.2	16	72067626	NR	HPR, TXNL4B			ENSG00000261701, ENSG00000140830			rs34042070-C	rs34042070	0	34042070.0	intron_variant	0.0	0.812364	1e-177	177.0		0.0700152	[0.065-0.075] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20q12	20	40551182	NR	LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		539859.0	134666.0	rs1883711-G	rs1883711	0	1883711.0	regulatory_region_variant	1.0	0.968555	4.0000000000000004e-171	170.39794000867204		0.156174	[0.15-0.17] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		17q24.2	17	69085137	NR	ABCA6			ENSG00000154262			rs77542162-A	rs77542162	0	77542162.0	missense_variant	0.0	0.977412	3e-169	168.52287874528034		0.17887	[0.17-0.19] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		Xq23	X	110520525	NR	TDGF1P3			ENSG00000225366			rs5942956-G	rs5942956	0	5942956.0	5_prime_UTR_variant	0.0	0.605477	2e-102	101.69897000433602		0.0351754	[0.032-0.038] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7p13	7	44542732	NR	NPC1L1 - DDX56	ENSG00000015520	ENSG00000136271		1402.0	23072.0	rs2073547-A	rs2073547	0	2073547.0	intergenic_variant	1.0	0.816043	4.0000000000000003e-88	87.39794000867204		0.0488167	[0.044-0.054] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		7p15.3	7	21562042	NR	DNAH11			ENSG00000105877			rs150169808-G	rs150169808	0	150169808.0	intron_variant	0.0	0.783315	2e-87	86.69897000433602		0.0462388	[0.042-0.051] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		12q24.31	12	120978847	NR	HNF1A-AS1, HNF1A			ENSG00000241388, ENSG00000135100			rs1169288-A	rs1169288	0	1169288.0	missense_variant	0.0	0.684239	2.9999999999999996e-76	75.52287874528034		0.0383025	[0.034-0.042] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		20p12.1	20	17863848	NR	BANF2 - RNU6-192P	ENSG00000125888	ENSG00000212555		127977.0	39914.0	rs2618567-G	rs2618567	0	2618567.0	regulatory_region_variant	1.0	0.34124	3e-73	72.52287874528034		0.036634	[0.033-0.041] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		3p25.2	3	12285932	NR	GSTM5P1 - PPARG	ENSG00000236062	ENSG00000132170		27472.0	1436.0	rs13076933-T	rs13076933	0	13076933.0	upstream_gene_variant	1.0	0.740546	8.000000000000001e-49	48.096910013008056		0.0322061	[0.028-0.037] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		4q13.2	4	68625566	NR	UGT2B17 - UGT2B15	ENSG00000197888	ENSG00000277132		49153.0	21031.0	rs4860987-A	rs4860987	0	4860987.0	downstream_gene_variant	1.0	0.740467	6e-49	48.22184874961636		0.0339193	[0.029-0.038] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals					NR							chr13:32976656-GC	chr13:32976656	0			1.0	0.522797	4e-47	46.39794000867204		0.0282486	[0.024-0.032] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		13q34	13	113849020	NR	GAS6			ENSG00000183087			rs6602909-T	rs6602909	0	6602909.0	intron_variant	0.0	0.672976	2.9999999999999997e-47	46.52287874528034		0.0296194	[0.026-0.034] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		10q23.33	10	93079885	NR	CYP26A1 - NIP7P1	ENSG00000095596	ENSG00000232805		2000.0	26987.0	rs2068888-G	rs2068888	0	2068888.0	downstream_gene_variant	1.0	0.549363	2e-46	45.69897000433602		0.0275689	[0.024-0.031] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		14q12	14	24402720	NR	NYNRIN			ENSG00000205978			rs11621792-C	rs11621792	0	11621792.0	intron_variant	0.0	0.547101	5e-43	42.30102999566398		0.0267004	[0.023-0.031] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		4p16.3	4	3442204	NR	HGFAC			ENSG00000109758			rs13108218-A	rs13108218	0	13108218.0	intron_variant	0.0	0.384571	1e-43	43.0		0.0275204	[0.024-0.031] unit increase	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		15q21.3	15	58430392	NR	LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs35980001-G	rs35980001	0	35980001.0	intron_variant	0.0	0.786565	1e-43	43.0		0.0327125	[0.028-0.037] unit decrease	Affymetrix [15000001]	N
2020-08-19	32493714	Klimentidis YC	2020-06-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/32493714	Phenotypic and Genetic Characterization of Lower LDL-C and Increased Type-2 Diabetes Risk in the UK Biobank.	Low density lipoprotein cholesterol levels	431,167 European ancestry individuals		11p15.4	11	5679844	NR	TRIM5			ENSG00000132256			rs11601507-C	rs11601507	0	11601507.0	missense_variant	0.0	0.930663	2.9999999999999998e-40	39.52287874528034		0.0493409	[0.042-0.057] unit decrease	Affymetrix [15000001]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		9q31.3	9	108918079	IKBKAP	ELP1			ENSG00000070061			rs16913693-G	rs16913693	0	16913693.0	3_prime_UTR_variant	0.0	0.0261591424111812	5e-06	5.301029995663981	(EA)	0.04786989	[0.027-0.069] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	0.0720163097610618	1e-06	6.0	(AA)	0.08397075	[0.05-0.118] unit increase	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		6p21.2	6	39079018	GLP1R	GLP1R			ENSG00000112164			rs10305492-A	rs10305492	0	10305492.0	missense_variant	0.0	0.01	3e-12	11.522878745280336		0.09	[0.065-0.115] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		9q34.2	9	133278431	ABO	ABO - Y_RNA	ENSG00000281879	ENSG00000264495		2407.0	59297.0	rs651007-A	rs651007	0	651007.0	upstream_gene_variant	1.0	0.2	1e-08	8.0		0.02	[0.012-0.028] unit increase	Illumina [197481]	N
2019-04-09	30767168	Shin JH	2019-02-14	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/30767168	Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	74 East Asian ancestry lymphoblastoid cell lines		1q23.3	1	163466050	NUF2	NA - RNA5SP62		ENSG00000200327			2446.0	rs10917760-T	rs10917760	0	10917760.0	intergenic_variant	1.0	0.98	3e-07	6.522878745280337		1.94	NR unit decrease	Affymetrix [352228] (imputed)	N
2019-04-09	30767168	Shin JH	2019-02-14	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/30767168	Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	74 East Asian ancestry lymphoblastoid cell lines		3p24.1	3	30693408	TGFBR2	TGFBR2			ENSG00000163513			rs6550008-T	rs6550008	0	6550008.0	3_prime_UTR_variant	0.0	0.99	2e-07	6.698970004336019		1.64	NR unit decrease	Affymetrix [352228] (imputed)	N
2019-04-09	30767168	Shin JH	2019-02-14	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/30767168	Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	74 East Asian ancestry lymphoblastoid cell lines		6p25.1	6	4957941	CDYL	CDYL - RPP40	ENSG00000153046	ENSG00000124787		2390.0	36776.0	rs795816-G	rs795816	0	795816.0	TF_binding_site_variant	1.0	0.97	7e-07	6.154901959985743		1.93	NR unit decrease	Affymetrix [352228] (imputed)	N
2019-04-09	30767168	Shin JH	2019-02-14	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/30767168	Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	74 East Asian ancestry lymphoblastoid cell lines		11p15.1	11	21226045	NELL1	NELL1			ENSG00000165973			rs10833478-G	rs10833478	0	10833478.0	intron_variant	0.0	0.71	4e-07	6.3979400086720375		0.45	NR unit decrease	Affymetrix [352228] (imputed)	N
2019-04-09	30767168	Shin JH	2019-02-14	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/30767168	Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	74 East Asian ancestry lymphoblastoid cell lines		12p13.1	12	13799202	GRIN2B	GRIN2B			ENSG00000273079			rs2300268-C	rs2300268	0	2300268.0	intron_variant	0.0	0.99	7e-07	6.154901959985743		1.93	NR unit decrease	Affymetrix [352228] (imputed)	N
2019-04-09	30767168	Shin JH	2019-02-14	Genes Genomics	www.ncbi.nlm.nih.gov/pubmed/30767168	Genetic risk score combining six genetic variants associated with the cellular NRF2 expression levels correlates with Type 2 diabetes in the human population.	Cellular nuclear factor (erythroid-derived 2)-like 2 levels	74 East Asian ancestry lymphoblastoid cell lines		20q13.33	20	62717268	NTSR1	NTSR1			ENSG00000101188			rs2427407-G	rs2427407	0	2427407.0	intron_variant	0.0	0.94	3e-07	6.522878745280337		0.84	NR unit decrease	Affymetrix [352228] (imputed)	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood insulin	35,380 European ancestry non-diabetic individuals, 12,738 African American non-diabetic individuals		1q41	1	219527177	LYPLAL1	LYPLAL1-AS1 - ZC3H11B	ENSG00000228536	ENSG00000215817		67808.0	80833.0	rs2785980-C	rs2785980	0	2785980.0	intergenic_variant	1.0	0.292340542493901	3e-09	8.522878745280337		0.017520346	[0.012-0.023] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood insulin	35,380 European ancestry non-diabetic individuals, 12,738 African American non-diabetic individuals		2p23.3	2	27518370	GCKR	GCKR			ENSG00000084734			rs780094-A	rs780094	0	780094.0	intron_variant	0.0	0.365345272103835	3e-10	9.522878745280336		0.017745968	[0.012-0.023] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood insulin	35,380 European ancestry non-diabetic individuals, 12,738 African American non-diabetic individuals		2q24.3	2	164694691	GRB14	COBLL1			ENSG00000082438			rs7607980-C	rs7607980	0	7607980.0	missense_variant	0.0	0.132599438204585	6e-11	10.221848749616356		0.026085194	[0.018-0.034] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood insulin	35,380 European ancestry non-diabetic individuals, 12,738 African American non-diabetic individuals		2q36.3	2	226203364	IRS1	NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		549346.0	455346.0	rs2943634-A	rs2943634	0	2943634.0	intergenic_variant	1.0	0.380538425555148	1e-12	12.0		0.020344472	[0.015-0.026] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood insulin	35,380 European ancestry non-diabetic individuals, 12,738 African American non-diabetic individuals		3p25.2	3	12348985	PPARG	PPARG			ENSG00000132170			rs17036328-G	rs17036328	0	17036328.0	intron_variant	0.0	0.10323383320661	7e-13	12.154901959985745		0.031257037	[0.023-0.04] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood insulin	35,380 European ancestry non-diabetic individuals, 12,738 African American non-diabetic individuals		5q11.2	5	56510924	ANKRD5, MAP3K1	RPL26P19 - C5orf67	ENSG00000226221	ENSG00000225940		5852.0	643.0	rs459193-T	rs459193	0	459193.0	downstream_gene_variant	1.0	0.287281916216699	2e-11	10.69897000433602		0.020481508	[0.015-0.026] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood insulin	35,380 European ancestry non-diabetic individuals, 12,738 African American non-diabetic individuals		8p23.1	8	9326086	PPP1R3B	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		38508.0	45004.0	rs4841132-A	rs4841132	0	4841132.0	non_coding_transcript_exon_variant	1.0	0.0888874869713659	1e-07	7.0		0.025656354	[0.016-0.035] unit increase	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		2p23.3	2	27518370	GCKR	GCKR			ENSG00000084734			rs780094-A	rs780094	0	780094.0	intron_variant	0.0	0.361159200900683	9.000000000000001e-23	22.045757490560675		0.03156466	[0.025-0.038] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		2q31.1	2	168906638	G6PC2	SPC25, SPC25, G6PC2, G6PC2			ENSG00000152253, ENSG00000277909, ENSG00000152254, ENSG00000278373			rs560887-A	rs560887	0	560887.0	intron_variant	0.0	0.258483922703246	4e-87	86.39794000867204		0.079494834	[0.072-0.087] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		3q21.1	3	123346931	ADCY5	ADCY5			ENSG00000173175			rs11708067-G	rs11708067	0	11708067.0	intron_variant	0.0	0.213381965316371	4e-16	15.397940008672036		0.030359665	[0.023-0.038] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		3q26.2	3	170999732	SLC2A2	SLC2A2			ENSG00000163581			rs11920090-A	rs11920090	0	11920090.0	intron_variant	0.0	0.165230247445282	5e-08	7.301029995663981		0.023512341	[0.015-0.032] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		6p22.3	6	20686765	CDKAL1	CDKAL1			ENSG00000145996			rs9368222-G	rs9368222	0	9368222.0	intron_variant	0.0	0.316134219089604	7e-06	5.154901959985743		0.015484853	[0.0087-0.0222] unit increase	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		7p21.2	7	15024684	DGKB, TMEM195	GTF3AP5 - NA	ENSG00000225816			38610.0		rs2191349-G	rs2191349	0	2191349.0	intergenic_variant	1.0	0.452877416253482	4e-12	11.397940008672036		0.021517994	[0.015-0.028] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		7p13	7	44196069	GCK	GCK			ENSG00000106633			rs4607517-A	rs4607517	0	4607517.0	intron_variant	0.0	0.156283963358949	9.999999999999999e-51	50.0		0.06261599	[0.054-0.071] unit increase	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		8p23.1	8	9326086	PPP1R3B	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		38508.0	45004.0	rs4841132-A	rs4841132	0	4841132.0	non_coding_transcript_exon_variant	1.0	0.0901823785419197	8e-12	11.096910013008056		0.03679102	[0.026-0.047] unit increase	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		8q24.11	8	117173494	SLC30A8	SLC30A8			ENSG00000164756			rs11558471-G	rs11558471	0	11558471.0	3_prime_UTR_variant	0.0	0.281391278898959	5e-24	23.30102999566398		0.03468724	[0.028-0.041] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		9p24.2	9	4289050	GLIS3	GLIS3			ENSG00000107249			rs7034200-C	rs7034200	0	7034200.0	intron_variant	0.0	0.496543973312704	3e-08	7.522878745280337		0.017206302	[0.011-0.023] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		9p21.3	9	22134095	CDKN2B	CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		5992.0	312729.0	rs10811661-G	rs10811661	0	10811661.0	intergenic_variant	1.0	0.184824870776567	2e-07	6.698970004336019		0.020698218	[0.013-0.029] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		10q25.2	10	112996282	TCF7L2	TCF7L2			ENSG00000148737			rs4506565-T	rs4506565	0	4506565.0	intron_variant	0.0	0.329613833793701	3e-13	12.522878745280336		0.024141746	[0.018-0.031] unit increase	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		11p11.2	11	47314769	MADD	MADD			ENSG00000110514			rs7944584-T	rs7944584	0	7944584.0	intron_variant	0.0	0.238511761691845	5e-12	11.30102999566398		0.024974186	[0.018-0.032] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		11q12.2	11	61804006	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824			rs174550-C	rs174550	0	174550.0	5_prime_UTR_variant	0.0	0.296351500690675	2e-09	8.698970004336019		0.020597532	[0.014-0.027] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		11q13.4	11	72721940	ARAP1	ARAP1			ENSG00000186635			rs11603334-A	rs11603334	0	11603334.0	5_prime_UTR_variant	0.0	0.137458222039974	2e-06	5.698970004336019		0.021059299	[0.012-0.03] unit decrease	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	0.240006758042847	5.0000000000000004e-89	88.30102999566398		0.07237465	[0.065-0.079] unit increase	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		13q12.2	13	27913462	PDX1	PLUT			ENSG00000247381			rs11619319-G	rs11619319	0	11619319.0	intron_variant	0.0	0.211522206149027	5e-08	7.301029995663981		0.020431833	[0.013-0.028] unit increase	Illumina [197481]	N
2019-06-17	25631608	Wessel J	2015-01-29	Nat Commun	www.ncbi.nlm.nih.gov/pubmed/25631608	Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.	Fasting blood glucose	50,900 European ancestry non-diabetic individuals, 9,664 African American non-diabetic individuals		13q13.1	13	32980164	KL	TOMM22P3 - KL	ENSG00000227604	ENSG00000133116		25763.0	36259.0	rs576674-G	rs576674	0	576674.0	intergenic_variant	1.0	0.237344679637169	2e-06	5.698970004336019		0.019068338	[0.011-0.027] unit increase	Illumina [197481]	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	2q31.1	2	168921085	ABCB11, G6PC2	ABCB11, ABCB11			ENSG00000073734, ENSG00000276582			rs557462-C	rs557462	0	557462.0	3_prime_UTR_variant	0.0	0.182	6e-29	28.22184874961636		0.03	[0.01-0.05] % decrease	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	7p13	7	44186502	GCK	GCK			ENSG00000106633			rs2971670-T	rs2971670	0	2971670.0	intron_variant	0.0	0.202	3e-11	10.522878745280336		0.04	[0.02-0.06] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	8p11.21	8	41772929	ANK1	ANK1			ENSG00000029534			rs4737010-A	rs4737010	0	4737010.0	intron_variant	0.0	0.263	5e-10	9.30102999566398		0.03	[0.01-0.05] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	10q22.1	10	69339353	HK1	HK1			ENSG00000156515			rs72805692-G	rs72805692	0	72805692.0	intron_variant	0.0	0.066	6e-26	25.22184874961636		0.1	[0.08-0.12] % decrease	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	17q25.3	17	82735405	FN3K	FN3KRP - FN3K	ENSG00000141560	ENSG00000167363		5077.0	210.0	rs2256339-T	rs2256339	0	2256339.0	TF_binding_site_variant	1.0	0.475	2e-11	10.69897000433602		0.03	[0.01-0.05] % decrease	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	22q12.3	22	37066896	TMPRSS6	TMPRSS6			ENSG00000187045			rs855791-A	rs855791	0	855791.0	missense_variant	0.0	0.438	9e-10	9.045757490560677		0.03	[0.01-0.05] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	1p36.32	1	3802028	CEP104	LRRC47 - CEP104	ENSG00000130764	ENSG00000116198		5530.0	10058.0	rs113282222-TGGAG	rs113282222	0	113282222.0	regulatory_region_variant	1.0	0.173	6e-06	5.221848749616356		0.031	[0.019-0.043] % decrease	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	1q32.3	1	212371300	TM1EM206	PACC1			ENSG00000065600			rs199584848-A	rs199584848	0	199584848.0	intron_variant	0.0	0.024	2e-07	6.698970004336019		0.08	[0.051-0.109] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	3q25.32	3	159187070	IQCJ-SCHIP1	IQCJ-SCHIP1, IQCJ			ENSG00000283154, ENSG00000214216			rs10513537-G	rs10513537	0	10513537.0	intron_variant	0.0	0.209	3e-06	5.522878745280337		0.031	[0.019-0.043] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	6p21.32	6	32701596	HLA-DQA2	HLA-DQB1 - MTCO3P1	ENSG00000231286	ENSG00000237145		33213.0	4528.0	rs11752643-T	rs11752643	0	11752643.0	intergenic_variant	1.0	0.017	2e-06	5.698970004336019		0.096	[0.061-0.131] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	8p12	8	36068884	UNC5D							rs6992753-A	rs6992753	0	6992753.0	intron_variant	1.0	0.016	1e-06	6.0		0.111	[0.072-0.15] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	10p13	10	16176533	FAM188A	NA - RNU6-1075P		ENSG00000201260			31288.0	rs116781682-T	rs116781682	0	116781682.0	intergenic_variant	1.0	0.012	3e-07	6.522878745280337		0.118	[0.073-0.163] % decrease	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	11p15.4	11	5227002	HBB	HBB			ENSG00000244734			rs334-A	rs334	0	334.0	missense_variant	0.0	0.013	3e-39	38.52287874528034		0.305	[0.26-0.35] % decrease	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	16p13.3	16	170584	HBM	HBAP1 - HBA2	ENSG00000225323	ENSG00000188536		1250.0	2292.0	rs145546625-T	rs145546625	0	145546625.0	regulatory_region_variant	1.0	0.066	1e-09	9.0		0.059	[0.039-0.079] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	17q25.3	17	78128784	TMC6	TMC6			ENSG00000141524			rs2748424-G	rs2748424	0	2748424.0	intron_variant	0.0	0.179	1e-16	16.0		0.051	[0.039-0.063] % increase	Illumina [11510031] (imputed)	N
2019-08-12	31213470	Moon JY	2019-06-18	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/31213470	A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos.	Glycated hemoglobin levels	9,636 Hispanic/Latino individuals	4,777 Hispanic/Latino individuals	Xq28	X	154536002	G6PD	G6PD			ENSG00000160211			rs1050828-T	rs1050828	0	1050828.0	missense_variant	0.0	0.02	1e-133	133.0		0.346	[0.32-0.37] % decrease	Illumina [11510031] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Percent glycated albumin	7,647 European ancestry individuals, 2,104 Black individuals	1,304 European ancestry individuals, 608 Black individuals	17q24.2	17	66530870	PRKCA	PRKCA			ENSG00000154229			rs59443763-C	rs59443763	0	59443763.0	intron_variant	0.0	0.06	4e-09	8.397940008672037	(AA, initial)	0.05	[0.032-0.068] unit increase	Affymetrix [NR] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Percent glycated albumin	7,647 European ancestry individuals, 2,104 Black individuals	1,304 European ancestry individuals, 608 Black individuals	2p23.3	2	27508073	GCKR	GCKR			ENSG00000084734			rs1260326-T	rs1260326	0	1260326.0	missense_variant	0.0	0.41	2e-08	7.698970004336019	(EA)	0.01	[0.0061-0.0139] unit decrease	Affymetrix [NR] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Total glycated albumin levels	7,647 European ancestry individuals, 2,104 Black individuals		19q13.33	19	49542659	RCN3	RCN3			ENSG00000142552			rs34459162-C	rs34459162	0	34459162.0	missense_variant	0.0	0.08	4e-08	7.397940008672037	(EA)	0.03	[0.02-0.04] unit decrease	Affymetrix [NR] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Total glycated albumin levels	7,647 European ancestry individuals, 2,104 Black individuals		11q22.1	11	98629680	CNTN5							rs2438321-G	rs2438321	0	2438321.0	intergenic_variant	1.0	0.11	2e-06	5.698970004336019	(AA)	0.05	[0.032-0.068] unit increase	Affymetrix [NR] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Total glycated albumin levels	7,647 European ancestry individuals, 2,104 Black individuals		17q24.2	17	66530870	PRKCA	PRKCA			ENSG00000154229			rs59443763-C	rs59443763	0	59443763.0	intron_variant	0.0	0.06	6e-07	6.221848749616356	(AA)	0.06	[0.04-0.08] unit increase	Affymetrix [NR] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Fasting blood glucose	7,647 European ancestry individuals, 2,104 Black individuals		11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	0.28	3e-07	6.522878745280337	(EA)	1.577	[0.97-2.18] unit increase	Affymetrix [NR] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Hemoglobin A1c levels	7,647 European ancestry individuals, 2,104 Black individuals		10q22.1	10	69331257	HK1	HK1			ENSG00000156515			rs10823343-G	rs10823343	0	10823343.0	intron_variant	0.0	0.26	1e-06	6.0	(EA)	0.047	[0.027-0.067] unit decrease	Affymetrix [NR] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Hemoglobin A1c levels	7,647 European ancestry individuals, 2,104 Black individuals		2q31.1	2	168900844	G6PC2	SPC25, SPC25			ENSG00000152253, ENSG00000277909			rs1402837-T	rs1402837	0	1402837.0	intron_variant	0.0	0.22	3e-07	6.522878745280337	(EA)	0.052	[0.032-0.072] unit increase	Affymetrix [NR] (imputed)	N
2018-08-10	29844224	Loomis SJ	2018-05-29	Diabetes	www.ncbi.nlm.nih.gov/pubmed/29844224	Genome-Wide Association Study of Serum Fructosamine and Glycated Albumin in Adults Without Diagnosed Diabetes: Results from the Atherosclerosis Risk in Communities Study.	Hemoglobin A1c levels	7,647 European ancestry individuals, 2,104 Black individuals		1q23.1	1	158656588	SPTA1	SPTA1			ENSG00000163554			rs857691-T	rs857691	0	857691.0	synonymous_variant	0.0	0.25	6e-06	5.221848749616356	(EA)	0.044	[0.024-0.064] unit increase	Affymetrix [NR] (imputed)	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		13q14.11	13	44128733	SERP2, LOC121838	LINC00390, SMIM2-AS1			ENSG00000226519, ENSG00000227258			rs9525916-T	rs9525916	0	9525916.0	intron_variant	0.0	0.43	7e-06	5.154901959985743	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		16p13.13	16	12091953	SNX29, FLJ32790	SNX29			ENSG00000048471			rs8048589-C	rs8048589	0	8048589.0	intron_variant	0.0	0.181	4e-06	5.3979400086720375	(Protein (control))			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		20p11.23	20	18905094	C20orf79, LOC100130062	SCP2D1-AS1 - NA	ENSG00000149443			74941.0		rs742731-A	rs742731	0	742731.0	regulatory_region_variant	1.0	0.407	2e-06	5.698970004336019	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		2q34	2	213683813	SPAG16	SPAG16			ENSG00000144451			rs6707387-A	rs6707387	0	6707387.0	intron_variant	0.0	0.272	6e-07	6.221848749616356	(Protein (control))			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		3q23	3	140504952	CLSTN2	CLSTN2			ENSG00000158258			rs9862730-A	rs9862730	0	9862730.0	intron_variant	0.0	0.109	3e-06	5.522878745280337	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		4q25	4	109806404	CFI, NOLA1	CFI - GAR1-DT	ENSG00000205403	ENSG00000272795		4405.0	8643.0	rs4698790-T	rs4698790	0	4698790.0	intergenic_variant	1.0	0.279	9e-06	5.045757490560675	(Protein (control))			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		5q12.1	5	62778891	HTR1A, ISCA1L	ISCA1P1 - NA	ENSG00000217416			1628.0		rs16891077-A	rs16891077	0	16891077.0	regulatory_region_variant	1.0	0.209	9e-10	9.045757490560677	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		6p25.2	6	3307629	SLC22A23	SLC22A23			ENSG00000137266			rs9391988-A	rs9391988	0	9391988.0	intron_variant	0.0	0.353	2e-06	5.698970004336019	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		12p13.32	12	3759002	EFCAB4B, PARP11	CRACR2A			ENSG00000130038			rs10744625-C	rs10744625	0	10744625.0	intron_variant	0.0	0.188	8e-06	5.096910013008056	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		13q34	13	111128713	ARHGEF7	ARHGEF7-IT1, ARHGEF7			ENSG00000233644, ENSG00000102606			rs12853515-G	rs12853515	0	12853515.0	intron_variant	0.0	0.14	4e-06	5.3979400086720375	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		15q25.3	15	86117489	LOC100129082, AGBL1	AGBL1			ENSG00000273540			rs12914656-C	rs12914656	0	12914656.0	intron_variant	0.0	0.114	2e-06	5.698970004336019	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		4q34.3	4	181861392	LOC728191, LOC100128118	RN7SKP13 - TENM3-AS1	ENSG00000251742	ENSG00000177822		26284.0	13046.0	rs10520514-A	rs10520514	0	10520514.0	intergenic_variant	1.0	0.415	5e-06	5.301029995663981	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		5q11.2	5	56537692	LOC441073, MAP3K1	C5orf67			ENSG00000225940			rs30360-G	rs30360	0	30360.0	non_coding_transcript_exon_variant	0.0	0.293	9e-07	6.045757490560675	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Fasting insulin (dietary factor interaction)	820 European ancestry individuals		10q23.1	10	81806930	LOC727960, NRG3	NA - NRG3		ENSG00000185737			68264.0	rs9787485-T	rs9787485	0	9787485.0	intergenic_variant	1.0	0.149	5e-08	7.301029995663981	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		12p13.32	12	3759002	EFCAB4B, PARP11	CRACR2A			ENSG00000130038			rs10744625-C	rs10744625	0	10744625.0	intron_variant	0.0	0.188	9e-06	5.045757490560675	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		5q11.2	5	56537692	LOC441073, MAP3K1	C5orf67			ENSG00000225940			rs30360-G	rs30360	0	30360.0	non_coding_transcript_exon_variant	0.0	0.293	1e-06	6.0	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		2q34	2	213683813	SPAG16	SPAG16			ENSG00000144451			rs6707387-A	rs6707387	0	6707387.0	intron_variant	0.0	0.272	1e-06	6.0	(Protein (control))			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		4q25	4	109806404	CFI, NOLA1	CFI - GAR1-DT	ENSG00000205403	ENSG00000272795		4405.0	8643.0	rs4698790-T	rs4698790	0	4698790.0	intergenic_variant	1.0	0.279	5e-06	5.301029995663981	(Protein (control))			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		5p15.2	5	14752741	ANKH	ANKH			ENSG00000154122			rs17250963-A	rs17250963	0	17250963.0	intron_variant	0.0	0.217	7e-06	5.154901959985743	(Protein (control))			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		13q14.11	13	44128733	SERP2, LOC121838	LINC00390, SMIM2-AS1			ENSG00000226519, ENSG00000227258			rs9525916-T	rs9525916	0	9525916.0	intron_variant	0.0	0.43	5e-06	5.301029995663981	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		3q23	3	140504952	CLSTN2	CLSTN2			ENSG00000158258			rs9862730-A	rs9862730	0	9862730.0	intron_variant	0.0	0.109	4e-06	5.3979400086720375	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		4q34.3	4	181861392	LOC728191, LOC100128118	RN7SKP13 - TENM3-AS1	ENSG00000251742	ENSG00000177822		26284.0	13046.0	rs10520514-A	rs10520514	0	10520514.0	intergenic_variant	1.0	0.415	5e-06	5.301029995663981	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		5q12.1	5	62778891	HTR1A, ISCA1L	ISCA1P1 - NA	ENSG00000217416			1628.0		rs16891077-A	rs16891077	0	16891077.0	regulatory_region_variant	1.0	0.209	1e-09	9.0	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		6p25.2	6	3307629	SLC22A23	SLC22A23			ENSG00000137266			rs9391988-A	rs9391988	0	9391988.0	intron_variant	0.0	0.353	2e-06	5.698970004336019	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		10q23.1	10	81806930	LOC727960, NRG3	NA - NRG3		ENSG00000185737			68264.0	rs9787485-T	rs9787485	0	9787485.0	intergenic_variant	1.0	0.149	4e-08	7.397940008672037	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		13q34	13	111128713	ARHGEF7	ARHGEF7-IT1, ARHGEF7			ENSG00000233644, ENSG00000102606			rs12853515-G	rs12853515	0	12853515.0	intron_variant	0.0	0.14	2e-06	5.698970004336019	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		15q25.3	15	86117489	LOC100129082, AGBL1	AGBL1			ENSG00000273540			rs12914656-C	rs12914656	0	12914656.0	intron_variant	0.0	0.114	2e-06	5.698970004336019	(Carbohydrate)			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		16p13.13	16	12091953	SNX29, FLJ32790	SNX29			ENSG00000048471			rs8048589-C	rs8048589	0	8048589.0	intron_variant	0.0	0.181	4e-06	5.3979400086720375	(Protein (control))			Affymetrix [590000]	N
2014-05-13	24204828	Zheng JS	2013-10-28	PLoS One	www.ncbi.nlm.nih.gov/pubmed/24204828	Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits.	Homeostasis model assessment of insulin resistance (dietary factor interaction)	820 European ancestry individuals		20p11.23	20	18905094	C20orf79, LOC100130062	SCP2D1-AS1 - NA	ENSG00000149443			74941.0		rs742731-A	rs742731	0	742731.0	regulatory_region_variant	1.0	0.407	5e-06	5.301029995663981	(Carbohydrate)			Affymetrix [590000]	N
2016-11-22	26902266	Giri AK	2016-02-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26902266	Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes.	Serum uric acid levels	1,109 Indo-European ancestry individuals	3,725 Indo-European ancestry individuals	4p16.1	4	9993558	SLC2A9	SLC2A9			ENSG00000109667			rs3775948-G	rs3775948	0	3775948.0	intron_variant	0.0	NR	2e-19	18.69897000433602		15.45	[12.10-18.80] unit decrease	Illumina [539662]	N
2016-11-22	26902266	Giri AK	2016-02-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26902266	Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes.	Serum uric acid levels	1,109 Indo-European ancestry individuals	3,725 Indo-European ancestry individuals	11q13.1	11	64566642	SLC22A11	SLC22A11			ENSG00000168065			rs2078267-A	rs2078267	0	2078267.0	non_coding_transcript_exon_variant	0.0	NR	3e-11	10.522878745280336		10.54	[7.43-13.66] unit decrease	Illumina [539662]	N
2016-11-22	26902266	Giri AK	2016-02-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26902266	Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes.	Serum uric acid levels	1,109 Indo-European ancestry individuals	3,725 Indo-European ancestry individuals	4q22.1	4	88131171	ABCG2	ABCG2			ENSG00000118777			rs2231142-A	rs2231142	0	2231142.0	missense_variant	0.0	NR	8e-08	7.096910013008056		15.75	[10.01-21.50] unit increase	Illumina [539662]	N
2016-11-22	26902266	Giri AK	2016-02-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26902266	Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes.	Serum uric acid levels	1,109 Indo-European ancestry individuals	3,725 Indo-European ancestry individuals	11q13.1	11	64589600	SLC22A12	SLC22A11 - SLC22A12	ENSG00000168065	ENSG00000197891		16725.0	1041.0	rs505802-G	rs505802	0	505802.0	upstream_gene_variant	1.0	NR	5e-06	5.301029995663981		7.36	NR unit increase	Illumina [539662]	N
2016-11-22	26902266	Giri AK	2016-02-23	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/26902266	Genome wide association study of uric acid in Indian population and interaction of identified variants with Type 2 diabetes.	Serum uric acid levels	1,109 Indo-European ancestry individuals	3,725 Indo-European ancestry individuals	4p16.1	4	9920543	SLC2A9	SLC2A9			ENSG00000109667			rs16890979-A	rs16890979	0	16890979.0	missense_variant	0.0	NR	3e-18	17.522878745280337		16.01	[12.41-19.61] unit decrease	Illumina [539662]	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		2q23.3	2	150050645	Intergenic	MMADHC-DT - NA	ENSG00000231969			3198.0		rs16827742-A	rs16827742	0	16827742.0	intergenic_variant	1.0	0.06	3e-06	5.522878745280337		0.3	[0.18-0.42] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		5p13.1	5	38778748	OSMR-AS1, LINC01265, OSMR	OSMR-AS1						rs13160548-T	rs13160548	0	13160548.0	intron_variant	0.0	0.69	8e-06	5.096910013008056		0.1	[0.055-0.145] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		1p36.22	1	10736809	CASZ1	CASZ1			ENSG00000130940			rs880315-T	rs880315	0	880315.0	intron_variant	0.0	0.65	9e-06	5.045757490560675		0.042	[0.024-0.06] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		15q21.3	15	55028930	Intergenic							rs1528472-A	rs1528472	0	1528472.0	intergenic_variant	1.0	0.48	5e-07	6.301029995663981		0.032	[0.02-0.044] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		9q22.32	9	94741703	C9orf3, MIR2278	AOPEP			ENSG00000148120			rs7851726-T	rs7851726	0	7851726.0	intron_variant	0.0	0.42	5e-06	5.301029995663981		0.027	[0.015-0.039] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		1q22	1	155192276	MUC1	MUC1			ENSG00000185499			rs4072037-T	rs4072037	0	4072037.0	synonymous_variant	0.0	0.54	3e-06	5.522878745280337		0.029	[0.017-0.041] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		2q32.1	2	186654611	ITGAV, FAM171B	ITGAV			ENSG00000138448			rs9333290-T	rs9333290	0	9333290.0	intron_variant	0.0	0.3	8e-07	6.096910013008056		0.038	[0.022-0.054] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		8q11.23	8	53946421	RGS20, TCEA1, LYPLA1	RGS20			ENSG00000147509			rs17301329-A	rs17301329	0	17301329.0	intron_variant	0.0	0.29	6e-07	6.221848749616356		0.042	[0.026-0.058] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		2q22.1	2	137166191	THSD7B	THSD7B			ENSG00000144229			rs17346504-T	rs17346504	0	17346504.0	intron_variant	0.0	0.12	7e-06	5.154901959985743		0.05	[0.028-0.072] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		10p13	10	16927924	CUBN	CUBN			ENSG00000107611			rs10795433-A	rs10795433	0	10795433.0	intron_variant	0.0	0.86	2e-10	9.69897000433602		0.061	[0.041-0.081] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		1q22	1	155206101	THBS3	THBS3			ENSG00000169231			rs914615-A	rs914615	0	914615.0	intron_variant	0.0	0.47	7e-06	5.154901959985743		0.03	[0.016-0.044] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		10p14	10	11204306	CELF2	CELF2			ENSG00000048740			rs1109861-A	rs1109861	0	1109861.0	intron_variant	0.0	0.55	2e-06	5.698970004336019		0.03	[0.018-0.042] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		19q13.12	19	35777165	ARHGAP33	ARHGAP33			ENSG00000004777			rs231227-A	rs231227	0	231227.0	intron_variant	0.0	0.38	5e-06	5.301029995663981		0.033	[0.019-0.047] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio	up to 54,450 European ancestry individuals		21q21.2	21	24065191	Intergenic							rs2828785-T	rs2828785	0	2828785.0	intron_variant	1.0	0.27	8e-06	5.096910013008056		0.038	[0.022-0.054] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-13	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in diabetes	up to 5,825 European ancestry cases	up to 1,962 European ancestry cases	2q14.3	2	128270387	HS6ST1	HS6ST1			ENSG00000136720			rs13427836-T	rs13427836	0	13427836.0	intron_variant	0.0	0.15	6e-07	6.221848749616356		0.19	[0.11-0.27] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-13	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in diabetes	up to 5,825 European ancestry cases	up to 1,962 European ancestry cases	11q14.2	11	88275083	RAB38	CTSC			ENSG00000109861			rs649529-T	rs649529	0	649529.0	intron_variant	0.0	0.43	6e-07	6.221848749616356		0.14	[0.081-0.199] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		18p11.31	18	3043518	MYOM1, LPIN2, LOC727896	SNORA70 - MYOM1	ENSG00000253027	ENSG00000101605		17952.0	23289.0	rs4528660-T	rs4528660	0	4528660.0	intergenic_variant	1.0	0.91	9e-06	5.045757490560675		0.073	[0.04-0.106] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		10p13	10	16877053	CUBN, RSU1	CUBN			ENSG00000107611			rs1801239-T	rs1801239	0	1801239.0	missense_variant	0.0	0.9	4e-06	5.3979400086720375		0.054	[0.03-0.078] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		7p21.3	7	13592603	Intergenic							rs12668467-T	rs12668467	0	12668467.0	intron_variant	1.0	0.27	4e-06	5.3979400086720375		0.043	[0.025-0.061] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		15q21.3	15	55028930	Intergenic							rs1528472-A	rs1528472	0	1528472.0	intergenic_variant	1.0	0.48	3e-06	5.522878745280337		0.03	[0.016-0.044] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		1q22	1	155192276	MUC1, MIR92B, THBS3, TRIM46, KRTC	MUC1			ENSG00000185499			rs4072037-T	rs4072037	0	4072037.0	synonymous_variant	0.0	0.54	9e-06	5.045757490560675		0.028	[0.016-0.04] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		2q33.1	2	200459162	SPATS2L, KCTD18, SGOL2	SPATS2L			ENSG00000196141			rs4674086-T	rs4674086	0	4674086.0	intron_variant	0.0	0.46	9e-06	5.045757490560675		0.028	[0.016-0.04] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		2q32.1	2	186654611	ITGAV, FAM171B	ITGAV			ENSG00000138448			rs9333290-T	rs9333290	0	9333290.0	intron_variant	0.0	0.3	4e-06	5.3979400086720375		0.037	[0.021-0.053] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		6q22.33	6	127487010	SOGA3, KIAA0408, C6orf58	SOGA3			ENSG00000214338			rs9372872-C	rs9372872	0	9372872.0	intron_variant	0.0	0.11	3e-06	5.522878745280337		0.046	[0.026-0.066] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		15q12	15	27131476	GABRG3, LOC101928869	GABRG3, GABRG3-AS1			ENSG00000182256, ENSG00000228740			rs2192224-T	rs2192224	0	2192224.0	intron_variant	0.0	0.13	6e-06	5.221848749616356		0.048	[0.026-0.07] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Urinary albumin-to-creatinine ratio in non-diabetics	up to 46,051 European ancestry individuals		1p22.3	1	84761130	LPAR3, SSX2IP	SSX2IP - LPAR3	ENSG00000117155	ENSG00000171517		70327.0	50472.0	rs17377079-A	rs17377079	0	17377079.0	intergenic_variant	1.0	0.15	7e-06	5.154901959985743		0.06	[0.035-0.085] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		10p13	10	16927924	CUBN	CUBN			ENSG00000107611			rs10795433-A	rs10795433	0	10795433.0	intron_variant	0.0	0.85	1e-10	10.0		0.2	[0.14-0.26] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		19q13.43	19	56181074	GALP, ZNF444, ZSCAN5A	GALP			ENSG00000197487			rs274173-C	rs274173	0	274173.0	intron_variant	0.0	0.17	5e-06	5.301029995663981		0.23	[0.13-0.33] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		1q23.3	1	160673321	SLAMF1, SLAMF7, CD	SETP9 - CD48	ENSG00000235101	ENSG00000117091		2342.0	5425.0	rs3795324-A	rs3795324	0	3795324.0	non_coding_transcript_exon_variant	1.0	0.82	9e-07	6.045757490560675		0.15	[0.089-0.211] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		5q23.1	5	119848245	Intergenic							rs12719264-A	rs12719264	0	12719264.0	intergenic_variant	1.0	0.3	6e-06	5.221848749616356		0.11	[0.061-0.159] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		10q22.1	10	70931894	PCBD1, SGPL1	PCBD1 - LINC02622	ENSG00000166228	ENSG00000259267		43329.0	7142.0	rs12764441-T	rs12764441	0	12764441.0	non_coding_transcript_exon_variant	1.0	0.48	4e-06	5.3979400086720375		0.1	[0.059-0.141] unit decrease	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		6q21	6	107273567	PDSS2	PDSS2			ENSG00000164494			rs2110904-T	rs2110904	0	2110904.0	intron_variant	0.0	0.65	9e-06	5.045757490560675		0.1	[0.057-0.143] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		14q11.2	14	22623202	ABHD4, DAD1	ABHD4 - OR6J1	ENSG00000100439	ENSG00000255804		9987.0	7727.0	rs7145202-T	rs7145202	0	7145202.0	regulatory_region_variant	1.0	0.62	4e-06	5.3979400086720375		0.1	[0.057-0.143] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		2q32.1	2	186686580	ITGAV, FAM171B	ITGAV - FAM171B	ENSG00000138448	ENSG00000144369		5679.0	7480.0	rs12615659-A	rs12615659	0	12615659.0	intron_variant	1.0	0.3	1e-06	6.0		0.11	[0.067-0.153] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		11q13.4	11	74682126	CHRDL2, MIR4696, POLD3	POLD3 - RN7SKP297	ENSG00000077514	ENSG00000223202		13009.0	3098.0	rs10899033-C	rs10899033	0	10899033.0	intergenic_variant	1.0	0.72	9e-06	5.045757490560675		0.11	[0.061-0.159] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		20q12	20	42429482	PTPRT	PTPRT			ENSG00000196090			rs6513791-T	rs6513791	0	6513791.0	intron_variant	0.0	0.18	4e-06	5.3979400086720375		0.12	[0.069-0.171] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		10q24.32	10	102876898	C10orf32-ASMT, C10orf32, CYP17A1, CNNM2	AS3MT, BORCS7-ASMT			ENSG00000214435, ENSG00000270316			rs3740393-C	rs3740393	0	3740393.0	intron_variant	0.0	0.21	6e-06	5.221848749616356		0.13	[0.075-0.185] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		3p21.31	3	46850671	MYL3, PRSS42, PTH1R, CCDC	MYL3			ENSG00000160808			rs1077216-T	rs1077216	0	1077216.0	intron_variant	0.0	0.07	5e-06	5.301029995663981		0.2	[0.11-0.29] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2016-10-14	26631737	Teumer A	2015-12-02	Diabetes	www.ncbi.nlm.nih.gov/pubmed/26631737	Genome-wide Association Studies Identify Genetic Loci Associated With Albuminuria in Diabetes.	Microalbuminuria	up to 54,116 European ancestry cases		8q22.3	8	101991475	NCALD	NCALD			ENSG00000104490			rs538641-A	rs538641	0	538641.0	intron_variant	0.0	0.05	8e-06	5.096910013008056		0.28	[0.16-0.4] unit increase	Affymetrix, Illumina [2191945] (imputed)	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		6q14.1	6	79437470	HMGN3, LCA5	DBIP1 - LCA5	ENSG00000218748	ENSG00000135338		303.0	47521.0	rs196701-?	rs196701	0	196701.0	intron_variant	1.0	NR	1e-06	6.0	(SI)	0.35	[0.15-0.55] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		11q12.1	11	57407086	PRG2	SLC43A3			ENSG00000134802			rs7124-?	rs7124	0	7124.0	3_prime_UTR_variant	0.0	NR	8e-06	5.096910013008056	(MCRI)	8.24	[4.69-11.79] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		11q22.3	11	108628158	intergenic	EXPH5 - DDX10	ENSG00000110723	ENSG00000178105		34390.0	36911.0	rs10160242-?	rs10160242	0	10160242.0	intergenic_variant	1.0	NR	4e-06	5.3979400086720375	(SI)	0.41	[0.19-0.63] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		1p36.11	1	26558373	RPS6KA1, LIN28A	RPS6KA1, RPS6KA1			ENSG00000281877, ENSG00000117676			rs3790645-?	rs3790645	0	3790645.0	intron_variant	0.0	NR	6e-06	5.221848749616356	(MCRI)	0.34	[0.2-0.48] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		20q13.33	20	60223978	AX747739	MIR646HG			ENSG00000228340			rs6100794-?	rs6100794	0	6100794.0	intron_variant	0.0	NR	5e-06	5.301029995663981	(SI)	0.63	[0.16-1.1] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		8q22.2	8	99885155	VPS13B, COX6C	COX6C			ENSG00000164919			rs13253073-?	rs13253073	0	13253073.0	intron_variant	0.0	NR	6e-06	5.221848749616356	(MCRI)	0.35	[0.19-0.51] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		1p22.3	1	84884975	LPAR3	LPAR3			ENSG00000171517			rs1886644-?	rs1886644	0	1886644.0	intron_variant	0.0	NR	6e-06	5.221848749616356	(M)	22.9	[12.28-33.52] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		11q13.4	11	73648191	PLEKHB1	PLEKHB1			ENSG00000021300			rs1784499-?	rs1784499	0	1784499.0	5_prime_UTR_variant	0.0	NR	6e-06	5.221848749616356	(MCRI)	0.97	[0.54-1.4] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2q23.3	2	153652726	intergenic							rs1546676-?	rs1546676	0	1546676.0	intergenic_variant	1.0	NR	8e-06	5.096910013008056	(M)	23.62	[12.86-34.38] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2q36.3	2	226721890	LOC646736, IRS1	MIR5702 - IRS1	ENSG00000263363	ENSG00000169047		63097.0	9422.0	rs11683087-?	rs11683087	0	11683087.0	regulatory_region_variant	1.0	NR	7e-07	6.154901959985743	(M)	20.54	[12.95-28.13] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		3p25.3	3	9476827	SETD5	SETD5			ENSG00000168137			rs2279440-?	rs2279440	0	2279440.0	3_prime_UTR_variant	0.0	NR	3e-06	5.522878745280337	(M)	21.57	[12.5-30.64] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		19p13.3	19	3150420	GNA15	GNA15-DT, GNA15			ENSG00000267551, ENSG00000060558			rs2302063-?	rs2302063	0	2302063.0	intron_variant	0.0	NR	7e-08	7.154901959985743	(MCRI)	0.29	[0.15-0.43] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2p25.3	2	2729105	MYT1L, TSSC1							rs896232-?	rs896232	0	896232.0	intron_variant	1.0	NR	1e-06	6.0	(SI+M)	0.2	[0.082-0.318] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		8p21.2	8	25339194	DOCK5	DOCK5			ENSG00000147459			rs13267838-?	rs13267838	0	13267838.0	intron_variant	0.0	NR	4e-06	5.3979400086720375	(M)	54.96	[33.48-76.44] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2p22.2	2	37127006	EIF2AK2	EIF2AK2			ENSG00000055332			rs4233921-?	rs4233921	0	4233921.0	intron_variant	0.0	NR	2e-06	5.698970004336019	(SI+M)	0.12	[-0.0172-0.2572] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		9q33.1	9	115016076	intergenic	DELEC1			ENSG00000173077			rs1888221-?	rs1888221	0	1888221.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(M)	19.08	[10.65-27.51] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		4q28.2	4	127922325	MFSD8	MFSD8			ENSG00000164073			rs1602084-?	rs1602084	0	1602084.0	intron_variant	0.0	NR	5e-07	6.301029995663981	(SI+M)	0.43	[0.12-0.74] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		13q22.1	13	74346049	LINC00347, KLF12	RNY1P5 - RPL21P108	ENSG00000206617	ENSG00000232701		56835.0	31114.0	rs10492494-?	rs10492494	0	10492494.0	intron_variant	1.0	NR	5e-07	6.301029995663981	(M)	22.02	[13.1-30.94] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		12q24.23	12	118353636	TAOK3	TAOK3			ENSG00000135090			rs673078-?	rs673078	0	673078.0	intron_variant	0.0	NR	5e-06	5.301029995663981	(SI+M)	0.08	[-0.0964-0.2564] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		20p11.22	20	22286420	intergenic	LINC01427 - NA	ENSG00000225321			2391.0		rs1028444-?	rs1028444	0	1028444.0	intergenic_variant	1.0	NR	5e-06	5.301029995663981	(M)	26.33	[14.1-38.56] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		17q21.2	17	40800750	KRT28, KRT10	KRT28 - KRT10	ENSG00000173908	ENSG00000186395		791.0	17367.0	rs7219451-?	rs7219451	0	7219451.0	intergenic_variant	1.0	NR	4e-06	5.3979400086720375	(SI+M)	0.17	[0.052-0.288] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		5q23.2	5	122917609	SNX24	SNX24			ENSG00000064652			rs193541-?	rs193541	0	193541.0	intron_variant	0.0	NR	8e-06	5.096910013008056	(AIRg)	1.71	[0.85-2.57] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		6p22.3	6	20694653	CDKAL1	CDKAL1			ENSG00000145996			rs2206734-?	rs2206734	0	2206734.0	intron_variant	0.0	NR	1e-06	6.0	(AIRg)	2.05	[1.17-2.93] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		7p12.2	7	50325030	IKZF1	IKZF1			ENSG00000185811			rs10230193-?	rs10230193	0	10230193.0	intron_variant	0.0	NR	7e-06	5.154901959985743	(AIRg)	1.79	[0.75-2.83] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		8p22	8	17138926	intergenic	MICU3 - ZDHHC2	ENSG00000155970	ENSG00000104219		16284.0	17556.0	rs4922265-?	rs4922265	0	4922265.0	intron_variant	1.0	NR	7e-06	5.154901959985743	(AIRg)	2.11	[1.15-3.07] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		6q21	6	110439986	SLC22A16	SLC22A16			ENSG00000004809			rs13219760-?	rs13219760	0	13219760.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(MCRI)	0.35	[0.17-0.53] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		10q23.33	10	94146558	PLCE1	PLCE1			ENSG00000138193			rs1223629-?	rs1223629	0	1223629.0	intron_variant	0.0	NR	5e-06	5.301029995663981	(SI)	0.74	[0.41-1.07] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		17p13.2	17	3962105	ATP2A3	ATP2A3			ENSG00000074370			rs1006703-?	rs1006703	0	1006703.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(AIRg)	2.13	[1.01-3.25] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		15q24.1	15	73754322	C15orf59, TBC1D21	INSYN1-AS1			ENSG00000260469			rs4887140-?	rs4887140	0	4887140.0	intron_variant	0.0	NR	7e-08	7.154901959985743	(SI)	0.31	[0.11-0.51] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		6p22.3	6	17283090	RBM24	RBM24			ENSG00000112183			rs3749855-?	rs3749855	0	3749855.0	splice_region_variant	0.0	NR	5e-06	5.301029995663981	(MCRI)	0.52	[0.28-0.76] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		1p31.2	1	69219314	intergenic	LINC01707, LINC02791			ENSG00000223883, ENSG00000235446			rs4650135-?	rs4650135	0	4650135.0	intron_variant	0.0	NR	2e-06	5.698970004336019	(M)	29.56	[17.8-41.32] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		10p12.33	10	17554122	intergenic	ST8SIA6 - PRPF38AP2	ENSG00000148488	ENSG00000236582		99527.0	23240.0	rs6602203-?	rs6602203	0	6602203.0	intergenic_variant	1.0	NR	5e-06	5.301029995663981	(MCRI)	0.32	[0.18-0.46] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2q21.2	2	134106773	intergenic	NA - MGAT5		ENSG00000152127			13210.0	rs10179986-?	rs10179986	0	10179986.0	intergenic_variant	1.0	NR	8e-06	5.096910013008056	(M)	17.78	[10.16-25.4] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		15q24.3	15	77527334	intergenic	HMG20A - LINGO1	ENSG00000140382	ENSG00000169783		41727.0	85693.0	rs7172809-?	rs7172809	0	7172809.0	intron_variant	1.0	NR	9e-06	5.045757490560675	(MCRI)	0.18	[0.082-0.278] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		17p13.2	17	4046930	ZZEF1	ZZEF1			ENSG00000074755			rs781856-?	rs781856	0	781856.0	intron_variant	0.0	NR	7e-06	5.154901959985743	(MCRI)	0.94	[0.45-1.43] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		18q21.2	18	52430885	DCC	DCC			ENSG00000187323			rs2339345-?	rs2339345	0	2339345.0	intron_variant	0.0	NR	8e-06	5.096910013008056	(MCRI)	0.25	[0.13-0.37] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		3q28	3	188528469	LPP	LPP			ENSG00000145012			rs11920292-?	rs11920292	0	11920292.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(M)	28.44	[16.52-40.36] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		6q21	6	106286533	ATG5	ATG5			ENSG00000057663			rs484621-?	rs484621	0	484621.0	intron_variant	0.0	NR	4e-06	5.3979400086720375	(M)	18.89	[10.62-27.16] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2p23.2	2	29750415	ALK	ALK			ENSG00000171094			rs13411840-?	rs13411840	0	13411840.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(SI+M)	0.28	[-0.0336-0.5936] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		9q21.13	9	75193603	OSTF1, PCSK5	Y_RNA - RNU6-1228P	ENSG00000264495	ENSG00000212316		11982.0	4468.0	rs17060946-?	rs17060946	0	17060946.0	intergenic_variant	1.0	NR	3e-06	5.522878745280337	(M)	37.86	[21.59-54.13] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		3q29	3	196755340	PAK2	PAK2			ENSG00000180370			rs843532-?	rs843532	0	843532.0	intron_variant	0.0	NR	9e-06	5.045757490560675	(SI+M)	0.29	[0.055-0.525] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		12q24.23	12	118353636	TAOK3, SUDS3	TAOK3			ENSG00000135090			rs673078-?	rs673078	0	673078.0	intron_variant	0.0	NR	2e-06	5.698970004336019	(M)	30.26	[17.42-43.1] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		10q23.33	10	94146558	PLCE1	PLCE1			ENSG00000138193			rs1223629-?	rs1223629	0	1223629.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(SI+M)	0.74	[0.41-1.07] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		15q21.3	15	54934372	intergenic	NA - MEX3B		ENSG00000183496			27107406.0	rs12438945-?	rs12438945	0	12438945.0	intergenic_variant	1.0	NR	4e-06	5.3979400086720375	(M)	21.63	[12.63-30.63] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		15q15.2	15	42567037	HAUS2, STARD9	HAUS2			ENSG00000137814			rs10851411-?	rs10851411	0	10851411.0	3_prime_UTR_variant	0.0	NR	6e-06	5.221848749616356	(SI+M)	0.14	[0.022-0.258] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		3q26.33	3	180398775	PEX5L, TTC14	RALBP1P1 - LINC02053	ENSG00000239880	ENSG00000241696		73716.0	14233.0	rs6803803-?	rs6803803	0	6803803.0	intergenic_variant	1.0	NR	2e-06	5.698970004336019	(AIRg)	17.53	[10.24-24.82] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2p21	2	43144403	HAAO, ZFP36L2, THADA	LINC02580 - ZFP36L2	ENSG00000230587	ENSG00000152518		11921.0	77999.0	rs1978648-?	rs1978648	0	1978648.0	intergenic_variant	1.0	NR	5e-07	6.301029995663981	(SI)	0.2	[0.082-0.318] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		4q13.2	4	67190895	intergenic							rs7690543-?	rs7690543	0	7690543.0	intergenic_variant	1.0	NR	2e-06	5.698970004336019	(SI)	0.28	[0.1-0.46] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		4q28.2	4	127922325	MFSD8	MFSD8			ENSG00000164073			rs1602084-?	rs1602084	0	1602084.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(SI)	0.43	[0.12-0.74] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		5q23.2	5	125220154	intergenic	LINC02240			ENSG00000260192			rs1898910-?	rs1898910	0	1898910.0	intron_variant	0.0	NR	7e-06	5.154901959985743	(SI)	0.38	[0.2-0.56] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		9p21.3	9	22137686	CDKN2B-AS1, DMRTA1	CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		9583.0	309138.0	rs7018475-?	rs7018475	0	7018475.0	regulatory_region_variant	1.0	NR	5e-06	5.301029995663981	(AIRg)	1.64	[0.97-2.31] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		9q33.1	9	117036606	ASTN2	ASTN2			ENSG00000148219			rs7036846-?	rs7036846	0	7036846.0	intron_variant	0.0	NR	9e-06	5.045757490560675	(AIRg)	10.86	[6.1-15.62] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		11q13.2	11	66287352	YIF1A	YIF1A			ENSG00000174851			rs510398-?	rs510398	0	510398.0	non_coding_transcript_exon_variant	0.0	NR	4e-06	5.3979400086720375	(AIRg)	12.63	[6.83-18.43] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		11q13.4	11	73241451	P2RY2	P2RY2			ENSG00000175591			rs10898909-?	rs10898909	0	10898909.0	3_prime_UTR_variant	0.0	NR	4e-06	5.3979400086720375	(AIRg)	1.41	[0.76-2.06] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		11q14.3	11	92975544	FAT3, MTNR1B	MTNR1B			ENSG00000134640			rs10830963-?	rs10830963	0	10830963.0	intron_variant	0.0	NR	5e-12	11.30102999566398	(AIRg)	2.76	[1.88-3.64] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		12q24.11	12	110344222	ATP2A2	ATP2A2			ENSG00000174437			rs3026485-?	rs3026485	0	3026485.0	intron_variant	0.0	NR	7e-06	5.154901959985743	(AIRg)	15.24	[5.32-25.16] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		17q25.1	17	73739346	intergenic	SDK2 - LINC00469	ENSG00000069188	ENSG00000177338		94901.0	9924.0	rs899596-?	rs899596	0	899596.0	intron_variant	1.0	NR	3e-06	5.522878745280337	(AIRg)	2.2	[1.32-3.08] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		18p11.23	18	8043663	PTPRM	PTPRM			ENSG00000173482			rs9950590-?	rs9950590	0	9950590.0	intron_variant	0.0	NR	5e-06	5.301029995663981	(AIRg)	11.99	[6.66-17.32] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2p16.1	2	60661067	intergenic	RN7SL361P - IFITM3P9	ENSG00000242158	ENSG00000271134		20065.0	21806.0	rs881952-?	rs881952	0	881952.0	intergenic_variant	1.0	NR	5e-06	5.301029995663981	(DI)	2.3	[1.28-3.32] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		7p14.3	7	30715967	INMT	INMT			ENSG00000241644			rs10267836-?	rs10267836	0	10267836.0	intron_variant	0.0	NR	6e-06	5.221848749616356	(DI)	3.2	[1.44-4.96] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		9q34.3	9	136380752	SNAPC4	SNAPC4			ENSG00000165684			rs3812570-?	rs3812570	0	3812570.0	synonymous_variant	0.0	NR	2e-06	5.698970004336019	(DI)	1.87	[0.85-2.89] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		10p11.22	10	31172670	intergenic	NA - LINC02664		ENSG00000272381			15045.0	rs1148233-?	rs1148233	0	1148233.0	intergenic_variant	1.0	NR	9e-06	5.045757490560675	(DI)	8.86	[4.61-13.11] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		11p15.4	11	2837316	KCNQ1	KCNQ1, KCNQ1			ENSG00000282076, ENSG00000053918			rs2237897-?	rs2237897	0	2237897.0	intron_variant	0.0	NR	7e-06	5.154901959985743	(DI)	1.75	[0.75-2.75] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-?	rs10830963	0	10830963.0	intron_variant	0.0	NR	1e-11	11.0	(DI)	3.4	[2.4-4.4] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		13q13.3	13	36198244	SOHLH2, CCDC169-SOHLH2	CCDC169-SOHLH2, SOHLH2			ENSG00000250709, ENSG00000120669			rs2149423-?	rs2149423	0	2149423.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(DI)	2.18	[1.24-3.12] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2p24.1	2	22979376	intergenic							rs7570259-?	rs7570259	0	7570259.0	intergenic_variant	1.0	NR	6e-06	5.221848749616356	(SG)	1.59	[0.9-2.28] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		2p23.3	2	27519736	GCKR	GCKR			ENSG00000084734			rs780093-?	rs780093	0	780093.0	intron_variant	0.0	NR	1e-06	6.0	(SG)	0.14	[0.081-0.199] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		3q27.3	3	187898074	BCL6, LPP	NA - LINC01991		ENSG00000224187			60701.0	rs523079-?	rs523079	0	523079.0	intergenic_variant	1.0	NR	2e-07	6.698970004336019	(SG)	0.25	[0.13-0.37] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		6p24.3	6	8998578	SLC35B3, TFAP2A	HULC			ENSG00000285219			rs2064197-?	rs2064197	0	2064197.0	intron_variant	0.0	NR	7e-06	5.154901959985743	(SG)	0.19	[0.11-0.27] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		12p11.22	12	30189001	intergenic	NA - LINC02386		ENSG00000257756			41778.0	rs10843647-?	rs10843647	0	10843647.0	intergenic_variant	1.0	NR	4e-06	5.3979400086720375	(SG)	0.17	[0.092-0.248] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		12q21.2	12	76233665	intergenic	RNU6-1271P - LNCOG	ENSG00000252858	ENSG00000257219		93994.0	26171.0	rs11104268-?	rs11104268	0	11104268.0	intergenic_variant	1.0	NR	7e-06	5.154901959985743	(SG)	0.33	[0.17-0.49] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		15q21.2	15	52211839	MYO5C	MYO5C			ENSG00000128833			rs17650440-?	rs17650440	0	17650440.0	missense_variant	0.0	NR	6e-06	5.221848749616356	(SG)	2.09	[1.23-2.95] unit increase	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		16q23.3	16	82891080	CDH13	CDH13			ENSG00000140945			rs12933472-?	rs12933472	0	12933472.0	intron_variant	0.0	NR	8e-06	5.096910013008056	(SG)	0.12	[0.061-0.179] unit decrease	Illumina [693128]	N
2015-09-22	25524916	Palmer ND	2014-12-18	Diabetes	www.ncbi.nlm.nih.gov/pubmed/25524916	Genetic Variants Associated With Quantitative Glucose Homeostasis Traits Translate to Type 2 Diabetes in Mexican Americans: The GUARDIAN (Genetics Underlying Diabetes in Hispanics) Consortium.	Glucose homeostasis traits	up to 4,176 Mexican American individuals		19q13.33	19	50275286	MYH14	MYH14			ENSG00000105357			rs788338-?	rs788338	0	788338.0	intron_variant	0.0	NR	2e-06	5.698970004336019	(SG)	0.17	[0.092-0.248] unit decrease	Illumina [693128]	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Waist Circumference - Triglycerides (WC-TG)	22,161 European ancestry individuals		2p23.3	2	27519736	GCKR	GCKR			ENSG00000084734			rs780093-A	rs780093	0	780093.0	intron_variant	0.0	NR	2e-12	11.69897000433602		0.19	[0.13-0.25] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Waist Circumference - Triglycerides (WC-TG)	22,161 European ancestry individuals		2p23.3	2	27629051	CCDC121	GPN1			ENSG00000198522			rs3749147-C	rs3749147	0	3749147.0	missense_variant	0.0	NR	1e-09	9.0		0.18	[0.12-0.24] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Waist Circumference - Triglycerides (WC-TG)	22,161 European ancestry individuals		11q23.3	11	116789970	APOA5	APOA5			ENSG00000110243			rs2266788-A	rs2266788	0	2266788.0	3_prime_UTR_variant	0.0	NR	2e-16	15.69897000433602		0.41	[0.31-0.51] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Waist Circumference - Triglycerides (WC-TG)	22,161 European ancestry individuals		2p23.3	2	27592643	ZNF512	ZNF512			ENSG00000243943			rs13022873-A	rs13022873	0	13022873.0	intron_variant	0.0	NR	5e-09	8.301029995663981		0.17	[0.11-0.23] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Waist Circumference - Triglycerides (WC-TG)	22,161 European ancestry individuals		11q23.3	11	116768388	BUD13	BUD13			ENSG00000137656			rs10790162-A	rs10790162	0	10790162.0	intron_variant	0.0	NR	7e-16	15.154901959985745		0.39	[0.29-0.49] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Waist Circumference - Triglycerides (WC-TG)	22,161 European ancestry individuals		2p23.3	2	27578892	C2orf16	C2orf16			ENSG00000221843			rs1919128-A	rs1919128	0	1919128.0	missense_variant	0.0	NR	2e-09	8.698970004336019		0.18	[0.12-0.24] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Waist Circumference - Triglycerides (WC-TG)	22,161 European ancestry individuals		11q23.3	11	116782580	ZNF259	ZPR1			ENSG00000109917			rs2075290-C	rs2075290	0	2075290.0	intron_variant	0.0	NR	1e-16	16.0		0.41	[0.31-0.51] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	HDL Cholesterol - Triglycerides (HDLC-TG)	22,161 European ancestry individuals		8p21.3	8	19966981	LPL	LPL			ENSG00000175445			rs13702-A	rs13702	0	13702.0	3_prime_UTR_variant	0.0	NR	1e-16	16.0		0.29	[0.23-0.35] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	HDL Cholesterol - Triglycerides (HDLC-TG)	22,161 European ancestry individuals		16q13	16	56954132	CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		9268.0	7791.0	rs173539-C	rs173539	0	173539.0	intergenic_variant	1.0	NR	5e-16	15.30102999566398		0.26	[0.20-0.32] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	HDL Cholesterol - Triglycerides (HDLC-TG)	22,161 European ancestry individuals		11q23.3	11	116789970	APOA5	APOA5			ENSG00000110243			rs2266788-C	rs2266788	0	2266788.0	3_prime_UTR_variant	0.0	NR	5e-13	12.30102999566398		0.39	[0.29-0.49] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	HDL Cholesterol - Triglycerides (HDLC-TG)	22,161 European ancestry individuals		11q23.3	11	116768388	BUD13	BUD13			ENSG00000137656			rs10790162-A	rs10790162	0	10790162.0	intron_variant	0.0	NR	3e-15	14.522878745280336		0.38	[0.28-0.48] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	HDL Cholesterol - Triglycerides (HDLC-TG)	22,161 European ancestry individuals		8q24.13	8	125472284	TRIB1	TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		33881.0	387437.0	rs2954026-G	rs2954026	0	2954026.0	intron_variant	1.0	NR	8e-09	8.096910013008056		0.16	[0.10-0.22] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	HDL Cholesterol - Triglycerides (HDLC-TG)	22,161 European ancestry individuals		8p23.1	8	9325848	LOC100129150	RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		38270.0	45242.0	rs9987289-A	rs9987289	0	9987289.0	non_coding_transcript_exon_variant	1.0	NR	1e-08	8.0		0.25	[0.17-0.33] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	HDL Cholesterol - Triglycerides (HDLC-TG)	22,161 European ancestry individuals		11q23.3	11	116782580	ZNF259	ZPR1			ENSG00000109917			rs2075290-C	rs2075290	0	2075290.0	intron_variant	0.0	NR	2e-14	13.69897000433602		0.39	[0.29-0.49] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	HDL Cholesterol - Triglycerides (HDLC-TG)	22,161 European ancestry individuals		19q13.32	19	44911194	LOC100129500	APOE - APOC1	ENSG00000130203	ENSG00000130208		1801.0	3053.0	rs439401-C	rs439401	0	439401.0	non_coding_transcript_exon_variant	1.0	NR	1e-08	8.0		0.24	[0.16-0.32] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Triglycerides-Blood Pressure (TG-BP)	22,161 European ancestry individuals		8p21.3	8	19967156	LPL	LPL			ENSG00000175445			rs15285-A	rs15285	0	15285.0	3_prime_UTR_variant	0.0	NR	1e-10	10.0		0.27	[0.19-0.35] unit decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Triglycerides-Blood Pressure (TG-BP)	22,161 European ancestry individuals		11q23.3	11	116778419	ZNF259	ZPR1			ENSG00000109917			rs11823543-A	rs11823543	0	11823543.0	3_prime_UTR_variant	0.0	NR	3e-09	8.522878745280337		0.35	[0.23-0.47] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Triglycerides-Blood Pressure (TG-BP)	22,161 European ancestry individuals		8q24.13	8	125481504	TRIB1	TRIB1 - NA	ENSG00000173334			43101.0		rs2954033-A	rs2954033	0	2954033.0	intron_variant	1.0	NR	9e-09	8.045757490560675		0.17	[0.11-0.23] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Triglycerides-Blood Pressure (TG-BP)	22,161 European ancestry individuals		2p23.3	2	27519736	GCKR	GCKR			ENSG00000084734			rs780093-A	rs780093	0	780093.0	intron_variant	0.0	NR	3e-10	9.522878745280336		0.18	[0.12-0.24] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Triglycerides-Blood Pressure (TG-BP)	22,161 European ancestry individuals		11q23.3	11	116755542	BUD13	BUD13			ENSG00000137656			rs11825181-A	rs11825181	0	11825181.0	intron_variant	0.0	NR	3e-09	8.522878745280337		0.32	[0.22-0.42] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2011-04-11	21386085	Kraja AT	2011-03-08	Diabetes	www.ncbi.nlm.nih.gov/pubmed/21386085	A bivariate genome-wide approach to metabolic syndrome: STAMPEED consortium.	Triglycerides-Blood Pressure (TG-BP)	22,161 European ancestry individuals		11q23.3	11	116789970	APOA5	APOA5			ENSG00000110243			rs2266788-C	rs2266788	0	2266788.0	3_prime_UTR_variant	0.0	NR	4e-08	7.397940008672037		0.37	[0.23-0.51] unit increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Fasting plasma glucose	1,027 individuals		4q27	4	120880635	PRDM5	PRDM5			ENSG00000138738			rs180730-?	rs180730	0	180730.0	intron_variant	0.0	NR	6e-06	5.221848749616356	(tFPG)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Fasting plasma glucose	1,027 individuals		8p11.21	8	40626720	ZMAT4	ZMAT4			ENSG00000165061			rs2722425-?	rs2722425	0	2722425.0	intron_variant	0.0	NR	9e-06	5.045757490560675	(FPG)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Fasting plasma glucose	1,027 individuals		8p11.21	8	40626720	ZMAT4	ZMAT4			ENSG00000165061			rs2722425-?	rs2722425	0	2722425.0	intron_variant	0.0	NR	2e-08	7.698970004336019	(tFPG)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Fasting plasma glucose	1,027 individuals		3p24.1	3	30305477	intergenic	U3 - NA	ENSG00000222666			941.0		rs10510634-?	rs10510634	0	10510634.0	intergenic_variant	1.0	NR	5e-06	5.301029995663981	(tFPG)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Fasting plasma glucose	1,027 individuals		4q27	4	120880635	PRDM5	PRDM5			ENSG00000138738			rs180730-?	rs180730	0	180730.0	intron_variant	0.0	NR	5e-06	5.301029995663981	(FPG)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Fasting plasma glucose	1,027 individuals		5q23.3	5	130607626	intergenic	ARL2BPP4 - NA	ENSG00000249312			77737.0		rs7731657-?	rs7731657	0	7731657.0	intergenic_variant	1.0	NR	7e-06	5.154901959985743	(tFPG)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Diabetes related insulin traits	Up to 982 individuals		14q12	14	27330971	intergenic							rs2877832-?	rs2877832	0	2877832.0	intron_variant	1.0	NR	3e-06	5.522878745280337	(HOMA-IR)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Diabetes related insulin traits	Up to 982 individuals		14q12	14	27330971	intergenic							rs2877832-?	rs2877832	0	2877832.0	intron_variant	1.0	NR	2e-06	5.698970004336019	(FI)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Diabetes related insulin traits	Up to 982 individuals		7p14.3	7	29144873	CPVL	CPVL			ENSG00000106066			rs10486607-?	rs10486607	0	10486607.0	intron_variant	0.0	NR	8e-06	5.096910013008056	(HbA1C)			Affymetrix [70897]	N
2008-09-10	17903298	Meigs JB	2007-09-19	BMC Med Genet	www.ncbi.nlm.nih.gov/pubmed/17903298	Genome-wide association with diabetes-related traits in the Framingham Heart Study.	Diabetes related insulin traits	Up to 982 individuals		13q21.33	13	68956532	intergenic	LINC02342 - ZDHHC20P4	ENSG00000280580	ENSG00000232380		62959.0	28526.0	rs2066219-?	rs2066219	0	2066219.0	intergenic_variant	1.0	NR	9e-06	5.045757490560675	(ISI_0-120)			Affymetrix [70897]	N
2017-07-24	21829393	Plagnol V	2011-08-04	PLoS Genet	www.ncbi.nlm.nih.gov/pubmed/21829393	Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases.	Insulinoma-associated antigen 2 autoantibody levels in type 1 diabetes	2,498 European ancestry cases	3,897 sibling cases	1q23.1	1	157701026	FCRL3	FCRL3 - VDAC1P9	ENSG00000160856	ENSG00000232366		257.0	23154.0	rs7528684-T	rs7528684	0	7528684.0	upstream_gene_variant	1.0	NR	8e-09	8.096910013008056		1.45		Affymetrix, Illumina [NR]	N
2010-10-05	20849430	Franklin CS	2010-09-16	Ann Hum Genet	www.ncbi.nlm.nih.gov/pubmed/20849430	The TCF7L2 diabetes risk variant is associated with HbA₁(C) levels: a genome-wide association meta-analysis.	Glycated hemoglobin levels	1,782 European ancestry individuals		10q25.2	10	112998590	TCF7L2	TCF7L2			ENSG00000148737			rs7903146-C	rs7903146	0	7903146.0	intron_variant	0.0	0.72	1e-07	7.0		0.05	[0.02-0.08] % HbA1C decrease	Illumina [256587]	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood insulin	38,238 European ancestry individuals	62,264 European ancestry individuals	12q23.2	12	102481791	IGF1	IGF1 - NA	ENSG00000017427			47.0		rs35767-G	rs35767	0	35767.0	intergenic_variant	1.0	0.85	3e-08	7.522878745280337		0.01	[-0.00176-0.02176] pmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood insulin	38,238 European ancestry individuals	62,264 European ancestry individuals	2p23.3	2	27518370	GCKR	GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.62	4e-20	19.39794000867204		0.032	[0.024-0.04] pmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	2q31.1	2	168906638	G6PC2	SPC25, SPC25, G6PC2, G6PC2			ENSG00000152253, ENSG00000277909, ENSG00000152254, ENSG00000278373			rs560887-C	rs560887	0	560887.0	intron_variant	0.0	0.7	9e-218	217.04575749056067		0.075	[0.069-0.081] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	15q22.2	15	62141763	C2CD4B	NPM1P47 - C2CD4B	ENSG00000259466	ENSG00000205502		58458.0	21772.0	rs11071657-A	rs11071657	0	11071657.0	regulatory_region_variant	1.0	0.63	4e-08	7.397940008672037		0.008	[0.0021-0.0139] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	8q24.11	8	117173494	SLC30A8	SLC30A8			ENSG00000164756			rs11558471-A	rs11558471	0	11558471.0	3_prime_UTR_variant	0.0	0.31	3e-11	10.522878745280336				Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	10q25.2	10	112996282	TCF7L2	TCF7L2			ENSG00000148737			rs4506565-T	rs4506565	0	4506565.0	intron_variant	0.0	0.31	1e-08	8.0				Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	7p13	7	44196069	GCK	GCK			ENSG00000106633			rs4607517-A	rs4607517	0	4607517.0	intron_variant	0.0	0.16	7e-92	91.15490195998576		0.062	[0.054-0.07] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	3q26.2	3	170999732	SLC2A2	SLC2A2			ENSG00000163581			rs11920090-T	rs11920090	0	11920090.0	intron_variant	0.0	0.87	8e-13	12.096910013008056		0.02	[0.012-0.028] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	7p21.2	7	15024684	TMEM195, DGKB	GTF3AP5 - NA	ENSG00000225816			38610.0		rs2191349-T	rs2191349	0	2191349.0	intergenic_variant	1.0	0.52	2.9999999999999997e-44	43.52287874528034		0.03	[0.024-0.036] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	2p23.3	2	27518370	GCKR	GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.62	6e-38	37.22184874961636		0.029	[0.023-0.035] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	3q21.1	3	123346931	ADCY5	ADCY5			ENSG00000173175			rs11708067-A	rs11708067	0	11708067.0	intron_variant	0.0	0.78	7e-22	21.154901959985743		0.027	[0.021-0.033] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	11p11.2	11	47314769	MADD	MADD			ENSG00000110514			rs7944584-A	rs7944584	0	7944584.0	intron_variant	0.0	0.75	2e-18	17.69897000433602		0.021	[0.015-0.027] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	10q25.2	10	111282335	ADRA2A	NA - BTBD7P2		ENSG00000237618			40443.0	rs10885122-G	rs10885122	0	10885122.0	intergenic_variant	1.0	0.87	3e-16	15.522878745280336		0.022	[0.014-0.03] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	11q12.2	11	61804006	FADS1	FADS1, FADS2			ENSG00000149485, ENSG00000134824			rs174550-T	rs174550	0	174550.0	5_prime_UTR_variant	0.0	0.64	2e-15	14.69897000433602		0.017	[0.011-0.023] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	9p24.2	9	4289050	GLIS3	GLIS3			ENSG00000107249			rs7034200-A	rs7034200	0	7034200.0	intron_variant	0.0	0.49	1e-12	12.0		0.018	[0.012-0.024] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	1q32.3	1	213985913	PROX1	PROX1-AS1, PROX1			ENSG00000230461, ENSG00000117707			rs340874-C	rs340874	0	340874.0	non_coding_transcript_exon_variant	0.0	0.52	7e-12	11.154901959985745		0.013	[0.0071-0.0189] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	11q14.3	11	92975544	MTNR1B	MTNR1B			ENSG00000134640			rs10830963-G	rs10830963	0	10830963.0	intron_variant	0.0	0.3	6e-175	174.22184874961636		0.067	[0.061-0.073] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-02-28	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Fasting blood glucose	46,186 European ancestry individuals	76,558 European ancestry individuals	11p11.2	11	45851540	CRY2	CRY2			ENSG00000121671			rs11605924-A	rs11605924	0	11605924.0	intron_variant	0.0	0.49	1e-14	14.0		0.015	[0.0091-0.0209] mmol/L increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2018-01-23	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Homeostasis model assessment of insulin resistance	37,037 European ancestry individuals	62,264 European ancestry individuals	2p23.3	2	27518370	GCKR	GCKR			ENSG00000084734			rs780094-C	rs780094	0	780094.0	intron_variant	0.0	0.62	3e-24	23.522878745280337		0.035	[0.027-0.043] unit increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2018-01-23	20081858	Dupuis J	2010-01-17	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/20081858	New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.	Homeostasis model assessment of insulin resistance	37,037 European ancestry individuals	62,264 European ancestry individuals	12q23.2	12	102481791	IGF1	IGF1 - NA	ENSG00000017427			47.0		rs35767-G	rs35767	0	35767.0	intergenic_variant	1.0	0.85	2e-09	8.698970004336019		0.013	[0.0012-0.0248] unit increase (replication)	Affymetrix, Illumina [~ 2500000] (imputed)	N
2009-02-13	17463246	Saxena R	2007-04-26	Science	www.ncbi.nlm.nih.gov/pubmed/17463246	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	Triglycerides	2,659 European ancestry type 2 diabetes cases and controls	5,217 European ancestry individuals	8p21.3	8	19975135	LPL	LPL - RPL30P9	ENSG00000175445	ENSG00000242709		7876.0	138208.0	rs17482753-T	rs17482753	0	17482753.0	intergenic_variant	1.0	0.1	5e-07	6.301029995663981		1.0	(% variance) increase	Affymetrix [389878]	N
2009-02-13	17463246	Saxena R	2007-04-26	Science	www.ncbi.nlm.nih.gov/pubmed/17463246	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	Triglycerides	2,659 European ancestry type 2 diabetes cases and controls	5,217 European ancestry individuals	2p23.3	2	27518370	GCKR	GCKR			ENSG00000084734			rs780094-T	rs780094	0	780094.0	intron_variant	0.0	0.35	9e-08	7.045757490560675		0.5	(% variance) increase	Affymetrix [389878]	N
2017-11-01	17463246	Saxena R	2007-04-26	Science	www.ncbi.nlm.nih.gov/pubmed/17463246	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	HDL cholesterol levels	2,623 European ancestry type 2 diabetes cases and controls		16q13	16	56961324	CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		16460.0	599.0	rs1800775-C	rs1800775	0	1800775.0	upstream_gene_variant	1.0	0.47	3e-13	12.522878745280336		2.1	(% variance) increase	Affymetrix [389878]	N
2017-11-01	17463246	Saxena R	2007-04-26	Science	www.ncbi.nlm.nih.gov/pubmed/17463246	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	LDL cholesterol levels	2,601 European ancestry type 2 diabetes cases and controls		2p24.1	2	21009323	APOB	APOB			ENSG00000084674			rs693-A	rs693	0	693.0	synonymous_variant	0.0	0.49	7e-07	6.154901959985743		1.0	(% variance) increase	Affymetrix [389878]	N
2017-11-01	17463246	Saxena R	2007-04-26	Science	www.ncbi.nlm.nih.gov/pubmed/17463246	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	LDL cholesterol levels	2,601 European ancestry type 2 diabetes cases and controls		19q13.32	19	44919689	APOE	APOC1 - APOC1P1	ENSG00000130208	ENSG00000214855		340.0	7110.0	rs4420638-G	rs4420638	0	4420638.0	downstream_gene_variant	1.0	0.22	3e-13	12.522878745280336		2.1	(% variance) increase	Affymetrix [389878]	N
2017-11-01	17463246	Saxena R	2007-04-26	Science	www.ncbi.nlm.nih.gov/pubmed/17463246	Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.	Apolipoprotein A1 levels	1,451 European ancestry type 2 diabetes cases and controls		16q13	16	56961324	CETP	HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		16460.0	599.0	rs1800775-C	rs1800775	0	1800775.0	upstream_gene_variant	1.0	0.44	3e-06	5.522878745280337		1.6	(% variance) increase	Affymetrix [389878]	N
2009-09-04	19651812	Chambers JC	2009-08-03	Diabetes	www.ncbi.nlm.nih.gov/pubmed/19651812	Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians.	Fasting plasma glucose	698 Asian Indian ancestry cases, 6,776 Asian Indian ancestry controls	4,462 European ancestry controls	11q14.3	11	92958366	MTNR1B	SNRPGP16 - MTNR1B	ENSG00000255287	ENSG00000134640		20700.0	11285.0	rs2166706-G	rs2166706	0	2166706.0	intergenic_variant	1.0	0.46	2e-09	8.698970004336019		0.07	(0.04-0.09) mmol/L increase	Illumina [up to 544390]	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		1q23.1	1	158615625	SPTA1	SPTA1			ENSG00000163554			rs2779116-T	rs2779116	0	2779116.0	intron_variant	0.0	0.27	3e-09	8.522878745280337		0.02	[0.01-0.03] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		2q31.1	2	168934928	G6PC2, ABCB11	ABCB11, ABCB11			ENSG00000073734, ENSG00000276582			rs552976-G	rs552976	0	552976.0	intron_variant	0.0	0.64	8e-18	17.096910013008056		0.05	[0.04-0.06] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		7p13	7	44189469	GCK	GCK			ENSG00000106633			rs1799884-T	rs1799884	0	1799884.0	intron_variant	0.0	0.18	1e-20	20.0		0.04	[0.03-0.05] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		11q14.3	11	92940662	MTNR1B	SNRPGP16 - MTNR1B	ENSG00000255287	ENSG00000134640		2996.0	28989.0	rs1387153-T	rs1387153	0	1387153.0	downstream_gene_variant	1.0	0.28	4e-11	10.397940008672036		0.03	[0.02-0.04] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		8p11.21	8	41772887	ANK1	ANK1			ENSG00000029534			rs4737009-A	rs4737009	0	4737009.0	intron_variant	0.0	0.24	6e-12	11.221848749616356		0.03	[0.02-0.04] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		17q25.3	17	82727657	FN3K	FN3KRP			ENSG00000141560			rs1046896-T	rs1046896	0	1046896.0	3_prime_UTR_variant	0.0	0.31	1.9999999999999998e-26	25.69897000433602		0.04	[0.03-0.05] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		22q12.3	22	37066896	TMPRSS6	TMPRSS6			ENSG00000187045			rs855791-A	rs855791	0	855791.0	missense_variant	0.0	0.42	3e-14	13.522878745280336		0.03	[0.02-0.04] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		8p11.21	8	41691676	ANK1	ANK1			ENSG00000029534			rs6474359-T	rs6474359	0	6474359.0	intron_variant	0.0	0.97	1e-08	8.0		0.06	[0.04-0.08] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		6p22.2	6	26092913	HFE	HFE			ENSG00000010704			rs1800562-G	rs1800562	0	1800562.0	missense_variant	0.0	0.94	3e-20	19.522878745280337		0.06	[0.05-0.07] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		10q22.1	10	69333636	HK1	HK1			ENSG00000156515			rs16926246-C	rs16926246	0	16926246.0	intron_variant	0.0	0.90	2.9999999999999995e-54	53.52287874528034		0.09	[0.08-0.10] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2010-10-07	20858683	Soranzo N	2010-09-21	Diabetes	www.ncbi.nlm.nih.gov/pubmed/20858683	Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.	Glycated hemoglobin levels	up to 46,368 European ancestry individuals		13q34	13	112677554	ATP11A, TUBGCP3	ATP11AUN			ENSG00000197595			rs7998202-G	rs7998202	0	7998202.0	intron_variant	0.0	0.14	5e-09	8.301029995663981		0.03	[0.02-0.04] % increase	Affymetrix, Illumina [~ 2500000] (imputed)	N
2013-09-07	23642732	Cox AJ	2013-04-19	Atherosclerosis	www.ncbi.nlm.nih.gov/pubmed/23642732	Association of SNPs in the UGT1A gene cluster with total bilirubin and mortality in the Diabetes Heart Study.	Bilirubin levels	1,180 European ancestry individuals from ~475 families		2q37.1	2	233759924	UGT1A	UGT1A4, UGT1A7, UGT1A10, UGT1A6, UGT1A3, UGT1A9, UGT1A5, UGT1A8			ENSG00000244474, ENSG00000244122, ENSG00000242515, ENSG00000167165, ENSG00000288702, ENSG00000241119, ENSG00000288705, ENSG00000242366			rs887829-T	rs887829	0	887829.0	intron_variant	0.0	0.312	9e-20	19.045757490560675				Affymetrix, Illumina [371951]	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		12q12	12	41960827		LINC02400 - GXYLT1	ENSG00000257784	ENSG00000151233		186156.0	121018.0	rs1234032-C	rs1234032	0	1234032.0	intron_variant	1.0	0.252	2e-08	7.698970004336019		0.141429	[0.092-0.19] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		12p12.1	12	21185472		SLCO1B1			ENSG00000134538			rs10770791-C	rs10770791	0	10770791.0	intron_variant	0.0	0.498	5e-08	7.301029995663981		0.107475	[0.068-0.147] unit increase	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		12p12.2	12	20954442		SLCO1B3-SLCO1B7			ENSG00000257046			rs2217693-G	rs2217693	0	2217693.0	intron_variant	0.0	0.925	8e-08	7.096910013008056		0.188639	[0.12-0.26] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		16q12.1	16	52442057		TOX3			ENSG00000103460			rs8062936-G	rs8062936	0	8062936.0	intron_variant	0.0	0.371	2e-07	6.698970004336019		0.122292	[0.077-0.167] unit increase	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		12p12.2	12	21008091		SLCO1B7, SLCO1B3-SLCO1B7			ENSG00000205754, ENSG00000257046			rs7965567-T	rs7965567	0	7965567.0	intron_variant	0.0	0.051	8e-07	6.096910013008056		0.251377	[0.15-0.35] unit increase	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		5q14.3	5	83926497		ZP3P1 - EDIL3	ENSG00000250013	ENSG00000164176		50676.0	14057.0	rs7703659-A	rs7703659	0	7703659.0	regulatory_region_variant	1.0	0.132	1e-06	6.0		0.14596	[0.087-0.205] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		13q31.1	13	84485465		UBE2D3P4 - MTND4P1	ENSG00000224188	ENSG00000228597		464703.0	34638.0	rs1900362-G	rs1900362	0	1900362.0	intergenic_variant	1.0	0.339	1e-06	6.0		0.102358	[0.061-0.144] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		10q21.2	10	59731285		SLC16A9			ENSG00000165449			rs11816402-T	rs11816402	0	11816402.0	intron_variant	0.0	0.082	3e-06	5.522878745280337		0.217113	[0.13-0.31] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		19p13.2	19	8707571		ACTL9 - OR2Z1	ENSG00000181786	ENSG00000181733		8776.0	14063.0	rs11667346-G	rs11667346	0	11667346.0	intergenic_variant	1.0	0.099	4e-06	5.3979400086720375		0.194814	[0.11-0.28] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		9q34.3	9	135527434		LCN1 - OBP2A	ENSG00000160349	ENSG00000122136		894.0	18692.0	rs59012839-G	rs59012839	0	59012839.0	intergenic_variant	1.0	0.097	5e-06	5.301029995663981		0.216643	[0.12-0.31] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		16p13.2	16	9973686		GRIN2A			ENSG00000183454			rs12928694-A	rs12928694	0	12928694.0	intron_variant	0.0	0.159	6e-06	5.221848749616356		0.123792	[0.071-0.177] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		19q12	19	29426745		VSTM2B-DT			ENSG00000264515			rs58013952-T	rs58013952	0	58013952.0	intron_variant	0.0	0.115	6e-06	5.221848749616356		0.160896	[0.09-0.231] unit increase	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		1p31.1	1	73548447		LINC01360 - LINC02238	ENSG00000233973	ENSG00000223479		193194.0	86769.0	rs75553467-C	rs75553467	0	75553467.0	intergenic_variant	1.0	0.059	6e-06	5.221848749616356		0.233071	[0.13-0.33] unit decrease	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		4p15.33	4	14121308		LINC01085			ENSG00000248698			rs73239453-T	rs73239453	0	73239453.0	intron_variant	0.0	0.106	9e-06	5.045757490560675		0.160255	[0.09-0.231] unit increase	Affymetrix, Illumina [538635] (imputed)	N
2021-12-07	34607834	Dawed AY	2021-10-04	Diabetes Care	www.ncbi.nlm.nih.gov/pubmed/34607834	Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas.	Reduction in HbA1c levels in response to sulfonylureas treatment in type 2 diabetes	5,485 European ancestry individuals		7p14.3	7	33449611		BBS9			ENSG00000122507			rs10250448-G	rs10250448	0	10250448.0	intron_variant	0.0	0.1	9e-06	5.045757490560675		0.15	[0.091-0.209] unit increase	Affymetrix, Illumina [538635] (imputed)	N
2022-12-13	34620218	Meeks KAC	2021-10-07	Genome Med	www.ncbi.nlm.nih.gov/pubmed/34620218	Genome-wide analyses of multiple obesity-related cytokines and hormones informs biology of cardiometabolic traits.	Glucose-dependent insulinotropic peptide levels in type 2 diabetes	1,844 Sub-Saharan African ancestry individuals		13q14.3	13	51334180		FAM124A - SERPINE3	ENSG00000150510	ENSG00000253309		49941.0	1593.0	rs9563043-C	rs9563043	0	9563043.0	upstream_gene_variant	1.0	NR	2e-08	7.698970004336019		0.832	[0.54-1.12] unit increase	Affymetrix, Illumina [NR] (imputed)	N
2021-10-04	34014961	Palmer ND	2021-05-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/34014961	Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study.	Serum vitamin D-binding protein levels in type 2 diabetes	697 African American individuals		4q13.3	4	71752617	GC	GC			ENSG00000145321			rs7041-?	rs7041	0	7041.0	missense_variant	0.0	NR	9e-86	85.04575749056067		0.44	[0.4-0.48] μg/mL increase	Illumina [3436913] (imputed)	N
2021-10-04	34014961	Palmer ND	2021-05-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/34014961	Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study.	Serum vitamin D-binding protein levels in type 2 diabetes	697 African American individuals		4q13.3	4	71742398	GC	GC			ENSG00000145321			rs705117-?	rs705117	0	705117.0	intron_variant	0.0	NR	5e-43	42.30102999566398		0.28	[0.24-0.32] μg/mL decrease	Illumina [3436913] (imputed)	N
2021-10-04	34014961	Palmer ND	2021-05-20	PLoS One	www.ncbi.nlm.nih.gov/pubmed/34014961	Genome-wide association study of vitamin D concentrations and bone mineral density in the African American-Diabetes Heart Study.	Serum vitamin D-binding protein levels in type 2 diabetes	697 African American individuals		4q13.3	4	71752606	GC	GC			ENSG00000145321			rs4588-?	rs4588	0	4588.0	missense_variant	0.0	NR	1e-14	14.0	conditional on [rs7041]	0.17	[0.13-0.21] μg/mL increase	Illumina [3436913] (imputed)	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting glucose (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting glucose, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		1q32.3	1	214007176		PROX1			ENSG00000117707			rs72753599-T	rs72753599	0	72753599.0	intron_variant	0.0	0.2	2e-12	11.69897000433602				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting glucose (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting glucose, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		3q21.1	3	123303023		ADCY5			ENSG00000173175			rs9844212-C	rs9844212	0	9844212.0	intron_variant	0.0	0.59	4e-13	12.397940008672036				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting glucose (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting glucose, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		11p11.2	11	46777081		CKAP5			ENSG00000175216			rs6485690-A	rs6485690	0	6485690.0	intron_variant	0.0	0.34	1e-10	10.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting insulin (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting insulin, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		8p23.1	8	11758186		GATA4			ENSG00000285109			rs745379-A	rs745379	0	745379.0	intron_variant	0.0	0.48	1e-09	9.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting insulin (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting insulin, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		16q23.2	16	79721183		MAFTRR, LINC01229			ENSG00000261390, ENSG00000260876			rs3813583-A	rs3813583	0	3813583.0	intron_variant	0.0	0.62	3e-08	7.522878745280337				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	Fasting insulin (adjusted for BMI) or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with fasting insulin, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		3p25.2	3	12355089		PPARG			ENSG00000132170			rs4135247-A	rs4135247	0	4135247.0	intron_variant	0.0	0.56	6e-09	8.221848749616356				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	HbA1c or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with HbA1c, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		16q12.2	16	53764710		FTO			ENSG00000140718			rs8047587-T	rs8047587	0	8047587.0	intron_variant	0.0	0.45	3e-10	9.522878745280336				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	HbA1c or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with HbA1c, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		12q24.11	12	111270654		CUX2			ENSG00000111249			rs1265564-A	rs1265564	0	1265564.0	non_coding_transcript_exon_variant	0.0	0.58	3e-13	12.522878745280336				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	HbA1c or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with HbA1c, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		19q13.32	19	45675403		GIPR			ENSG00000010310			rs2238689-T	rs2238689	0	2238689.0	non_coding_transcript_exon_variant	0.0	0.57	1e-08	8.0				NR [NR]	N
2022-09-13	35771237	Liu Q	2022-06-30	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35771237	A genome-wide cross-trait analysis identifies shared loci and causal relationships of type 2 diabetes and glycaemic traits with polycystic ovary syndrome.	HbA1c or polycystic ovary syndrome (pleiotropy)	upto 20,000 European ancestry individuals with HbA1c, upto 10,074 polycystic ovary syndrome European ancestry cases, upto 103,164 polycystic ovary syndrome European ancestry controls without polycystic ovary syndrome		7q31.32	7	123643895		ASB15 - LMOD2	ENSG00000146809	ENSG00000170807		4414.0	11971.0	rs4731113-T	rs4731113	0	4731113.0	downstream_gene_variant	1.0	0.97	3e-09	8.522878745280337				NR [NR]	N
2023-06-16	36653889	Jin H	2023-01-19	Diabetes Metab J	www.ncbi.nlm.nih.gov/pubmed/36653889	Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population.	Fasting plasma glucose	1,027 East Asian ancestry cases, 9,501 East Asian ancestry controls		2q31.1	2	168920787		ABCB11, ABCB11			ENSG00000073734, ENSG00000276582			rs78529720-?	rs78529720	0	78529720.0	3_prime_UTR_variant	0.0	NR	3e-16	15.522878745280336		1.017	[0.77-1.26] unit increase	Affymetrix [2713317] (imputed)	N
2023-06-16	36653889	Jin H	2023-01-19	Diabetes Metab J	www.ncbi.nlm.nih.gov/pubmed/36653889	Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population.	Fasting plasma glucose	1,027 East Asian ancestry cases, 9,501 East Asian ancestry controls		2p21	2	44961214		SIX3 - KRTCAP2P1	ENSG00000138083	ENSG00000231848		15143.0	35199.0	rs895636-?	rs895636	0	895636.0	non_coding_transcript_exon_variant	1.0	NR	2e-08	7.698970004336019		0.668	[0.43-0.9] unit increase	Affymetrix [2713317] (imputed)	N
2023-06-16	36653889	Jin H	2023-01-19	Diabetes Metab J	www.ncbi.nlm.nih.gov/pubmed/36653889	Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population.	Fasting plasma glucose	1,027 East Asian ancestry cases, 9,501 East Asian ancestry controls		7p13	7	44186502		GCK			ENSG00000106633			rs2971670-?	rs2971670	0	2971670.0	intron_variant	0.0	NR	8e-20	19.096910013008056		1.365	[1.07-1.66] unit increase	Affymetrix [2713317] (imputed)	N
2023-06-16	36653889	Jin H	2023-01-19	Diabetes Metab J	www.ncbi.nlm.nih.gov/pubmed/36653889	Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population.	Fasting plasma glucose	1,027 East Asian ancestry cases, 9,501 East Asian ancestry controls		11q14.3	11	92933881		LINC02746 - SNRPGP16	ENSG00000282916	ENSG00000255287		18237.0	3560.0	rs12222793-?	rs12222793	0	12222793.0	upstream_gene_variant	1.0	NR	4e-10	9.397940008672036		0.731	[0.51-0.96] unit increase	Affymetrix [2713317] (imputed)	N
2023-06-16	36653889	Jin H	2023-01-19	Diabetes Metab J	www.ncbi.nlm.nih.gov/pubmed/36653889	Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population.	Fasting plasma glucose change	1,027 East Asian ancestry cases, 9,501 East Asian ancestry controls		6p21.31	6	34295966		RPS10-NUDT3, NUDT3			ENSG00000270800, ENSG00000272325			rs10947494-?	rs10947494	0	10947494.0	intron_variant	0.0	NR	4e-06	5.3979400086720375		0.183	[0.11-0.26] unit increase	Affymetrix [2713317] (imputed)	N
2023-06-16	36653889	Jin H	2023-01-19	Diabetes Metab J	www.ncbi.nlm.nih.gov/pubmed/36653889	Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population.	Fasting plasma glucose change	1,027 East Asian ancestry cases, 9,501 East Asian ancestry controls		10q23.33	10	94308723		PLCE1			ENSG00000138193			rs11187850-?	rs11187850	0	11187850.0	intron_variant	0.0	NR	5e-08	7.301029995663981		0.187	[0.12-0.25] unit increase	Affymetrix [2713317] (imputed)	N
2023-06-16	36653889	Jin H	2023-01-19	Diabetes Metab J	www.ncbi.nlm.nih.gov/pubmed/36653889	Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population.	Fasting plasma glucose change	1,027 East Asian ancestry cases, 9,501 East Asian ancestry controls		15q22.2	15	62362014		MIR6085 - HMGN1P26	ENSG00000275451	ENSG00000259557		18876.0	15.0	rs2414772-?	rs2414772	0	2414772.0	downstream_gene_variant	1.0	NR	6e-06	5.221848749616356		0.153	[0.09-0.216] unit decrease	Affymetrix [2713317] (imputed)	N
2023-06-16	36653889	Jin H	2023-01-19	Diabetes Metab J	www.ncbi.nlm.nih.gov/pubmed/36653889	Genome-Wide Association Study on Longitudinal Change in Fasting Plasma Glucose in Korean Population.	Fasting plasma glucose change	1,027 East Asian ancestry cases, 9,501 East Asian ancestry controls		16q21	16	58020195		USB1			ENSG00000103005			rs16959641-?	rs16959641	0	16959641.0	missense_variant	0.0	NR	2e-06	5.698970004336019		0.263	[0.15-0.37] unit increase	Affymetrix [2713317] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Fasting plasma glucose in prediabetes	451 East Asian ancestry individuals		1q41	1	223225986		SUSD4			ENSG00000143502			rs4661250-?	rs4661250	0	4661250.0	intron_variant	0.0	NR	5e-06	5.301029995663981	(recessive)	1.243	[-0.40928-2.89528] unit decrease	Affymetrix [1752717] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Fasting plasma glucose in prediabetes	451 East Asian ancestry individuals		6p21.33	6	31124986		PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1			ENSG00000231094, ENSG00000233439, ENSG00000206458, ENSG00000233734, ENSG00000204540, ENSG00000235487			rs3094201-?	rs3094201	0	3094201.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(recessive)	1.304	[-0.34632-2.95432] unit decrease	Affymetrix [1752717] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Postprandial glucose in prediabetes	451 East Asian ancestry individuals		21q22.11	21	34093207		MRPS6, SLC5A3			ENSG00000243927, ENSG00000198743			rs62212118-?	rs62212118	0	62212118.0	intron_variant	0.0	NR	4e-06	5.3979400086720375		0.927	[-2.28152-4.13552] unit decrease	Affymetrix [1752717] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Postprandial glucose in prediabetes	451 East Asian ancestry individuals		13q12.3	13	30690780		Metazoa_SRP - ALOX5AP	ENSG00000276525	ENSG00000132965		6502.0	22698.0	rs9550371-?	rs9550371	0	9550371.0	intergenic_variant	1.0	NR	4e-06	5.3979400086720375	(dominant)	1.149	[-2.05952-4.35752] unit decrease	Affymetrix [1752717] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Postprandial glucose in prediabetes	451 East Asian ancestry individuals		4q21.1	4	77424709		CCNG2			ENSG00000138764			rs34938732-?	rs34938732	0	34938732.0	intron_variant	0.0	NR	2e-06	5.698970004336019	(recessive)	0.895	[-2.30764-4.09764] unit decrease	Affymetrix [1752717] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Glycated hemoglobin levels in prediabetes	451 East Asian ancestry individuals		1p35.2	1	30116659		LINC01648 - MATN1	ENSG00000233399	ENSG00000162510		79047.0	594618.0	rs142002616-?	rs142002616	0	142002616.0	intergenic_variant	1.0	NR	2e-06	5.698970004336019		1.357	[-1.6712-4.3852] unit decrease	Affymetrix [1752717] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Glycated hemoglobin levels in prediabetes	451 East Asian ancestry individuals		15q26.1	15	91744926		THRAP3P2 - SLCO3A1	ENSG00000259057	ENSG00000176463		971.0	108782.0	rs11853125-?	rs11853125	0	11853125.0	upstream_gene_variant	1.0	NR	5e-06	5.301029995663981		1.619	[-1.41704-4.65504] unit decrease	Affymetrix [1752717] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Glycated hemoglobin levels in prediabetes	451 East Asian ancestry individuals		5p13.2	5	34504277		C1QTNF3-AMACR - RAI14	ENSG00000273294	ENSG00000039560		379749.0	152051.0	rs6880621-?	rs6880621	0	6880621.0	intergenic_variant	1.0	NR	2e-06	5.698970004336019	(dominant)	1.162	[-1.87012-4.19412] unit decrease	Affymetrix [1752717] (imputed)	N
2022-06-07	35299963	Lin L	2022-03-01	Front Endocrinol (Lausanne)	www.ncbi.nlm.nih.gov/pubmed/35299963	Genetic Variants Relate to Fasting Plasma Glucose, 2-Hour Postprandial Glucose, Glycosylated Hemoglobin, and BMI in Prediabetes.	Glycated hemoglobin levels in prediabetes	451 East Asian ancestry individuals		14q21.1	14	38039549		TTC6			ENSG00000139865			rs946911-?	rs946911	0	946911.0	intron_variant	0.0	NR	1e-06	6.0	(recessive)	1.466	[-1.56024-4.49224] unit decrease	Affymetrix [1752717] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		13q13.1	13	32402221		N4BP2L1			ENSG00000139597			rs10492397-?	rs10492397	0	10492397.0	3_prime_UTR_variant	0.0	NR	1e-10	10.0		0.004	[0.0028-0.0052] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		1q41	1	220811022		MTARC1			ENSG00000186205			rs11118607-?	rs11118607	0	11118607.0	intron_variant	0.0	NR	2e-10	9.69897000433602		0.0057	[0.0039-0.0075] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		22q13.2	22	42138592		NDUFA6-DT - CYP2D7	ENSG00000273616	ENSG00000283008		850.0	1611.0	rs2743450-?	rs2743450	0	2743450.0	intron_variant	1.0	NR	2e-10	9.69897000433602		0.0038	[0.0026-0.005] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		20p12.1	20	17865277		BANF2 - RNU6-192P	ENSG00000125888	ENSG00000212555		129406.0	38485.0	rs2328223-?	rs2328223	0	2328223.0	intergenic_variant	1.0	NR	4e-10	9.397940008672036		0.0046	[0.0032-0.006] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		1p31.3	1	62586017		DOCK7			ENSG00000116641			rs12030293-?	rs12030293	0	12030293.0	intron_variant	0.0	NR	8e-10	9.096910013008056		0.0045	[0.0031-0.0059] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		10q22.1	10	72879221		MCU			ENSG00000156026			rs11000435-?	rs11000435	0	11000435.0	intron_variant	0.0	NR	1e-09	9.0		0.0044	[0.003-0.0058] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		10q25.2	10	112153464		GPAM			ENSG00000119927			rs2297991-?	rs2297991	0	2297991.0	3_prime_UTR_variant	0.0	NR	1e-09	9.0		0.0039	[0.0027-0.0051] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		9q34.11	9	127966536		FAM102A			ENSG00000167106			rs74987020-?	rs74987020	0	74987020.0	intron_variant	0.0	NR	2e-09	8.698970004336019		0.0043	[0.0029-0.0057] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		17q24.2	17	69086125		ABCA6			ENSG00000154262			rs12162136-?	rs12162136	0	12162136.0	intron_variant	0.0	NR	2e-09	8.698970004336019		0.0036	[0.0024-0.0048] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		8q23.3	8	115658120		TRPS1			ENSG00000104447			rs3808477-?	rs3808477	0	3808477.0	intron_variant	0.0	NR	4e-09	8.397940008672037		0.0037	[0.0025-0.0049] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		12q24.31	12	120977112		HNF1A-AS1			ENSG00000241388			rs2255531-?	rs2255531	0	2255531.0	intron_variant	0.0	NR	5e-09	8.301029995663981		0.0035	[0.0023-0.0047] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		1q42.3	1	234712862		LINC00184 - LINC01132	ENSG00000224939	ENSG00000227630		78082.0	11180.0	rs486142-?	rs486142	0	486142.0	non_coding_transcript_exon_variant	1.0	NR	8e-09	8.096910013008056		0.0041	[0.0027-0.0055] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		1p36.11	1	25474918		MACO1			ENSG00000204178			rs61775184-?	rs61775184	0	61775184.0	intron_variant	0.0	NR	8e-09	8.096910013008056		0.0039	[0.0025-0.0053] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		19q13.32	19	45970068		NOVA2			ENSG00000104967			rs149521600-?	rs149521600	0	149521600.0	intron_variant	0.0	NR	9e-09	8.045757490560675		0.0172	[0.011-0.023] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		6p22.1	6	29969018		HLA-W - MICD	ENSG00000230915	ENSG00000237395		10448.0	1783.0	rs41267238-?	rs41267238	0	41267238.0	intron_variant	1.0	NR	9e-09	8.045757490560675		0.0037	[0.0025-0.0049] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		6p21.2	6	39942978		TUBBP9			ENSG00000220586			rs139042980-?	rs139042980	0	139042980.0	intron_variant	0.0	NR	1e-08	8.0		0.013	[0.0085-0.0175] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		17q21.32	17	47294237		ITGB3			ENSG00000259207			rs999323-?	rs999323	0	999323.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.0033	[0.0021-0.0045] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		2p21	2	43725556		PLEKHH2			ENSG00000152527			rs11695642-?	rs11695642	0	11695642.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.0052	[0.0034-0.007] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		20q11.22	20	35555321		ERGIC3			ENSG00000125991			rs224419-?	rs224419	0	224419.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.0039	[0.0025-0.0053] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		19q13.31	19	44217383		ZNF227			ENSG00000131115			rs144882440-?	rs144882440	0	144882440.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.0151	[0.0098-0.0204] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		6p21.33	6	31357968		HLA-B - DHFRP2	ENSG00000206450	ENSG00000228432		780.0	8384.0	rs74618856-?	rs74618856	0	74618856.0	upstream_gene_variant	1.0	NR	3e-08	7.522878745280337		0.0033	[0.0021-0.0045] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		11q24.2	11	126371958		ST3GAL4			ENSG00000110080			rs72085277-?	rs72085277	0	72085277.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.0034	[0.0022-0.0046] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		19q13.32	19	44908822		APOE			ENSG00000130203			rs7412-?	rs7412	0	7412.0	missense_variant	0.0	NR	1.0000000000000001e-307	307.0		0.0912	[0.089-0.093] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		1p13.3	1	109274968		CELSR2			ENSG00000143126			rs12740374-?	rs12740374	0	12740374.0	3_prime_UTR_variant	0.0	NR	5.000000000000001e-81	80.30102999566398		0.0222	[0.02-0.025] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		19p13.2	19	11131631		SPC24, LDLR			ENSG00000161888, ENSG00000130164			rs2738464-?	rs2738464	0	2738464.0	3_prime_UTR_variant	0.0	NR	4.0000000000000003e-75	74.39794000867204		0.012	[0.011-0.013] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		2p24.1	2	21029662		APOB			ENSG00000084674			rs13306194-?	rs13306194	0	13306194.0	missense_variant	0.0	NR	5e-67	66.30102999566398		0.0145	[0.013-0.016] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		5q13.3	5	75343720		HMGCR			ENSG00000113161			rs3064191-?	rs3064191	0	3064191.0	intron_variant	0.0	NR	2e-46	45.69897000433602		0.0084	[0.0072-0.0096] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		9q34.2	9	133266456		ABO, ABO			ENSG00000175164, ENSG00000281879			rs2519093-?	rs2519093	0	2519093.0	intron_variant	0.0	NR	3e-45	44.52287874528034		0.0107	[0.0091-0.0123] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		5q33.3	5	156970662		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		7436.0	58751.0	rs6882345-?	rs6882345	0	6882345.0	intergenic_variant	1.0	NR	1e-21	21.0		0.0063	[0.0049-0.0077] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		20q12	20	41325964		ZHX3 - ADI1P1	ENSG00000174306	ENSG00000235102		8233.0	5159.0	rs6124341-?	rs6124341	0	6124341.0	intergenic_variant	1.0	NR	3e-18	17.522878745280337		0.0059	[0.0045-0.0073] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		16q22.2	16	72194607		PMFBP1 - LINC01572	ENSG00000118557	ENSG00000261008		17729.0	41674.0	rs3852789-?	rs3852789	0	3852789.0	regulatory_region_variant	1.0	NR	9e-18	17.045757490560675		0.0054	[0.0042-0.0066] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		6q25.3	6	160596331		LPA			ENSG00000198670			rs73596816-?	rs73596816	0	73596816.0	intron_variant	0.0	NR	4e-17	16.397940008672037		0.0111	[0.0086-0.0136] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		16p13.3	16	377772		PGAP6			ENSG00000129925			rs375498857-?	rs375498857	0	375498857.0	missense_variant	0.0	NR	1e-16	16.0		0.0198	[0.015-0.025] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		11q23.3	11	116715567		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		57272.0	32603.0	rs7350481-?	rs7350481	0	7350481.0	regulatory_region_variant	1.0	NR	2e-15	14.69897000433602		0.0055	[0.0041-0.0069] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	7e-15	14.154901959985745		0.0046	[0.0034-0.0058] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		2p15	2	62679481		EHBP1			ENSG00000115504			rs10184918-?	rs10184918	0	10184918.0	intron_variant	0.0	NR	2e-14	13.69897000433602		0.0048	[0.0036-0.006] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		1p32.3	1	55035303		BSND - PCSK9	ENSG00000162399	ENSG00000169174		18131.0	4144.0	rs10788994-?	rs10788994	0	10788994.0	upstream_gene_variant	1.0	NR	2e-14	13.69897000433602		0.0047	[0.0035-0.0059] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		2q24.1	2	157625480		ACVR1C			ENSG00000123612			rs10164853-?	rs10164853	0	10164853.0	intron_variant	0.0	NR	3e-14	13.522878745280336		0.0048	[0.0036-0.006] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		14q24.1	14	69778476		SLC10A1			ENSG00000100652			rs2296651-?	rs2296651	0	2296651.0	missense_variant	0.0	NR	4e-14	13.397940008672036		0.0075	[0.0055-0.0095] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		20p12.1	20	17565577		BFSP1			ENSG00000125864			rs6105777-?	rs6105777	0	6105777.0	non_coding_transcript_exon_variant	0.0	NR	4e-14	13.397940008672036		0.0082	[0.006-0.0104] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		8q24.13	8	125467120		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		28717.0	392601.0	rs6982502-?	rs6982502	0	6982502.0	intron_variant	1.0	NR	5e-13	12.30102999566398		0.0043	[0.0031-0.0055] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		1q31.3	1	196729914		CFH			ENSG00000000971			rs10801558-?	rs10801558	0	10801558.0	intron_variant	0.0	NR	9e-13	12.045757490560677		0.0042	[0.003-0.0054] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		6q16.3	6	100970961		GRIK2			ENSG00000164418			rs629192-?	rs629192	0	629192.0	intron_variant	0.0	NR	4e-12	11.397940008672036		0.005	[0.0036-0.0064] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		8q12.1	8	58493931		CYP7A1			ENSG00000167910			rs112784971-?	rs112784971	0	112784971.0	intron_variant	0.0	NR	8e-12	11.096910013008056		0.0048	[0.0034-0.0062] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		16q22.2	16	71419076		LINC02136			ENSG00000261348			rs184643955-?	rs184643955	0	184643955.0	intron_variant	0.0	NR	3e-11	10.522878745280336		0.015	[0.01-0.02] unit increase	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		11p15.4	11	5670559		TRIM5			ENSG00000132256			rs16934050-?	rs16934050	0	16934050.0	intron_variant	0.0	NR	3e-11	10.522878745280336		0.0039	[0.0027-0.0051] unit decrease	Affymetrix [3639888] (imputed)	N
2022-10-27	36142332	Hsu LA	2022-09-08	Int J Mol Sci	www.ncbi.nlm.nih.gov/pubmed/36142332	Common and Rare <i>PCSK9</i> Variants Associated with Low-Density Lipoprotein Cholesterol Levels and the Risk of Diabetes Mellitus: A Mendelian Randomization Study.	LDL cholesterol levels	75,441 East Asian ancestry individuals		17q21.32	17	47685707		KPNB1 - TBKBP1	ENSG00000108424	ENSG00000198933		202.0	8454.0	rs4794048-?	rs4794048	0	4794048.0	upstream_gene_variant	1.0	NR	4e-11	10.397940008672036		0.0041	[0.0029-0.0053] unit increase	Affymetrix [3639888] (imputed)	N
2021-11-12	33889958	Gurung RL	2021-04-23	J Clin Endocrinol Metab	www.ncbi.nlm.nih.gov/pubmed/33889958	Association of genetic variants for plasma LRG1 with rapid decline in kidney function in patients with type 2 diabetes.	Leucine-rich alpha-2-glycoprotein 1 levels in type 2 diabetes	983 Chinese ancestry individuals, 420 Malay ancestry individuals, 478 Indian ancestry individuals	1,813 Chinese ancestry individuals											rs4806985-G	rs4806985	0	4806985.0		1.0	0.685	7e-16	15.154901959985745		0.189	[0.14-0.23] unit increase	Illumina [705416]	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		10q24.31	10	100726389	LBX1	Metazoa_SRP - PAX2	ENSG00000276525	ENSG00000075891		59380.0	9007.0	rs112480585-T	rs112480585	0	112480585.0	intergenic_variant	1.0	0.0720876	3e-06	5.522878745280337		0.598	[0.481 - 0.742]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		15q21.3	15	54006722	UNC13C	UNC13C			ENSG00000137766			rs17731916-C	rs17731916	0	17731916.0	intron_variant	0.0	0.124853	4e-06	5.3979400086720375		0.686	[0.584 - 0.806]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		2p24.3	2	12678384	GREB1, LPIN1	MIR3681HG			ENSG00000224184			rs1126191-A	rs1126191	0	1126191.0	intron_variant	0.0	0.444617	6e-06	5.221848749616356		0.789	[0.711 - 0.874]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		12q24.32	12	125432745	TMEM132B	TMEM132B			ENSG00000139364			rs79411961-T	rs79411961	0	79411961.0	intron_variant	0.0	0.0934152	6e-06	5.221848749616356		1.463	[1.24 - 1.725]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		4p14	4	40386718	APBB2	RNU7-74P - RBM47	ENSG00000239010	ENSG00000163694		9205.0	36549.0	rs113221462-T	rs113221462	0	113221462.0	intergenic_variant	1.0	0.226849	7e-06	5.154901959985743		1.351	[1.185 - 1.541]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		16p13.2	16	8161021	RBFOX1	RBFOX1 - LINC02152	ENSG00000078328	ENSG00000261319		447681.0	137471.0	rs11649532-T	rs11649532	0	11649532.0	intergenic_variant	1.0	0.0777408	7e-06	5.154901959985743		0.587	[0.465 - 0.741]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		10q24.2	10	97878426	AL139239.1	CRTAC1			ENSG00000095713			rs3793695-T	rs3793695	0	3793695.0	3_prime_UTR_variant	0.0	0.376051	8e-06	5.096910013008056		1.272	[1.145 - 1.413]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		10q24.2	10	97878426	CRTAC1	CRTAC1			ENSG00000095713			rs3793695-T	rs3793695	0	3793695.0	3_prime_UTR_variant	0.0	0.376051	8e-06	5.096910013008056		1.272	[1.145 - 1.413]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		9q21.31	9	79636444	TLE4	TLE4			ENSG00000106829			rs4436200-C	rs4436200	0	4436200.0	intron_variant	0.0	0.129024	8e-06	5.096910013008056		0.695	[0.592 - 0.816]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		2q34	2	211011362	LANCL1	CPS1 - RPS27P10	ENSG00000021826	ENSG00000231017		332255.0	287579.0	rs319702-C	rs319702	0	319702.0	intergenic_variant	1.0	0.0689911	8e-06	5.096910013008056		0.619	[0.5 - 0.764]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		10q25.2	10	112998590	TCF7L2	TCF7L2			ENSG00000148737			rs7903146-T	rs7903146	0	7903146.0	intron_variant	0.0	0.259	9e-15	14.045757490560677		1.559	[1.394 - 1.745]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		2q13	2	111566066	SAMD9L	SOCAR			ENSG00000240350			rs11679897-A	rs11679897	0	11679897.0	intron_variant	0.0	0.109	3e-07	6.522878745280337		1.679	[1.376 - 2.048]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		4p15.32	4	15941248	FGFBP1	FGFBP1 - FGFBP2	ENSG00000137440	ENSG00000137441		2508.0	18997.0	rs28736332-C	rs28736332	0	28736332.0	intergenic_variant	1.0	0.048	7e-07	6.154901959985743		1.844	[1.447 - 2.351]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		2p21	2	47389315	EPCAM	EPCAM - MSH2	ENSG00000119888	ENSG00000095002		1714.0	13752.0	rs201308575-T	rs201308575	0	201308575.0	regulatory_region_variant	1.0	0.099	2e-06	5.698970004336019		0.512	[0.389 - 0.674]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		17p13.3	17	1754359	SERPINF2	SERPINF2, SERPINF2			ENSG00000276838, ENSG00000167711			rs1057335-A	rs1057335	0	1057335.0	missense_variant	0.0	0.198	2e-06	5.698970004336019		0.73	[0.642 - 0.831]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		16q24.1	16	85759282	IRF8	C16orf74 - EMC8	ENSG00000154102	ENSG00000131148		8153.0	12476.0	rs439967-A	rs439967	0	439967.0	intergenic_variant	1.0	0.398	2e-06	5.698970004336019		1.388	[1.213 - 1.588]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		3q21.2	3	125204682	SLC12A8	SLC12A8			ENSG00000221955			rs595907-T	rs595907	0	595907.0	intron_variant	0.0	0.096	2e-06	5.698970004336019		0.663	[0.559 - 0.787]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		21q22.3	21	42148002	UMODL1	UMODL1 - ABCG1	ENSG00000177398	ENSG00000160179		4549.0	51687.0	rs62215138-T	rs62215138	0	62215138.0	intergenic_variant	1.0	0.092	2e-06	5.698970004336019		1.55	[1.292 - 1.86]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		6p22.3	6	22730009	CDKAL1	CASC15 - RNU6-1060P	ENSG00000272168	ENSG00000207394		75554.0	394972.0	rs4267949-C	rs4267949	0	4267949.0	intergenic_variant	1.0	0.185	3e-06	5.522878745280337		1.352	[1.19 - 1.535]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		9p13.3	9	35664627	CCDC107, ARHGEF39	ARHGEF39			ENSG00000137135			rs1361338-A	rs1361338	0	1361338.0	intron_variant	0.0	0.489	7e-06	5.154901959985743		1.262	[1.14 - 1.397]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		5q14.2	5	82630623	ATP6AP1L	ATP6AP1L - RPL5P16	ENSG00000205464	ENSG00000240411		243646.0	147174.0	rs1979871-G	rs1979871	0	1979871.0	intergenic_variant	1.0	0.326	7e-06	5.154901959985743		1.276	[1.147 - 1.42]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		19p13.3	19	1937194	CSNK1G2	SCAMP4 - CSNK1G2	ENSG00000227500	ENSG00000133275		11181.0	3978.0	rs11672550-T	rs11672550	0	11672550.0	upstream_gene_variant	1.0	0.435	9e-06	5.045757490560675		1.272	[1.144 - 1.414]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		20q11.23	20	38392336	ATF6	LBP - SNHG17	ENSG00000129988	ENSG00000196756		15323.0	27302.0	rs736368-A	rs736368	0	736368.0	intergenic_variant	1.0	0.153	9e-06	5.045757490560675		0.725	[0.629 - 0.836]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		18q23	18	79903863	KCNG2, PQLC1	SLC66A2			ENSG00000122490			rs12928-G	rs12928	0	12928.0	3_prime_UTR_variant	0.0	0.354006	4e-07	6.3979400086720375		0.759	[0.683 - 0.844]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-resistant type 2 diabetes	1,130 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		1p36.12	1	22688745	ASAP3, E2F2, TCEA3	C1QB - EPHB2	ENSG00000173369	ENSG00000133216		27108.0	22094.0	rs17433836-C	rs17433836	0	17433836.0	intergenic_variant	1.0	0.0904838	5e-07	6.301029995663981		1.596	[1.329 - 1.916]	Illumina [5397362] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		8p22	8	15021883	SGCZ	SGCZ			ENSG00000185053			rs7846057-C	rs7846057	0	7846057.0	intron_variant	0.0	0.069	4e-06	5.3979400086720375		0.621	[0.508 - 0.76]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		13q14.2	13	48186035	ITM2B	POLR2KP2 - ITM2B	ENSG00000224510	ENSG00000136156		51501.0	46577.0	rs1925746-A	rs1925746	0	1925746.0	intergenic_variant	1.0	0.274	4e-06	5.3979400086720375		0.77	[0.689 - 0.86]	Illumina [5398302] (imputed)	N
2021-11-24	34737425	Mansour Aly D	2021-11-04	Nat Genet	www.ncbi.nlm.nih.gov/pubmed/34737425	Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes.	Severe insulin-deficient type 2 diabetes	1,193 Scandinavian ancestry cases, 2,744 Scandinavian ancestry controls		12p13.32	12	3997742	CRACR2A, THCAT155	PARP11-AS1 - HSPA8P5	ENSG00000256862	ENSG00000256356		87360.0	99709.0	rs73051414-A	rs73051414	0	73051414.0	regulatory_region_variant	1.0	0.056	4e-06	5.3979400086720375		1.805	[1.403 - 2.323]	Illumina [5398302] (imputed)	N
2022-01-06	30547231	Ahluwalia TS	2018-12-13	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/30547231	A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria.	Albuminuria	13,226 European ancestry individuals	23,364 European ancestry individuals	6p21.2	6	39207146	KCNK5	KCNK5			ENSG00000164626			rs10947789-A	rs10947789	0	10947789.0	intron_variant	0.0	0.24	9e-06	5.045757490560675				Illumina [142397]	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1p34.2	1	42004603		HIVEP3			ENSG00000127124			rs238675-G	rs238675	0	238675.0	intron_variant	0.0	0.26	4e-06	5.3979400086720375		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p22.3	6	20488666		E2F3			ENSG00000112242			rs1322842-A	rs1322842	0	1322842.0	intron_variant	0.0	0.39	3e-06	5.522878745280337		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1p34.3	1	39206873		MACF1			ENSG00000127603			rs17491275-G	rs17491275	0	17491275.0	3_prime_UTR_variant	0.0	0.16	1e-52	52.0		0.037	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		18q12.3	18	42334557		LINC00907			ENSG00000267586			rs16975918-T	rs16975918	0	16975918.0	intron_variant	0.0	0.32	3e-07	6.522878745280337		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q22.3	2	147145814		LINC01911 - RNU6-692P	ENSG00000231040	ENSG00000207225		267594.0	262528.0	rs429343-A	rs429343	0	429343.0	upstream_gene_variant	1.0	0.42	6e-08	7.221848749616356		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		9q31.1	9	100351370		TEX10			ENSG00000136891			rs3931548-A	rs3931548	0	3931548.0	intron_variant	0.0	0.38	2e-06	5.698970004336019		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17p13.2	17	4077854		ZZEF1			ENSG00000074755			rs8074454-C	rs8074454	0	8074454.0	intron_variant	0.0	0.33	4e-08	7.397940008672037		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3p13	3	71632336		FOXP1 - EIF4E3	ENSG00000114861	ENSG00000163412		48347.0	43078.0	rs7630228-T	rs7630228	0	7630228.0	intron_variant	1.0	0.56	2e-12	11.69897000433602		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		22q13.32	22	48478600		MIR3201 - TAFA5	ENSG00000266508	ENSG00000219438		204185.0	10953.0	rs10854853-T	rs10854853	0	10854853.0	intron_variant	1.0	0.46	2e-07	6.698970004336019		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3q26.31	3	173396515		NLGN1			ENSG00000169760			rs529200-G	rs529200	0	529200.0	5_prime_UTR_variant	0.0	0.53	7e-07	6.154901959985743		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p22.1	6	29942701		HLA-A, HLA-A, HLA-A, HLA-A, HLA-A			ENSG00000223980, ENSG00000224320, ENSG00000206505, ENSG00000206503, ENSG00000235657			rs9260127-G	rs9260127	0	9260127.0	non_coding_transcript_exon_variant	0.0	0.45	4e-13	12.397940008672036		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11q23.3	11	119033523		SLC37A4 - HYOU1	ENSG00000137700	ENSG00000149428		2617.0	10665.0	rs583893-G	rs583893	0	583893.0	intergenic_variant	1.0	0.57	3e-12	11.522878745280336		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17q21.2	17	42561053		HSD17B1 - COASY	ENSG00000108786	ENSG00000068120		5839.0	414.0	rs12945575-T	rs12945575	0	12945575.0	intron_variant	1.0	0.25	2e-18	17.69897000433602		0.018	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		9q22.2	9	89591874		SEMA4D - GADD45G	ENSG00000187764	ENSG00000130222		93744.0	13138.0	rs10681181-TTTG	rs10681181	0	10681181.0	intron_variant	1.0	0.48	4e-06	5.3979400086720375		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3p11.1	3	88693553		NDUFA5P5 - ICE2P2	ENSG00000242365	ENSG00000242705		92151.0	254589.0	rs67518031-G	rs67518031	1	34705333.0	intergenic_variant	1.0	0.5	6e-06	5.221848749616356		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q21.2	5	104604714		LINC02163 - RNU6-334P	ENSG00000251026	ENSG00000252881		198593.0	175574.0	rs254027-A	rs254027	0	254027.0	intron_variant	1.0	0.44	5e-11	10.30102999566398		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16q22.3	16	73061532		ZFHX3			ENSG00000140836			rs747489841-AAC	rs747489841	1	3081665.0	non_coding_transcript_exon_variant	0.0	0.36	9e-07	6.045757490560675		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q21.3	2	134840058		CCNT2-AS1, ACMSD			ENSG00000224043, ENSG00000153086			rs10496731-T	rs10496731	0	10496731.0	intron_variant	0.0	0.63	3e-12	11.522878745280336		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q31.1	2	170774748		EIF2S2P4 - Y_RNA	ENSG00000128692	ENSG00000264495		21960.0	8419.0	rs4668314-G	rs4668314	0	4668314.0	intron_variant	1.0	0.39	9e-07	6.045757490560675		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		14q24.3	14	74815413		YLPM1			ENSG00000119596			rs12432026-G	rs12432026	0	12432026.0	intron_variant	0.0	0.54	2e-17	16.69897000433602		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		9q34.2	9	133273813		ABO, ABO			ENSG00000175164, ENSG00000281879			rs505922-C	rs505922	0	505922.0	intron_variant	0.0	0.32	7e-11	10.154901959985745		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12q13.2	12	56100038		ERBB3			ENSG00000065361			rs2292238-A	rs2292238	0	2292238.0	intron_variant	0.0	0.59	1e-07	7.0		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		8q12.3	8	63844100		LINC01414			ENSG00000253554			rs4737188-A	rs4737188	0	4737188.0	intron_variant	0.0	0.53	2e-10	9.69897000433602		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16q12.2	16	53768582		FTO			ENSG00000140718			rs11642015-T	rs11642015	0	11642015.0	intron_variant	0.0	0.4	4e-16	15.397940008672036		0.014	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		4q24	4	102267552		SLC39A8			ENSG00000138821			rs13107325-T	rs13107325	0	13107325.0	missense_variant	0.0	0.07	5e-118	117.30102999566398		0.078	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		18q21.32	18	60161902		RPS3AP49 - RNU4-17P	ENSG00000242060	ENSG00000202468		11537.0	1665.0	rs6567160-C	rs6567160	0	6567160.0	upstream_gene_variant	1.0	0.23	5e-25	24.30102999566398		0.023	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals												chr6:34650934-C	chr6:34650934	0			1.0	0.14	4.0000000000000003e-28	27.39794000867204		0.027	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16p11.2	16	28814632		NPIPB9 - ATXN2L	ENSG00000196993	ENSG00000168488		41825.0	8367.0	rs56186137-G	rs56186137	0	56186137.0	non_coding_transcript_exon_variant	1.0	0.4	4e-07	6.3979400086720375		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11p11.2	11	47508395		CELF1			ENSG00000149187			rs7124681-A	rs7124681	0	7124681.0	intron_variant	0.0	0.41	1.9999999999999998e-97	96.69897000433602		0.038	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p22.2	6	26210918		H4C5 - H2BC8	ENSG00000276966	ENSG00000273802		4880.0	4241.0	rs9358912-G	rs9358912	0	9358912.0	intergenic_variant	1.0	0.73	7e-08	7.154901959985743		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17q24.2	17	67858486		BPTF			ENSG00000171634			rs55931203-T	rs55931203	0	55931203.0	intron_variant	0.0	0.19	2e-06	5.698970004336019		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals												chr1:72767554-CA	chr1:72767554	0			1.0	0.79	3e-08	7.522878745280337		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12q13.12	12	49869365		FAIM2			ENSG00000135472			rs7132908-A	rs7132908	0	7132908.0	3_prime_UTR_variant	0.0	0.38	9e-08	7.045757490560675		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q13.3	5	75719417		POC5 - SLC25A5P9	ENSG00000152359	ENSG00000251078		1969.0	33153.0	rs2112347-T	rs2112347	0	2112347.0	upstream_gene_variant	1.0	0.64	2e-22	21.69897000433602		0.018	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11p14.1	11	27688083		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs61888762-G	rs61888762	0	61888762.0	intron_variant	0.0	0.32	1e-18	18.0		0.017	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		18q11.2	18	23542244		NPC1			ENSG00000141458			rs771025058-AAG	rs771025058	1	36019635.0	intron_variant	0.0	0.54	4e-17	16.397940008672037		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11p11.2	11	43616425		MIR129-2 - HSD17B12	ENSG00000199077	ENSG00000149084		34942.0	64255.0	rs4755725-C	rs4755725	0	4755725.0	intron_variant	1.0	0.33	7e-07	6.154901959985743		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16q22.1	16	69517564		CYB5B - NFAT5	ENSG00000103018	ENSG00000102908		51300.0	47530.0	rs8049669-A	rs8049669	0	8049669.0	intergenic_variant	1.0	0.43	1e-06	6.0		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals												chr15:73322940-A	chr15:73322940	0			1.0	0.59	6e-07	6.221848749616356		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		7q11.23	7	75420803		POM121C			ENSG00000272391			rs236660-C	rs236660	0	236660.0	non_coding_transcript_exon_variant	0.0	0.57	7e-07	6.154901959985743		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q23.3	5	128021834		LINC01184			ENSG00000245937			rs17764730-C	rs17764730	0	17764730.0	non_coding_transcript_exon_variant	0.0	0.75	2e-15	14.69897000433602		0.017	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3q22.3	3	136609428		HMGN1P10, STAG1			ENSG00000244101, ENSG00000118007			rs1471740-C	rs1471740	0	1471740.0	non_coding_transcript_exon_variant	0.0	0.74	3e-25	24.522878745280337		0.021	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1q42.13	1	230166065		GALNT2			ENSG00000143641			rs11122450-T	rs11122450	0	11122450.0	intron_variant	0.0	0.39	5e-212	211.301029995664		0.058	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12q24.31	12	122479003		ZCCHC8			ENSG00000033030			rs12369179-C	rs12369179	0	12369179.0	intron_variant	0.0	0.91	3e-34	33.52287874528034		0.038	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3p25.2	3	12344838		PPARG			ENSG00000132170			rs4684847-T	rs4684847	0	4684847.0	5_prime_UTR_variant	0.0	0.12	6e-12	11.221848749616356		0.019	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		19q13.32	19	45679774		GIPR			ENSG00000010310			rs555162510-A	rs555162510	1	71338792.0	intron_variant	0.0	0.82	2e-06	5.698970004336019		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3q25.1	3	150348753		LINC01214 - TSC22D2	ENSG00000289524	ENSG00000196428		52148.0	59545.0	rs62271373-T	rs62271373	0	62271373.0	regulatory_region_variant	1.0	0.94	3.9999999999999996e-26	25.39794000867204		0.04	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6q22.33	6	127133748		RSPO3			ENSG00000146374			rs72959041-G	rs72959041	0	72959041.0	intron_variant	0.0	0.95	9e-33	32.045757490560675		0.05	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1q41	1	219457962		LYPLAL1-AS1			ENSG00000228536			rs12130231-A	rs12130231	0	12130231.0	intron_variant	0.0	0.41	1e-17	17.0		0.015	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12q24.31	12	123924955		DNAH10, CCDC92			ENSG00000197653, ENSG00000119242			rs7133378-A	rs7133378	0	7133378.0	intron_variant	0.0	0.32	2e-78	77.69897000433602		0.037	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		22q13.1	22	38203357		MAFF, PLA2G6			ENSG00000185022, ENSG00000184381			rs4821764-G	rs4821764	0	4821764.0	non_coding_transcript_exon_variant	0.0	0.42	9.000000000000001e-29	28.045757490560675		0.021	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q24.3	2	164672366		COBLL1			ENSG00000082438			rs13389219-T	rs13389219	0	13389219.0	intron_variant	0.0	0.39	5e-51	50.30102999566398		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2q36.3	2	226183055		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		529037.0	475655.0	rs2943653-C	rs2943653	0	2943653.0	intron_variant	1.0	0.33	2e-100	99.69897000433602		0.04	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		19q13.11	19	33447894		PEPD			ENSG00000124299			rs7258937-T	rs7258937	0	7258937.0	intron_variant	0.0	0.51	2e-14	13.69897000433602		0.014	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		7q32.2	7	130782095		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		47888.0	41110.0	rs972283-A	rs972283	0	972283.0	intergenic_variant	1.0	0.49	2.0000000000000002e-60	59.69897000433602		0.03	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q33.3	5	158503125		LINC02227 - EBF1	ENSG00000276778	ENSG00000164330		93352.0	192791.0	rs11135038-G	rs11135038	0	11135038.0	non_coding_transcript_exon_variant	1.0	0.27	8e-11	10.096910013008056		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		4q22.1	4	88785492		FAM13A			ENSG00000138640			rs987469-C	rs987469	0	987469.0	intron_variant	0.0	0.54	5.0000000000000004e-29	28.30102999566398		0.02	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		8q24.13	8	125495066		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-C	rs2980888	0	2980888.0	intron_variant	1.0	0.7	3e-85	84.52287874528034		0.038	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q11.2	5	56498805		LINC01948 - RPL26P19	ENSG00000248727	ENSG00000226221		16859.0	5830.0	rs30351-G	rs30351	0	30351.0	regulatory_region_variant	1.0	0.26	2e-38	37.69897000433602		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		7q36.1	7	150845623		AOC1			ENSG00000002726			rs6977416-G	rs6977416	0	6977416.0	intron_variant	0.0	0.67	7e-17	16.154901959985743		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q13.1	5	68418419		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-A	rs4976033	0	4976033.0	regulatory_region_variant	1.0	0.6	3e-11	10.522878745280336		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11q12.3	11	62612555		EML3, ROM1			ENSG00000149499, ENSG00000149489			rs113222038-C	rs113222038	0	113222038.0	5_prime_UTR_variant	0.0	0.72	1e-07	7.0		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		12p12.2	12	20317287		LINC02468 - PDE3A-AS1	ENSG00000256499	ENSG00000256879		181124.0	44445.0	rs11045172-C	rs11045172	0	11045172.0	intergenic_variant	1.0	0.2	7.999999999999999e-32	31.096910013008056		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		5q23.1	5	119390967		TNFAIP8			ENSG00000145779			rs9764678-C	rs9764678	0	9764678.0	intron_variant	0.0	0.27	2e-14	13.69897000433602		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p21.1	6	43790159		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-C	rs998584	0	998584.0	downstream_gene_variant	1.0	0.52	2e-83	82.69897000433602		0.035	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6q24.1	6	139516292		LINC01625 - ATP5PBP6	ENSG00000238099	ENSG00000219806		41634.0	98146.0	rs573454216-A	rs573454216	0	573454216.0	intron_variant	1.0	0.6	4.0000000000000004e-23	22.39794000867204		0.019	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		4p16.2	4	4988571		RN7SKP113 - CYTL1	ENSG00000200761	ENSG00000170891		67507.0	26015.0	rs4450871-G	rs4450871	0	4450871.0	intergenic_variant	1.0	0.44	5e-07	6.301029995663981		0.008	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		8q21.11	8	72523729		RNA5SP271 - KCNB2	ENSG00000252509	ENSG00000182674		165914.0	13496.0	rs1808629-G	rs1808629	0	1808629.0	intergenic_variant	1.0	0.31	7e-09	8.154901959985743		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6q16.1	6	97973845		MMS22L - MIR2113	ENSG00000146263	ENSG00000238367		690628.0	50686.0	rs6938973-C	rs6938973	0	6938973.0	intron_variant	1.0	0.6	2e-07	6.698970004336019		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3p21.31	3	49883138		ACTL11P - MST1R	ENSG00000234667	ENSG00000164078		5833.0	3864.0	rs9843653-C	rs9843653	0	9843653.0	downstream_gene_variant	1.0	0.51	1e-27	27.0		0.019	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		9p21.1	9	28414627		LINGO2			ENSG00000174482			rs17770336-T	rs17770336	0	17770336.0	intron_variant	0.0	0.32	8e-09	8.096910013008056		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		19q12	19	29795544		C19orf12 - CCNE1	ENSG00000131943	ENSG00000105173		79755.0	16447.0	rs569541320-GA	rs569541320	1	145999262.0	intergenic_variant	1.0	0.33	8e-09	8.096910013008056		0.012	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		1q32.1	1	201831383		IPO9			ENSG00000198700			rs2678204-G	rs2678204	0	2678204.0	intron_variant	0.0	0.34	1e-06	6.0		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6p22.1	6	28610509		ZBED9			ENSG00000232040			rs34388845-G	rs34388845	0	34388845.0	intron_variant	0.0	0.21	2.0000000000000002e-28	27.69897000433602		0.028	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6p22.1	6	29942701		HLA-A, HLA-A, HLA-A, HLA-A, HLA-A			ENSG00000223980, ENSG00000224320, ENSG00000206505, ENSG00000206503, ENSG00000235657			rs9260127-G	rs9260127	0	9260127.0	non_coding_transcript_exon_variant	0.0	0.45	4e-17	16.397940008672037		0.016	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		13q31.1	13	80530125		RNU6-61P - HNRNPA1P31	ENSG00000202398	ENSG00000227862		160591.0	88973.0	rs68177066-C	rs68177066	0	68177066.0	intergenic_variant	1.0	0.34	6e-12	11.221848749616356		0.014	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		2q33.1	2	202105527		KIAA2012-AS1, KIAA2012			ENSG00000222035, ENSG00000182329			rs12997625-T	rs12997625	0	12997625.0	intron_variant	0.0	0.53	9e-06	5.045757490560675		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		3q26.2	3	171016588		SLC2A2			ENSG00000163581			rs61791109-C	rs61791109	0	61791109.0	intron_variant	0.0	0.28	3e-08	7.522878745280337		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		8p23.1	8	9615919		TNKS, TNKS			ENSG00000285372, ENSG00000173273			rs33994795-C	rs33994795	0	33994795.0	intron_variant	0.0	0.36	1e-19	19.0		0.018	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		9q21.32	9	83848295		KIF27			ENSG00000165115			rs143020014-G	rs143020014	0	143020014.0	intron_variant	0.0	0.55	5e-09	8.301029995663981		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		9q34.2	9	133273813		ABO, ABO			ENSG00000175164, ENSG00000281879			rs505922-C	rs505922	0	505922.0	intron_variant	0.0	0.32	3e-43	42.52287874528034		0.03	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		15q22.2	15	60616108		RORA, RORA-AS1			ENSG00000069667, ENSG00000245534			rs340025-C	rs340025	0	340025.0	intron_variant	0.0	0.58	1e-07	7.0		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		12q13.2	12	56100038		ERBB3			ENSG00000065361			rs2292238-A	rs2292238	0	2292238.0	intron_variant	0.0	0.59	1e-09	9.0		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		12q13.2	12	56100038		ERBB3			ENSG00000065361			rs2292238-A	rs2292238	0	2292238.0	intron_variant	0.0	0.59	2e-08	7.698970004336019		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		16q12.2	16	53768582		FTO			ENSG00000140718			rs11642015-T	rs11642015	0	11642015.0	intron_variant	0.0	0.4	7e-07	6.154901959985743		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		4q24	4	102267552		SLC39A8			ENSG00000138821			rs13107325-T	rs13107325	0	13107325.0	missense_variant	0.0	0.07	2.9999999999999995e-54	53.52287874528034		0.058	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals												chr6:34650934-C	chr6:34650934	0			1.0	0.14	3e-11	10.522878745280336		0.019	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		11p11.2	11	47508395		CELF1			ENSG00000149187			rs7124681-A	rs7124681	0	7124681.0	intron_variant	0.0	0.41	7e-10	9.154901959985745		0.013	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		11p14.1	11	27688083		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs61888762-G	rs61888762	0	61888762.0	intron_variant	0.0	0.32	7e-07	6.154901959985743		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		10q23.33	10	94279840		PLCE1, PLCE1-AS1			ENSG00000138193, ENSG00000268894			rs2274224-G	rs2274224	0	2274224.0	missense_variant	0.0	0.57	1e-09	9.0		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals												chr15:73322940-A	chr15:73322940	0			1.0	0.59	5e-08	7.301029995663981		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals												chr1:113202203-TCTCTC	chr1:113202203	0			1.0	0.8	1e-09	9.0		0.015	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		7q11.23	7	75420803		POM121C			ENSG00000272391			rs236660-C	rs236660	0	236660.0	non_coding_transcript_exon_variant	0.0	0.57	6e-08	7.221848749616356		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		5q23.3	5	128021834		LINC01184			ENSG00000245937			rs17764730-C	rs17764730	0	17764730.0	non_coding_transcript_exon_variant	0.0	0.75	3e-06	5.522878745280337		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		1q42.13	1	230166065		GALNT2			ENSG00000143641			rs11122450-T	rs11122450	0	11122450.0	intron_variant	0.0	0.39	3e-09	8.522878745280337		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		3p25.2	3	12344838		PPARG			ENSG00000132170			rs4684847-T	rs4684847	0	4684847.0	5_prime_UTR_variant	0.0	0.12	1e-16	16.0		0.024	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6q22.33	6	127133748		RSPO3			ENSG00000146374			rs72959041-G	rs72959041	0	72959041.0	intron_variant	0.0	0.95	4e-09	8.397940008672037		0.029	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		1q41	1	219457962		LYPLAL1-AS1			ENSG00000228536			rs12130231-A	rs12130231	0	12130231.0	intron_variant	0.0	0.41	8e-10	9.096910013008056		0.012	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		2q24.3	2	164672366		COBLL1			ENSG00000082438			rs13389219-T	rs13389219	0	13389219.0	intron_variant	0.0	0.39	1e-07	7.0		0.01	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		2q36.3	2	226183055		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		529037.0	475655.0	rs2943653-C	rs2943653	0	2943653.0	intron_variant	1.0	0.33	4e-17	16.397940008672037		0.017	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		19q13.11	19	33447894		PEPD			ENSG00000124299			rs7258937-T	rs7258937	0	7258937.0	intron_variant	0.0	0.51	2e-10	9.69897000433602		0.013	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		4q22.1	4	88785492		FAM13A			ENSG00000138640			rs987469-C	rs987469	0	987469.0	intron_variant	0.0	0.54	4e-06	5.3979400086720375		0.009	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		8q24.13	8	125495066		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-C	rs2980888	0	2980888.0	intron_variant	1.0	0.7	2.0000000000000002e-28	27.69897000433602		0.024	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		5q13.1	5	68418419		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-A	rs4976033	0	4976033.0	regulatory_region_variant	1.0	0.6	4e-08	7.397940008672037		0.011	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		17p13.1	17	7550602		TNFSF12-TNFSF13, TNFSF12			ENSG00000248871, ENSG00000239697			rs12940684-C	rs12940684	0	12940684.0	intron_variant	0.0	0.3	4e-10	9.397940008672036		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6p21.1	6	43790159		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-C	rs998584	0	998584.0	downstream_gene_variant	1.0	0.52	4e-18	17.397940008672037		0.018	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		6p21.33	6	31628105		PRRC2A, PRRC2A, PRRC2A, PRRC2A, PRRC2A, PRRC2A			ENSG00000231825, ENSG00000204469, ENSG00000231370, ENSG00000206427, ENSG00000226618, ENSG00000225164			rs1046080-A	rs1046080	0	1046080.0	missense_variant	0.0	0.72	2e-07	6.698970004336019		0.011	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Aspartate aminotransferase levels	424,778 European ancestry individuals		10p12.31	10	21541175		MLLT10			ENSG00000078403			rs11012732-G	rs11012732	0	11012732.0	intron_variant	0.0	0.33	3e-07	6.522878745280337		0.011	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		15q13.3	15	31397340		KLF13, KLF13			ENSG00000275746, ENSG00000169926			rs12441543-A	rs12441543	0	12441543.0	intron_variant	0.0	0.29	2e-06	5.698970004336019		0.01	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		6p21.1	6	43790159		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-C	rs998584	0	998584.0	downstream_gene_variant	1.0	0.52	3e-18	17.522878745280337		0.017	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		20q12	20	40550283		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		538960.0	135565.0	rs6029180-G	rs6029180	0	6029180.0	intergenic_variant	1.0	0.33	6e-10	9.221848749616356		0.013	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4p14	4	38678394		KLF3			ENSG00000109787			rs13132853-A	rs13132853	0	13132853.0	intron_variant	0.0	0.64	9e-08	7.045757490560675		0.011	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		6q24.1	6	139516292		LINC01625 - ATP5PBP6	ENSG00000238099	ENSG00000219806		41634.0	98146.0	rs573454216-A	rs573454216	0	573454216.0	intron_variant	1.0	0.6	1e-11	11.0		0.014	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4p16.2	4	4988571		RN7SKP113 - CYTL1	ENSG00000200761	ENSG00000170891		67507.0	26015.0	rs4450871-G	rs4450871	0	4450871.0	intergenic_variant	1.0	0.44	9e-07	6.045757490560675		0.009	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2p16.1	2	59067423		LINC01122 - LINC01793	ENSG00000233723	ENSG00000222030		3657.0	150285.0	rs10172678-T	rs10172678	0	10172678.0	intron_variant	1.0	0.4	6e-08	7.221848749616356		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals												chr3:185821409-A	chr3:185821409	0			1.0	0.85	5e-07	6.301029995663981		0.014	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q11.2	3	94319241		NSUN3 - ARMC10P1	ENSG00000178694	ENSG00000178660		187409.0	187525.0	rs1454687-C	rs1454687	0	1454687.0	intergenic_variant	1.0	0.48	6e-07	6.221848749616356		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		20p11.21	20	25393146		ABHD12 - GINS1	ENSG00000100997	ENSG00000101003		2311.0	14527.0	rs59934506-C	rs59934506	0	59934506.0	intergenic_variant	1.0	0.44	2e-10	9.69897000433602		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		19q13.32	19	47065746		ZC3H4			ENSG00000130749			rs3810291-A	rs3810291	0	3810291.0	3_prime_UTR_variant	0.0	0.68	2e-06	5.698970004336019		0.01	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		13q13.1	13	32803692		PDS5B - LINC00423	ENSG00000083642	ENSG00000226968		25673.0	73739.0	rs7328213-T	rs7328213	0	7328213.0	intergenic_variant	1.0	0.55	1e-11	11.0		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q12.3	3	101417558		SENP7			ENSG00000138468			rs9859077-G	rs9859077	0	9859077.0	intron_variant	0.0	0.66	9e-06	5.045757490560675		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		1p13.3	1	107074019		PRMT6 - NTNG1	ENSG00000198890	ENSG00000162631		6383.0	65988.0	rs9435341-T	rs9435341	0	9435341.0	intergenic_variant	1.0	0.34	3e-06	5.522878745280337		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		11q23.3	11	119033523		SLC37A4 - HYOU1	ENSG00000137700	ENSG00000149428		2617.0	10665.0	rs583893-G	rs583893	0	583893.0	intergenic_variant	1.0	0.57	9e-06	5.045757490560675		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4p16.3	4	3062277		HTT-AS, HTT			ENSG00000251075, ENSG00000197386			rs2798297-A	rs2798297	0	2798297.0	intron_variant	0.0	0.37	6e-07	6.221848749616356		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		10q21.3	10	68587536		TET1			ENSG00000138336			rs112454648-A	rs112454648	0	112454648.0	intron_variant	0.0	0.44	9e-07	6.045757490560675		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2q33.1	2	202105527		KIAA2012-AS1, KIAA2012			ENSG00000222035, ENSG00000182329			rs12997625-T	rs12997625	0	12997625.0	intron_variant	0.0	0.53	4e-06	5.3979400086720375		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q26.2	3	171016588		SLC2A2			ENSG00000163581			rs61791109-C	rs61791109	0	61791109.0	intron_variant	0.0	0.28	2e-08	7.698970004336019		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		8q24.3	8	142687834		PSCA - LY6K	ENSG00000167653	ENSG00000160886		5109.0	12277.0	rs2717609-A	rs2717609	0	2717609.0	intergenic_variant	1.0	0.53	5e-07	6.301029995663981		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		8p23.1	8	9615919		TNKS, TNKS			ENSG00000285372, ENSG00000173273			rs33994795-C	rs33994795	0	33994795.0	intron_variant	0.0	0.36	7e-19	18.154901959985743		0.018	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		9q34.2	9	133273813		ABO, ABO			ENSG00000175164, ENSG00000281879			rs505922-C	rs505922	0	505922.0	intron_variant	0.0	0.32	2.0000000000000003e-34	33.69897000433602		0.026	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		15q22.2	15	60616108		RORA, RORA-AS1			ENSG00000069667, ENSG00000245534			rs340025-C	rs340025	0	340025.0	intron_variant	0.0	0.58	6e-19	18.22184874961636		0.017	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		16q21	16	58081130		MMP15 - Y_RNA	ENSG00000102996	ENSG00000264495		34229.0	1938.0	rs7191378-G	rs7191378	0	7191378.0	regulatory_region_variant	1.0	0.31	2e-06	5.698970004336019		0.01	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2p16.3	2	48463457		PPP1R21			ENSG00000162869			rs4497915-G	rs4497915	0	4497915.0	intron_variant	0.0	0.54	6e-12	11.221848749616356		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		7p14.3	7	32339367		PDE1C			ENSG00000154678			rs215669-G	rs215669	0	215669.0	intron_variant	0.0	0.39	2e-06	5.698970004336019		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6p22.3	6	20488666		E2F3			ENSG00000112242			rs1322842-A	rs1322842	0	1322842.0	intron_variant	0.0	0.39	3e-07	6.522878745280337		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q31.1	2	174301908		LRRC2P1 - HNRNPA1P39	ENSG00000227180	ENSG00000237804		952.0	8107.0	rs34234296-G	rs34234296	0	34234296.0	upstream_gene_variant	1.0	0.61	5e-09	8.301029995663981		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		11p15.3	11	13280328		ARNTL			ENSG00000133794			rs72867447-G	rs72867447	0	72867447.0	intron_variant	0.0	0.57	8e-08	7.096910013008056		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1p34.3	1	39206873		MACF1			ENSG00000127603			rs17491275-G	rs17491275	0	17491275.0	3_prime_UTR_variant	0.0	0.16	3e-19	18.522878745280337		0.023	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q22.3	2	147145814		LINC01911 - RNU6-692P	ENSG00000231040	ENSG00000207225		267594.0	262528.0	rs429343-A	rs429343	0	429343.0	upstream_gene_variant	1.0	0.42	2e-06	5.698970004336019		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5p12	5	43204024		NIM1K			ENSG00000177453			rs67913249-C	rs67913249	0	67913249.0	intron_variant	0.0	0.66	6e-06	5.221848749616356		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q26.31	3	173396515		NLGN1			ENSG00000169760			rs529200-G	rs529200	0	529200.0	5_prime_UTR_variant	0.0	0.53	5e-06	5.301029995663981		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6p22.1	6	29942701		HLA-A, HLA-A, HLA-A, HLA-A, HLA-A			ENSG00000223980, ENSG00000224320, ENSG00000206505, ENSG00000206503, ENSG00000235657			rs9260127-G	rs9260127	0	9260127.0	non_coding_transcript_exon_variant	0.0	0.45	7e-14	13.154901959985745		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		17q21.2	17	42561053		HSD17B1 - COASY	ENSG00000108786	ENSG00000068120		5839.0	414.0	rs12945575-T	rs12945575	0	12945575.0	intron_variant	1.0	0.25	2e-16	15.69897000433602		0.018	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		9q22.2	9	89591874		SEMA4D - GADD45G	ENSG00000187764	ENSG00000130222		93744.0	13138.0	rs10681181-TTTG	rs10681181	0	10681181.0	intron_variant	1.0	0.48	7e-12	11.154901959985745		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4p16.3	4	3062277		HTT-AS, HTT			ENSG00000251075, ENSG00000197386			rs2798297-A	rs2798297	0	2798297.0	intron_variant	0.0	0.37	1e-12	12.0		0.014	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q21.2	5	104604714		LINC02163 - RNU6-334P	ENSG00000251026	ENSG00000252881		198593.0	175574.0	rs254027-A	rs254027	0	254027.0	intron_variant	1.0	0.44	2e-08	7.698970004336019		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q33.1	2	202105527		KIAA2012-AS1, KIAA2012			ENSG00000222035, ENSG00000182329			rs12997625-T	rs12997625	0	12997625.0	intron_variant	0.0	0.53	2e-07	6.698970004336019		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q26.2	3	171016588		SLC2A2			ENSG00000163581			rs61791109-C	rs61791109	0	61791109.0	intron_variant	0.0	0.28	3e-07	6.522878745280337		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8p23.1	8	9615919		TNKS, TNKS			ENSG00000285372, ENSG00000173273			rs33994795-C	rs33994795	0	33994795.0	intron_variant	0.0	0.36	6e-19	18.22184874961636		0.017	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		16q22.2	16	72217233		PMFBP1 - LINC01572	ENSG00000118557	ENSG00000261008		40355.0	19048.0	rs811054-T	rs811054	0	811054.0	intergenic_variant	1.0	0.54	2e-07	6.698970004336019		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q31.1	2	170774748		EIF2S2P4 - Y_RNA	ENSG00000128692	ENSG00000264495		21960.0	8419.0	rs4668314-G	rs4668314	0	4668314.0	intron_variant	1.0	0.39	2e-11	10.69897000433602		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		9q34.2	9	133273813		ABO, ABO			ENSG00000175164, ENSG00000281879			rs505922-C	rs505922	0	505922.0	intron_variant	0.0	0.32	8e-10	9.096910013008056		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8q12.3	8	63844100		LINC01414			ENSG00000253554			rs4737188-A	rs4737188	0	4737188.0	intron_variant	0.0	0.53	2e-07	6.698970004336019		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8q24.13	8	125495066		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-C	rs2980888	0	2980888.0	intron_variant	1.0	0.7	0.0	367.0		0.085	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		16q12.2	16	53768582		FTO			ENSG00000140718			rs11642015-T	rs11642015	0	11642015.0	intron_variant	0.0	0.4	8e-20	19.096910013008056		0.018	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4q24	4	102267552		SLC39A8			ENSG00000138821			rs13107325-T	rs13107325	0	13107325.0	missense_variant	0.0	0.07	8e-10	9.096910013008056		0.022	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		16p11.2	16	28814632		NPIPB9 - ATXN2L	ENSG00000196993	ENSG00000168488		41825.0	8367.0	rs56186137-G	rs56186137	0	56186137.0	non_coding_transcript_exon_variant	1.0	0.4	2e-07	6.698970004336019		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals												chr14:79940130-T	chr14:79940130	0			1.0	0.2	2e-08	7.698970004336019		0.014	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		17q24.2	17	67858486		BPTF			ENSG00000171634			rs55931203-T	rs55931203	0	55931203.0	intron_variant	0.0	0.19	1e-19	19.0		0.023	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		4p12	4	45180510		PRDX4P1 - THAP12P9	ENSG00000248987	ENSG00000248320		235549.0	142743.0	rs10938397-G	rs10938397	0	10938397.0	intergenic_variant	1.0	0.43	5e-06	5.301029995663981		0.009	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		11p14.1	11	27688083		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs61888762-G	rs61888762	0	61888762.0	intron_variant	0.0	0.32	1e-06	6.0		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		18q11.2	18	23542244		NPC1			ENSG00000141458			rs771025058-AAG	rs771025058	1	36019635.0	intron_variant	0.0	0.54	4e-07	6.3979400086720375		0.01	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		11p11.2	11	43616425		MIR129-2 - HSD17B12	ENSG00000199077	ENSG00000149084		34942.0	64255.0	rs4755725-C	rs4755725	0	4755725.0	intron_variant	1.0	0.33	4e-09	8.397940008672037		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		19p13.11	19	18272696		IQCN			ENSG00000130518			rs11666808-T	rs11666808	0	11666808.0	intron_variant	0.0	0.37	2e-09	8.698970004336019		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		10q23.33	10	94279840		PLCE1, PLCE1-AS1			ENSG00000138193, ENSG00000268894			rs2274224-G	rs2274224	0	2274224.0	missense_variant	0.0	0.57	5e-10	9.30102999566398		0.012	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		5q21.3	5	108142979		FBXL17			ENSG00000145743			rs10623997-T	rs10623997	0	10623997.0	intron_variant	0.0	0.76	2e-07	6.698970004336019		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals												chr1:113202203-TCTCTC	chr1:113202203	0			1.0	0.8	4e-06	5.3979400086720375		0.011	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		7q11.23	7	75420803		POM121C			ENSG00000272391			rs236660-C	rs236660	0	236660.0	non_coding_transcript_exon_variant	0.0	0.57	3e-11	10.522878745280336		0.013	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		5q23.3	5	128021834		LINC01184			ENSG00000245937			rs17764730-C	rs17764730	0	17764730.0	non_coding_transcript_exon_variant	0.0	0.75	8e-11	10.096910013008056		0.014	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q22.3	3	136609428		HMGN1P10, STAG1			ENSG00000244101, ENSG00000118007			rs1471740-C	rs1471740	0	1471740.0	non_coding_transcript_exon_variant	0.0	0.74	2e-27	26.69897000433602		0.025	U/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		12q24.31	12	122479003		ZCCHC8			ENSG00000033030			rs12369179-C	rs12369179	0	12369179.0	intron_variant	0.0	0.91	4e-07	6.3979400086720375		0.018	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3p25.2	3	12344838		PPARG			ENSG00000132170			rs4684847-T	rs4684847	0	4684847.0	5_prime_UTR_variant	0.0	0.12	3.0000000000000003e-31	30.522878745280337		0.034	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		3q25.1	3	150348753		LINC01214 - TSC22D2	ENSG00000289524	ENSG00000196428		52148.0	59545.0	rs62271373-T	rs62271373	0	62271373.0	regulatory_region_variant	1.0	0.94	9e-07	6.045757490560675		0.022	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		6q22.33	6	127133748		RSPO3			ENSG00000146374			rs72959041-G	rs72959041	0	72959041.0	intron_variant	0.0	0.95	9e-16	15.045757490560677		0.038	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		1q41	1	219457962		LYPLAL1-AS1			ENSG00000228536			rs12130231-A	rs12130231	0	12130231.0	intron_variant	0.0	0.41	4e-14	13.397940008672036		0.015	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		22q13.1	22	38203357		MAFF, PLA2G6			ENSG00000185022, ENSG00000184381			rs4821764-G	rs4821764	0	4821764.0	non_coding_transcript_exon_variant	0.0	0.42	7e-17	16.154901959985743		0.017	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2q24.3	2	164672366		COBLL1			ENSG00000082438			rs13389219-T	rs13389219	0	13389219.0	intron_variant	0.0	0.39	5e-30	29.30102999566398		0.023	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		2q36.3	2	226183055		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		529037.0	475655.0	rs2943653-C	rs2943653	0	2943653.0	intron_variant	1.0	0.33	4.0000000000000006e-34	33.39794000867204		0.025	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		19q13.11	19	33447894		PEPD			ENSG00000124299			rs7258937-T	rs7258937	0	7258937.0	intron_variant	0.0	0.51	8e-06	5.096910013008056		0.009	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		7q32.2	7	130782095		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		47888.0	41110.0	rs972283-A	rs972283	0	972283.0	intergenic_variant	1.0	0.49	4e-09	8.397940008672037		0.012	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		8q24.13	8	125495066		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56663.0	364655.0	rs2980888-C	rs2980888	0	2980888.0	intron_variant	1.0	0.7	4e-70	69.39794000867204		0.038	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		5q11.2	5	56498805		LINC01948 - RPL26P19	ENSG00000248727	ENSG00000226221		16859.0	5830.0	rs30351-G	rs30351	0	30351.0	regulatory_region_variant	1.0	0.26	7e-16	15.154901959985745		0.018	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Alanine aminotransferase levels	429,203 European ancestry individuals		5q13.1	5	68418419		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-A	rs4976033	0	4976033.0	regulatory_region_variant	1.0	0.6	3e-11	10.522878745280336		0.013	U/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8q23.3	8	115659621		TRPS1			ENSG00000104447			rs4876611-G	rs4876611	0	4876611.0	intron_variant	0.0	0.72	6e-10	9.221848749616356		0.014	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		11p14.1	11	27688083		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs61888762-G	rs61888762	0	61888762.0	intron_variant	0.0	0.32	1e-09	9.0		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		18q11.2	18	23542244		NPC1			ENSG00000141458			rs771025058-AAG	rs771025058	1	36019635.0	intron_variant	0.0	0.54	5e-15	14.30102999566398		0.015	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		19p13.11	19	18272696		IQCN			ENSG00000130518			rs11666808-T	rs11666808	0	11666808.0	intron_variant	0.0	0.37	3e-09	8.522878745280337		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		10q23.33	10	94279840		PLCE1, PLCE1-AS1			ENSG00000138193, ENSG00000268894			rs2274224-G	rs2274224	0	2274224.0	missense_variant	0.0	0.57	3e-06	5.522878745280337		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		16q22.1	16	69517564		CYB5B - NFAT5	ENSG00000103018	ENSG00000102908		51300.0	47530.0	rs8049669-A	rs8049669	0	8049669.0	intergenic_variant	1.0	0.43	4e-16	15.397940008672036		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals												chr15:73322940-A	chr15:73322940	0			1.0	0.59	3e-06	5.522878745280337		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q22.3	3	136609428		HMGN1P10, STAG1			ENSG00000244101, ENSG00000118007			rs1471740-C	rs1471740	0	1471740.0	non_coding_transcript_exon_variant	0.0	0.74	5e-33	32.30102999566398		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1q42.13	1	230166065		GALNT2			ENSG00000143641			rs11122450-T	rs11122450	0	11122450.0	intron_variant	0.0	0.39	3.0000000000000005e-131	130.52287874528034		0.048	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12q24.31	12	122479003		ZCCHC8			ENSG00000033030			rs12369179-C	rs12369179	0	12369179.0	intron_variant	0.0	0.91	1e-08	8.0		0.02	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3p25.2	3	12344838		PPARG			ENSG00000132170			rs4684847-T	rs4684847	0	4684847.0	5_prime_UTR_variant	0.0	0.12	1e-18	18.0		0.025	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		19q13.32	19	45679774		GIPR			ENSG00000010310			rs555162510-A	rs555162510	1	71338792.0	intron_variant	0.0	0.82	2e-06	5.698970004336019		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q25.1	3	150348753		LINC01214 - TSC22D2	ENSG00000289524	ENSG00000196428		52148.0	59545.0	rs62271373-T	rs62271373	0	62271373.0	regulatory_region_variant	1.0	0.94	7.999999999999999e-25	24.096910013008056		0.043	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6q22.33	6	127133748		RSPO3			ENSG00000146374			rs72959041-G	rs72959041	0	72959041.0	intron_variant	0.0	0.95	6e-43	42.22184874961636		0.063	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1q41	1	219457962		LYPLAL1-AS1			ENSG00000228536			rs12130231-A	rs12130231	0	12130231.0	intron_variant	0.0	0.41	2e-21	20.69897000433602		0.019	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12q24.31	12	123924955		DNAH10, CCDC92			ENSG00000197653, ENSG00000119242			rs7133378-A	rs7133378	0	7133378.0	intron_variant	0.0	0.32	1.9999999999999998e-42	41.69897000433602		0.029	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		22q13.1	22	38203357		MAFF, PLA2G6			ENSG00000185022, ENSG00000184381			rs4821764-G	rs4821764	0	4821764.0	non_coding_transcript_exon_variant	0.0	0.42	2.0000000000000002e-29	28.69897000433602		0.023	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q24.3	2	164672366		COBLL1			ENSG00000082438			rs13389219-T	rs13389219	0	13389219.0	intron_variant	0.0	0.39	3.9999999999999997e-84	83.39794000867204		0.038	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2q36.3	2	226183055		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		529037.0	475655.0	rs2943653-C	rs2943653	0	2943653.0	intron_variant	1.0	0.33	2.9999999999999996e-76	75.52287874528034		0.038	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		19q13.11	19	33447894		PEPD			ENSG00000124299			rs7258937-T	rs7258937	0	7258937.0	intron_variant	0.0	0.51	3e-06	5.522878745280337		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		7q32.2	7	130782095		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		47888.0	41110.0	rs972283-A	rs972283	0	972283.0	intergenic_variant	1.0	0.49	2e-62	61.69897000433602		0.033	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q33.3	5	158503125		LINC02227 - EBF1	ENSG00000276778	ENSG00000164330		93352.0	192791.0	rs11135038-G	rs11135038	0	11135038.0	non_coding_transcript_exon_variant	1.0	0.27	3e-10	9.522878745280336		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		17q25.1	17	75883770		TRIM65			ENSG00000141569			rs142186653-C	rs142186653	0	142186653.0	intron_variant	0.0	0.23	7e-06	5.154901959985743		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4q22.1	4	88785492		FAM13A			ENSG00000138640			rs987469-C	rs987469	0	987469.0	intron_variant	0.0	0.54	1e-14	14.0		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q11.2	5	56498805		LINC01948 - RPL26P19	ENSG00000248727	ENSG00000226221		16859.0	5830.0	rs30351-G	rs30351	0	30351.0	regulatory_region_variant	1.0	0.26	9e-44	43.04575749056068		0.031	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		8p11.23	8	37001668		KCNU1 - SMARCE1P4	ENSG00000215262	ENSG00000253650		65543.0	93482.0	rs12681990-T	rs12681990	0	12681990.0	intergenic_variant	1.0	0.84	1e-06	6.0		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		7q36.1	7	150845623		AOC1			ENSG00000002726			rs6977416-G	rs6977416	0	6977416.0	intron_variant	0.0	0.67	3e-08	7.522878745280337		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q13.1	5	68418419		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-A	rs4976033	0	4976033.0	regulatory_region_variant	1.0	0.6	2e-21	20.69897000433602		0.019	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		11q12.3	11	62612555		EML3, ROM1			ENSG00000149499, ENSG00000149489			rs113222038-C	rs113222038	0	113222038.0	5_prime_UTR_variant	0.0	0.72	4e-09	8.397940008672037		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12p12.2	12	20317287		LINC02468 - PDE3A-AS1	ENSG00000256499	ENSG00000256879		181124.0	44445.0	rs11045172-C	rs11045172	0	11045172.0	intergenic_variant	1.0	0.2	8.999999999999998e-25	24.045757490560675		0.025	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1q32.1	1	203558684		OPTC - ATP2B4	ENSG00000188770	ENSG00000058668		49735.0	68103.0	rs2802774-A	rs2802774	0	2802774.0	intergenic_variant	1.0	0.55	1e-07	7.0		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		5q23.1	5	119390967		TNFAIP8			ENSG00000145779			rs9764678-C	rs9764678	0	9764678.0	intron_variant	0.0	0.27	7e-22	21.154901959985743		0.021	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12q13.13	12	54028026		HOXC6, HOXC4			ENSG00000197757, ENSG00000198353			rs10876529-C	rs10876529	0	10876529.0	intron_variant	0.0	0.37	5e-09	8.301029995663981		0.012	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		18p11.32	18	2846814		SMCHD1 - EMILIN2	ENSG00000101596	ENSG00000132205		41797.0	192.0	rs11664106-T	rs11664106	0	11664106.0	non_coding_transcript_exon_variant	1.0	0.37	1e-09	9.0		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6p21.1	6	43790159		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-C	rs998584	0	998584.0	downstream_gene_variant	1.0	0.52	4e-96	95.39794000867204		0.04	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		20q12	20	40550283		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		538960.0	135565.0	rs6029180-G	rs6029180	0	6029180.0	intergenic_variant	1.0	0.33	2e-14	13.69897000433602		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4p14	4	38678394		KLF3			ENSG00000109787			rs13132853-A	rs13132853	0	13132853.0	intron_variant	0.0	0.64	1e-07	7.0		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6q24.1	6	139516292		LINC01625 - ATP5PBP6	ENSG00000238099	ENSG00000219806		41634.0	98146.0	rs573454216-A	rs573454216	0	573454216.0	intron_variant	1.0	0.6	2e-44	43.69897000433602		0.028	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4p16.2	4	4988571		RN7SKP113 - CYTL1	ENSG00000200761	ENSG00000170891		67507.0	26015.0	rs4450871-G	rs4450871	0	4450871.0	intergenic_variant	1.0	0.44	1e-12	12.0		0.014	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		16p11.2	16	31014320		STX1B - STX4	ENSG00000099365	ENSG00000103496		3682.0	18569.0	rs34898535-C	rs34898535	0	34898535.0	upstream_gene_variant	1.0	0.62	3e-15	14.522878745280336		0.015	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1p31.3	1	62104649		PATJ			ENSG00000132849			rs1013293-G	rs1013293	0	1013293.0	intron_variant	0.0	0.57	1e-06	6.0		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		2p16.1	2	59067423		LINC01122 - LINC01793	ENSG00000233723	ENSG00000222030		3657.0	150285.0	rs10172678-T	rs10172678	0	10172678.0	intron_variant	1.0	0.4	3e-11	10.522878745280336		0.012	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1p21.3	1	97850337		DPYD			ENSG00000188641			rs12072739-G	rs12072739	0	12072739.0	intron_variant	0.0	0.23	2e-13	12.69897000433602		0.017	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		1q32.1	1	201831383		IPO9			ENSG00000198700			rs2678204-G	rs2678204	0	2678204.0	intron_variant	0.0	0.34	7e-07	6.154901959985743		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		3q11.2	3	94319241		NSUN3 - ARMC10P1	ENSG00000178694	ENSG00000178660		187409.0	187525.0	rs1454687-C	rs1454687	0	1454687.0	intergenic_variant	1.0	0.48	4e-07	6.3979400086720375		0.01	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		10q24.2	10	98013128		CRTAC1			ENSG00000095713			rs522110-G	rs522110	0	522110.0	intron_variant	0.0	0.56	3e-17	16.522878745280337		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals												chr13:99119385-TAA	chr13:99119385	0			1.0	0.71	8e-06	5.096910013008056		0.009	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		21q22.3	21	45161883		ADARB1			ENSG00000197381			rs394608-C	rs394608	0	394608.0	intron_variant	0.0	0.54	1e-07	7.0		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		6q16.3	6	100181202		PRDX2P4 - SIM1	ENSG00000213177	ENSG00000112246		44539.0	203807.0	rs57989773-C	rs57989773	0	57989773.0	downstream_gene_variant	1.0	0.24	4e-08	7.397940008672037		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		19q13.32	19	47065746		ZC3H4			ENSG00000130749			rs3810291-A	rs3810291	0	3810291.0	3_prime_UTR_variant	0.0	0.68	1e-07	7.0		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		16p11.2	16	31014320		STX1B - STX4	ENSG00000099365	ENSG00000103496		3682.0	18569.0	rs34898535-C	rs34898535	0	34898535.0	upstream_gene_variant	1.0	0.62	3e-08	7.522878745280337		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1p31.3	1	62104649		PATJ			ENSG00000132849			rs1013293-G	rs1013293	0	1013293.0	intron_variant	0.0	0.57	3e-07	6.522878745280337		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		20q13.12	20	47736892		SULF2			ENSG00000196562			rs56218501-C	rs56218501	0	56218501.0	missense_variant	0.0	0.79	7e-17	16.154901959985743		0.018	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2p16.1	2	59067423		LINC01122 - LINC01793	ENSG00000233723	ENSG00000222030		3657.0	150285.0	rs10172678-T	rs10172678	0	10172678.0	intron_variant	1.0	0.4	5e-06	5.301029995663981		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		3q22.1	3	131899697		CPNE4			ENSG00000196353			rs9847672-T	rs9847672	0	9847672.0	intron_variant	0.0	0.28	7e-11	10.154901959985745		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1p21.3	1	97850337		DPYD			ENSG00000188641			rs12072739-G	rs12072739	0	12072739.0	intron_variant	0.0	0.23	5e-06	5.301029995663981		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		18q12.3	18	43188344		RIT2 - SYT4	ENSG00000152214	ENSG00000132872		72653.0	79548.0	rs59499656-A	rs59499656	0	59499656.0	intergenic_variant	1.0	0.66	5e-11	10.30102999566398		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11p15.4	11	8669171		TRIM66			ENSG00000166436			rs11042030-T	rs11042030	0	11042030.0	intron_variant	0.0	0.72	8e-06	5.096910013008056		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals												chr3:185821409-A	chr3:185821409	0			1.0	0.85	7.999999999999999e-25	24.096910013008056		0.027	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		1q32.1	1	201831383		IPO9			ENSG00000198700			rs2678204-G	rs2678204	0	2678204.0	intron_variant	0.0	0.34	2e-07	6.698970004336019		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		4q31.1	4	139942211		MAML3			ENSG00000196782			rs57800857-A	rs57800857	0	57800857.0	intron_variant	0.0	0.63	1e-06	6.0		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		11q13.2	11	66156746		PACS1			ENSG00000175115			rs801738-C	rs801738	0	801738.0	intron_variant	0.0	0.64	6e-13	12.221848749616356		0.014	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		14q32.12	14	93557626		UNC79, UNC79			ENSG00000276416, ENSG00000133958			rs6575340-A	rs6575340	0	6575340.0	intron_variant	0.0	0.64	4e-06	5.3979400086720375		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		10q24.2	10	98013128		CRTAC1			ENSG00000095713			rs522110-G	rs522110	0	522110.0	intron_variant	0.0	0.56	3e-14	13.522878745280336		0.013	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17q21.32	17	49013423		IGF2BP1			ENSG00000159217			rs11079849-C	rs11079849	0	11079849.0	intron_variant	0.0	0.67	1e-07	7.0		0.01	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		20q13.33	20	63715839		ZGPAT			ENSG00000197114			rs62217799-T	rs62217799	0	62217799.0	intron_variant	0.0	0.66	2e-10	9.69897000433602		0.011	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		6p22.1	6	28610509		ZBED9			ENSG00000232040			rs34388845-G	rs34388845	0	34388845.0	intron_variant	0.0	0.21	2e-14	13.69897000433602		0.017	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		21q22.3	21	45161883		ADARB1			ENSG00000197381			rs394608-C	rs394608	0	394608.0	intron_variant	0.0	0.54	1e-06	6.0		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		14q32.32	14	102780133		TRAF3			ENSG00000131323			rs3803286-A	rs3803286	0	3803286.0	intron_variant	0.0	0.33	3e-17	16.522878745280337		0.016	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		13q12.2	13	27438390		MTIF3			ENSG00000122033			rs9512696-G	rs9512696	0	9512696.0	intron_variant	0.0	0.66	9e-07	6.045757490560675		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		2p22.2	2	36562023		FEZ2			ENSG00000171055			rs13410783-G	rs13410783	0	13410783.0	intron_variant	0.0	0.37	5e-08	7.301029995663981		0.009	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		17q11.2	17	29747545		SSH2			ENSG00000141298			rs1038088-G	rs1038088	0	1038088.0	intron_variant	0.0	0.52	8e-06	5.096910013008056		0.008	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	High density lipoprotein cholesterol levels	392,965 European ancestry individuals		19q13.32	19	47065746		ZC3H4			ENSG00000130749			rs3810291-A	rs3810291	0	3810291.0	3_prime_UTR_variant	0.0	0.68	4e-15	14.397940008672036		0.015	mmol/L decrease	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		4q24	4	102267552		SLC39A8			ENSG00000138821			rs13107325-T	rs13107325	0	13107325.0	missense_variant	0.0	0.07	2e-14	13.69897000433602		0.029	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		18q21.32	18	60161902		RPS3AP49 - RNU4-17P	ENSG00000242060	ENSG00000202468		11537.0	1665.0	rs6567160-C	rs6567160	0	6567160.0	upstream_gene_variant	1.0	0.23	4e-08	7.397940008672037		0.013	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		11p11.2	11	47508395		CELF1			ENSG00000149187			rs7124681-A	rs7124681	0	7124681.0	intron_variant	0.0	0.41	5e-15	14.30102999566398		0.016	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		17q24.2	17	67858486		BPTF			ENSG00000171634			rs55931203-T	rs55931203	0	55931203.0	intron_variant	0.0	0.19	3e-20	19.522878745280337		0.024	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals												chr1:72767554-CA	chr1:72767554	0			1.0	0.79	3e-06	5.522878745280337		0.011	mmol/L increase	NR [NR] (imputed)	N
2021-10-18	33980691	Martin S	2021-05-12	Diabetes	www.ncbi.nlm.nih.gov/pubmed/33980691	Genetic evidence for different adiposity phenotypes and their opposing influence on ectopic fat and risk of cardiometabolic disease.	Triglycerides	429,011 European ancestry individuals		12q23.3	12	108224853		WSCD2			ENSG00000075035			rs3764002-C	rs3764002	0	3764002.0	missense_variant	0.0	0.74	1e-06	6.0		0.011	mmol/L increase	NR [NR] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		9q31.3	9	109482136		PTPN3			ENSG00000070159			rs75024825-?	rs75024825	0	75024825.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.537798	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		2p23.3	2	27173179		TCF23 - SLC5A6	ENSG00000163792	ENSG00000138074		16205.0	26408.0	rs78250434-?	rs78250434	0	78250434.0	intergenic_variant	1.0	NR	3e-07	6.522878745280337	(Conditioned on rs6547692)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		5q11.2	5	52897406		ITGA1			ENSG00000213949			rs870992-?	rs870992	0	870992.0	intron_variant	0.0	NR	8e-11	10.096910013008056		1.0131	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		14q32.32	14	103104598		EXOC3L4			ENSG00000205436			rs9324058-?	rs9324058	0	9324058.0	non_coding_transcript_exon_variant	0.0	NR	4.0000000000000003e-28	27.39794000867204		0.926581	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		12q24.31	12	120985856		HNF1A			ENSG00000135100			rs9738226-?	rs9738226	0	9738226.0	intron_variant	0.0	NR	3e-41	40.52287874528034		1.11192	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		3q25.1	3	149492656		TM4SF4			ENSG00000169903			rs9857970-?	rs9857970	0	9857970.0	intron_variant	0.0	NR	8e-11	10.096910013008056		0.525398	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		14q24.2	14	72964930		DCAF4 - ZFYVE1	ENSG00000119599	ENSG00000165861		5227.0	4521.0	rs150441843-?	rs150441843	0	150441843.0	upstream_gene_variant	1.0	NR	6e-09	8.221848749616356		0.56629	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		10q22.3	10	77896074		DLG5, DLG5			ENSG00000151208, ENSG00000274429			rs1781825-?	rs1781825	0	1781825.0	intron_variant	0.0	NR	2e-13	12.69897000433602	(Conditioned on rs12220902)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		20p13	20	3692649		SIGLEC1			ENSG00000088827			rs200137244-?	rs200137244	0	200137244.0	missense_variant	0.0	NR	6e-06	5.221848749616356	(Conditioned on rs525339)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		5q33.3	5	157311532		CYFIP2			ENSG00000055163			rs2289852-?	rs2289852	0	2289852.0	non_coding_transcript_exon_variant	0.0	NR	6e-12	11.221848749616356		0.620411	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		14q24.1	14	69778476		SLC10A1			ENSG00000100652			rs2296651-?	rs2296651	0	2296651.0	missense_variant	0.0	NR	4e-11	10.397940008672036		0.907804	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		2q24.3	2	168861031		NOSTRIN, NOSTRIN, SPC25, SPC25			ENSG00000275326, ENSG00000163072, ENSG00000152253, ENSG00000277909			rs2632372-?	rs2632372	0	2632372.0	intron_variant	0.0	NR	7e-06	5.154901959985743	(Conditioned on rs112779928)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		19q13.11	19	33029021		RHPN2			ENSG00000131941			rs28840750-?	rs28840750	0	28840750.0	intron_variant	0.0	NR	1e-19	19.0		0.950989	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		15q22.2	15	60591082		RORA, RORA-AS1			ENSG00000069667, ENSG00000245534			rs339969-?	rs339969	0	339969.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.767886	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		7q11.23	7	73603327		MLXIPL			ENSG00000009950			rs35368205-?	rs35368205	0	35368205.0	intron_variant	0.0	NR	5e-16	15.30102999566398		1.16041	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		4q31.21	4	145888426		ZNF827			ENSG00000151612			rs36007872-?	rs36007872	0	36007872.0	intron_variant	0.0	NR	1.0000000000000001e-75	75.0		1.49723	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		4q22.1	4	87311036		HSD17B13			ENSG00000170509			rs36015293-?	rs36015293	0	36015293.0	intron_variant	0.0	NR	1e-08	8.0		0.485667	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		12q24.23	12	120268025		PXN - NME2P1	ENSG00000089159	ENSG00000123009		2254.0	14278.0	rs3956833-?	rs3956833	0	3956833.0	upstream_gene_variant	1.0	NR	8e-08	7.096910013008056	(Conditioned on rs9738226)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		7q21.2	7	92779056		CDK6			ENSG00000105810			rs445-?	rs445	0	445.0	intron_variant	0.0	NR	5e-09	8.301029995663981		0.48824	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		16q23.2	16	80463704		DYNLRB2-AS1			ENSG00000259867			rs4581712-?	rs4581712	0	4581712.0	intron_variant	0.0	NR	1e-08	8.0		0.457715	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		12q24.12	12	111792215		ALDH2			ENSG00000111275			rs4646776-?	rs4646776	0	4646776.0	intron_variant	0.0	NR	7e-35	34.15490195998574		1.09885	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		20p13	20	3696367		SIGLEC1			ENSG00000088827			rs525339-?	rs525339	0	525339.0	intron_variant	0.0	NR	5e-09	8.301029995663981		0.740776	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		1p36.11	1	26913775		NUDC, NR0B2			ENSG00000090273, ENSG00000131910			rs540387719-?	rs540387719	0	540387719.0	frameshift_variant	0.0	NR	1e-08	8.0		2.55512	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		11q12.3	11	62427324		SCGB1A1 - AHNAK	ENSG00000149021	ENSG00000124942		4129.0	6218.0	rs56184507-?	rs56184507	0	56184507.0	upstream_gene_variant	1.0	NR	2e-13	12.69897000433602		0.677282	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		11q13.4	11	71544894		KRTAP5-8 - KRTAP5-9	ENSG00000241233	ENSG00000254997		5685.0	3526.0	rs561859655-?	rs561859655	0	561859655.0	upstream_gene_variant	1.0	NR	8e-10	9.096910013008056		4.64515	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		22q11.23	22	24596299		GGT1			ENSG00000100031			rs5751901-?	rs5751901	0	5751901.0	intron_variant	0.0	NR	3e-281	280.5228787452804		2.97935	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		12q24.11	12	110992086		LINC01405 - CUX2	ENSG00000185847	ENSG00000111249		32993.0	42079.0	rs5800916-?	rs5800916	0	5800916.0	intergenic_variant	1.0	NR	2e-09	8.698970004336019	(Conditioned on rs4646776)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		7p15.2	7	26033545		MIR148A - NFE2L3	ENSG00000199085	ENSG00000050344		83559.0	118653.0	rs59592842-?	rs59592842	0	59592842.0	intergenic_variant	1.0	NR	2e-06	5.698970004336019	(Conditioned on rs10236909)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		15q24.1	15	73657725		NPTN - CD276	ENSG00000156642	ENSG00000103855		23591.0	26241.0	rs62004612-?	rs62004612	0	62004612.0	intergenic_variant	1.0	NR	2e-09	8.698970004336019		0.497429	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	5e-35	34.30102999566398		0.99352	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		22q11.23	22	24592953		LRRC75B			ENSG00000178026			rs737128-?	rs737128	0	737128.0	synonymous_variant	0.0	NR	2.0000000000000002e-66	65.69897000433602	(Conditioned on rs5751901)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals												chr10:92507108-?	chr10:92507108	0			1.0	NR	1e-09	9.0		0.35293	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		9p21.3	9	22134069		CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		5966.0	312755.0	rs10811660-?	rs10811660	0	10811660.0	intergenic_variant	1.0	NR	2e-37	36.69897000433602		0.707868	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		11q14.3	11	92975544		MTNR1B			ENSG00000134640			rs10830963-?	rs10830963	0	10830963.0	intron_variant	0.0	NR	2e-52	51.69897000433602		0.838195	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		10p13	10	12218020		CDC123			ENSG00000151465			rs10906100-?	rs10906100	0	10906100.0	intron_variant	0.0	NR	2e-11	10.69897000433602		0.368009	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		7q21.13	7	90175927		STEAP2-AS1, STEAP2			ENSG00000227646, ENSG00000157214			rs11770630-?	rs11770630	0	11770630.0	intron_variant	0.0	NR	7e-09	8.154901959985743		0.39771	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		13q13.1	13	32986355		TOMM22P3 - KL	ENSG00000227604	ENSG00000133116		31954.0	30068.0	rs11839569-?	rs11839569	0	11839569.0	intergenic_variant	1.0	NR	2e-15	14.69897000433602		0.53112	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		2q31.1	2	172726470		RAPGEF4-AS1			ENSG00000228016			rs11884105-?	rs11884105	0	11884105.0	non_coding_transcript_exon_variant	0.0	NR	3e-13	12.522878745280336		0.399008	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		2q31.1	2	168900844		SPC25, SPC25			ENSG00000152253, ENSG00000277909			rs1402837-?	rs1402837	0	1402837.0	intron_variant	0.0	NR	7e-55	54.15490195998574		0.867848	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		13q13.1	13	32998802		TOMM22P3 - KL	ENSG00000227604	ENSG00000133116		44401.0	17621.0	rs1438315561-?	rs1438315561	0	1438315561.0	intergenic_variant	1.0	NR	2e-08	7.698970004336019	(Conditioned on rs11839569)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		11p15.4	11	2817183		KCNQ1, KCNQ1			ENSG00000282076, ENSG00000053918			rs163177-?	rs163177	0	163177.0	intron_variant	0.0	NR	2e-18	17.69897000433602		0.476718	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		9p24.3	9	590735		KANK1			ENSG00000107104			rs16920619-?	rs16920619	0	16920619.0	intron_variant	0.0	NR	7e-16	15.154901959985745		0.49927	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		7p21.2	7	14858657		DGKB			ENSG00000136267			rs17168486-?	rs17168486	0	17168486.0	intron_variant	0.0	NR	3e-25	24.522878745280337		0.565975	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		11q12.2	11	61824890		FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs174566-?	rs174566	0	174566.0	intron_variant	0.0	NR	2e-19	18.69897000433602		0.502575	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		7p21.2	7	15025675		GTF3AP5 - AGMO	ENSG00000225816	ENSG00000187546		39601.0	174642.0	rs1974619-?	rs1974619	0	1974619.0	intergenic_variant	1.0	NR	7e-20	19.154901959985743	(Conditioned on rs17168486)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		7q36.3	7	156988068		NOM1 - MNX1	ENSG00000146909	ENSG00000130675		14892.0	5983.0	rs1974632-?	rs1974632	0	1974632.0	intergenic_variant	1.0	NR	1e-09	9.0		0.375642	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		2q24.3	2	168861031		NOSTRIN, NOSTRIN, SPC25, SPC25			ENSG00000275326, ENSG00000163072, ENSG00000152253, ENSG00000277909			rs2632372-?	rs2632372	0	2632372.0	intron_variant	0.0	NR	3e-08	7.522878745280337	(Conditioned on rs1402837)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		7p13	7	44176538		GCK			ENSG00000106633			rs2908290-?	rs2908290	0	2908290.0	intron_variant	0.0	NR	4e-15	14.397940008672036	(Conditioned on rs730497)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		8q24.11	8	117179236		SLC30A8 - MED30	ENSG00000164756	ENSG00000164758		2522.0	341477.0	rs35859536-?	rs35859536	0	35859536.0	downstream_gene_variant	1.0	NR	3e-41	40.52287874528034		0.735516	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		1q22	1	156288085		TMEM79			ENSG00000163472			rs12121805-?	rs12121805	0	12121805.0	intron_variant	0.0	NR	8e-19	18.096910013008056		0.0278785	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		2q31.1	2	168900844		SPC25, SPC25			ENSG00000152253, ENSG00000277909			rs1402837-?	rs1402837	0	1402837.0	intron_variant	0.0	NR	4e-22	21.39794000867204		0.0269811	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		3p25.1	3	15584876		HACL1			ENSG00000131373			rs1481559294-?	rs1481559294	0	1481559294.0	intron_variant	0.0	NR	4e-08	7.397940008672037		0.209393	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		11p15.4	11	2817183		KCNQ1, KCNQ1			ENSG00000282076, ENSG00000053918			rs163177-?	rs163177	0	163177.0	intron_variant	0.0	NR	5e-08	7.301029995663981	(Conditioned on rs2283228)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		17q25.3	17	82747694		FN3K			ENSG00000167363			rs2251989-?	rs2251989	0	2251989.0	intron_variant	0.0	NR	3e-14	13.522878745280336	(Conditioned on rs113373052)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		11p15.4	11	2828300		KCNQ1, KCNQ1			ENSG00000282076, ENSG00000053918			rs2283228-?	rs2283228	0	2283228.0	intron_variant	0.0	NR	9e-28	27.045757490560675		0.0310931	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		7p13	7	44186502		GCK			ENSG00000106633			rs2971670-?	rs2971670	0	2971670.0	intron_variant	0.0	NR	9.999999999999999e-27	26.0		0.0370664	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		12p11.21	12	31324008		SINHCAF, SINHCAF			ENSG00000139146, ENSG00000276371			rs3214606-?	rs3214606	0	3214606.0	5_prime_UTR_variant	0.0	NR	3e-08	7.522878745280337		0.0199426	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		2p21	2	44961231		SIX3 - KRTCAP2P1	ENSG00000138083	ENSG00000231848		15160.0	35182.0	rs340515-?	rs340515	0	340515.0	non_coding_transcript_exon_variant	1.0	NR	2e-18	17.69897000433602		0.0242354	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		6p22.3	6	20675561		CDKAL1			ENSG00000145996			rs35261542-?	rs35261542	0	35261542.0	intron_variant	0.0	NR	4e-41	40.39794000867204		0.0386191	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		8q24.11	8	117179236		SLC30A8 - MED30	ENSG00000164756	ENSG00000164758		2522.0	341477.0	rs35859536-?	rs35859536	0	35859536.0	downstream_gene_variant	1.0	NR	2e-27	26.69897000433602		0.0297079	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		10q23.33	10	92664665		RN7SL644P - EIF2S2P3	ENSG00000264313	ENSG00000236493		5363.0	4080.0	rs35978445-?	rs35978445	0	35978445.0	downstream_gene_variant	1.0	NR	4e-13	12.397940008672036		0.0211237	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		1q22	1	155420617		ASH1L			ENSG00000116539			rs371382391-?	rs371382391	0	371382391.0	intron_variant	0.0	NR	1e-08	8.0	(Conditioned on rs12121805)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		16p13.3	16	377772		PGAP6			ENSG00000129925			rs375498857-?	rs375498857	0	375498857.0	missense_variant	0.0	NR	5e-28	27.30102999566398		0.122438	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		9p24.2	9	4290085		GLIS3			ENSG00000107249			rs4237150-?	rs4237150	0	4237150.0	intron_variant	0.0	NR	1e-09	9.0		0.0166971	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		5q11.2	5	56515514		C5orf67			ENSG00000225940			rs459447-?	rs459447	0	459447.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.0161494	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		19p13.11	19	17144924		MYO9B			ENSG00000099331			rs4808579-?	rs4808579	0	4808579.0	intron_variant	0.0	NR	4e-10	9.397940008672036		0.0180442	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		9p21.3	9	22134652		CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		6549.0	312172.0	rs7019778-?	rs7019778	0	7019778.0	intergenic_variant	1.0	NR	3e-06	5.522878745280337	(Conditioned on rs10811660)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		4p16.3	4	1252250		CTBP1-DT			ENSG00000196810			rs72501962-?	rs72501962	0	72501962.0	non_coding_transcript_exon_variant	0.0	NR	2e-14	13.69897000433602		0.0221732	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		6p21.2	6	39078879		GLP1R			ENSG00000112164			rs742761-?	rs742761	0	742761.0	intron_variant	0.0	NR	3e-10	9.522878745280336		0.0204817	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		2q24.3	2	164525008		GRB14			ENSG00000115290			rs75536691-?	rs75536691	0	75536691.0	missense_variant	0.0	NR	2e-08	7.698970004336019		0.0405893	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		7q32.1	7	128211575		MIR129-1 - LEP	ENSG00000207705	ENSG00000174697		3632.0	29703.0	rs7778167-?	rs7778167	0	7778167.0	downstream_gene_variant	1.0	NR	8e-13	12.096910013008056		0.0298304	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		7p13	7	44134973		RNA5SP230 - MYL7	ENSG00000252848	ENSG00000106631		9100.0	3891.0	rs78078339-?	rs78078339	0	78078339.0	downstream_gene_variant	1.0	NR	5e-12	11.30102999566398	(Conditioned on rs2971670)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		13q13.1	13	32988367		TOMM22P3 - KL	ENSG00000227604	ENSG00000133116		33966.0	28056.0	rs7997912-?	rs7997912	0	7997912.0	intergenic_variant	1.0	NR	2e-09	8.698970004336019		0.019863	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		16q24.3	16	88787321		PIEZO1 - CDT1	ENSG00000103335	ENSG00000167513		2101.0	16468.0	rs837763-?	rs837763	0	837763.0	upstream_gene_variant	1.0	NR	6e-16	15.221848749616356		0.0227803	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		11p15.5	11	2698445		KCNQ1OT1, KCNQ1, KCNQ1			ENSG00000269821, ENSG00000282076, ENSG00000053918			rs35957135-?	rs35957135	0	35957135.0	non_coding_transcript_exon_variant	0.0	NR	3e-09	8.522878745280337	(Conditioned on rs163177)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		9p24.2	9	4290085		GLIS3			ENSG00000107249			rs4237150-?	rs4237150	0	4237150.0	intron_variant	0.0	NR	4e-16	15.397940008672036		0.44556	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		6p22.3	6	20693997		CDKAL1			ENSG00000145996			rs4710941-?	rs4710941	0	4710941.0	intron_variant	0.0	NR	2e-31	30.69897000433602		0.67052	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		13q12.2	13	27908320		PLUT			ENSG00000247381			rs56209434-?	rs56209434	0	56209434.0	intron_variant	0.0	NR	2e-10	9.69897000433602		0.349209	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		20p11.21	20	22580744		LINC00261 - FOXA2	ENSG00000259974	ENSG00000125798		2102.0	254.0	rs6048206-?	rs6048206	0	6048206.0	upstream_gene_variant	1.0	NR	5e-18	17.30102999566398		0.678357	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		10p12.1	10	26226737		GAD2			ENSG00000136750			rs61839365-?	rs61839365	0	61839365.0	intron_variant	0.0	NR	1e-11	11.0		0.414271	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		3q27.2	3	185818435		IGF2BP2			ENSG00000073792			rs6444082-?	rs6444082	0	6444082.0	intron_variant	0.0	NR	3e-10	9.522878745280336		0.402244	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	4e-31	30.39794000867204		0.634691	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		9p21.3	9	22134652		CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		6549.0	312172.0	rs7019778-?	rs7019778	0	7019778.0	intergenic_variant	1.0	NR	6e-06	5.221848749616356	(Conditioned on rs10811660)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		15q22.2	15	62099409		NPM1P47 - C2CD4B	ENSG00000259466	ENSG00000205502		16104.0	64126.0	rs7163757-?	rs7163757	0	7163757.0	regulatory_region_variant	1.0	NR	5e-21	20.30102999566398		0.541094	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		4p16.3	4	1252250		CTBP1-DT			ENSG00000196810			rs72501962-?	rs72501962	0	72501962.0	non_coding_transcript_exon_variant	0.0	NR	2e-13	12.69897000433602		0.424871	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		7p13	7	44184122		GCK			ENSG00000106633			rs730497-?	rs730497	0	730497.0	intron_variant	0.0	NR	3e-63	62.52287874528034		1.15111	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		6p21.2	6	39062676		GLP1R			ENSG00000112164			rs742763-?	rs742763	0	742763.0	intron_variant	0.0	NR	3e-08	7.522878745280337	(Conditioned on rs9380826)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		11q13.4	11	72767275		ARAP1, STARD10			ENSG00000186635, ENSG00000214530			rs77106637-?	rs77106637	0	77106637.0	intron_variant	0.0	NR	1e-13	13.0		0.801806	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		5q15	5	96381018		MIR583HG - PCSK1	ENSG00000250551	ENSG00000175426		165499.0	9315.0	rs7713317-?	rs7713317	0	7713317.0	intron_variant	1.0	NR	2e-13	12.69897000433602		0.427592	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		2p21	2	44961214		SIX3 - KRTCAP2P1	ENSG00000138083	ENSG00000231848		15143.0	35199.0	rs895636-?	rs895636	0	895636.0	non_coding_transcript_exon_variant	1.0	NR	8e-62	61.096910013008056		0.914536	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		6p21.2	6	39069886		GLP1R			ENSG00000112164			rs9380826-?	rs9380826	0	9380826.0	intron_variant	0.0	NR	8e-17	16.096910013008056		0.531655	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Fasting glucose	75,627 Taiwanese ancestry individuals		3q25.2	3	152669934		MBNL1 - ATP5MGP5	ENSG00000152601	ENSG00000242561		204154.0	130500.0	rs9873341-?	rs9873341	0	9873341.0	intron_variant	1.0	NR	1e-08	8.0		0.360682	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		9p21.3	9	22134069		CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		5966.0	312755.0	rs10811660-?	rs10811660	0	10811660.0	intergenic_variant	1.0	NR	3.0000000000000003e-31	30.522878745280337		0.0322774	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		11q14.3	11	92975544		MTNR1B			ENSG00000134640			rs10830963-?	rs10830963	0	10830963.0	intron_variant	0.0	NR	3e-21	20.522878745280337		0.0260448	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		10p13	10	12218020		CDC123			ENSG00000151465			rs10906100-?	rs10906100	0	10906100.0	intron_variant	0.0	NR	1e-21	21.0		0.0262413	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		3q27.2	3	185802298		IGF2BP2			ENSG00000073792			rs11269661-?	rs11269661	0	11269661.0	intron_variant	0.0	NR	2e-13	12.69897000433602		0.0236902	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		17q25.3	17	82739582		FN3K			ENSG00000167363			rs113373052-?	rs113373052	0	113373052.0	intron_variant	0.0	NR	4.0000000000000004e-275	274.39794000867204		0.0969191	unit increase	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		7p21.2	7	15025163		GTF3AP5 - AGMO	ENSG00000225816	ENSG00000187546		39089.0	175154.0	rs11760782-?	rs11760782	0	11760782.0	intergenic_variant	1.0	NR	1e-10	10.0		0.0221003	unit decrease	NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Glycated hemoglobin HbA1c levels	76,171 Taiwanese ancestry individuals		16p13.3	16	190281		LUC7L			ENSG00000007392			rs1211375-?	rs1211375	0	1211375.0	intron_variant	0.0	NR	3e-07	6.522878745280337	(Conditioned on rs375498857)			NR [5926877] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		19q13.32	19	44912383		APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-?	rs445925	0	445925.0	non_coding_transcript_exon_variant	1.0	NR	1e-300	300.0		6.25687	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		8p21.3	8	19960248		LPL			ENSG00000175445			rs565084540-?	rs565084540	0	565084540.0	intron_variant	0.0	NR	6e-49	48.22184874961636	(Conditioned on rs79236614)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		10q22.1	10	72888987		MCU - OIT3	ENSG00000156026	ENSG00000138315		1293.0	4597.0	rs59776913-?	rs59776913	0	59776913.0	upstream_gene_variant	1.0	NR	3e-08	7.522878745280337		0.499262	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		19p13.2	19	8435691		MARCHF2			ENSG00000099785			rs60748247-?	rs60748247	0	60748247.0	intron_variant	0.0	NR	1e-09	9.0		1.90758	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	6e-56	55.22184874961636		1.14615	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		4p16.3	4	3298808		RGS12			ENSG00000159788			rs73193354-?	rs73193354	0	73193354.0	intron_variant	0.0	NR	1e-08	8.0		0.438517	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		11q23.3	11	116715567		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		57272.0	32603.0	rs7350481-?	rs7350481	0	7350481.0	regulatory_region_variant	1.0	NR	1e-300	300.0		3.47407	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		11q23.3	11	116779090		ZPR1			ENSG00000109917			rs75198898-?	rs75198898	0	75198898.0	intron_variant	0.0	NR	1e-300	300.0	(Conditioned on rs7350481)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		7p21.3	7	10830492		MGC4859 - Y_RNA	ENSG00000283117	ENSG00000264495		50548.0	71486.0	rs76087060-?	rs76087060	0	76087060.0	intergenic_variant	1.0	NR	2e-08	7.698970004336019		4.88184	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		8p21.3	8	20002949		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		35690.0	110394.0	rs79236614-?	rs79236614	0	79236614.0	intergenic_variant	1.0	NR	1e-61	61.0		1.99731	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		11q22.1	11	99676051		CNTN5			ENSG00000149972			rs80052283-?	rs80052283	0	80052283.0	intron_variant	0.0	NR	7e-09	8.154901959985743		3.53542	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		2p23.3	2	27499104		GCKR			ENSG00000084734			rs813592-?	rs813592	0	813592.0	intron_variant	0.0	NR	2e-09	8.698970004336019	(Conditioned on rs6547692)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		13q13.1	13	32402221		N4BP2L1			ENSG00000139597			rs10492397-?	rs10492397	0	10492397.0	3_prime_UTR_variant	0.0	NR	7e-10	9.154901959985745		1.01711	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1q31.3	1	196729914		CFH			ENSG00000000971			rs10801558-?	rs10801558	0	10801558.0	intron_variant	0.0	NR	3e-09	8.522878745280337		0.924639	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		8q12.1	8	58493931		CYP7A1			ENSG00000167910			rs112784971-?	rs112784971	0	112784971.0	intron_variant	0.0	NR	2e-13	12.69897000433602		1.36615	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		16q22.2	16	72113517		PMFBP1			ENSG00000118557			rs117891475-?	rs117891475	0	117891475.0	intron_variant	0.0	NR	1e-21	21.0		4.60168	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		2p21	2	43824071		ABCG5			ENSG00000138075			rs119480069-?	rs119480069	0	119480069.0	missense_variant	0.0	NR	5e-16	15.30102999566398		11.1806	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1p36.11	1	25449191		MACO1			ENSG00000204178			rs12027110-?	rs12027110	0	12027110.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.973053	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		6q16.3	6	100881405		ASCC3 - GRIK2	ENSG00000112249	ENSG00000164418		33.0	81296.0	rs12209186-?	rs12209186	0	12209186.0	upstream_gene_variant	1.0	NR	1e-12	12.0		1.35675	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		5q33.3	5	156968992		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		5766.0	60421.0	rs12657266-?	rs12657266	0	12657266.0	intergenic_variant	1.0	NR	5e-25	24.30102999566398		1.80562	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1p13.3	1	109274968		CELSR2			ENSG00000143126			rs12740374-?	rs12740374	0	12740374.0	3_prime_UTR_variant	0.0	NR	4.0000000000000003e-75	74.39794000867204		5.69083	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		2p24.1	2	21082813		APOB - TDRD15	ENSG00000084674	ENSG00000218819		38740.0	41155.0	rs17399144-?	rs17399144	0	17399144.0	intergenic_variant	1.0	NR	3e-29	28.522878745280337	(Conditioned on rs57825321)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		10q25.2	10	112153794		GPAM			ENSG00000119927			rs1807800-?	rs1807800	0	1807800.0	intron_variant	0.0	NR	5e-10	9.30102999566398		1.06706	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		6q26	6	160687260		LPA - PLG	ENSG00000198670	ENSG00000122194		22985.0	14978.0	rs188951644-?	rs188951644	0	188951644.0	intergenic_variant	1.0	NR	4e-21	20.39794000867204	(Conditioned on rs73596816)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		11p15.4	11	5663172		TRIM6-TRIM34 - TRIM5	ENSG00000258588	ENSG00000132256		18774.0	23.0	rs1976339-?	rs1976339	0	1976339.0	intron_variant	1.0	NR	4e-10	9.397940008672036	(Conditioned on rs998870472)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		14q24.1	14	69778476		SLC10A1			ENSG00000100652			rs2296651-?	rs2296651	0	2296651.0	missense_variant	0.0	NR	1e-16	16.0		2.20171	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		20p12.1	20	17865277		BANF2 - RNU6-192P	ENSG00000125888	ENSG00000212555		129406.0	38485.0	rs2328223-?	rs2328223	0	2328223.0	intergenic_variant	1.0	NR	8e-10	9.096910013008056	(Conditioned on rs6131973)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		9q34.2	9	133266456		ABO, ABO			ENSG00000175164, ENSG00000281879			rs2519093-?	rs2519093	0	2519093.0	intron_variant	0.0	NR	2e-43	42.69897000433602		2.77722	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		19p13.2	19	11131631		SPC24, LDLR			ENSG00000161888, ENSG00000130164			rs2738464-?	rs2738464	0	2738464.0	3_prime_UTR_variant	0.0	NR	6e-69	68.22184874961636		3.04627	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		22q13.2	22	42138592		NDUFA6-DT - CYP2D7	ENSG00000273616	ENSG00000283008		850.0	1611.0	rs2743450-?	rs2743450	0	2743450.0	intron_variant	1.0	NR	1e-10	10.0		1.0089	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		5q13.3	5	75343720		HMGCR			ENSG00000113161			rs3064191-?	rs3064191	0	3064191.0	intron_variant	0.0	NR	5e-41	40.30102999566398		2.08282	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		16p13.3	16	377772		PGAP6			ENSG00000129925			rs375498857-?	rs375498857	0	375498857.0	missense_variant	0.0	NR	5e-18	17.30102999566398		5.46177	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		16q22.2	16	72194607		PMFBP1 - LINC01572	ENSG00000118557	ENSG00000261008		17729.0	41674.0	rs3852789-?	rs3852789	0	3852789.0	regulatory_region_variant	1.0	NR	9.999999999999999e-27	26.0	(Conditioned on rs117891475)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		19q13.32	19	44901322		TOMM40			ENSG00000130204			rs394819-?	rs394819	0	394819.0	missense_variant	0.0	NR	4e-141	140.39794000867204	(Conditioned on rs445925)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		10q22.1	10	72932888		OIT3			ENSG00000138315			rs41280378-?	rs41280378	0	41280378.0	3_prime_UTR_variant	0.0	NR	1e-08	8.0		1.0327	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		19q13.32	19	44912383		APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-?	rs445925	0	445925.0	non_coding_transcript_exon_variant	1.0	NR	1e-300	300.0		18.0597	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		17q21.32	17	47685639		KPNB1 - TBKBP1	ENSG00000108424	ENSG00000198933		134.0	8522.0	rs4794047-?	rs4794047	0	4794047.0	upstream_gene_variant	1.0	NR	3e-11	10.522878745280336		1.08896	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals												chr11:75759077-?	chr11:75759077	0			1.0	NR	5e-16	15.30102999566398		0.724769	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		4q22.1	4	87143279		AFF1 - KLHL8	ENSG00000172493	ENSG00000145332		2240.0	16824.0	rs10023050-?	rs10023050	0	10023050.0	downstream_gene_variant	1.0	NR	3e-13	12.522878745280336		0.538112	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		8p22	8	18400285		NAT2			ENSG00000156006			rs1041983-?	rs1041983	0	1041983.0	synonymous_variant	0.0	NR	3e-22	21.522878745280337		0.711013	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		4p15.32	4	17075812		MTND5P4 - LINC02493	ENSG00000251212	ENSG00000250819		13647.0	95945.0	rs116853057-?	rs116853057	0	116853057.0	upstream_gene_variant	1.0	NR	2e-08	7.698970004336019		2.08156	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		12q24.11	12	109267806		ACACB			ENSG00000076555			rs12013-?	rs12013	0	12013.0	3_prime_UTR_variant	0.0	NR	6e-08	7.221848749616356	(Conditioned on rs201010974)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		12q24.13	12	112136812		TRAFD1			ENSG00000135148			rs12231737-?	rs12231737	0	12231737.0	intron_variant	0.0	NR	2e-09	8.698970004336019		0.482483	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		22q13.31	22	43930116		PNPLA3			ENSG00000100344			rs12483959-?	rs12483959	0	12483959.0	intron_variant	0.0	NR	1e-13	13.0		0.551521	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		16q13	16	56966973		CETP			ENSG00000087237			rs12720922-?	rs12720922	0	12720922.0	intron_variant	0.0	NR	4e-12	11.397940008672036	(Conditioned on rs36229491)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		2p24.1	2	20989476		LINC02850 - APOB	ENSG00000236436	ENSG00000084674		127815.0	11953.0	rs1320143-?	rs1320143	0	1320143.0	intergenic_variant	1.0	NR	1e-20	20.0		1.04144	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		2p24.1	2	21029662		APOB			ENSG00000084674			rs13306194-?	rs13306194	0	13306194.0	missense_variant	0.0	NR	2e-10	9.69897000433602	(Conditioned on rs1320143)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		11q11	11	55178574		OR4A6P - TRIM48	ENSG00000255078	ENSG00000150244		452758.0	83581.0	rs148827430-?	rs148827430	0	148827430.0	intergenic_variant	1.0	NR	3e-09	8.522878745280337		3.21825	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		19p13.11	19	19259532		HAPLN4			ENSG00000187664			rs150641967-?	rs150641967	0	150641967.0	intron_variant	0.0	NR	8e-16	15.096910013008056		1.22981	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		15q21.3	15	58391167		ALDH1A2			ENSG00000128918			rs1532085-?	rs1532085	0	1532085.0	intron_variant	0.0	NR	2e-78	77.69897000433602		1.37233	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		1p31.3	1	62637546		DOCK7			ENSG00000116641			rs1570694-?	rs1570694	0	1570694.0	intron_variant	0.0	NR	6e-27	26.22184874961636		0.95601	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		11q12.2	11	61814184		FADS1, FADS2			ENSG00000149485, ENSG00000134824			rs174559-?	rs174559	0	174559.0	non_coding_transcript_exon_variant	0.0	NR	1e-95	95.0		1.53449	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		9q31.1	9	104902020		ABCA1			ENSG00000165029			rs1883025-?	rs1883025	0	1883025.0	intron_variant	0.0	NR	5e-21	20.30102999566398		0.801317	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		4q25	4	109717709		PLA2G12A			ENSG00000123739			rs192244114-?	rs192244114	0	192244114.0	missense_variant	0.0	NR	1e-08	8.0		4.14587	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		12q24.11	12	109227395		ACACB			ENSG00000076555			rs201010974-?	rs201010974	0	201010974.0	missense_variant	0.0	NR	6e-10	9.221848749616356		4.47731	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		15q21.3	15	58431740		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs2070895-?	rs2070895	0	2070895.0	intron_variant	0.0	NR	9e-62	61.04575749056068	(Conditioned on rs1532085)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		8q24.13	8	125464631		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		26228.0	395090.0	rs2954017-?	rs2954017	0	2954017.0	upstream_gene_variant	1.0	NR	3e-45	44.52287874528034		1.03153	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		16q13	16	56960333		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15469.0	1590.0	rs36229491-?	rs36229491	0	36229491.0	upstream_gene_variant	1.0	NR	1e-18	18.0		0.863462	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		11q12.1	11	56742322		OR9G4, OR9G4			ENSG00000262647, ENSG00000172457			rs370724533-?	rs370724533	0	370724533.0	3_prime_UTR_variant	0.0	NR	2e-11	10.69897000433602		3.65309	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		7q11.23	7	73606007		MLXIPL			ENSG00000009950			rs3812316-?	rs3812316	0	3812316.0	missense_variant	0.0	NR	6e-28	27.22184874961636		1.42615	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		19q13.32	19	44901322		TOMM40			ENSG00000130204			rs394819-?	rs394819	0	394819.0	missense_variant	0.0	NR	1e-31	31.0	(Conditioned on rs445925)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Very low density lipoprotein cholesterol levels	75,388 Taiwanese ancestry individuals		9q31.1	9	104827463		ABCA1			ENSG00000165029			rs4149307-?	rs4149307	0	4149307.0	intron_variant	0.0	NR	2e-16	15.69897000433602	(Conditioned on rs1883025)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		11q23.3	11	116786951		ZPR1			ENSG00000109917			rs3741297-?	rs3741297	0	3741297.0	intron_variant	0.0	NR	1e-76	76.0	(Conditioned on rs662799)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		3p21.1	3	52511910		STAB1			ENSG00000010327			rs376663293-?	rs376663293	0	376663293.0	intron_variant	0.0	NR	2e-14	13.69897000433602		6.20757	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		1p34.3	1	39571682		PABPC4-AS1, PABPC4			ENSG00000228060, ENSG00000090621			rs41264487-?	rs41264487	0	41264487.0	synonymous_variant	0.0	NR	6e-15	14.221848749616356		0.745559	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		5q11.2	5	56511543		RPL26P19 - C5orf67	ENSG00000226221	ENSG00000225940		6471.0	24.0	rs464605-?	rs464605	0	464605.0	downstream_gene_variant	1.0	NR	4e-08	7.397940008672037		0.333063	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		12q24.12	12	111792215		ALDH2			ENSG00000111275			rs4646776-?	rs4646776	0	4646776.0	intron_variant	0.0	NR	7e-13	12.154901959985745		0.483078	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		12p13.31	12	8929985		PHC1			ENSG00000111752			rs4883201-?	rs4883201	0	4883201.0	intron_variant	0.0	NR	2e-09	8.698970004336019		0.388673	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		1p36.11	1	26913775		NUDC, NR0B2			ENSG00000090273, ENSG00000131910			rs540387719-?	rs540387719	0	540387719.0	frameshift_variant	0.0	NR	9e-09	8.045757490560675		1.92682	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		8p21.3	8	19960248		LPL			ENSG00000175445			rs565084540-?	rs565084540	0	565084540.0	intron_variant	0.0	NR	1e-37	37.0	(Conditioned on rs35495249)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		7q21.11	7	80661110		CD36			ENSG00000135218			rs572295823-?	rs572295823	0	572295823.0	frameshift_variant	0.0	NR	5e-19	18.30102999566398		1.94671	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		7q11.23	7	73605645		MLXIPL			ENSG00000009950			rs61010704-?	rs61010704	0	61010704.0	intron_variant	0.0	NR	1e-11	11.0		0.737091	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		9p22.3	9	15297631		TTC39B			ENSG00000155158			rs661048-?	rs661048	0	661048.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.988407	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		11q23.3	11	116792991		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		571.0	27709.0	rs662799-?	rs662799	0	662799.0	upstream_gene_variant	1.0	NR	4e-232	231.39794000867204		2.19011	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		6p21.1	6	43791136		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		4649.0	53742.0	rs6905288-?	rs6905288	0	6905288.0	downstream_gene_variant	1.0	NR	9e-18	17.045757490560675		0.567166	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		3q22.3	3	136391176		STAG1			ENSG00000118007			rs711972-?	rs711972	0	711972.0	intron_variant	0.0	NR	1e-08	8.0		0.459884	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		12q24.31	12	123297492		SBNO1			ENSG00000139697			rs73231950-?	rs73231950	0	73231950.0	intron_variant	0.0	NR	2e-13	12.69897000433602		0.488567	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		10q26.12	10	121156240		RPL19P16 - LINC01153	ENSG00000236762	ENSG00000227143		22517.0	22460.0	rs73366917-?	rs73366917	0	73366917.0	intergenic_variant	1.0	NR	9e-10	9.045757490560677		0.384306	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		20q13.12	20	45960177		ZNF335			ENSG00000198026			rs79645412-?	rs79645412	0	79645412.0	intron_variant	0.0	NR	1e-14	14.0	(Conditioned on rs2868346)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		15q23	15	69889112		DRAIC - TLE3	ENSG00000245750	ENSG00000140332		45992.0	158678.0	rs80287865-?	rs80287865	0	80287865.0	intergenic_variant	1.0	NR	2e-13	12.69897000433602		0.531025	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		7p22.1	7	6395481		RAC1			ENSG00000136238			rs836471-?	rs836471	0	836471.0	intron_variant	0.0	NR	2e-09	8.698970004336019		0.372946	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		7p12.2	7	50268931		SPATA48 - IKZF1	ENSG00000164500	ENSG00000185811		109675.0	35137.0	rs876038-?	rs876038	0	876038.0	intergenic_variant	1.0	NR	2e-17	16.69897000433602		0.586499	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		4q23	4	99632066		MTTP - C4orf54	ENSG00000138823	ENSG00000248713		8069.0	4463.0	rs958868-?	rs958868	0	958868.0	downstream_gene_variant	1.0	NR	3e-19	18.522878745280337		0.725451	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		11p15.4	11	5245613		BGLT3 - HBG1	ENSG00000260629	ENSG00000213934		67.0	2656.0	rs998870472-?	rs998870472	0	998870472.0	upstream_gene_variant	1.0	NR	5e-10	9.30102999566398		3.58056	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		5q13.3	5	75410836		CERT1			ENSG00000113163			rs10067900-?	rs10067900	0	10067900.0	3_prime_UTR_variant	0.0	NR	2e-12	11.69897000433602	(Conditioned on rs3064191)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		2q24.1	2	157625480		ACVR1C			ENSG00000123612			rs10164853-?	rs10164853	0	10164853.0	intron_variant	0.0	NR	1e-11	11.0		1.12928	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		2p15	2	62679481		EHBP1			ENSG00000115504			rs10184918-?	rs10184918	0	10184918.0	intron_variant	0.0	NR	5e-15	14.30102999566398		1.30936	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		8p21.3	8	19960248		LPL			ENSG00000175445			rs565084540-?	rs565084540	0	565084540.0	intron_variant	0.0	NR	7e-26	25.154901959985743	(Conditioned on rs77237194)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		19p13.11	19	19268740		TM6SF2			ENSG00000213996			rs58542926-?	rs58542926	0	58542926.0	missense_variant	0.0	NR	3e-24	23.522878745280337		6.39697	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		17q24.2	17	67965117		BPTF			ENSG00000171634			rs60626066-?	rs60626066	0	60626066.0	non_coding_transcript_exon_variant	0.0	NR	1e-08	8.0		1.89283	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	4.0000000000000003e-112	111.39794000867204		7.04775	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		11q23.3	11	116792991		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		571.0	27709.0	rs662799-?	rs662799	0	662799.0	upstream_gene_variant	1.0	NR	1.0000000000000001e-268	268.0	(Conditioned on rs7350481)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		11q23.3	11	116715567		LINC02702 - BUD13	ENSG00000237937	ENSG00000137656		57272.0	32603.0	rs7350481-?	rs7350481	0	7350481.0	regulatory_region_variant	1.0	NR	1e-300	300.0		14.3697	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		8p21.3	8	20007944		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		40685.0	105399.0	rs77237194-?	rs77237194	0	77237194.0	intergenic_variant	1.0	NR	2e-74	73.69897000433602		9.43473	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		14q22.1	14	52045251		NID2			ENSG00000087303			rs79823890-?	rs79823890	0	79823890.0	intron_variant	0.0	NR	8e-09	8.096910013008056		2.78504	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		5q11.2	5	56565768		C5orf67			ENSG00000225940			rs9687832-?	rs9687832	0	9687832.0	intron_variant	0.0	NR	4e-06	5.3979400086720375	(Conditioned on rs465002)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals												chr6:32251007-?	chr6:32251007	0			1.0	NR	4e-09	8.397940008672037		0.433124	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		11q13.1	11	65600963		MAP3K11			ENSG00000173327			rs10750763-?	rs10750763	0	10750763.0	intron_variant	0.0	NR	2e-09	8.698970004336019		0.508703	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		18q21.1	18	49593209		LIPG			ENSG00000101670			rs11082764-?	rs11082764	0	11082764.0	3_prime_UTR_variant	0.0	NR	1e-67	67.0		1.07136	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		22q11.21	22	21624807		UBE2L3 - YDJC	ENSG00000185651	ENSG00000161179		773.0	3282.0	rs11089637-?	rs11089637	0	11089637.0	downstream_gene_variant	1.0	NR	2e-14	13.69897000433602		0.463958	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		10q25.2	10	112289955		TECTB			ENSG00000119913			rs11195876-?	rs11195876	0	11195876.0	intron_variant	0.0	NR	1e-14	14.0		0.486479	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		16q22.1	16	67965313		SLC12A4			ENSG00000124067			rs11383451-?	rs11383451	0	11383451.0	intron_variant	0.0	NR	2e-12	11.69897000433602		0.696648	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		17q25.3	17	78391193		PGS1			ENSG00000087157			rs11657865-?	rs11657865	0	11657865.0	intron_variant	0.0	NR	9e-10	9.045757490560677		0.378376	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		11p13	11	36285791		COMMD9			ENSG00000110442			rs11820100-?	rs11820100	0	11820100.0	intron_variant	0.0	NR	1e-08	8.0		0.44108	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		12p13.31	12	7586745		GAPDHP31 - NIFKP3	ENSG00000235868	ENSG00000256331		19363.0	17605.0	rs12146828-?	rs12146828	0	12146828.0	intergenic_variant	1.0	NR	2e-15	14.69897000433602		0.490912	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		16q13	16	56966973		CETP			ENSG00000087237			rs12720922-?	rs12720922	0	12720922.0	intron_variant	0.0	NR	4e-79	78.39794000867204	(Conditioned on rs247617)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		1p22.1	1	93371576		DR1 - Y_RNA	ENSG00000117505	ENSG00000264495		2083.0	14135.0	rs12752223-?	rs12752223	0	12752223.0	downstream_gene_variant	1.0	NR	7e-11	10.154901959985745		0.414722	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		3p21.31	3	48410132		PLXNB1			ENSG00000164050			rs1300035001-?	rs1300035001	0	1300035001.0	intron_variant	0.0	NR	3e-09	8.522878745280337		4.41284	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		2p24.1	2	20991280		LINC02850 - APOB	ENSG00000236436	ENSG00000084674		129619.0	10149.0	rs1318006-?	rs1318006	0	1318006.0	intergenic_variant	1.0	NR	2e-12	11.69897000433602		0.652992	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		10q25.2	10	111958691		RPS6P15 - GPAM	ENSG00000230809	ENSG00000119927		459750.0	191174.0	rs140956697-?	rs140956697	0	140956697.0	intron_variant	1.0	NR	3e-13	12.522878745280336	(Conditioned on rs11195876)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		19q13.32	19	44923535		APOC1 - APOC1P1	ENSG00000130208	ENSG00000214855		4186.0	3264.0	rs141622900-?	rs141622900	0	141622900.0	upstream_gene_variant	1.0	NR	6e-19	18.22184874961636	(Conditioned on rs34342646)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		8p23.1	8	9329732		RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		42154.0	41358.0	rs1461729-?	rs1461729	0	1461729.0	intron_variant	1.0	NR	3e-11	10.522878745280336		2.01336	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		20q12	20	40559285		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		547962.0	126563.0	rs4812441-?	rs4812441	0	4812441.0	intergenic_variant	1.0	NR	1e-06	6.0	(Conditioned on rs6029632)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		2p24.1	2	22324522		RN7SL117P - RNA5SP87	ENSG00000264192	ENSG00000206882		401234.0	14364.0	rs527429575-?	rs527429575	0	527429575.0	intron_variant	1.0	NR	1.0000000000000001e-39	39.0	(Conditioned on rs57825321)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1p22.1	1	91801530		TGFBR3			ENSG00000069702			rs529192228-?	rs529192228	0	529192228.0	intron_variant	0.0	NR	1e-09	9.0		5.91496	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		7p13	7	44228566		CAMK2B			ENSG00000058404			rs555844715-?	rs555844715	0	555844715.0	intron_variant	0.0	NR	1e-08	8.0		6.7576	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		2p21	2	43814669		ABCG5			ENSG00000138075			rs575127146-?	rs575127146	0	575127146.0	intron_variant	0.0	NR	4e-08	7.397940008672037	(Conditioned on rs119480069)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		2p24.1	2	21024193		APOB			ENSG00000084674			rs57825321-?	rs57825321	0	57825321.0	3_prime_UTR_variant	0.0	NR	9e-62	61.04575749056068		3.65001	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		22q12.2	22	30036856		HORMAD2-AS1			ENSG00000227117			rs5844888-?	rs5844888	0	5844888.0	intron_variant	0.0	NR	1e-09	9.0		1.45611	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		10q25.2	10	112229237		GPAM - TECTB	ENSG00000119927	ENSG00000119913		13860.0	54163.0	rs60191209-?	rs60191209	0	60191209.0	upstream_gene_variant	1.0	NR	5e-08	7.301029995663981	(Conditioned on rs1807800)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		20q12	20	41331702		ADI1P1 - LPIN3	ENSG00000235102	ENSG00000132793		42.0	9119.0	rs6029632-?	rs6029632	0	6029632.0	downstream_gene_variant	1.0	NR	2e-13	12.69897000433602		1.35524	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		20p12.1	20	17575540		DSTN			ENSG00000125868			rs6131973-?	rs6131973	0	6131973.0	intron_variant	0.0	NR	1e-12	12.0		2.04592	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	3e-12	11.522878745280336		1.08201	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1p22.1	1	92790780		EVI5			ENSG00000067208			rs6604024-?	rs6604024	0	6604024.0	intron_variant	0.0	NR	9e-06	5.045757490560675	(Conditioned on rs529192228)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		8q24.13	8	125467120		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		28717.0	392601.0	rs6982502-?	rs6982502	0	6982502.0	intron_variant	1.0	NR	9e-12	11.045757490560677		1.06351	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		11q24.2	11	126371958		ST3GAL4			ENSG00000110080			rs72085277-?	rs72085277	0	72085277.0	intron_variant	0.0	NR	4e-08	7.397940008672037		0.89068	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		6q25.3	6	160596331		LPA			ENSG00000198670			rs73596816-?	rs73596816	0	73596816.0	intron_variant	0.0	NR	1e-21	21.0		3.31774	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		9q34.11	9	127966536		FAM102A			ENSG00000167106			rs74987020-?	rs74987020	0	74987020.0	intron_variant	0.0	NR	3e-10	9.522878745280336		1.18182	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1p32.3	1	55033483		BSND - PCSK9	ENSG00000162399	ENSG00000169174		16311.0	5964.0	rs7525649-?	rs7525649	0	7525649.0	intergenic_variant	1.0	NR	2e-13	12.69897000433602		1.19327	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1p32.3	1	55058155		PCSK9			ENSG00000169174			rs757143429-?	rs757143429	0	757143429.0	missense_variant	0.0	NR	7e-09	8.154901959985743	(Conditioned on rs7525649)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		7p13	7	44539470		NPC1L1			ENSG00000015520			rs764300904-?	rs764300904	0	764300904.0	frameshift_variant	0.0	NR	1e-05	5.0	(Conditioned on rs555844715)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		17q24.2	17	68757243		LINC01482			ENSG00000267659			rs768295380-?	rs768295380	0	768295380.0	intron_variant	0.0	NR	9e-06	5.045757490560675	(Conditioned on rs8077252)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1p31.3	1	62460056		DOCK7			ENSG00000116641			rs77064258-?	rs77064258	0	77064258.0	intron_variant	0.0	NR	5e-08	7.301029995663981		1.11309	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		17q24.2	17	69088921		ABCA6			ENSG00000154262			rs8077252-?	rs8077252	0	8077252.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.88027	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		1q41	1	220799001		MTARC1			ENSG00000186205			rs867772-?	rs867772	0	867772.0	intron_variant	0.0	NR	8e-10	9.096910013008056		1.21238	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		19p13.2	19	10691437		ILF3			ENSG00000129351			rs920352257-?	rs920352257	0	920352257.0	3_prime_UTR_variant	0.0	NR	4e-41	40.39794000867204	(Conditioned on rs2738464)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Low density lipoprotein cholesterol levels	76,650 Taiwanese ancestry individuals		11p15.4	11	5245613		BGLT3 - HBG1	ENSG00000260629	ENSG00000213934		67.0	2656.0	rs998870472-?	rs998870472	0	998870472.0	upstream_gene_variant	1.0	NR	6e-17	16.221848749616356		12.2747	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		5q23.1	5	119374385		TNFAIP8			ENSG00000145779			rs151300053-?	rs151300053	0	151300053.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.878009	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		11p15.2	11	14623692		PSMA1			ENSG00000129084			rs1522633-?	rs1522633	0	1522633.0	intron_variant	0.0	NR	3e-09	8.522878745280337		0.379846	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		6q26	6	160661429		LPA			ENSG00000198670			rs1652507-?	rs1652507	0	1652507.0	intron_variant	0.0	NR	4e-20	19.39794000867204		0.556478	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		12q24.31	12	122716390		HCAR3			ENSG00000255398			rs1696352-?	rs1696352	0	1696352.0	synonymous_variant	0.0	NR	6e-07	6.221848749616356	(Conditioned on rs73231950)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		20q13.12	20	44413724		HNF4A			ENSG00000101076			rs1800961-?	rs1800961	0	1800961.0	missense_variant	0.0	NR	1e-08	8.0		1.43587	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		7q21.11	7	80759234		SEMA3C			ENSG00000075223			rs181495259-?	rs181495259	0	181495259.0	intron_variant	0.0	NR	4e-10	9.397940008672036	(Conditioned on rs572295823)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		9q31.1	9	104802565		ABCA1			ENSG00000165029			rs1883023-?	rs1883023	0	1883023.0	intron_variant	0.0	NR	1.0000000000000001e-28	28.0	(Conditioned on rs1883025)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		9q31.1	9	104902020		ABCA1			ENSG00000165029			rs1883025-?	rs1883025	0	1883025.0	intron_variant	0.0	NR	3e-65	64.52287874528034		1.21246	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		18q21.1	18	49653146		SMUG1P1 - ACAA2	ENSG00000267444	ENSG00000167315		1986.0	129018.0	rs1943973-?	rs1943973	0	1943973.0	downstream_gene_variant	1.0	NR	8e-33	32.096910013008056	(Conditioned on rs11082764)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		15q21.3	15	58431740		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs2070895-?	rs2070895	0	2070895.0	intron_variant	0.0	NR	1.0000000000000001e-88	88.0		1.24059	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		12q24.11	12	109512339		UBE3B			ENSG00000151148			rs2241210-?	rs2241210	0	2241210.0	intron_variant	0.0	NR	1e-09	9.0		0.407278	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		19p13.2	19	11239812		DOCK6, ANGPTL8			ENSG00000130158, ENSG00000130173			rs2278426-?	rs2278426	0	2278426.0	missense_variant	0.0	NR	7e-67	66.15490195998575		1.19358	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		1q42.13	1	230161390		GALNT2			ENSG00000143641			rs2281721-?	rs2281721	0	2281721.0	intron_variant	0.0	NR	4e-11	10.397940008672036		0.488699	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		11p11.2	11	47335319		MYBPC3			ENSG00000134571			rs2301216-?	rs2301216	0	2301216.0	intron_variant	0.0	NR	4e-08	7.397940008672037		0.368282	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-?	rs247617	0	247617.0	regulatory_region_variant	1.0	NR	1e-300	300.0		3.32961	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		14q32.33	14	104790576		AKT1			ENSG00000142208			rs2494745-?	rs2494745	0	2494745.0	intron_variant	0.0	NR	3e-19	18.522878745280337		0.586934	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		15q21.3	15	58387979		ALDH1A2			ENSG00000128918			rs261291-?	rs261291	0	261291.0	intron_variant	0.0	NR	3e-69	68.52287874528034	(Conditioned on rs2070895)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		8q23.3	8	115612760		TRPS1			ENSG00000104447			rs2737214-?	rs2737214	0	2737214.0	intron_variant	0.0	NR	3e-14	13.522878745280336		0.702687	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		20q13.12	20	45919331		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		7176.0	15352.0	rs2868346-?	rs2868346	0	2868346.0	regulatory_region_variant	1.0	NR	3e-24	23.522878745280337		0.631193	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		16q23.2	16	81501185		CMIP			ENSG00000153815			rs2925979-?	rs2925979	0	2925979.0	intron_variant	0.0	NR	3e-24	23.522878745280337		0.621882	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		8q13.3	8	70239265		NCOA2			ENSG00000140396			rs2926714-?	rs2926714	0	2926714.0	intron_variant	0.0	NR	4e-08	7.397940008672037		0.343688	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		8q24.13	8	125495147		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56744.0	364574.0	rs2954038-?	rs2954038	0	2954038.0	intron_variant	1.0	NR	3e-10	9.522878745280336		0.425156	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		19q13.32	19	44884873		NECTIN2			ENSG00000130202			rs34342646-?	rs34342646	0	34342646.0	intron_variant	0.0	NR	9.999999999999999e-27	26.0		1.18447	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		17q22	17	58477688		HSF5			ENSG00000176160			rs34763794-?	rs34763794	0	34763794.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.337923	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	High density lipoprotein cholesterol levels	76,531 Taiwanese ancestry individuals		8p21.3	8	20007998		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		40739.0	105345.0	rs35495249-?	rs35495249	0	35495249.0	intergenic_variant	1.0	NR	2e-85	84.69897000433602		1.48987	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		9q21.13	9	72154912		GDA			ENSG00000119125			rs531362158-?	rs531362158	0	531362158.0	intron_variant	0.0	NR	4e-08	7.397940008672037		11.4242	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		6p12.3	6	50890282		RPS17P5 - FTH1P5	ENSG00000060303	ENSG00000230204		32620.0	22430.0	rs9473932-?	rs9473932	0	9473932.0	intergenic_variant	1.0	NR	6e-09	8.221848749616356		1.43442	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		11p15.3	11	13215196		RASSF10 - ARNTL	ENSG00000189431	ENSG00000133794		203077.0	61456.0	rs961322577-?	rs961322577	0	961322577.0	intergenic_variant	1.0	NR	1e-09	9.0		17.0858	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		10q21.3	10	63419392		JMJD1C			ENSG00000171988			rs10761760-?	rs10761760	0	10761760.0	intron_variant	0.0	NR	5e-17	16.30102999566398		0.011622	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		12q24.31	12	124827879		SCARB1			ENSG00000073060			rs10846744-?	rs10846744	0	10846744.0	intron_variant	0.0	NR	1e-08	8.0		0.0071884	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		6p21.32	6	32436186		TSBP1-AS1 - HLA-DRA	ENSG00000225914	ENSG00000234794		28423.0	3692.0	rs117433623-?	rs117433623	0	117433623.0	upstream_gene_variant	1.0	NR	6e-10	9.221848749616356		0.0157137	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		1q22	1	156278506		SMG5			ENSG00000198952			rs12038217-?	rs12038217	0	12038217.0	intron_variant	0.0	NR	1e-13	13.0		0.0106617	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		7p21.1	7	17242196		AHR			ENSG00000106546			rs12531256-?	rs12531256	0	12531256.0	intron_variant	0.0	NR	7e-14	13.154901959985745		0.00958356	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		12p12.2	12	20853181		SLCO1B3-SLCO1B7, SLCO1B3			ENSG00000257046, ENSG00000111700			rs1304539-?	rs1304539	0	1304539.0	intron_variant	0.0	NR	8.999999999999999e-121	120.04575749056067		0.0398475	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		8q12.1	8	56901872		RPL37P6 - RNU6-13P	ENSG00000241431	ENSG00000206975		313085.0	15212.0	rs140869496-?	rs140869496	0	140869496.0	regulatory_region_variant	1.0	NR	3e-09	8.522878745280337		0.102802	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		16p13.3	16	377772		PGAP6			ENSG00000129925			rs375498857-?	rs375498857	0	375498857.0	missense_variant	0.0	NR	7e-14	13.154901959985745		0.0379492	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		2q37.1	2	233612023		UGT1A11P - UGT1A8	ENSG00000227846	ENSG00000242366		7622.0	5610.0	rs4281899-?	rs4281899	0	4281899.0	intergenic_variant	1.0	NR	1e-300	300.0		0.0601397	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		3q22.3	3	136093681		PPP2R3A			ENSG00000073711			rs4678322-?	rs4678322	0	4678322.0	intron_variant	0.0	NR	9e-12	11.045757490560677		0.0133191	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		11p15.4	11	2942062		PHLDA2 - NAP1L4	ENSG00000181649	ENSG00000205531		12642.0	2369.0	rs4758561-?	rs4758561	0	4758561.0	downstream_gene_variant	1.0	NR	3e-14	13.522878745280336		0.0170151	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		11p15.3	11	13339977		ARNTL			ENSG00000133794			rs6486122-?	rs6486122	0	6486122.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.00723753	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		7p15.3	7	22713112		STEAP1B			ENSG00000105889			rs6969599-?	rs6969599	0	6969599.0	intron_variant	0.0	NR	1e-10	10.0		0.00892921	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		11q13.5	11	75763150		DGAT2-DT, DGAT2			ENSG00000247867, ENSG00000062282			rs72997616-?	rs72997616	0	72997616.0	intron_variant	0.0	NR	1e-09	9.0		0.00940946	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		2q37.1	2	233677928		UGT1A10, UGT1A9, UGT1A8			ENSG00000242515, ENSG00000241119, ENSG00000242366			rs7571915-?	rs7571915	0	7571915.0	intron_variant	0.0	NR	1e-300	300.0	(Conditioned on rs4281899)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		9q22.31	9	91212271		LINC00484 - AUH	ENSG00000229694	ENSG00000148090		45999.0	1544.0	rs773507-?	rs773507	0	773507.0	intron_variant	1.0	NR	2e-09	8.698970004336019		0.00755948	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		12p12.2	12	20826423		SLCO1B3-SLCO1B7, SLCO1B3			ENSG00000257046, ENSG00000111700			rs77515162-?	rs77515162	0	77515162.0	intron_variant	0.0	NR	8.000000000000001e-39	38.096910013008056	(Conditioned on rs1304539)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		7p15.3	7	22657557		STEAP1B			ENSG00000105889			rs80085481-?	rs80085481	0	80085481.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(Conditioned on rs6969599)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total bilirubin levels	76,535 Taiwanese ancestry individuals		11p15.4	11	5245613		BGLT3 - HBG1	ENSG00000260629	ENSG00000213934		67.0	2656.0	rs998870472-?	rs998870472	0	998870472.0	upstream_gene_variant	1.0	NR	8e-35	34.096910013008056		0.146358	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		4q13.3	4	73368504		ANKRD17-DT - ALB	ENSG00000250220	ENSG00000163631		50551.0	28610.0	rs1000669403-?	rs1000669403	0	1000669403.0	intergenic_variant	1.0	NR	3e-22	21.522878745280337		0.082414	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		1p36.12	1	23472508		ASAP3, ASAP3			ENSG00000088280, ENSG00000282854			rs10917386-?	rs10917386	0	10917386.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.00626095	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		13q31.3	13	91352880		MIR17HG			ENSG00000215417			rs111371822-?	rs111371822	0	111371822.0	intron_variant	0.0	NR	4e-08	7.397940008672037		0.00722928	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		15q26.3	15	98747207		IGF1R			ENSG00000140443			rs112970502-?	rs112970502	0	112970502.0	intron_variant	0.0	NR	1e-10	10.0		0.103893	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		6p12.3	6	50866053		RPS17P5 - FTH1P5	ENSG00000060303	ENSG00000230204		8391.0	46659.0	rs11307648-?	rs11307648	0	11307648.0	intergenic_variant	1.0	NR	2e-10	9.69897000433602		0.145776	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		15q24.2	15	75946679		NRG4			ENSG00000169752			rs11636251-?	rs11636251	0	11636251.0	intron_variant	0.0	NR	8e-12	11.096910013008056		0.108067	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		19q13.32	19	45676926		GIPR			ENSG00000010310			rs11672660-?	rs11672660	0	11672660.0	intron_variant	0.0	NR	4e-41	40.39794000867204		0.262296	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		8p21.2	8	23874737		STC1 - RNU1-148P	ENSG00000159167	ENSG00000207201		19931.0	202260.0	rs11785244-?	rs11785244	0	11785244.0	intergenic_variant	1.0	NR	2e-09	8.698970004336019		0.104942	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		17q23.2	17	61161860		BCAS3			ENSG00000141376			rs11868441-?	rs11868441	0	11868441.0	intron_variant	0.0	NR	2e-15	14.69897000433602		0.152043	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		8q24.21	8	126496993		LINC00861 - RNU6-869P	ENSG00000245164	ENSG00000207138		204205.0	7770.0	rs12546489-?	rs12546489	0	12546489.0	upstream_gene_variant	1.0	NR	4e-08	7.397940008672037		0.0958316	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		3p14.1	3	66768525		RPL21P41 - KBTBD8	ENSG00000214560	ENSG00000163376		131113.0	229782.0	rs13066345-?	rs13066345	0	13066345.0	intergenic_variant	1.0	NR	8.000000000000001e-29	28.096910013008056		0.233447	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		11q13.3	11	69434278		MYEOV - LINC02747	ENSG00000172927	ENSG00000255774		92596.0	41289.0	rs147862410-?	rs147862410	0	147862410.0	downstream_gene_variant	1.0	NR	1e-09	9.0		0.096191	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		17q21.32	17	46918879		GOSR2-DT			ENSG00000261886			rs1662576-?	rs1662576	0	1662576.0	intron_variant	0.0	NR	2e-16	15.69897000433602		0.130893	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		3q26.2	3	169382169		MECOM			ENSG00000085276			rs16853618-?	rs16853618	0	16853618.0	intron_variant	0.0	NR	4e-13	12.397940008672036		0.136219	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		6p12.1	6	54877470		FAM83B			ENSG00000168143			rs189656378-?	rs189656378	0	189656378.0	intron_variant	0.0	NR	3e-07	6.522878745280337	(Conditioned on rs9370400)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		18q12.3	18	45613111		SLC14A2			ENSG00000132874			rs2363613-?	rs2363613	0	2363613.0	intron_variant	0.0	NR	3e-11	10.522878745280336	(Conditioned on rs4890568)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		12q24.31	12	120986771		HNF1A			ENSG00000135100			rs2393775-?	rs2393775	0	2393775.0	intron_variant	0.0	NR	1e-09	9.0		0.0988251	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		4q21.1	4	76472865		SHROOM3			ENSG00000138771			rs28394165-?	rs28394165	0	28394165.0	intron_variant	0.0	NR	8e-09	8.096910013008056		0.107671	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		16q22.1	16	69703943		NFAT5			ENSG00000102908			rs2965757-?	rs2965757	0	2965757.0	3_prime_UTR_variant	0.0	NR	2e-10	9.69897000433602		0.106784	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		6q27	6	166003730		LINC00602 - GAPDHP72	ENSG00000281832	ENSG00000216624		14115.0	54775.0	rs300132-?	rs300132	0	300132.0	intergenic_variant	1.0	NR	5e-09	8.301029995663981		0.134274	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		11p14.1	11	30738788		MPPED2-AS1 - DCDC1	ENSG00000254489	ENSG00000170959		106205.0	91581.0	rs3925584-?	rs3925584	0	3925584.0	intergenic_variant	1.0	NR	9e-27	26.045757490560675		0.175818	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		2p23.2	2	27798099		MRPL33, RBKS			ENSG00000243147, ENSG00000171174			rs3935148-?	rs3935148	0	3935148.0	intron_variant	0.0	NR	5e-10	9.30102999566398		0.100357	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		3p14.1	3	66705743		RPL21P41 - KBTBD8	ENSG00000214560	ENSG00000163376		68331.0	292564.0	rs41357846-?	rs41357846	0	41357846.0	intergenic_variant	1.0	NR	8e-08	7.096910013008056	(Conditioned on rs13066345)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		10q21.3	10	68370006		RUFY2			ENSG00000204130			rs3927445-?	rs3927445	0	3927445.0	intron_variant	0.0	NR	7e-07	6.154901959985743	(Conditioned on rs10997975)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		5q35.3	5	177357611		LMAN2 - RGS14	ENSG00000169223	ENSG00000169220		5943.0	313.0	rs4075959-?	rs4075959	0	4075959.0	upstream_gene_variant	1.0	NR	3e-19	18.522878745280337		0.00870652	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		1q22	1	155183255		TRIM46			ENSG00000163462			rs4971100-?	rs4971100	0	4971100.0	intron_variant	0.0	NR	1e-18	18.0		0.00662534	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		13q21.33	13	71774636		DACH1			ENSG00000276644			rs500830-?	rs500830	0	500830.0	intron_variant	0.0	NR	1e-10	10.0		0.00641908	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		17p11.2	17	19564783		SLC47A1			ENSG00000142494			rs559750356-?	rs559750356	0	559750356.0	intron_variant	0.0	NR	4e-06	5.3979400086720375	(Conditioned on rs77630697)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		10p15.3	10	801748		DIP2C - LARP4B	ENSG00000151240	ENSG00000107929		112080.0	5185.0	rs60692108-?	rs60692108	0	60692108.0	intergenic_variant	1.0	NR	4e-08	7.397940008672037		0.00617708	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		15q21.3	15	53645745		WDR72			ENSG00000166415			rs62005954-?	rs62005954	0	62005954.0	intron_variant	0.0	NR	4e-12	11.397940008672036		0.00453612	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		2q31.1	2	169334455		LRP2			ENSG00000081479			rs6433115-?	rs6433115	0	6433115.0	intron_variant	0.0	NR	3e-22	21.522878745280337	(Conditioned on rs2673172)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		9q21.11	9	68816258		PIP5K1B			ENSG00000107242			rs7042786-?	rs7042786	0	7042786.0	intron_variant	0.0	NR	2e-14	13.69897000433602		0.00500168	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		11q14.1	11	78338704		GAB2			ENSG00000033327			rs7119933-?	rs7119933	0	7119933.0	intron_variant	0.0	NR	2e-10	9.69897000433602		0.00426145	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		19q13.11	19	32869463		SLC7A9			ENSG00000021488			rs7252778-?	rs7252778	0	7252778.0	intron_variant	0.0	NR	3e-10	9.522878745280336		0.00449215	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		15q24.2	15	75996931		NRG4			ENSG00000169752			rs72734574-?	rs72734574	0	72734574.0	intron_variant	0.0	NR	1e-06	6.0	(Conditioned on rs11636251)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		22q13.1	22	40489495		MRTFA			ENSG00000196588			rs73167082-?	rs73167082	0	73167082.0	intron_variant	0.0	NR	4e-15	14.397940008672036		0.00630858	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		4p16.1	4	10110174		WDR1			ENSG00000071127			rs73212870-?	rs73212870	0	73212870.0	intron_variant	0.0	NR	2e-10	9.69897000433602		0.00549927	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		6p21.1	6	43837625		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		51138.0	7253.0	rs744103-?	rs744103	0	744103.0	intron_variant	1.0	NR	4e-13	12.397940008672036		0.00576553	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		4q22.1	4	88128874		ABCG2			ENSG00000118777			rs74904971-?	rs74904971	0	74904971.0	intron_variant	0.0	NR	1e-11	11.0		0.00476409	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		2q35	2	216813276		FABP5P14 - TNP1	ENSG00000234588	ENSG00000118245		7147.0	46182.0	rs7598172-?	rs7598172	0	7598172.0	intron_variant	1.0	NR	7e-12	11.154901959985745		0.00450418	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		2q24.2	2	162232433		FAP			ENSG00000078098			rs76099239-?	rs76099239	0	76099239.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.00543835	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		3p22.2	3	38474878		ACVR2B			ENSG00000114739			rs762318-?	rs762318	0	762318.0	non_coding_transcript_exon_variant	0.0	NR	7e-09	8.154901959985743		0.00380473	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		6p12.1	6	54732039		RPSAP44 - KRASP1	ENSG00000220773	ENSG00000220635		106551.0	38544.0	rs76975968-?	rs76975968	0	76975968.0	intergenic_variant	1.0	NR	8e-07	6.096910013008056	(Conditioned on rs146677015)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		17p11.2	17	19542448		SLC47A1			ENSG00000142494			rs77630697-?	rs77630697	0	77630697.0	missense_variant	0.0	NR	4e-13	12.397940008672036		0.0270795	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		6q21	6	106725104		LINC02532			ENSG00000235142			rs7766720-?	rs7766720	0	7766720.0	non_coding_transcript_exon_variant	0.0	NR	9e-11	10.045757490560677		0.00590361	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		20q13.32	20	58901754		GNAS			ENSG00000087460			rs8121252-?	rs8121252	0	8121252.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.00417816	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		7q21.11	7	77922810		PHTF2			ENSG00000006576			rs848486-?	rs848486	0	848486.0	missense_variant	0.0	NR	6e-09	8.221848749616356		0.00471967	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		1p31.1	1	77604773		ZZZ3			ENSG00000036549			rs9787306-?	rs9787306	0	9787306.0	intron_variant	0.0	NR	9e-09	8.045757490560675		0.00384426	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		15q21.3	15	57492707		CGNL1			ENSG00000128849			rs11444227-?	rs11444227	0	11444227.0	intron_variant	0.0	NR	1e-09	9.0		0.00609136	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		15q24.2	15	75946679		NRG4			ENSG00000169752			rs11636251-?	rs11636251	0	11636251.0	intron_variant	0.0	NR	3e-16	15.522878745280336		0.0053591	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		13q14.11	13	42127805		DGKH			ENSG00000102780			rs1170158-?	rs1170158	0	1170158.0	intron_variant	0.0	NR	4e-11	10.397940008672036		0.00434925	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		8p21.2	8	23874737		STC1 - RNU1-148P	ENSG00000159167	ENSG00000207201		19931.0	202260.0	rs11785244-?	rs11785244	0	11785244.0	intergenic_variant	1.0	NR	2e-13	12.69897000433602		0.00532729	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		1q22	1	155720704		DAP3			ENSG00000132676			rs118037036-?	rs118037036	0	118037036.0	intron_variant	0.0	NR	9e-09	8.045757490560675	(Conditioned on rs4971100)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		17q23.2	17	61161860		BCAS3			ENSG00000141376			rs11868441-?	rs11868441	0	11868441.0	intron_variant	0.0	NR	4e-12	11.397940008672036	(Conditioned on rs2240736)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		1p36.12	1	23286851		LINC01355, LINC01355			ENSG00000261326, ENSG00000283124			rs12043534-?	rs12043534	0	12043534.0	non_coding_transcript_exon_variant	0.0	NR	1e-11	11.0		0.00455866	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		17q12	17	39358417		FBXL20			ENSG00000108306			rs12935933-?	rs12935933	0	12935933.0	intron_variant	0.0	NR	2e-13	12.69897000433602		0.00558659	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		17q12	17	39466264		CDK12			ENSG00000167258			rs12950666-?	rs12950666	0	12950666.0	intron_variant	0.0	NR	2e-06	5.698970004336019	(Conditioned on rs12935933)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		15q21.3	15	57181295		TCF12			ENSG00000140262			rs140036500-?	rs140036500	0	140036500.0	intron_variant	0.0	NR	9e-07	6.045757490560675	(Conditioned on rs11444227)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		6p12.1	6	54558447		CLNS1AP1 - RPL10P10	ENSG00000213335	ENSG00000216347		72597.0	44040.0	rs146677015-?	rs146677015	0	146677015.0	intergenic_variant	1.0	NR	2e-13	12.69897000433602		0.0205739	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		4q21.21	4	80263187		PRDM8 - FGF5	ENSG00000152784	ENSG00000138675		58858.0	3452.0	rs16998073-?	rs16998073	0	16998073.0	upstream_gene_variant	1.0	NR	3e-12	11.522878745280336		0.0046667	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		7p14.1	7	41018175		LINC01450 - LINC01449	ENSG00000232458	ENSG00000224017		38236.0	71364.0	rs17715435-?	rs17715435	0	17715435.0	intergenic_variant	1.0	NR	1e-10	10.0		0.00570921	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		6q25.3	6	160241558		SLC22A2			ENSG00000112499			rs201478523-?	rs201478523	0	201478523.0	missense_variant	0.0	NR	1e-11	11.0	(Conditioned on rs3798156)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		4q24	4	102766881		MANBA - UBE2D3	ENSG00000109323	ENSG00000109332		5887.0	27502.0	rs223480-?	rs223480	0	223480.0	intergenic_variant	1.0	NR	4e-08	7.397940008672037		0.00363042	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		17q23.2	17	61408032		TBX2, TBX2-AS1			ENSG00000121068, ENSG00000267280			rs2240736-?	rs2240736	0	2240736.0	non_coding_transcript_exon_variant	0.0	NR	1.9999999999999998e-26	25.69897000433602		0.0070514	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		3q27.3	3	186727263		KNG1			ENSG00000113889			rs2304456-?	rs2304456	0	2304456.0	missense_variant	0.0	NR	2e-10	9.69897000433602		0.00555016	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		2q31.1	2	169348290		LRP2			ENSG00000081479			rs2673172-?	rs2673172	0	2673172.0	intron_variant	0.0	NR	4e-19	18.39794000867204		0.00587103	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		4q21.1	4	76480299		SHROOM3			ENSG00000138771			rs28817415-?	rs28817415	0	28817415.0	intron_variant	0.0	NR	1.0000000000000001e-23	23.0		0.00776983	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		2p23.3	2	27527678		GCKR - C2orf16	ENSG00000084734	ENSG00000221843		3994.0	9708.0	rs2950835-?	rs2950835	0	2950835.0	downstream_gene_variant	1.0	NR	1e-17	17.0		0.0056703	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		16p12.3	16	20377607		PDILT			ENSG00000169340			rs35208507-?	rs35208507	0	35208507.0	intron_variant	0.0	NR	1e-08	8.0		0.00541836	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		15q21.1	15	45423962		SPATA5L1 - C15orf48	ENSG00000171763	ENSG00000166920		2547.0	6617.0	rs36047699-?	rs36047699	0	36047699.0	downstream_gene_variant	1.0	NR	3e-11	10.522878745280336		0.00797565	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		11p15.5	11	2148654		INS-IGF2, IGF2-AS			ENSG00000129965, ENSG00000099869			rs3741205-?	rs3741205	0	3741205.0	non_coding_transcript_exon_variant	0.0	NR	3e-09	8.522878745280337		0.00391192	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		6q25.3	6	160255184		SLC22A2			ENSG00000112499			rs3798156-?	rs3798156	0	3798156.0	intron_variant	0.0	NR	2e-14	13.69897000433602		0.00850071	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		11p14.1	11	30738788		MPPED2-AS1 - DCDC1	ENSG00000254489	ENSG00000170959		106205.0	91581.0	rs3925584-?	rs3925584	0	3925584.0	intergenic_variant	1.0	NR	1e-27	27.0		0.00741765	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		4p15.2	4	23731214		ERVH-1			ENSG00000251292			rs9999768-?	rs9999768	0	9999768.0	intron_variant	0.0	NR	5e-08	7.301029995663981		0.00758266	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		11p14.1	11	30747131		MPPED2-AS1 - DCDC1	ENSG00000254489	ENSG00000170959		114548.0	83238.0	rs10767873-?	rs10767873	0	10767873.0	intergenic_variant	1.0	NR	5e-14	13.30102999566398		0.0472705	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		1p36.21	1	15582985		DNAJC16, AGMAT			ENSG00000116138, ENSG00000116771			rs10803394-?	rs10803394	0	10803394.0	intron_variant	0.0	NR	5e-09	8.301029995663981		0.0357905	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		10q23.2	10	87149628		SHLD2			ENSG00000122376			rs11202347-?	rs11202347	0	11202347.0	intron_variant	0.0	NR	5e-23	22.30102999566398		0.0617457	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		15q26.3	15	98747207		IGF1R			ENSG00000140443			rs112970502-?	rs112970502	0	112970502.0	intron_variant	0.0	NR	7e-16	15.154901959985745		0.049764	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		15q24.2	15	75946679		NRG4			ENSG00000169752			rs11636251-?	rs11636251	0	11636251.0	intron_variant	0.0	NR	8e-11	10.096910013008056		0.0392581	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		17q23.2	17	61370008		BCAS3			ENSG00000141376			rs11653176-?	rs11653176	0	11653176.0	intron_variant	0.0	NR	1e-10	10.0		0.0386018	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		11q13.1	11	64937214		GPHA2 - MAJIN	ENSG00000149735	ENSG00000168070		1321.0	303.0	rs1174410819-?	rs1174410819	0	1174410819.0	upstream_gene_variant	1.0	NR	1.9999999999999999e-63	62.69897000433602		1.11862	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		1q21.3	1	155089923		EFNA3 - Y_RNA	ENSG00000143590	ENSG00000264495		2385.0	30567.0	rs117518444-?	rs117518444	0	117518444.0	downstream_gene_variant	1.0	NR	3e-07	6.522878745280337	(Conditioned on rs2070803)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		11q13.3	11	69349597		MYEOV - LINC02747	ENSG00000172927	ENSG00000255774		7915.0	125970.0	rs1189631841-?	rs1189631841	0	1189631841.0	intron_variant	1.0	NR	3e-06	5.522878745280337	(Conditioned on rs528151380)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		12q24.13	12	112136812		TRAFD1			ENSG00000135148			rs12231737-?	rs12231737	0	12231737.0	intron_variant	0.0	NR	2e-10	9.69897000433602		0.0429921	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		17q23.1	17	59836488		VMP1			ENSG00000062716			rs1292060-?	rs1292060	0	1292060.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.0337457	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		1q21.1	1	145711421		PDZK1 - CD160	ENSG00000174827	ENSG00000117281		3273.0	8050.0	rs1967017-?	rs1967017	0	1967017.0	upstream_gene_variant	1.0	NR	4e-21	20.39794000867204		0.070958	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		1q22	1	155185239		TRIM46 - MUC1	ENSG00000163462	ENSG00000185499		268.0	585.0	rs2070803-?	rs2070803	0	2070803.0	intron_variant	1.0	NR	8.000000000000001e-28	27.096910013008056		0.0757105	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		14q24.1	14	69778476		SLC10A1			ENSG00000100652			rs2296651-?	rs2296651	0	2296651.0	missense_variant	0.0	NR	4e-09	8.397940008672037		0.0606344	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		6p22.2	6	25801855		SLC17A1			ENSG00000124568			rs2328895-?	rs2328895	0	2328895.0	intron_variant	0.0	NR	2e-17	16.69897000433602		0.0803025	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		4q22.1	4	88169296		ABCG2			ENSG00000118777			rs28395359-?	rs28395359	0	28395359.0	intron_variant	0.0	NR	3e-32	31.522878745280337	(Conditioned on rs74904971)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		8p21.2	8	23900816		STC1 - RNU1-148P	ENSG00000159167	ENSG00000207201		46010.0	176181.0	rs2872991-?	rs2872991	0	2872991.0	intergenic_variant	1.0	NR	4e-13	12.397940008672036		0.0498502	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		20q13.2	20	54088791		BCAS1 - CYP24A1	ENSG00000064787	ENSG00000019186		18197.0	64655.0	rs290409-?	rs290409	0	290409.0	regulatory_region_variant	1.0	NR	9e-10	9.045757490560677		0.0382268	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		8q21.13	8	75566533		HNF4G			ENSG00000164749			rs2941484-?	rs2941484	0	2941484.0	3_prime_UTR_variant	0.0	NR	6e-15	14.221848749616356		0.0502171	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		2q31.1	2	169155683		LRP2			ENSG00000081479			rs34806803-?	rs34806803	0	34806803.0	intron_variant	0.0	NR	3e-10	9.522878745280336		0.0381181	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		5q13.2	5	73141588		TMEM171 - TMEM174	ENSG00000157111	ENSG00000164325		9779.0	31605.0	rs4704055-?	rs4704055	0	4704055.0	intron_variant	1.0	NR	4e-10	9.397940008672036		0.0434482	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		11q13.3	11	69212058		SMIM38 - MYEOV	ENSG00000284713	ENSG00000172927		49618.0	82093.0	rs528151380-?	rs528151380	0	528151380.0	regulatory_region_variant	1.0	NR	2e-08	7.698970004336019		0.486253	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		2q24.2	2	162200415		FAP			ENSG00000078098			rs56732199-?	rs56732199	0	56732199.0	intron_variant	0.0	NR	4e-09	8.397940008672037		0.0525045	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		10q21.1	10	58507917		TFAM - BICC1	ENSG00000108064	ENSG00000122870		108697.0	4955.0	rs5785324-?	rs5785324	0	5785324.0	upstream_gene_variant	1.0	NR	7e-19	18.154901959985743		0.0539979	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		18q12.3	18	45651657		SLC14A2			ENSG00000132874			rs4890568-?	rs4890568	0	4890568.0	intron_variant	0.0	NR	1.0000000000000001e-45	45.0		0.263081	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		1q22	1	155185159		TRIM46 - MUC1	ENSG00000163462	ENSG00000185499		188.0	665.0	rs4971101-?	rs4971101	0	4971101.0	intron_variant	1.0	NR	4.0000000000000006e-45	44.39794000867204		0.255572	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		2q14.1	2	113259452		PAX8, PAX8-AS1			ENSG00000125618, ENSG00000189223			rs6734610-?	rs6734610	0	6734610.0	non_coding_transcript_exon_variant	0.0	NR	5e-07	6.301029995663981	(Conditioned on rs7578633)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		3q26.2	3	168991431		LINC02082 - LINC01997	ENSG00000242268	ENSG00000241383		66841.0	11591.0	rs6765431-?	rs6765431	0	6765431.0	intergenic_variant	1.0	NR	5e-08	7.301029995663981	(Conditioned on rs16853618)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		5p13.2	5	35190646		PRLR			ENSG00000113494			rs6887898-?	rs6887898	0	6887898.0	intron_variant	0.0	NR	4e-12	11.397940008672036		0.111114	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		15q21.3	15	53673800		WDR72			ENSG00000166415			rs690255-?	rs690255	0	690255.0	intron_variant	0.0	NR	2e-10	9.69897000433602		0.101428	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		5q13.2	5	73104069		FCHO2 - TMEM171	ENSG00000157107	ENSG00000157111		13547.0	16500.0	rs703869-?	rs703869	0	703869.0	intergenic_variant	1.0	NR	8e-06	5.096910013008056	(Conditioned on rs7445131)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		2q34	2	210731176		CPS1 - RPS27P10	ENSG00000021826	ENSG00000231017		52069.0	567765.0	rs72933889-?	rs72933889	0	72933889.0	intergenic_variant	1.0	NR	1e-08	8.0		0.119802	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		15q22.2	15	60894817		RORA			ENSG00000069667			rs729978-?	rs729978	0	729978.0	intron_variant	0.0	NR	3e-09	8.522878745280337		0.0975052	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		5q13.2	5	73157060		TMEM171 - TMEM174	ENSG00000157111	ENSG00000164325		25251.0	16133.0	rs7445131-?	rs7445131	0	7445131.0	upstream_gene_variant	1.0	NR	4e-16	15.397940008672036		0.132522	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		2q14.1	2	113221073		PAX8, PAX8-AS1			ENSG00000125618, ENSG00000189223			rs7578633-?	rs7578633	0	7578633.0	intron_variant	0.0	NR	2e-12	11.69897000433602		0.119185	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		1q22	1	155179729		TRIM46			ENSG00000163462			rs76872124-?	rs76872124	0	76872124.0	missense_variant	0.0	NR	3e-09	8.522878745280337	(Conditioned on rs4971101)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		3q27.3	3	187982267		LINC01991 - LPP-AS2	ENSG00000224187	ENSG00000270959		5860.0	168939.0	rs77472525-?	rs77472525	0	77472525.0	intergenic_variant	1.0	NR	7e-14	13.154901959985745	(Conditioned on rs9290867)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		21q21.1	21	15143502		NRIP1 - CYCSP42	ENSG00000180530	ENSG00000224524		77566.0	347028.0	rs79797837-?	rs79797837	0	79797837.0	upstream_gene_variant	1.0	NR	1e-09	9.0		0.0966228	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		20q13.32	20	58901754		GNAS			ENSG00000087460			rs8121252-?	rs8121252	0	8121252.0	intron_variant	0.0	NR	9e-21	20.045757490560675		0.166623	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		3q27.3	3	188003749		LINC01991 - LPP-AS2	ENSG00000224187	ENSG00000270959		27342.0	147457.0	rs9290867-?	rs9290867	0	9290867.0	intron_variant	1.0	NR	1.9999999999999999e-56	55.69897000433602		0.252771	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		6p12.1	6	55192537		HCRTR2			ENSG00000137252			rs9370400-?	rs9370400	0	9370400.0	intron_variant	0.0	NR	5e-15	14.30102999566398		0.141248	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Blood urea nitrogen levels	76,637 Taiwanese ancestry individuals		6q22.33	6	127134977		RSPO3			ENSG00000146374			rs9491697-?	rs9491697	0	9491697.0	intron_variant	0.0	NR	5e-13	12.30102999566398		0.114984	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals												chr12:111398967-?	chr12:111398967	0			1.0	NR	1e-08	8.0		0.0042683	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		15q26.3	15	98740689		IGF1R			ENSG00000140443			rs1007212-?	rs1007212	0	1007212.0	intron_variant	0.0	NR	2e-12	11.69897000433602		0.00474093	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		8q21.3	8	86336365		WWP1-AS1			ENSG00000254231			rs10089781-?	rs10089781	0	10089781.0	non_coding_transcript_exon_variant	0.0	NR	5e-08	7.301029995663981		0.00364424	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		11q13.1	11	64639913		NRXN2			ENSG00000110076			rs10400348-?	rs10400348	0	10400348.0	intron_variant	0.0	NR	6e-09	8.221848749616356		0.00417582	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		1p36.21	1	15582985		DNAJC16, AGMAT			ENSG00000116138, ENSG00000116771			rs10803394-?	rs10803394	0	10803394.0	intron_variant	0.0	NR	4.999999999999999e-32	31.30102999566398		0.00783182	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		3q26.2	3	169396966		MECOM			ENSG00000085276			rs10804832-?	rs10804832	0	10804832.0	intron_variant	0.0	NR	6e-10	9.221848749616356		0.00409198	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Creatinine levels	76,850 Taiwanese ancestry individuals		10q21.3	10	68174164		MYPN			ENSG00000138347			rs10997975-?	rs10997975	0	10997975.0	missense_variant	0.0	NR	2e-10	9.69897000433602		0.0050744	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		7q11.23	7	73605645		MLXIPL			ENSG00000009950			rs61010704-?	rs61010704	0	61010704.0	intron_variant	0.0	NR	1e-09	9.0		0.0660651	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	3e-30	29.522878745280337		0.0692967	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		3p21.1	3	53044467		SFMBT1			ENSG00000163935			rs66926262-?	rs66926262	0	66926262.0	intron_variant	0.0	NR	1e-10	10.0		0.0410714	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		19p13.3	19	3488182		SMIM24 - DOHH	ENSG00000095932	ENSG00000129932		7657.0	2639.0	rs7255097-?	rs7255097	0	7255097.0	upstream_gene_variant	1.0	NR	2e-13	12.69897000433602		0.0586485	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		4q22.1	4	88128874		ABCG2			ENSG00000118777			rs74904971-?	rs74904971	0	74904971.0	intron_variant	0.0	NR	2.9999999999999996e-300	299.5228787452804		0.239393	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		4p16.1	4	10003154		SLC2A9			ENSG00000109667			rs74915949-?	rs74915949	0	74915949.0	intron_variant	0.0	NR	2.0000000000000002e-60	59.69897000433602	(Conditioned on rs9994216)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		6p12.1	6	54732039		RPSAP44 - KRASP1	ENSG00000220773	ENSG00000220635		106551.0	38544.0	rs76975968-?	rs76975968	0	76975968.0	intergenic_variant	1.0	NR	1e-07	7.0	(Conditioned on rs78828070)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		6p12.1	6	54486360		CLNS1AP1 - RPL10P10	ENSG00000213335	ENSG00000216347		510.0	116127.0	rs78828070-?	rs78828070	0	78828070.0	upstream_gene_variant	1.0	NR	1e-15	15.0		0.0844946	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		10q24.32	10	102727686		SFXN2			ENSG00000156398			rs7917772-?	rs7917772	0	7917772.0	3_prime_UTR_variant	0.0	NR	5e-09	8.301029995663981		0.0353939	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		20q13.32	20	58901754		GNAS			ENSG00000087460			rs8121252-?	rs8121252	0	8121252.0	intron_variant	0.0	NR	1e-09	9.0		0.0415301	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		2q31.1	2	169345333		LRP2			ENSG00000081479			rs831037-?	rs831037	0	831037.0	intron_variant	0.0	NR	8e-08	7.096910013008056	(Conditioned on rs34806803)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		11q13.1	11	65013298		BATF2 - ARL2	ENSG00000168062	ENSG00000213465		16280.0	862.0	rs928510961-?	rs928510961	0	928510961.0	upstream_gene_variant	1.0	NR	8.000000000000001e-45	44.096910013008056	(Conditioned on rs1174410819)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		7p14.3	7	29549794		CHN2 - GTF3C6P3	ENSG00000106069	ENSG00000270196		35466.0	1727.0	rs933490-?	rs933490	0	933490.0	intron_variant	1.0	NR	6e-09	8.221848749616356		0.0367953	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		6q21	6	106721947		LINC02532			ENSG00000235142			rs9373896-?	rs9373896	0	9373896.0	intron_variant	0.0	NR	7e-10	9.154901959985745		0.0518737	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		13q21.33	13	71792034		DACH1			ENSG00000276644			rs9599882-?	rs9599882	0	9599882.0	intron_variant	0.0	NR	4e-09	8.397940008672037		0.0575721	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		1p12	1	119621770		ZNF697			ENSG00000143067			rs992558276-?	rs992558276	0	992558276.0	3_prime_UTR_variant	0.0	NR	2e-12	11.69897000433602		0.624095	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Uric acid levels	76,779 Taiwanese ancestry individuals		4p16.1	4	9982917		SLC2A9			ENSG00000109667			rs9994216-?	rs9994216	0	9994216.0	intron_variant	0.0	NR	1e-300	300.0		0.245727	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		12q14.2	12	62930304		PPM1H			ENSG00000111110			rs1017303584-?	rs1017303584	0	1017303584.0	intron_variant	0.0	NR	2e-09	8.698970004336019		18.3122	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		3q13.33	3	119498636		TIMMDC1			ENSG00000113845			rs1158163355-?	rs1158163355	0	1158163355.0	5_prime_UTR_variant	0.0	NR	2e-08	7.698970004336019		17.4491	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		5q22.3	5	113915491		YTHDC2 - KCNN2	ENSG00000047188	ENSG00000080709		320206.0	140435.0	rs1473330598-?	rs1473330598	0	1473330598.0	intergenic_variant	1.0	NR	3e-08	7.522878745280337		18.3707	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		12q14.1	12	62504044		MON2			ENSG00000061987			rs1474139385-?	rs1474139385	0	1474139385.0	intron_variant	0.0	NR	7e-07	6.154901959985743	(Conditioned on rs1017303584)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		7p12.1	7	51877045		RN7SL292P - SGO1P2	ENSG00000242650	ENSG00000234304		160123.0	1014792.0	rs185314338-?	rs185314338	0	185314338.0	intergenic_variant	1.0	NR	5e-08	7.301029995663981		14.2074	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		7q35	7	146628713		CNTNAP2			ENSG00000174469			rs185900475-?	rs185900475	0	185900475.0	intron_variant	0.0	NR	2e-08	7.698970004336019		18.5795	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		1p35.2	1	31360523		ZCCHC17			ENSG00000121766			rs188053687-?	rs188053687	0	188053687.0	intron_variant	0.0	NR	4e-08	7.397940008672037		18.4059	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Urinary microalbumin levels	76,435 Taiwanese ancestry individuals		7p21.2	7	16016453		RPL36AP26 - CRPPA	ENSG00000235828	ENSG00000214960		314701.0	71072.0	rs367789826-?	rs367789826	0	367789826.0	intergenic_variant	1.0	NR	3e-08	7.522878745280337		12.2596	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		2p21	2	46133768		PRKCE			ENSG00000171132			rs10168349-?	rs10168349	0	10168349.0	intron_variant	0.0	NR	1e-22	22.0		0.0320267	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		11p15.4	11	5071456		OR52E1 - OR52S1P	ENSG00000273085	ENSG00000237354		959.0	4674.0	rs1028909881-?	rs1028909881	0	1028909881.0	downstream_gene_variant	1.0	NR	1e-300	300.0		0.771362	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		9p24.1	9	4852599		RCL1			ENSG00000120158			rs10758656-?	rs10758656	0	10758656.0	intron_variant	0.0	NR	5e-12	11.30102999566398		0.0145829	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		13q14.11	13	40694192		FOXO1 - MIR320D1	ENSG00000150907	ENSG00000211491		27551.0	33636.0	rs115535790-?	rs115535790	0	115535790.0	intergenic_variant	1.0	NR	1e-09	9.0		0.0140911	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		3p24.3	3	16849028		PLCL2, PLCL2			ENSG00000154822, ENSG00000284017			rs116184520-?	rs116184520	0	116184520.0	intron_variant	0.0	NR	6e-11	10.221848749616356	(Conditioned on rs9876137)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		2p21	2	46372891		EPAS1			ENSG00000116016			rs116611511-?	rs116611511	0	116611511.0	intron_variant	0.0	NR	1e-07	7.0	(Conditioned on rs10168349)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		12q24.12	12	111576247		ATXN2			ENSG00000204842			rs118002600-?	rs118002600	0	118002600.0	intron_variant	0.0	NR	3e-13	12.522878745280336		0.0156862	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6p21.1	6	41768718		PGC - FRS3	ENSG00000096088	ENSG00000137218		14609.0	1458.0	rs11962743-?	rs11962743	0	11962743.0	upstream_gene_variant	1.0	NR	3e-10	9.522878745280336	(Conditioned on rs71714426)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		9q34.11	9	127822752		ENG			ENSG00000106991			rs12001427-?	rs12001427	0	12001427.0	intron_variant	0.0	NR	5e-10	9.30102999566398		0.0204701	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		1q22	1	156344356		CCT3, TSACC			ENSG00000163468, ENSG00000163467			rs12022657-?	rs12022657	0	12022657.0	intron_variant	0.0	NR	2e-18	17.69897000433602		0.0209471	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		16p13.3	16	190281		LUC7L			ENSG00000007392			rs1211375-?	rs1211375	0	1211375.0	intron_variant	0.0	NR	8e-13	12.096910013008056	(Conditioned on rs375498857)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		1q31.3	1	198625788		ATP6V1G3 - PTPRC	ENSG00000263014	ENSG00000081237		84843.0	12669.0	rs12132271-?	rs12132271	0	12132271.0	intergenic_variant	1.0	NR	1e-15	15.0		0.0255301	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6q21	6	109313396		CCDC162P			ENSG00000203799			rs13191948-?	rs13191948	0	13191948.0	intron_variant	0.0	NR	2e-09	8.698970004336019		0.0185814	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6p22.3	6	16295117		GMPR			ENSG00000137198			rs142002554-?	rs142002554	0	142002554.0	frameshift_variant	0.0	NR	1e-09	9.0		0.0408245	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		4q12	4	54494937		LINC02283 - LINC02260	ENSG00000248184	ENSG00000250456		138983.0	108274.0	rs1507951-?	rs1507951	0	1507951.0	intergenic_variant	1.0	NR	1e-07	7.0	(Conditioned on rs172629)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6p22.1	6	29830005		HLA-G, HLA-G, HLA-G, HLA-G, HLA-G, HLA-G			ENSG00000206506, ENSG00000233095, ENSG00000204632, ENSG00000230413, ENSG00000235346, ENSG00000235680			rs1611627-?	rs1611627	0	1611627.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.0149894	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		2q22.3	2	144447191		ZEB2			ENSG00000169554			rs16823732-?	rs16823732	0	16823732.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.0218981	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		1q32.1	1	199042410		LINC01221			ENSG00000235492			rs16844101-?	rs16844101	0	16844101.0	intron_variant	0.0	NR	4e-06	5.3979400086720375	(Conditioned on rs12132271)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		4q12	4	54541595		LINC02283 - LINC02260	ENSG00000248184	ENSG00000250456		185641.0	61616.0	rs172629-?	rs172629	0	172629.0	intergenic_variant	1.0	NR	1e-70	70.0		0.0395452	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		9q34.2	9	133266456		ABO, ABO			ENSG00000175164, ENSG00000281879			rs2519093-?	rs2519093	0	2519093.0	intron_variant	0.0	NR	6e-33	32.22184874961636		0.0324894	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		3q23	3	142525750		ATR			ENSG00000175054			rs9843148-?	rs9843148	0	9843148.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.011937	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		3p24.3	3	16919773		PLCL2, PLCL2			ENSG00000154822, ENSG00000284017			rs9876137-?	rs9876137	0	9876137.0	intron_variant	0.0	NR	1e-20	20.0		0.0198082	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		11p15.4	11	5245613		BGLT3 - HBG1	ENSG00000260629	ENSG00000213934		67.0	2656.0	rs998870472-?	rs998870472	0	998870472.0	upstream_gene_variant	1.0	NR	5e-94	93.30102999566398	(Conditioned on rs1028909881)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		19p13.11	19	16437564		EPS15L1			ENSG00000127527			rs10411936-?	rs10411936	0	10411936.0	intron_variant	0.0	NR	2e-10	9.69897000433602		0.0492299	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		6p21.33	6	31354106		HLA-B, HLA-B, HLA-B, HLA-B, HLA-B, HLA-B			ENSG00000228964, ENSG00000223532, ENSG00000234745, ENSG00000232126, ENSG00000224608, ENSG00000206450			rs1056429-?	rs1056429	0	1056429.0	3_prime_UTR_variant	0.0	NR	4e-08	7.397940008672037	(Conditioned on rs2524144)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		10q24.31	10	100335365		PKD2L1 - SCD	ENSG00000107593	ENSG00000099194		5101.0	11868.0	rs10883462-?	rs10883462	0	10883462.0	downstream_gene_variant	1.0	NR	2e-08	7.698970004336019		0.0446357	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		3p21.31	3	46968315		CCDC12			ENSG00000160799			rs11130111-?	rs11130111	0	11130111.0	intron_variant	0.0	NR	4e-09	8.397940008672037		0.0450113	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		1p34.2	1	43340066		MPL			ENSG00000117400			rs117656396-?	rs117656396	0	117656396.0	missense_variant	0.0	NR	1e-10	10.0		0.16173	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		2q24.2	2	159870088		LY75-CD302, LY75			ENSG00000248672, ENSG00000054219			rs12692570-?	rs12692570	0	12692570.0	intron_variant	0.0	NR	1e-06	6.0	(Conditioned on rs6432541)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		17q23.1	17	59850929		RNU6-450P - TUBD1	ENSG00000201524	ENSG00000108423		3385.0	8550.0	rs1292069-?	rs1292069	0	1292069.0	upstream_gene_variant	1.0	NR	8e-11	10.096910013008056		0.0497531	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		4q21.22	4	83019764		LIN54 - COPS4	ENSG00000189308	ENSG00000138663		6838.0	14683.0	rs13131243-?	rs13131243	0	13131243.0	intergenic_variant	1.0	NR	3e-06	5.522878745280337	(Conditioned on rs17005896)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		4q13.3	4	74097158		CXCL2			ENSG00000081041			rs1431705167-?	rs1431705167	0	1431705167.0	3_prime_UTR_variant	0.0	NR	5e-08	7.301029995663981	(Conditioned on rs3806792)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		8q13.3	8	69811180		SLCO5A1			ENSG00000137571			rs16936450-?	rs16936450	0	16936450.0	intron_variant	0.0	NR	5.999999999999999e-44	43.22184874961636		0.121749	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		4q21.22	4	82629015		LINC00575 - SCD5	ENSG00000231782	ENSG00000145284		7405.0	524.0	rs17005896-?	rs17005896	0	17005896.0	downstream_gene_variant	1.0	NR	4e-15	14.397940008672036		0.0618541	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		11q23.2	11	114126363		ZBTB16			ENSG00000109906			rs1989278-?	rs1989278	0	1989278.0	intron_variant	0.0	NR	3e-09	8.522878745280337		0.0473914	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		14q12	14	24992783		STXBP6			ENSG00000168952			rs2038700-?	rs2038700	0	2038700.0	intron_variant	0.0	NR	1e-12	12.0		0.0543047	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		8q24.21	8	129585339		CCDC26			ENSG00000229140			rs2163950-?	rs2163950	0	2163950.0	intron_variant	0.0	NR	1e-16	16.0		0.0930786	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		1q31.3	1	198697103		PTPRC, PTPRC			ENSG00000262418, ENSG00000081237			rs2296618-?	rs2296618	0	2296618.0	intron_variant	0.0	NR	1e-09	9.0		0.0735218	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		9q34.2	9	133266456		ABO, ABO			ENSG00000175164, ENSG00000281879			rs2519093-?	rs2519093	0	2519093.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.0553735	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		6p21.33	6	31295573		LINC02571			ENSG00000256166			rs2524144-?	rs2524144	0	2524144.0	intron_variant	0.0	NR	2e-14	13.69897000433602		0.109705	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		8p23.1	8	6966703		DEFA9P - DEFA10P	ENSG00000284789	ENSG00000233531		6542.0	1438.0	rs2702909-?	rs2702909	0	2702909.0	downstream_gene_variant	1.0	NR	1e-11	11.0		0.0559004	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		11q23.2	11	114071034		ZBTB16			ENSG00000109906			rs2846629-?	rs2846629	0	2846629.0	intron_variant	0.0	NR	2e-07	6.698970004336019	(Conditioned on rs1989278)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		15q25.1	15	80015374		BCL2A1 - Metazoa_SRP	ENSG00000140379	ENSG00000276525		44178.0	42051.0	rs2866101-?	rs2866101	0	2866101.0	non_coding_transcript_exon_variant	1.0	NR	1e-08	8.0		0.0462837	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		10q11.23	10	50528032		SGMS1			ENSG00000198964			rs3011780-?	rs3011780	0	3011780.0	intron_variant	0.0	NR	6e-08	7.221848749616356	(Conditioned on rs57040666)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		6q23.3	6	135103041		HBS1L			ENSG00000112339			rs35959442-?	rs35959442	0	35959442.0	5_prime_UTR_variant	0.0	NR	8e-19	18.096910013008056		0.0771688	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		5p15.33	5	1286401		TERT			ENSG00000164362			rs2736100-?	rs2736100	0	2736100.0	3_prime_UTR_variant	0.0	NR	2e-12	11.69897000433602		0.0150183	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		11p15.4	11	9768382		SBF2-AS1			ENSG00000246273			rs34328537-?	rs34328537	0	34328537.0	intron_variant	0.0	NR	1e-10	10.0		0.0139382	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		7q22.1	7	100723128		EPO			ENSG00000130427			rs369859204-?	rs369859204	0	369859204.0	frameshift_variant	0.0	NR	1e-13	13.0	(Conditioned on rs9801017)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		16p13.3	16	377772		PGAP6			ENSG00000129925			rs375498857-?	rs375498857	0	375498857.0	missense_variant	0.0	NR	1e-300	300.0		0.864903	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		1q44	1	247876149		TRIM58			ENSG00000162722			rs3811444-?	rs3811444	0	3811444.0	missense_variant	0.0	NR	1e-09	9.0		0.0147877	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6p12.1	6	55178438		HCRTR2			ENSG00000137252			rs4454139-?	rs4454139	0	4454139.0	intron_variant	0.0	NR	4e-08	7.397940008672037		0.0133564	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		12p13.32	12	4221049		HSPA8P5 - CCND2-AS1	ENSG00000256356	ENSG00000255920		121530.0	26932.0	rs4573764-?	rs4573764	0	4573764.0	regulatory_region_variant	1.0	NR	5e-13	12.30102999566398		0.0180034	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		22q13.33	22	50528485		TYMP			ENSG00000025708			rs470119-?	rs470119	0	470119.0	non_coding_transcript_exon_variant	0.0	NR	4e-13	12.397940008672036		0.0167336	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6q23.3	6	135105420		HBS1L - MYB	ENSG00000112339	ENSG00000118513		2364.0	75888.0	rs4895440-?	rs4895440	0	4895440.0	upstream_gene_variant	1.0	NR	3e-128	127.52287874528034		0.0575987	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		17p11.2	17	16938999		TNFRSF13B			ENSG00000240505			rs55672385-?	rs55672385	0	55672385.0	intron_variant	0.0	NR	4e-18	17.397940008672037		0.0184788	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		20q13.13	20	50477252		RN7SL636P - COX6CP2	ENSG00000244376	ENSG00000231715		47769.0	2515.0	rs6126017-?	rs6126017	0	6126017.0	upstream_gene_variant	1.0	NR	2e-10	9.69897000433602		0.0146625	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		12p13.33	12	2405104		CACNA1C, CACNA1C			ENSG00000151067, ENSG00000285479			rs714277-?	rs714277	0	714277.0	intron_variant	0.0	NR	1e-09	9.0		0.0141392	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6p21.1	6	41948134		CCND3			ENSG00000112576			rs71714426-?	rs71714426	0	71714426.0	intron_variant	0.0	NR	4e-44	43.39794000867204		0.0317405	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		11q12.2	11	61852802		FADS2			ENSG00000134824			rs72643559-?	rs72643559	0	72643559.0	intron_variant	0.0	NR	3e-12	11.522878745280336		0.0150592	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		11p15.4	11	10333504		AMPD3			ENSG00000133805			rs72852806-?	rs72852806	0	72852806.0	intron_variant	0.0	NR	7e-06	5.154901959985743	(Conditioned on rs34328537)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		13q22.2	13	75484269		TBC1D4 - COMMD6	ENSG00000136111	ENSG00000188243		2100.0	40945.0	rs75754019-?	rs75754019	0	75754019.0	upstream_gene_variant	1.0	NR	1e-16	16.0		0.0191138	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6q23.3	6	135087334		HBS1L			ENSG00000112339			rs76732255-?	rs76732255	0	76732255.0	intron_variant	0.0	NR	1e-14	14.0	(Conditioned on rs4895440)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		1q22	1	155179729		TRIM46			ENSG00000163462			rs76872124-?	rs76872124	0	76872124.0	missense_variant	0.0	NR	4e-08	7.397940008672037	(Conditioned on rs12022657)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		11q23.2	11	114137270		ZBTB16			ENSG00000109906			rs7925369-?	rs7925369	0	7925369.0	intron_variant	0.0	NR	1e-08	8.0		0.0141785	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		9q34.2	9	133257367		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176722-?	rs8176722	0	8176722.0	intron_variant	0.0	NR	2e-19	18.69897000433602	(Conditioned on rs2519093)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		16q24.3	16	88787321		PIEZO1 - CDT1	ENSG00000103335	ENSG00000167513		2101.0	16468.0	rs837763-?	rs837763	0	837763.0	upstream_gene_variant	1.0	NR	8e-13	12.096910013008056		0.0155005	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		6p21.32	6	32602235		HLA-DRB1 - HLA-DQA1	ENSG00000196126	ENSG00000196735		12387.0	25944.0	rs9270821-?	rs9270821	0	9270821.0	intron_variant	1.0	NR	1e-08	8.0		0.0141484	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		19p13.13	19	12899829		SYCE2, GCDH			ENSG00000161860, ENSG00000105607			rs9384-?	rs9384	0	9384.0	3_prime_UTR_variant	0.0	NR	3e-10	9.522878745280336		0.0185064	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		13q14.11	13	40660626		FOXO1			ENSG00000150907			rs9549254-?	rs9549254	0	9549254.0	intron_variant	0.0	NR	6e-06	5.221848749616356	(Conditioned on rs115535790)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Red blood cell count	76,086 Taiwanese ancestry individuals		7q22.1	7	100638579		TFR2			ENSG00000106327			rs9801017-?	rs9801017	0	9801017.0	intron_variant	0.0	NR	2e-18	17.69897000433602		0.022705	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		18q21.1	18	49593209		LIPG			ENSG00000101670			rs11082764-?	rs11082764	0	11082764.0	3_prime_UTR_variant	0.0	NR	5e-35	34.30102999566398		2.14785	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		8q12.1	8	58493931		CYP7A1			ENSG00000167910			rs112784971-?	rs112784971	0	112784971.0	intron_variant	0.0	NR	1e-16	16.0		1.69429	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		4q22.1	4	87143279		AFF1 - KLHL8	ENSG00000172493	ENSG00000145332		2240.0	16824.0	rs10023050-?	rs10023050	0	10023050.0	downstream_gene_variant	1.0	NR	1e-09	9.0		1.9404	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		5q33.3	5	156997238		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		34012.0	32175.0	rs10075548-?	rs10075548	0	10075548.0	intergenic_variant	1.0	NR	2e-08	7.698970004336019		2.51633	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		8p22	8	18400285		NAT2			ENSG00000156006			rs1041983-?	rs1041983	0	1041983.0	synonymous_variant	0.0	NR	1e-12	12.0		2.23417	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		1p31.3	1	62527078		DOCK7			ENSG00000116641			rs11207980-?	rs11207980	0	11207980.0	intron_variant	0.0	NR	3e-23	22.522878745280337		3.80823	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		7p13	7	44180143		GCK			ENSG00000106633			rs12534104-?	rs12534104	0	12534104.0	intron_variant	0.0	NR	4e-10	9.397940008672036		2.36728	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		2p24.1	2	20991336		LINC02850 - APOB	ENSG00000236436	ENSG00000084674		129675.0	10093.0	rs1318005-?	rs1318005	0	1318005.0	intergenic_variant	1.0	NR	2e-15	14.69897000433602		3.84104	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		2p24.1	2	21029662		APOB			ENSG00000084674			rs13306194-?	rs13306194	0	13306194.0	missense_variant	0.0	NR	7e-11	10.154901959985745	(Conditioned on rs1318005)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		6p21.1	6	43796814		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		10327.0	48064.0	rs1358980-?	rs1358980	0	1358980.0	regulatory_region_variant	1.0	NR	3e-11	10.522878745280336		2.0784	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		8q23.3	8	115731797		TRPS1			ENSG00000104447			rs139674239-?	rs139674239	0	139674239.0	intron_variant	0.0	NR	1e-08	8.0		1.90581	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		2p23.3	2	27498323		GCKR			ENSG00000084734			rs143881585-?	rs143881585	0	143881585.0	splice_region_variant	0.0	NR	5e-15	14.30102999566398	(Conditioned on rs6547692)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		20q13.12	20	45907568		PLTP			ENSG00000100979			rs148753678-?	rs148753678	0	148753678.0	intron_variant	0.0	NR	9e-11	10.045757490560677		4.08437	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		15q21.3	15	58391167		ALDH1A2			ENSG00000128918			rs1532085-?	rs1532085	0	1532085.0	intron_variant	0.0	NR	7e-18	17.154901959985743		2.71526	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		4p16.3	4	3422504		RGS12			ENSG00000159788			rs16844330-?	rs16844330	0	16844330.0	synonymous_variant	0.0	NR	5e-07	6.301029995663981	(Conditioned on rs2857860)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		11q12.2	11	61814292		FADS1, FADS2			ENSG00000149485, ENSG00000134824			rs174560-?	rs174560	0	174560.0	non_coding_transcript_exon_variant	0.0	NR	1.0000000000000001e-24	24.0		3.26737	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		15q21.3	15	58431740		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs2070895-?	rs2070895	0	2070895.0	intron_variant	0.0	NR	4e-09	8.397940008672037	(Conditioned on rs1532085)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		4p16.3	4	3328062		RGS12			ENSG00000159788			rs2857860-?	rs2857860	0	2857860.0	intron_variant	0.0	NR	1e-10	10.0		2.15471	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		8q24.13	8	125464631		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		26228.0	395090.0	rs2954017-?	rs2954017	0	2954017.0	upstream_gene_variant	1.0	NR	2e-41	40.69897000433602		4.2479	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		8q24.13	8	125495147		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		56744.0	364574.0	rs2954038-?	rs2954038	0	2954038.0	intron_variant	1.0	NR	5e-07	6.301029995663981	(Conditioned on rs2954017)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		7q11.23	7	73606007		MLXIPL			ENSG00000009950			rs3812316-?	rs3812316	0	3812316.0	missense_variant	0.0	NR	1e-47	47.0		8.10439	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		19q13.32	19	44911194		APOE - APOC1	ENSG00000130203	ENSG00000130208		1801.0	3053.0	rs439401-?	rs439401	0	439401.0	non_coding_transcript_exon_variant	1.0	NR	1e-13	13.0	(Conditioned on rs483082)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		5q11.2	5	56512648		C5orf67			ENSG00000225940			rs465002-?	rs465002	0	465002.0	intron_variant	0.0	NR	6e-10	9.221848749616356		1.93551	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		19q13.32	19	44912921		APOE - APOC1	ENSG00000130203	ENSG00000130208		3528.0	1326.0	rs483082-?	rs483082	0	483082.0	non_coding_transcript_exon_variant	1.0	NR	9e-73	72.04575749056067		7.4509	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Triglyceride levels	76,053 Taiwanese ancestry individuals		6p21.32	6	32663777		HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1, HLA-DQB1			ENSG00000233209, ENSG00000179344, ENSG00000225824, ENSG00000231939, ENSG00000231286			rs56260471-?	rs56260471	0	56260471.0	non_coding_transcript_exon_variant	0.0	NR	4e-10	9.397940008672036		7.1893	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		6q26	6	160687260		LPA - PLG	ENSG00000198670	ENSG00000122194		22985.0	14978.0	rs188951644-?	rs188951644	0	188951644.0	intergenic_variant	1.0	NR	6e-18	17.221848749616356	(Conditioned on rs73596816)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		18q21.1	18	49653146		SMUG1P1 - ACAA2	ENSG00000267444	ENSG00000167315		1986.0	129018.0	rs1943973-?	rs1943973	0	1943973.0	downstream_gene_variant	1.0	NR	4e-19	18.39794000867204	(Conditioned on rs11082764)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		15q21.3	15	58431740		LIPC, ALDH1A2			ENSG00000166035, ENSG00000128918			rs2070895-?	rs2070895	0	2070895.0	intron_variant	0.0	NR	1.9999999999999998e-30	29.69897000433602	(Conditioned on rs1532085)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		19p13.2	19	11239812		DOCK6, ANGPTL8			ENSG00000130158, ENSG00000130173			rs2278426-?	rs2278426	0	2278426.0	missense_variant	0.0	NR	5e-53	52.30102999566398	(Conditioned on rs2738464)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		14q24.1	14	69778476		SLC10A1			ENSG00000100652			rs2296651-?	rs2296651	0	2296651.0	missense_variant	0.0	NR	2e-16	15.69897000433602		2.39743	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		11p15.4	11	5671209		TRIM5			ENSG00000132256			rs2342387-?	rs2342387	0	2342387.0	intron_variant	0.0	NR	3e-10	9.522878745280336	(Conditioned on rs998870472)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		9q34.2	9	133266456		ABO, ABO			ENSG00000175164, ENSG00000281879			rs2519093-?	rs2519093	0	2519093.0	intron_variant	0.0	NR	5e-51	50.30102999566398		3.32982	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		9q31.1	9	104903458		ABCA1			ENSG00000165029			rs2575876-?	rs2575876	0	2575876.0	intron_variant	0.0	NR	4e-51	50.39794000867204		3.02911	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		8q23.3	8	115651671		TRPS1			ENSG00000104447			rs2737252-?	rs2737252	0	2737252.0	intron_variant	0.0	NR	2e-08	7.698970004336019		1.03564	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		19p13.2	19	11131631		SPC24, LDLR			ENSG00000161888, ENSG00000130164			rs2738464-?	rs2738464	0	2738464.0	3_prime_UTR_variant	0.0	NR	8e-62	61.096910013008056		3.17614	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1q42.3	1	234878288		RNY4P16 - RN7SL668P	ENSG00000201638	ENSG00000239690		40219.0	25898.0	rs2802950-?	rs2802950	0	2802950.0	intron_variant	1.0	NR	8e-07	6.096910013008056	(Conditioned on rs486142)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		4q13.2	4	68719023		UGT2B15 - UGT2B10	ENSG00000277132	ENSG00000275190		48371.0	96971.0	rs293440-?	rs293440	0	293440.0	intergenic_variant	1.0	NR	7e-07	6.154901959985743	(Conditioned on rs9994887)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		8q24.13	8	125468458		TRIB1 - LINC00861	ENSG00000173334	ENSG00000245164		30055.0	391263.0	rs2980882-?	rs2980882	0	2980882.0	intron_variant	1.0	NR	9e-24	23.045757490560675		1.72784	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		11q23.3	11	116789734		APOA5			ENSG00000110243			rs33984246-?	rs33984246	0	33984246.0	3_prime_UTR_variant	0.0	NR	2e-07	6.698970004336019	(Conditioned on rs662799)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		16p13.3	16	377772		PGAP6			ENSG00000129925			rs375498857-?	rs375498857	0	375498857.0	missense_variant	0.0	NR	5e-24	23.30102999566398		7.03976	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		16q22.2	16	72194607		PMFBP1 - LINC01572	ENSG00000118557	ENSG00000261008		17729.0	41674.0	rs3852789-?	rs3852789	0	3852789.0	regulatory_region_variant	1.0	NR	5e-23	22.30102999566398		1.81378	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		9q31.1	9	104827463		ABCA1			ENSG00000165029			rs4149307-?	rs4149307	0	4149307.0	intron_variant	0.0	NR	3e-22	21.522878745280337	(Conditioned on rs2575876)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1p22.1	1	92789516		EVI5			ENSG00000067208			rs4622073-?	rs4622073	0	4622073.0	intron_variant	0.0	NR	3e-07	6.522878745280337	(Conditioned on rs529192228)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		17q21.32	17	47685639		KPNB1 - TBKBP1	ENSG00000108424	ENSG00000198933		134.0	8522.0	rs4794047-?	rs4794047	0	4794047.0	upstream_gene_variant	1.0	NR	8e-11	10.096910013008056		1.17626	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		19q13.33	19	49456107		ALDH16A1			ENSG00000161618			rs4802607-?	rs4802607	0	4802607.0	intron_variant	0.0	NR	5e-10	9.30102999566398		1.09951	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		20q12	20	40559285		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		547962.0	126563.0	rs4812441-?	rs4812441	0	4812441.0	intergenic_variant	1.0	NR	3e-08	7.522878745280337	(Conditioned on rs6029632)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1q42.3	1	234712862		LINC00184 - LINC01132	ENSG00000224939	ENSG00000227630		78082.0	11180.0	rs486142-?	rs486142	0	486142.0	non_coding_transcript_exon_variant	1.0	NR	3e-09	8.522878745280337		1.22092	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		7p12.2	7	50279753		SPATA48 - IKZF1	ENSG00000164500	ENSG00000185811		120497.0	24315.0	rs4917015-?	rs4917015	0	4917015.0	upstream_gene_variant	1.0	NR	1e-08	8.0		1.10513	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2p24.1	2	22324522		RN7SL117P - RNA5SP87	ENSG00000264192	ENSG00000206882		401234.0	14364.0	rs527429575-?	rs527429575	0	527429575.0	intron_variant	1.0	NR	1e-33	33.0	(Conditioned on rs13306194)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1p22.1	1	91801530		TGFBR3			ENSG00000069702			rs529192228-?	rs529192228	0	529192228.0	intron_variant	0.0	NR	5e-10	9.30102999566398		6.69762	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		7p13	7	44228566		CAMK2B			ENSG00000058404			rs555844715-?	rs555844715	0	555844715.0	intron_variant	0.0	NR	5e-09	8.301029995663981		7.65069	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		22q12.2	22	30133752		HORMAD2			ENSG00000176635			rs5753021-?	rs5753021	0	5753021.0	intron_variant	0.0	NR	2e-10	9.69897000433602		1.61215	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		10q25.2	10	112229237		GPAM - TECTB	ENSG00000119927	ENSG00000119913		13860.0	54163.0	rs60191209-?	rs60191209	0	60191209.0	upstream_gene_variant	1.0	NR	3e-13	12.522878745280336		1.31562	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		20q12	20	41331702		ADI1P1 - LPIN3	ENSG00000235102	ENSG00000132793		42.0	9119.0	rs6029632-?	rs6029632	0	6029632.0	downstream_gene_variant	1.0	NR	1e-15	15.0		1.63404	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1p36.11	1	25482457		MACO1			ENSG00000204178			rs61775190-?	rs61775190	0	61775190.0	intron_variant	0.0	NR	3e-09	8.522878745280337		1.16543	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	1e-38	38.0		2.23037	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		11q23.3	11	116792991		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		571.0	27709.0	rs662799-?	rs662799	0	662799.0	upstream_gene_variant	1.0	NR	3.9999999999999995e-54	53.39794000867204		2.95542	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2p15	2	62660749		RSL24D1P2 - EHBP1	ENSG00000230595	ENSG00000115504		99326.0	13102.0	rs6727888-?	rs6727888	0	6727888.0	intron_variant	1.0	NR	7e-18	17.154901959985743		1.64915	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		6q25.3	6	160596331		LPA			ENSG00000198670			rs73596816-?	rs73596816	0	73596816.0	intron_variant	0.0	NR	3e-18	17.522878745280337		3.33783	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1p32.3	1	55164674		USP24			ENSG00000162402			rs74492184-?	rs74492184	0	74492184.0	intron_variant	0.0	NR	1e-08	8.0	(Conditioned on rs7525649)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		9q34.11	9	127966536		FAM102A			ENSG00000167106			rs74987020-?	rs74987020	0	74987020.0	intron_variant	0.0	NR	1e-12	12.0		1.46947	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1p32.3	1	55033483		BSND - PCSK9	ENSG00000162399	ENSG00000169174		16311.0	5964.0	rs7525649-?	rs7525649	0	7525649.0	intergenic_variant	1.0	NR	3e-11	10.522878745280336		1.19246	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		7p13	7	44539470		NPC1L1			ENSG00000015520			rs764300904-?	rs764300904	0	764300904.0	frameshift_variant	0.0	NR	8e-06	5.096910013008056	(Conditioned on rs555844715)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1p31.3	1	62460056		DOCK7			ENSG00000116641			rs77064258-?	rs77064258	0	77064258.0	intron_variant	0.0	NR	2.0000000000000002e-24	23.69897000433602		2.29484	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		17q24.2	17	69088921		ABCA6			ENSG00000154262			rs8077252-?	rs8077252	0	8077252.0	intron_variant	0.0	NR	3e-11	10.522878745280336		1.1622	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2p23.3	2	27499104		GCKR			ENSG00000084734			rs813592-?	rs813592	0	813592.0	intron_variant	0.0	NR	3e-06	5.522878745280337	(Conditioned on rs6547692)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1q41	1	220799001		MTARC1			ENSG00000186205			rs867772-?	rs867772	0	867772.0	intron_variant	0.0	NR	1e-13	13.0		1.61696	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2p24.1	2	21044589		APOB - TDRD15	ENSG00000084674	ENSG00000218819		516.0	79379.0	rs934197-?	rs934197	0	934197.0	upstream_gene_variant	1.0	NR	4e-27	26.39794000867204	(Conditioned on rs13306194)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		6q16.3	6	100838460		ASCC3			ENSG00000112249			rs9386258-?	rs9386258	0	9386258.0	intron_variant	0.0	NR	1e-11	11.0		1.42552	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		13q13.1	13	32377317		BRCA2			ENSG00000139618			rs9567623-?	rs9567623	0	9567623.0	intron_variant	0.0	NR	1e-08	8.0		1.00846	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		11p15.4	11	5245613		BGLT3 - HBG1	ENSG00000260629	ENSG00000213934		67.0	2656.0	rs998870472-?	rs998870472	0	998870472.0	upstream_gene_variant	1.0	NR	5e-27	26.30102999566398		17.3933	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		4q13.2	4	68671757		UGT2B15 - UGT2B10	ENSG00000277132	ENSG00000275190		1105.0	144237.0	rs9994887-?	rs9994887	0	9994887.0	upstream_gene_variant	1.0	NR	3e-09	8.522878745280337		1.03746	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2q24.1	2	157625480		ACVR1C			ENSG00000123612			rs10164853-?	rs10164853	0	10164853.0	intron_variant	0.0	NR	5e-11	10.30102999566398		1.20857	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		8p22	8	18400285		NAT2			ENSG00000156006			rs1041983-?	rs1041983	0	1041983.0	synonymous_variant	0.0	NR	6e-11	10.221848749616356		1.12838	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		5q13.3	5	75321018		ANKRD31 - HMGCR	ENSG00000145700	ENSG00000113161		84107.0	15311.0	rs10474433-?	rs10474433	0	10474433.0	intron_variant	1.0	NR	3e-33	32.52287874528034		2.21366	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		12q24.31	12	120982123		HNF1A			ENSG00000135100			rs1169284-?	rs1169284	0	1169284.0	intron_variant	0.0	NR	2e-10	9.69897000433602		1.1196	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		5q33.3	5	157025306		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		62080.0	4107.0	rs117033847-?	rs117033847	0	117033847.0	downstream_gene_variant	1.0	NR	7e-06	5.154901959985743	(Conditioned on rs12657266)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		16q22.2	16	72113517		PMFBP1			ENSG00000118557			rs117891475-?	rs117891475	0	117891475.0	intron_variant	0.0	NR	4.0000000000000003e-29	28.39794000867204	(Conditioned on rs3852789)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2p21	2	43824071		ABCG5			ENSG00000138075			rs119480069-?	rs119480069	0	119480069.0	missense_variant	0.0	NR	1e-16	16.0		12.5828	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		5q33.3	5	156968992		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		5766.0	60421.0	rs12657266-?	rs12657266	0	12657266.0	intergenic_variant	1.0	NR	2e-27	26.69897000433602		2.09358	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		1p13.3	1	109274968		CELSR2			ENSG00000143126			rs12740374-?	rs12740374	0	12740374.0	3_prime_UTR_variant	0.0	NR	2e-62	61.69897000433602		5.71752	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		19q13.32	19	44884339		NECTIN2			ENSG00000130202			rs12972970-?	rs12972970	0	12972970.0	intron_variant	0.0	NR	1e-40	40.0	(Conditioned on rs141622900)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2p24.1	2	21029662		APOB			ENSG00000084674			rs13306194-?	rs13306194	0	13306194.0	missense_variant	0.0	NR	2e-70	69.69897000433602		4.37698	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		22q12.2	22	30397978		RNF215, SEC14L2			ENSG00000099999, ENSG00000100003			rs141433657-?	rs141433657	0	141433657.0	intron_variant	0.0	NR	8e-07	6.096910013008056	(Conditioned on rs5753021)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		19q13.32	19	44923535		APOC1 - APOC1P1	ENSG00000130208	ENSG00000214855		4186.0	3264.0	rs141622900-?	rs141622900	0	141622900.0	upstream_gene_variant	1.0	NR	5e-303	302.30102999566395		12.2016	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		2p21	2	43728417		PLEKHH2			ENSG00000152527			rs149613830-?	rs149613830	0	149613830.0	intron_variant	0.0	NR	2e-08	7.698970004336019	(Conditioned on rs119480069)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		5q13.3	5	75370169		CERT1			ENSG00000113163			rs150454634-?	rs150454634	0	150454634.0	3_prime_UTR_variant	0.0	NR	9e-09	8.045757490560675	(Conditioned on rs10474433)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		15q21.3	15	58391167		ALDH1A2			ENSG00000128918			rs1532085-?	rs1532085	0	1532085.0	intron_variant	0.0	NR	3e-34	33.52287874528034		2.10538	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		16q13	16	56965867		CETP			ENSG00000087237			rs17231569-?	rs17231569	0	17231569.0	intron_variant	0.0	NR	2e-07	6.698970004336019	(Conditioned on rs183130)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		11q12.2	11	61779120		TMEM258, MYRF			ENSG00000134825, ENSG00000124920			rs174530-?	rs174530	0	174530.0	non_coding_transcript_exon_variant	0.0	NR	2e-27	26.69897000433602		1.89902	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		8p23.1	8	9322624		RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		35046.0	48466.0	rs17716118-?	rs17716118	0	17716118.0	intron_variant	1.0	NR	3e-08	7.522878745280337		5.0522	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		10q25.2	10	112153794		GPAM			ENSG00000119927			rs1807800-?	rs1807800	0	1807800.0	intron_variant	0.0	NR	4e-12	11.397940008672036	(Conditioned on rs60191209)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Total cholesterol levels	76,578 Taiwanese ancestry individuals		16q13	16	56957451		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		12587.0	4472.0	rs183130-?	rs183130	0	183130.0	upstream_gene_variant	1.0	NR	6e-26	25.22184874961636		2.44519	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		11p15.4	11	4534397		OR52K3P - OR52M1	ENSG00000225101	ENSG00000197790		13492.0	10794.0	rs184764790-?	rs184764790	0	184764790.0	intergenic_variant	1.0	NR	5e-10	9.30102999566398	(Conditioned on rs998870472)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		1q42.2	1	231421877		EGLN1			ENSG00000135766			rs186996510-?	rs186996510	0	186996510.0	missense_variant	0.0	NR	5e-10	9.30102999566398		0.15257	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		2p21	2	46356442		EPAS1			ENSG00000116016			rs189807021-?	rs189807021	0	189807021.0	intron_variant	0.0	NR	3e-15	14.522878745280336	(Conditioned on rs10168349)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		19q13.33	19	49496752		RPS11			ENSG00000142534			rs2280401-?	rs2280401	0	2280401.0	intron_variant	0.0	NR	3e-11	10.522878745280336		0.0470394	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		9q34.2	9	133266456		ABO, ABO			ENSG00000175164, ENSG00000281879			rs2519093-?	rs2519093	0	2519093.0	intron_variant	0.0	NR	8e-27	26.096910013008056		0.0818747	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		7q22.1	7	100723128		EPO			ENSG00000130427			rs369859204-?	rs369859204	0	369859204.0	frameshift_variant	0.0	NR	1e-15	15.0		0.244037	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		1q22	1	155420617		ASH1L			ENSG00000116539			rs371382391-?	rs371382391	0	371382391.0	intron_variant	0.0	NR	1e-09	9.0	(Conditioned on rs76872124)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		16p13.3	16	377772		PGAP6			ENSG00000129925			rs375498857-?	rs375498857	0	375498857.0	missense_variant	0.0	NR	1e-300	300.0		1.17393	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		6q23.3	6	135105420		HBS1L - MYB	ENSG00000112339	ENSG00000118513		2364.0	75888.0	rs4895440-?	rs4895440	0	4895440.0	upstream_gene_variant	1.0	NR	1e-10	10.0		0.0433702	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		19q13.2	19	40794579		RAB4B, RAB4B-EGLN2, MIA-RAB4B			ENSG00000167578, ENSG00000171570, ENSG00000268975			rs60533951-?	rs60533951	0	60533951.0	non_coding_transcript_exon_variant	0.0	NR	2e-13	12.69897000433602		0.0538656	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		12p13.33	12	2405104		CACNA1C, CACNA1C			ENSG00000151067, ENSG00000285479			rs714277-?	rs714277	0	714277.0	intron_variant	0.0	NR	4e-10	9.397940008672036		0.0409317	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		1q22	1	155179729		TRIM46			ENSG00000163462			rs76872124-?	rs76872124	0	76872124.0	missense_variant	0.0	NR	5e-14	13.30102999566398		0.0667327	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		15q24.2	15	75898700		UBE2Q2			ENSG00000140367			rs79063526-?	rs79063526	0	79063526.0	intron_variant	0.0	NR	3e-09	8.522878745280337		0.0483629	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		21q22.13	21	36446773		CHAF1B - CLDN14	ENSG00000159259	ENSG00000159261		27758.0	13848.0	rs8134233-?	rs8134233	0	8134233.0	intron_variant	1.0	NR	6e-09	8.221848749616356		0.0348425	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		9q34.2	9	133256028		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176743-?	rs8176743	0	8176743.0	missense_variant	0.0	NR	1e-14	14.0	(Conditioned on rs2519093)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		16q24.3	16	88787321		PIEZO1 - CDT1	ENSG00000103335	ENSG00000167513		2101.0	16468.0	rs837763-?	rs837763	0	837763.0	upstream_gene_variant	1.0	NR	1e-10	10.0		0.0392145	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		22q12.3	22	37068584		TMPRSS6			ENSG00000187045			rs877908-?	rs877908	0	877908.0	intron_variant	0.0	NR	2e-41	40.69897000433602		0.0797212	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		11p15.4	11	5245613		BGLT3 - HBG1	ENSG00000260629	ENSG00000213934		67.0	2656.0	rs998870472-?	rs998870472	0	998870472.0	upstream_gene_variant	1.0	NR	1e-273	273.0		1.9765	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		2p21	2	46133768		PRKCE			ENSG00000171132			rs10168349-?	rs10168349	0	10168349.0	intron_variant	0.0	NR	4.0000000000000003e-29	28.39794000867204		0.296007	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		11p15.4	11	9833310		SBF2			ENSG00000133812			rs10840311-?	rs10840311	0	10840311.0	intron_variant	0.0	NR	5e-08	7.301029995663981		0.132684	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		17p13.1	17	7911350		CHD3			ENSG00000170004			rs117629638-?	rs117629638	0	117629638.0	intron_variant	0.0	NR	2e-06	5.698970004336019	(Conditioned on rs4792590)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		21q22.13	21	36483556		CLDN14			ENSG00000159261			rs13051241-?	rs13051241	0	13051241.0	intron_variant	0.0	NR	3e-09	8.522878745280337		0.102701	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		5q23.3	5	127901674		CCDC192			ENSG00000230561			rs13166824-?	rs13166824	0	13166824.0	intron_variant	0.0	NR	6e-09	8.221848749616356		0.106079	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		19q13.2	19	40631655		LTBP4 - NUMBL	ENSG00000090006	ENSG00000105245		1837.0	34250.0	rs142208757-?	rs142208757	0	142208757.0	downstream_gene_variant	1.0	NR	5e-10	9.30102999566398	(Conditioned on rs60533951)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		7q22.1	7	100670785		ACTL6B - GNB2	ENSG00000077080	ENSG00000172354		14337.0	2782.0	rs147732016-?	rs147732016	0	147732016.0	upstream_gene_variant	1.0	NR	4e-08	7.397940008672037	(Conditioned on rs369859204)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		8q13.3	8	69832577		SLCO5A1			ENSG00000137571			rs3750266-?	rs3750266	0	3750266.0	missense_variant	0.0	NR	1.0000000000000001e-29	29.0	(Conditioned on rs16936450)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		4q13.3	4	74099557		CXCL2 - MTHFD2L	ENSG00000081041	ENSG00000163738		361.0	14617.0	rs3806792-?	rs3806792	0	3806792.0	non_coding_transcript_exon_variant	1.0	NR	2e-09	8.698970004336019		0.0499078	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		17q21.1	17	39984271		PSMD3			ENSG00000108344			rs3816471-?	rs3816471	0	3816471.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(Conditioned on rs55846942)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		7q21.2	7	92779056		CDK6			ENSG00000105810			rs445-?	rs445	0	445.0	intron_variant	0.0	NR	4e-64	63.39794000867204		0.133394	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		13q12.2	13	28100707		FLT3 - CHCHD2P8	ENSG00000122025	ENSG00000235115		115.0	6724.0	rs550248715-?	rs550248715	0	550248715.0	upstream_gene_variant	1.0	NR	9e-11	10.045757490560677		0.223784	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		17q21.1	17	40008217		PSMD3 - CSF3	ENSG00000108344	ENSG00000108342		10258.0	7144.0	rs55846942-?	rs55846942	0	55846942.0	downstream_gene_variant	1.0	NR	2e-62	61.69897000433602		0.126863	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		6q23.3	6	135093071		HBS1L			ENSG00000112339			rs56076748-?	rs56076748	0	56076748.0	intron_variant	0.0	NR	8e-07	6.096910013008056	(Conditioned on rs35959442)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		10q11.23	10	50639968		SGMS1-AS1			ENSG00000226200			rs57040666-?	rs57040666	0	57040666.0	non_coding_transcript_exon_variant	0.0	NR	2e-47	46.69897000433602		0.112466	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		6p24.3	6	7220146		RREB1			ENSG00000124782			rs57340203-?	rs57340203	0	57340203.0	intron_variant	0.0	NR	4e-08	7.397940008672037		0.0428172	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		2q24.2	2	159594316		BAZ2B			ENSG00000123636			rs6432541-?	rs6432541	0	6432541.0	intron_variant	0.0	NR	1e-12	12.0		0.0549961	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		2p23.3	2	27527272		GCKR - C2orf16	ENSG00000084734	ENSG00000221843		3588.0	10114.0	rs6744393-?	rs6744393	0	6744393.0	downstream_gene_variant	1.0	NR	2e-10	9.69897000433602		0.0511454	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		16q12.1	16	51211576		SALL1 - UNGP1	ENSG00000103449	ENSG00000260818		59242.0	66276.0	rs7185923-?	rs7185923	0	7185923.0	intron_variant	1.0	NR	4e-08	7.397940008672037		0.042259	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		2q31.3	2	181451158		LINC01934 - ITGA4	ENSG00000234663	ENSG00000115232		41837.0	6044.0	rs7573465-?	rs7573465	0	7573465.0	intergenic_variant	1.0	NR	5e-10	9.30102999566398		0.0495321	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		2q21.3	2	136012449		DARS1-AS1			ENSG00000231890			rs76806892-?	rs76806892	0	76806892.0	intron_variant	0.0	NR	4e-52	51.39794000867204		0.142353	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		12p13.1	12	12725049		CDKN1B - APOLD1	ENSG00000111276	ENSG00000178878		2680.0	868.0	rs77216612-?	rs77216612	0	77216612.0	upstream_gene_variant	1.0	NR	2e-09	8.698970004336019		0.0459566	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	White blood cell count	76,317 Taiwanese ancestry individuals		10q11.21	10	44396071		CXCL12 - RPL9P21	ENSG00000107562	ENSG00000214089		9578.0	18578.0	rs77976419-?	rs77976419	0	77976419.0	regulatory_region_variant	1.0	NR	3e-09	8.522878745280337		0.0801485	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		5q13.2	5	72807423		TNPO1-DT			ENSG00000249085			rs10070639-?	rs10070639	0	10070639.0	intron_variant	0.0	NR	8e-13	12.096910013008056		0.0576034	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		2p21	2	46133768		PRKCE			ENSG00000171132			rs10168349-?	rs10168349	0	10168349.0	intron_variant	0.0	NR	1.0000000000000001e-28	28.0		0.101896	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		9q34.11	9	127843106		ENG			ENSG00000106991			rs11545664-?	rs11545664	0	11545664.0	synonymous_variant	0.0	NR	5e-08	7.301029995663981		0.0781919	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		22q12.3	22	37093733		TMPRSS6			ENSG00000187045			rs12172465-?	rs12172465	0	12172465.0	intron_variant	0.0	NR	2e-11	10.69897000433602	(Conditioned on rs877908)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		6p22.3	6	16295117		GMPR			ENSG00000137198			rs142002554-?	rs142002554	0	142002554.0	frameshift_variant	0.0	NR	2e-12	11.69897000433602		0.13203	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		19q13.2	19	40631655		LTBP4 - NUMBL	ENSG00000090006	ENSG00000105245		1837.0	34250.0	rs142208757-?	rs142208757	0	142208757.0	downstream_gene_variant	1.0	NR	3e-08	7.522878745280337	(Conditioned on rs60533951)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		7q22.1	7	100670785		ACTL6B - GNB2	ENSG00000077080	ENSG00000172354		14337.0	2782.0	rs147732016-?	rs147732016	0	147732016.0	upstream_gene_variant	1.0	NR	2e-07	6.698970004336019	(Conditioned on rs369859204)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		16p13.3	16	627854		RAB40C			ENSG00000197562			rs15564-?	rs15564	0	15564.0	3_prime_UTR_variant	0.0	NR	4e-08	7.397940008672037	(Conditioned on rs375498857)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hemoglobin levels	76,354 Taiwanese ancestry individuals		11q12.2	11	61815236		FADS1, FADS2, MIR1908			ENSG00000149485, ENSG00000134824, ENSG00000284416			rs174561-?	rs174561	0	174561.0	5_prime_UTR_variant	0.0	NR	9e-17	16.045757490560675		0.0499727	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		1q42.2	1	231421877		EGLN1			ENSG00000135766			rs186996510-?	rs186996510	0	186996510.0	missense_variant	0.0	NR	9e-09	8.045757490560675		0.405553	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		4q12	4	54541738		LINC02283 - LINC02260	ENSG00000248184	ENSG00000250456		185784.0	61473.0	rs218262-?	rs218262	0	218262.0	intergenic_variant	1.0	NR	4e-13	12.397940008672036		0.131056	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		19q13.33	19	49496752		RPS11			ENSG00000142534			rs2280401-?	rs2280401	0	2280401.0	intron_variant	0.0	NR	1e-11	11.0		0.138597	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		1q42.2	1	231352778		SPRTN			ENSG00000010072			rs2437150-?	rs2437150	0	2437150.0	missense_variant	0.0	NR	1e-06	6.0	(Conditioned on rs186996510)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		12p13.33	12	2411714		CACNA1C, CACNA1C			ENSG00000151067, ENSG00000285479			rs2887781-?	rs2887781	0	2887781.0	intron_variant	0.0	NR	9e-11	10.045757490560677		0.119346	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		17p11.2	17	16939677		TNFRSF13B			ENSG00000240505			rs34562254-?	rs34562254	0	34562254.0	missense_variant	0.0	NR	1e-09	9.0		0.104426	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		7q22.1	7	100723128		EPO			ENSG00000130427			rs369859204-?	rs369859204	0	369859204.0	frameshift_variant	0.0	NR	1e-17	17.0		0.750082	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		1q22	1	155420617		ASH1L			ENSG00000116539			rs371382391-?	rs371382391	0	371382391.0	intron_variant	0.0	NR	1e-10	10.0	(Conditioned on rs3814316)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		16p13.3	16	377772		PGAP6			ENSG00000129925			rs375498857-?	rs375498857	0	375498857.0	missense_variant	0.0	NR	2e-136	135.69897000433602		1.71462	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		1q22	1	155177242		TRIM46			ENSG00000163462			rs3814316-?	rs3814316	0	3814316.0	synonymous_variant	0.0	NR	1e-13	13.0		0.148085	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		17p13.1	17	8213797		AURKB - LINC00324	ENSG00000178999	ENSG00000178977		3197.0	6827.0	rs4792590-?	rs4792590	0	4792590.0	upstream_gene_variant	1.0	NR	4e-10	9.397940008672036		0.112018	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		18q12.3	18	45728118		SLC14A1			ENSG00000141469			rs4890587-?	rs4890587	0	4890587.0	intron_variant	0.0	NR	3e-12	11.522878745280336		0.121163	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		6q23.3	6	135105420		HBS1L - MYB	ENSG00000112339	ENSG00000118513		2364.0	75888.0	rs4895440-?	rs4895440	0	4895440.0	upstream_gene_variant	1.0	NR	7.000000000000001e-23	22.154901959985743		0.190845	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		9q34.2	9	133276354		ABO - Y_RNA	ENSG00000281879	ENSG00000264495		330.0	26116.0	rs600038-?	rs600038	0	600038.0	upstream_gene_variant	1.0	NR	7.000000000000001e-23	22.154901959985743		0.216682	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		19q13.2	19	40794579		RAB4B, RAB4B-EGLN2, MIA-RAB4B			ENSG00000167578, ENSG00000171570, ENSG00000268975			rs60533951-?	rs60533951	0	60533951.0	non_coding_transcript_exon_variant	0.0	NR	3e-12	11.522878745280336		0.146887	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		4p15.1	4	29613072		U6 - EEF1A1P21	ENSG00000266784	ENSG00000249542		102335.0	135685.0	rs6823799-?	rs6823799	0	6823799.0	intergenic_variant	1.0	NR	4e-08	7.397940008672037		1.24703	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		11q12.2	11	61811955		FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs72643557-?	rs72643557	0	72643557.0	synonymous_variant	0.0	NR	4e-13	12.397940008672036		0.126114	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		2p21	2	46361893		EPAS1			ENSG00000116016			rs74898705-?	rs74898705	0	74898705.0	intron_variant	0.0	NR	2e-17	16.69897000433602	(Conditioned on rs10168349)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		12q13.11	12	48122833		PFKM			ENSG00000152556			rs755992543-?	rs755992543	0	755992543.0	missense_variant	0.0	NR	3e-10	9.522878745280336		0.997011	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		15q24.2	15	75928941		FBXO22			ENSG00000167196			rs75629444-?	rs75629444	0	75629444.0	intron_variant	0.0	NR	9e-10	9.045757490560677		0.143167	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		16p12.3	16	19366370		LINC02858 - TMC5	ENSG00000285869	ENSG00000103534		28566.0	44126.0	rs75702122-?	rs75702122	0	75702122.0	intron_variant	1.0	NR	5e-08	7.301029995663981		0.148996	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		15q25.1	15	78263734		DNAJA4-DT			ENSG00000259708			rs77185764-?	rs77185764	0	77185764.0	intron_variant	0.0	NR	4e-16	15.397940008672036		0.206653	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		9q34.2	9	133257367		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176722-?	rs8176722	0	8176722.0	intron_variant	0.0	NR	5e-06	5.301029995663981	(Conditioned on rs600038)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		22q12.3	22	37068584		TMPRSS6			ENSG00000187045			rs877908-?	rs877908	0	877908.0	intron_variant	0.0	NR	1e-11	11.0		0.116025	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Hematocrit	76,452 Taiwanese ancestry individuals		11p15.4	11	5245613		BGLT3 - HBG1	ENSG00000260629	ENSG00000213934		67.0	2656.0	rs998870472-?	rs998870472	0	998870472.0	upstream_gene_variant	1.0	NR	5e-173	172.30102999566398		4.5189	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	2e-14	13.69897000433602		2.0768	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		11q23.3	11	116792991		APOA5 - APOA4	ENSG00000110243	ENSG00000110244		571.0	27709.0	rs662799-?	rs662799	0	662799.0	upstream_gene_variant	1.0	NR	1e-10	10.0		1.93706	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1q44	1	247878519		TRIM58			ENSG00000162722			rs66858280-?	rs66858280	0	66858280.0	3_prime_UTR_variant	0.0	NR	4e-09	8.397940008672037	(Conditioned on rs12567154)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		17q12	17	35546753		SLFN14			ENSG00000236320			rs7221322-?	rs7221322	0	7221322.0	3_prime_UTR_variant	0.0	NR	1e-10	10.0		1.77339	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		17p13.2	17	4923297		CHRNE			ENSG00000108556			rs72835078-?	rs72835078	0	72835078.0	intron_variant	0.0	NR	7.999999999999999e-26	25.096910013008056		7.4083	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		17q21.31	17	44574514		FZD2 - SMCO4P1	ENSG00000180340	ENSG00000267384		13252.0	70897.0	rs74978087-?	rs74978087	0	74978087.0	intergenic_variant	1.0	NR	6e-06	5.221848749616356	(Conditioned on rs850736)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1q42.12	1	226363828		PARP1			ENSG00000143799			rs752307-?	rs752307	0	752307.0	non_coding_transcript_exon_variant	0.0	NR	7e-09	8.154901959985743		1.57002	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		18q12.3	18	44498817		LINC01478			ENSG00000267337			rs75354229-?	rs75354229	0	75354229.0	intron_variant	0.0	NR	8e-10	9.096910013008056		2.07067	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		20q13.32	20	58809775		PIEZO1P2 - MIR296	ENSG00000237121	ENSG00000284040		25954.0	7840.0	rs75881074-?	rs75881074	0	75881074.0	intergenic_variant	1.0	NR	2e-06	5.698970004336019	(Conditioned on rs151352)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		3p25.2	3	12226280		SYN2 - GSTM5P1	ENSG00000157152	ENSG00000236062		34248.0	31521.0	rs7650082-?	rs7650082	0	7650082.0	intron_variant	1.0	NR	2e-09	8.698970004336019		1.76189	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		6q23.3	6	135107399		HBS1L - MYB	ENSG00000112339	ENSG00000118513		4343.0	73909.0	rs7758845-?	rs7758845	0	7758845.0	upstream_gene_variant	1.0	NR	5.9999999999999996e-92	91.22184874961636		6.28678	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		6p12.2	6	52388151		EFHC1, PAQR8			ENSG00000096093, ENSG00000170915			rs7775435-?	rs7775435	0	7775435.0	intron_variant	0.0	NR	4e-06	5.3979400086720375	(Conditioned on rs9395819)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		2q24.2	2	159850033		LY75-CD302, LY75			ENSG00000248672, ENSG00000054219			rs78685880-?	rs78685880	0	78685880.0	missense_variant	0.0	NR	2e-11	10.69897000433602	(Conditioned on rs35284483)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		7q21.11	7	80567951		CD36			ENSG00000135218			rs78929872-?	rs78929872	0	78929872.0	intron_variant	0.0	NR	3e-17	16.522878745280337	(Conditioned on rs3211875)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		12q24.12	12	111748839		ACAD10			ENSG00000111271			rs79290585-?	rs79290585	0	79290585.0	non_coding_transcript_exon_variant	0.0	NR	2e-27	26.69897000433602	(Conditioned on rs4766462)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		9q34.2	9	133270880		ABO, ABO			ENSG00000175164, ENSG00000281879			rs79343853-?	rs79343853	0	79343853.0	intron_variant	0.0	NR	3e-09	8.522878745280337		2.15115	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		7q31.32	7	123776519		WASL-DT - RNU6-11P	ENSG00000272686	ENSG00000201104		25353.0	14086.0	rs79947009-?	rs79947009	0	79947009.0	intergenic_variant	1.0	NR	1e-12	12.0		3.05035	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		7p15.3	7	22657557		STEAP1B			ENSG00000105889			rs80085481-?	rs80085481	0	80085481.0	intron_variant	0.0	NR	7e-07	6.154901959985743	(Conditioned on rs1800796)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		17q21.31	17	44369052		RPL7L1P5 - ITGA2B	ENSG00000267634	ENSG00000005961		3301.0	3128.0	rs850736-?	rs850736	0	850736.0	upstream_gene_variant	1.0	NR	3e-09	8.522878745280337		1.6217	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		4q12	4	56879522		SPINK2 - REST	ENSG00000128040	ENSG00000084093		57780.0	28354.0	rs872779-?	rs872779	0	872779.0	regulatory_region_variant	1.0	NR	1e-08	8.0		1.54795	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		6q23.3	6	135040002		HBS1L			ENSG00000112339			rs9389258-?	rs9389258	0	9389258.0	intron_variant	0.0	NR	9e-16	15.045757490560677	(Conditioned on rs7758845)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		6p12.2	6	52779189		GSTA12P - GSTA1	ENSG00000217228	ENSG00000243955		842.0	12182.0	rs9395819-?	rs9395819	0	9395819.0	upstream_gene_variant	1.0	NR	1e-08	8.0		2.45812	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		13q34	13	113294304		LDHBP1 - LAMP1	ENSG00000232662	ENSG00000185896		16570.0	2935.0	rs9604052-?	rs9604052	0	9604052.0	upstream_gene_variant	1.0	NR	5e-09	8.301029995663981		2.13862	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		19q13.2	19	38683692		ACTN4, ACTN4			ENSG00000130402, ENSG00000282844			rs973009-?	rs973009	0	973009.0	intron_variant	0.0	NR	2e-06	5.698970004336019	(Conditioned on rs2306197)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		9q22.32	9	96327892		SLC35D2			ENSG00000130958			rs149672562-?	rs149672562	0	149672562.0	intron_variant	0.0	NR	1e-15	15.0		2.20413	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		20q13.32	20	59026940		ATP5F1E			ENSG00000124172			rs151352-?	rs151352	0	151352.0	3_prime_UTR_variant	0.0	NR	3e-14	13.522878745280336		3.22993	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		12p13.31	12	6179901		VWF - CD9	ENSG00000110799	ENSG00000010278		55131.0	19814.0	rs1558327-?	rs1558327	0	1558327.0	intergenic_variant	1.0	NR	5e-22	21.30102999566398		2.64267	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1q32.1	1	199042410		LINC01221			ENSG00000235492			rs16844101-?	rs16844101	0	16844101.0	intron_variant	0.0	NR	2e-16	15.69897000433602		2.82999	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		12q13.13	12	54230590		SMUG1 - CBX5	ENSG00000123415	ENSG00000094916		41582.0	352.0	rs17109475-?	rs17109475	0	17109475.0	downstream_gene_variant	1.0	NR	6e-09	8.221848749616356		1.61767	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		11q12.2	11	61851136		FADS2			ENSG00000134824			rs174592-?	rs174592	0	174592.0	intron_variant	0.0	NR	1e-17	17.0		2.36267	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		18q12.3	18	44558619		LINC01478			ENSG00000267337			rs17707466-?	rs17707466	0	17707466.0	intron_variant	0.0	NR	2e-07	6.698970004336019	(Conditioned on rs75354229)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		7p15.3	7	22726627		IL6-AS1, IL6, STEAP1B			ENSG00000179428, ENSG00000136244, ENSG00000105889			rs1800796-?	rs1800796	0	1800796.0	non_coding_transcript_exon_variant	0.0	NR	5e-10	9.30102999566398		1.98822	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		22q11.21	22	20671302		ABHD17AP4 - POM121L4P	ENSG00000229107	ENSG00000217261		318.0	18627.0	rs181045861-?	rs181045861	0	181045861.0	upstream_gene_variant	1.0	NR	3e-13	12.522878745280336		4.14003	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		11q23.3	11	119218345		CBL			ENSG00000110395			rs1893033-?	rs1893033	0	1893033.0	intron_variant	0.0	NR	2e-16	15.69897000433602	(Conditioned on rs2155380)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1p34.2	1	43465820		HYI-AS1 - PTPRF	ENSG00000229348	ENSG00000142949		8825.0	59367.0	rs200983716-?	rs200983716	0	200983716.0	regulatory_region_variant	1.0	NR	1e-57	57.0		14.2571	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		4q31.3	4	153536367		TMEM131L			ENSG00000121210			rs2014511-?	rs2014511	0	2014511.0	intron_variant	0.0	NR	6e-12	11.221848749616356		2.22083	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		12p11.22	12	29282547		FAR2			ENSG00000064763			rs2015599-?	rs2015599	0	2015599.0	non_coding_transcript_exon_variant	0.0	NR	6e-10	9.221848749616356		1.66576	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1q24.3	1	171970150		DNM3			ENSG00000197959			rs2038479-?	rs2038479	0	2038479.0	5_prime_UTR_variant	0.0	NR	2e-22	21.69897000433602		3.07823	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		11q23.3	11	119209327		CBL			ENSG00000110395			rs2155380-?	rs2155380	0	2155380.0	intron_variant	0.0	NR	1.9999999999999998e-54	53.69897000433602		4.19679	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1q24.3	1	171923265		DNM3			ENSG00000197959			rs2208368-?	rs2208368	0	2208368.0	intron_variant	0.0	NR	5e-09	8.301029995663981	(Conditioned on rs2038479)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		22q13.31	22	43936613		PNPLA3			ENSG00000100344			rs2281137-?	rs2281137	0	2281137.0	intron_variant	0.0	NR	3e-12	11.522878745280336		1.92486	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		3q27.1	3	184388705		CHRD			ENSG00000090539			rs2293606-?	rs2293606	0	2293606.0	synonymous_variant	0.0	NR	2e-22	21.69897000433602		4.21634	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		19q13.2	19	38721760		ACTN4, ACTN4			ENSG00000130402, ENSG00000282844			rs2306197-?	rs2306197	0	2306197.0	non_coding_transcript_exon_variant	0.0	NR	1e-09	9.0		2.38633	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		5p15.33	5	1286401		TERT			ENSG00000164362			rs2736100-?	rs2736100	0	2736100.0	3_prime_UTR_variant	0.0	NR	2e-16	15.69897000433602		2.24878	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		9p13.1	9	38199824		U8 - ALDH1B1	ENSG00000239142	ENSG00000137124		52263.0	192878.0	rs2810747-?	rs2810747	0	2810747.0	intergenic_variant	1.0	NR	2e-09	8.698970004336019		1.6461	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		7q21.11	7	80658553		CD36			ENSG00000135218			rs3211875-?	rs3211875	0	3211875.0	intron_variant	0.0	NR	6.999999999999999e-30	29.154901959985743		3.43834	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		7q22.3	7	106733200		CCDC71L - LINC02577	ENSG00000253276	ENSG00000228742		72042.0	41755.0	rs342298-?	rs342298	0	342298.0	intron_variant	1.0	NR	9e-13	12.045757490560677		2.27918	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		3q27.1	3	184375252		THPO			ENSG00000090534			rs34623301-?	rs34623301	0	34623301.0	intron_variant	0.0	NR	1e-08	8.0	(Conditioned on rs2293606)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		2q24.2	2	159904625		LY75-CD302, LY75			ENSG00000248672, ENSG00000054219			rs35284483-?	rs35284483	0	35284483.0	missense_variant	0.0	NR	7e-17	16.154901959985743		2.82066	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals												chr6:33580919-?	chr6:33580919	0			1.0	NR	2.0000000000000003e-49	48.69897000433602		4.4698	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		14q32.31	14	102430336		TECPR2			ENSG00000196663			rs1005776-?	rs1005776	0	1005776.0	intron_variant	0.0	NR	7e-07	6.154901959985743	(Conditioned on rs4900545)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		17p13.3	17	2063163		SMG6, HIC1			ENSG00000070366, ENSG00000177374			rs1048483-?	rs1048483	0	1048483.0	3_prime_UTR_variant	0.0	NR	3e-09	8.522878745280337		1.76382	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		5q31.3	5	142139376		NDFIP1			ENSG00000131507			rs10699671-?	rs10699671	0	10699671.0	intron_variant	0.0	NR	1e-14	14.0		2.17311	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		10q21.3	10	63419392		JMJD1C			ENSG00000171988			rs10761760-?	rs10761760	0	10761760.0	intron_variant	0.0	NR	6e-19	18.22184874961636		2.67091	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		15q22.2	15	63049797		TPM1			ENSG00000140416			rs11071720-?	rs11071720	0	11071720.0	intron_variant	0.0	NR	4e-08	7.397940008672037		1.5359	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		18q11.2	18	23141009		CABLES1			ENSG00000134508			rs11082304-?	rs11082304	0	11082304.0	intron_variant	0.0	NR	1e-18	18.0		2.3764	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		6p21.31	6	36533022		STK38			ENSG00000112079			rs113412960-?	rs113412960	0	113412960.0	intron_variant	0.0	NR	3e-32	31.522878745280337		4.38016	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		17p13.1	17	7835555		KDM6B			ENSG00000132510			rs117267286-?	rs117267286	0	117267286.0	intron_variant	0.0	NR	5e-10	9.30102999566398		2.047	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		4p16.1	4	6889792		KIAA0232 - TBC1D14	ENSG00000170871	ENSG00000132405		5622.0	19450.0	rs11734132-?	rs11734132	0	11734132.0	intergenic_variant	1.0	NR	1e-18	18.0		2.41128	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		13q34	13	109840279		IRS2 - RN7SKP10	ENSG00000185950	ENSG00000201161		53696.0	74817.0	rs11841319-?	rs11841319	0	11841319.0	regulatory_region_variant	1.0	NR	1e-10	10.0		2.94859	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		5q31.1	5	132480549		IRF1, IRF1-AS1			ENSG00000125347, ENSG00000197536			rs11954400-?	rs11954400	0	11954400.0	intron_variant	0.0	NR	1e-08	8.0		1.61705	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1q23.1	1	156899922		PEAR1			ENSG00000187800			rs12041331-?	rs12041331	0	12041331.0	intron_variant	0.0	NR	4e-17	16.397940008672037		2.29568	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		9p21.3	9	22142757		CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		14654.0	304067.0	rs12376511-?	rs12376511	0	12376511.0	regulatory_region_variant	1.0	NR	4e-12	11.397940008672036		1.98924	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1q44	1	247547523		GCSAML			ENSG00000169224			rs12567154-?	rs12567154	0	12567154.0	intron_variant	0.0	NR	1e-12	12.0		1.94765	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		5q12.1	5	60910298		ERCC8			ENSG00000049167			rs12657309-?	rs12657309	0	12657309.0	intron_variant	0.0	NR	6e-18	17.221848749616356		2.88108	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		15q22.31	15	64873757		PLEKHO2 - ANKDD1A	ENSG00000241839	ENSG00000166839		5755.0	38145.0	rs12911407-?	rs12911407	0	12911407.0	intron_variant	1.0	NR	2e-12	11.69897000433602		2.15611	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		17q23.1	17	59856808		RNU6-450P - TUBD1	ENSG00000201524	ENSG00000108423		9264.0	2671.0	rs1292043-?	rs1292043	0	1292043.0	downstream_gene_variant	1.0	NR	3e-09	8.522878745280337		1.65918	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		19q13.12	19	35538950		GAPDHS			ENSG00000105679			rs12984928-?	rs12984928	0	12984928.0	intron_variant	0.0	NR	2e-09	8.698970004336019		1.91909	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		22q11.21	22	19703133		LINC00895 - SEPTIN5	ENSG00000281548	ENSG00000184702		136294.0	11370.0	rs13055644-?	rs13055644	0	13055644.0	regulatory_region_variant	1.0	NR	1e-11	11.0	(Conditioned on rs181045861)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		3p14.3	3	56815721		ARHGEF3			ENSG00000163947			rs1354034-?	rs1354034	0	1354034.0	intron_variant	0.0	NR	8e-40	39.096910013008056		3.59989	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		11q14.1	11	78251114		GAB2			ENSG00000033327			rs142239882-?	rs142239882	0	142239882.0	intron_variant	0.0	NR	1e-08	8.0		1.5984	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		20q11.21	20	31274436		DKKL1P1			ENSG00000215546			rs144203216-?	rs144203216	0	144203216.0	non_coding_transcript_exon_variant	0.0	NR	4e-18	17.397940008672037		14.2337	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		5q22.1	5	111711707		STARD4-AS1, NREP			ENSG00000246859, ENSG00000134986			rs146239224-?	rs146239224	0	146239224.0	intron_variant	0.0	NR	5e-11	10.30102999566398		2.1548	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1p34.2	1	43340495		MPL			ENSG00000117400			rs149265851-?	rs149265851	0	149265851.0	missense_variant	0.0	NR	7e-18	17.154901959985743	(Conditioned on rs200983716)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		9p24.1	9	4831641		RCL1			ENSG00000120158			rs35842041-?	rs35842041	0	35842041.0	intron_variant	0.0	NR	3e-16	15.522878745280336	(Conditioned on rs385893)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		6p22.2	6	25599006		CARMIL1			ENSG00000079691			rs3788991-?	rs3788991	0	3788991.0	intron_variant	0.0	NR	2e-12	11.69897000433602		1.91609	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		4q25	4	109952770		EGF			ENSG00000138798			rs3796944-?	rs3796944	0	3796944.0	intron_variant	0.0	NR	2e-07	6.698970004336019	(Conditioned on rs3822285)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		19q13.42	19	55180232		SYT5			ENSG00000129990			rs3810353-?	rs3810353	0	3810353.0	5_prime_UTR_variant	0.0	NR	1e-11	11.0	(Conditioned on rs583330)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		4q25	4	110008970		EGF			ENSG00000138798			rs3822285-?	rs3822285	0	3822285.0	intron_variant	0.0	NR	4e-52	51.39794000867204		4.65405	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		9p24.1	9	4763176		AK3 - ECM1P1	ENSG00000147853	ENSG00000270639		21133.0	5441.0	rs385893-?	rs385893	0	385893.0	downstream_gene_variant	1.0	NR	5e-50	49.30102999566398		5.10795	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		13q32.1	13	95247462		ABCC4			ENSG00000125257			rs4148435-?	rs4148435	0	4148435.0	intron_variant	0.0	NR	1e-21	21.0		3.17185	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		12p13.31	12	6338356		TNFRSF1A			ENSG00000067182			rs4149577-?	rs4149577	0	4149577.0	intron_variant	0.0	NR	4e-07	6.3979400086720375	(Conditioned on rs1558327)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		5q13.2	5	72742397		H2BL1P - Y_RNA	ENSG00000223497	ENSG00000264495		8188.0	26305.0	rs4540158-?	rs4540158	0	4540158.0	intron_variant	1.0	NR	7e-09	8.154901959985743		2.1428	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		8q23.1	8	105578477		ZFPM2-AS1, ZFPM2			ENSG00000251003, ENSG00000169946			rs4541868-?	rs4541868	0	4541868.0	intron_variant	0.0	NR	3e-29	28.522878745280337		3.0706	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		3p21.1	3	52596532		PBRM1			ENSG00000163939			rs4687633-?	rs4687633	0	4687633.0	intron_variant	0.0	NR	7e-12	11.154901959985745		1.87142	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		6q26	6	164038193		RN7SL366P - C6orf118	ENSG00000266128	ENSG00000112539		197341.0	1241471.0	rs4709034-?	rs4709034	0	4709034.0	intergenic_variant	1.0	NR	5e-15	14.30102999566398		2.15589	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		12q24.12	12	111433337		SH2B3			ENSG00000111252			rs4766462-?	rs4766462	0	4766462.0	intron_variant	0.0	NR	2.9999999999999997e-47	46.52287874528034		7.42815	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		1p36.22	1	11982386		MFN2			ENSG00000116688			rs4846082-?	rs4846082	0	4846082.0	intron_variant	0.0	NR	2e-17	16.69897000433602		2.35594	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		14q32.31	14	102584795		RN7SL546P - RCOR1	ENSG00000239224	ENSG00000089902		1618.0	7854.0	rs4900545-?	rs4900545	0	4900545.0	upstream_gene_variant	1.0	NR	2e-16	15.69897000433602		2.22932	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		20p13	20	1852343		CKAP2LP1 - SIRPA	ENSG00000271461	ENSG00000198053		93403.0	41824.0	rs548475-?	rs548475	0	548475.0	regulatory_region_variant	1.0	NR	3e-06	5.522878745280337	(Conditioned on rs6045612)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		2q34	2	210685132		CPS1 - RPS27P10	ENSG00000021826	ENSG00000231017		6025.0	613809.0	rs55932961-?	rs55932961	0	55932961.0	intergenic_variant	1.0	NR	5e-13	12.30102999566398		2.6103	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		19q13.33	19	49951091		SIGLEC11			ENSG00000161640			rs57663431-?	rs57663431	0	57663431.0	intron_variant	0.0	NR	7e-13	12.154901959985745		2.19264	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		19q13.43	19	56123650		ZNF787 - ZNF444	ENSG00000142409	ENSG00000167685		2355.0	8949.0	rs583330-?	rs583330	0	583330.0	upstream_gene_variant	1.0	NR	2e-17	16.69897000433602		2.48798	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		14q23.3	14	65011237		FNTB, CHURC1-FNTB, MAX			ENSG00000257365, ENSG00000125954, ENSG00000125952			rs58784215-?	rs58784215	0	58784215.0	intron_variant	0.0	NR	1e-09	9.0		1.84693	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		7q33	7	135666562		STMP1			ENSG00000243317			rs59543286-?	rs59543286	0	59543286.0	intron_variant	0.0	NR	6e-09	8.221848749616356		2.05072	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		20p13	20	1950355		PDYN-AS1			ENSG00000233896			rs6045612-?	rs6045612	0	6045612.0	intron_variant	0.0	NR	2e-11	10.69897000433602		2.328	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		16q12.2	16	53335358		CHD9 - RNA5SP427	ENSG00000177200	ENSG00000202193		6208.0	2095.0	rs60853285-?	rs60853285	0	60853285.0	upstream_gene_variant	1.0	NR	9e-09	8.045757490560675		1.71554	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		5q12.1	5	61241574		LINC02057			ENSG00000249279			rs6449522-?	rs6449522	0	6449522.0	intron_variant	0.0	NR	8e-07	6.096910013008056	(Conditioned on rs12657309)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Platelet count	76,345 Taiwanese ancestry individuals		2p23.1	2	31241963		EHD3			ENSG00000013016			rs647316-?	rs647316	0	647316.0	intron_variant	0.0	NR	2e-10	9.69897000433602		3.95138	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		14q32.13	14	94359333		SERPINA6 - SERPINA2	ENSG00000170099	ENSG00000274821		35944.0	4980.0	rs58622098-?	rs58622098	0	58622098.0	downstream_gene_variant	1.0	NR	2e-06	5.698970004336019	(Conditioned on rs1884080)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		2q37.3	2	241298487		HDLBP			ENSG00000115677			rs59104589-?	rs59104589	0	59104589.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.00610301	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		20q12	20	40335727		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		324404.0	350121.0	rs6016319-?	rs6016319	0	6016319.0	regulatory_region_variant	1.0	NR	3e-11	10.522878745280336		0.0098781	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		2p23.3	2	27512105		GCKR			ENSG00000084734			rs6547692-?	rs6547692	0	6547692.0	intron_variant	0.0	NR	4.9999999999999997e-64	63.30102999566398		0.0185748	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		19q13.11	19	33398687		PEPD			ENSG00000124299			rs7256564-?	rs7256564	0	7256564.0	intron_variant	0.0	NR	3e-19	18.522878745280337		0.00991361	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		4q21.21	4	78698045		LINC01094 - BMP2K-DT	ENSG00000251442	ENSG00000260278		14860.0	75609.0	rs75759936-?	rs75759936	0	75759936.0	intergenic_variant	1.0	NR	6e-18	17.221848749616356		0.019272	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		2p23.3	2	27523079		GCKR			ENSG00000084734			rs7589217-?	rs7589217	0	7589217.0	intron_variant	0.0	NR	3e-11	10.522878745280336	(Conditioned on rs6547692)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		15q21.2	15	51314989		CYP19A1			ENSG00000137869			rs77348531-?	rs77348531	0	77348531.0	intron_variant	0.0	NR	4e-08	7.397940008672037		0.00704337	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		19q13.33	19	49504342		COX6CP7 - FCGRT	ENSG00000268681	ENSG00000104870		1703.0	2474.0	rs79068664-?	rs79068664	0	79068664.0	upstream_gene_variant	1.0	NR	2.0000000000000002e-28	27.69897000433602	(Conditioned on rs2280401)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		14q32.33	14	105505333		TEDC1 - TMEM121	ENSG00000185347	ENSG00000184986		5758.0	21250.0	rs8003942-?	rs8003942	0	8003942.0	intergenic_variant	1.0	NR	3e-08	7.522878745280337		0.00614939	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		9q34.2	9	133257367		ABO, ABO			ENSG00000175164, ENSG00000281879			rs8176722-?	rs8176722	0	8176722.0	intron_variant	0.0	NR	6e-17	16.221848749616356		0.0123131	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		6p21.32	6	32609608		HLA-DRB1 - HLA-DQA1	ENSG00000196126	ENSG00000196735		19760.0	18571.0	rs9271147-?	rs9271147	0	9271147.0	intron_variant	1.0	NR	2e-15	14.69897000433602		0.014446	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals												chr8:26602281-?	chr8:26602281	0			1.0	NR	3e-08	7.522878745280337		0.962843	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		5p13.3	5	31021251		HPRT1P2 - RPL19P11	ENSG00000250587	ENSG00000241668		772358.0	32314.0	rs10075805-?	rs10075805	0	10075805.0	regulatory_region_variant	1.0	NR	8e-16	15.096910013008056		0.842464	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		7p15.2	7	25969871		MIR148A - NFE2L3	ENSG00000199085	ENSG00000050344		19885.0	182327.0	rs10236909-?	rs10236909	0	10236909.0	intergenic_variant	1.0	NR	3e-11	10.522878745280336		0.541298	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		8q11.23	8	54558857		RP1			ENSG00000104237			rs10504167-?	rs10504167	0	10504167.0	non_coding_transcript_exon_variant	0.0	NR	2e-09	8.698970004336019		0.646911	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		10q11.23	10	50924840		A1CF - MIX23P2	ENSG00000148584	ENSG00000236944		39165.0	38153.0	rs10821947-?	rs10821947	0	10821947.0	intergenic_variant	1.0	NR	1e-08	8.0		0.515198	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		18q21.31	18	58427551		NEDD4L - MIR122HG	ENSG00000049759	ENSG00000267391		26011.0	18237.0	rs10871755-?	rs10871755	0	10871755.0	intergenic_variant	1.0	NR	4e-21	20.39794000867204		1.10484	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		2q31.1	2	169003206		ABCB11, ABCB11			ENSG00000073734, ENSG00000276582			rs112779928-?	rs112779928	0	112779928.0	intron_variant	0.0	NR	7e-13	12.154901959985745		0.603481	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		10q22.3	10	77923160		DLG5, DLG5			ENSG00000151208, ENSG00000274429			rs12220902-?	rs12220902	0	12220902.0	intron_variant	0.0	NR	9e-26	25.045757490560675		1.13609	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		14q32.32	14	103125001		TNFAIP2			ENSG00000185215			rs147057843-?	rs147057843	0	147057843.0	intron_variant	0.0	NR	4e-06	5.3979400086720375	(Conditioned on rs9324058)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Liver enzyme levels (gamma-glutamyl transferase)	76,131 Taiwanese ancestry individuals		1p36.13	1	16178825		EPHA2 - ARHGEF19-AS1	ENSG00000142627	ENSG00000234166		22756.0	19029.0	rs1497406-?	rs1497406	0	1497406.0	intergenic_variant	1.0	NR	3e-35	34.52287874528034		1.16274	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		8p23.1	8	9325593		RNU6-1151P - RNU6-526P	ENSG00000284864	ENSG00000201815		38015.0	45497.0	rs111675407-?	rs111675407	0	111675407.0	intron_variant	1.0	NR	1e-12	12.0		0.039195	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		1q31.3	1	196692483		CFH			ENSG00000000971			rs12405238-?	rs12405238	0	12405238.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.00624955	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		11q23.3	11	119123965		HINFP			ENSG00000172273			rs12577019-?	rs12577019	0	12577019.0	5_prime_UTR_variant	0.0	NR	1e-11	11.0		0.0200512	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		3q27.2	3	185746700		IGF2BP2			ENSG00000073792			rs13076013-?	rs13076013	0	13076013.0	intron_variant	0.0	NR	7e-10	9.154901959985745		0.0629067	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		7q21.11	7	80550968		CD36			ENSG00000135218			rs145638771-?	rs145638771	0	145638771.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.0214053	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		9q31.3	9	109451408		PTPN3			ENSG00000070159			rs1541091-?	rs1541091	0	1541091.0	intron_variant	0.0	NR	5e-14	13.30102999566398		0.00893018	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		4p16.3	4	3422504		RGS12			ENSG00000159788			rs16844330-?	rs16844330	0	16844330.0	synonymous_variant	0.0	NR	7e-08	7.154901959985743	(Conditioned on rs2749778)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		1q41	1	220881419		HLX			ENSG00000136630			rs17597773-?	rs17597773	0	17597773.0	non_coding_transcript_exon_variant	0.0	NR	1e-08	8.0		0.00726418	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		14q32.13	14	94595248		SERPINA5 - SERPINA3	ENSG00000188488	ENSG00000196136		2130.0	17136.0	rs1884080-?	rs1884080	0	1884080.0	intron_variant	1.0	NR	1e-15	15.0		0.0090122	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		1p13.3	1	109923933		CSF1			ENSG00000184371			rs2229165-?	rs2229165	0	2229165.0	missense_variant	0.0	NR	4e-08	7.397940008672037		0.00823551	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		19q13.12	19	35541399		TMEM147-AS1, GAPDHS			ENSG00000236144, ENSG00000105679			rs2239944-?	rs2239944	0	2239944.0	non_coding_transcript_exon_variant	0.0	NR	3e-06	5.522878745280337	(Conditioned on rs2452000)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		19q13.33	19	49496752		RPS11			ENSG00000142534			rs2280401-?	rs2280401	0	2280401.0	intron_variant	0.0	NR	4e-52	51.39794000867204		0.0200372	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		11p11.2	11	47276650		MADD			ENSG00000110514			rs2291119-?	rs2291119	0	2291119.0	intron_variant	0.0	NR	6e-10	9.221848749616356		0.00770848	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		19q13.11	19	35063480		HPN, HPN-AS1			ENSG00000105707, ENSG00000227392			rs2452000-?	rs2452000	0	2452000.0	intron_variant	0.0	NR	1.9999999999999998e-50	49.69897000433602		0.0222253	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		5q13.2	5	72950455		TNPO1 - FCHO2-DT	ENSG00000083312	ENSG00000272081		33722.0	4751.0	rs2666747-?	rs2666747	0	2666747.0	downstream_gene_variant	1.0	NR	3e-11	10.522878745280336		0.00781624	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		4p16.3	4	3349978		RGS12			ENSG00000159788			rs2749778-?	rs2749778	0	2749778.0	intron_variant	0.0	NR	7e-13	12.154901959985745		0.00825623	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		4p15.2	4	26169885		RBPJ			ENSG00000168214			rs28802419-?	rs28802419	0	28802419.0	intron_variant	0.0	NR	1e-08	8.0		0.00874744	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		6p21.33	6	31137488		PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1, PSORS1C1			ENSG00000231094, ENSG00000233439, ENSG00000206458, ENSG00000233734, ENSG00000204540, ENSG00000235487			rs3132559-?	rs3132559	0	3132559.0	intron_variant	0.0	NR	2e-09	8.698970004336019	(Conditioned on rs9271147)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		17p11.2	17	16939677		TNFRSF13B			ENSG00000240505			rs34562254-?	rs34562254	0	34562254.0	missense_variant	0.0	NR	1e-31	31.0		0.0130587	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		22q13.1	22	37645186		SH3BP1, PDXP-DT			ENSG00000100092, ENSG00000233360			rs35001542-?	rs35001542	0	35001542.0	intron_variant	0.0	NR	2e-08	7.698970004336019		0.0072303	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		7q11.23	7	73603327		MLXIPL			ENSG00000009950			rs35368205-?	rs35368205	0	35368205.0	intron_variant	0.0	NR	2e-12	11.69897000433602		0.0137849	unit decrease	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		7q21.11	7	80763101		SEMA3C			ENSG00000075223			rs3778676-?	rs3778676	0	3778676.0	intron_variant	0.0	NR	4e-06	5.3979400086720375	(Conditioned on rs145638771)			NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		17p13.1	17	7578807		EIF4A1			ENSG00000161960			rs3809719-?	rs3809719	0	3809719.0	3_prime_UTR_variant	0.0	NR	4e-13	12.397940008672036		0.0096403	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		8p22	8	18414956		NAT2 - PSD3	ENSG00000156006	ENSG00000156011		13738.0	112347.0	rs4921915-?	rs4921915	0	4921915.0	intergenic_variant	1.0	NR	2e-08	7.698970004336019		0.00614344	unit increase	NR [5925277] (imputed)	N
2022-11-17	36329257	Lee CJ	2022-11-03	Commun Biol	www.ncbi.nlm.nih.gov/pubmed/36329257	Phenome-wide analysis of Taiwan Biobank reveals novel glycemia-related loci and genetic risks for diabetes.	Albumin levels	76,638 Taiwanese ancestry individuals		4q13.3	4	73347893		ANKRD17-DT - ALB	ENSG00000250220	ENSG00000163631		29940.0	49221.0	rs566142026-?	rs566142026	0	566142026.0	intergenic_variant	1.0	NR	1e-12	12.0	(Conditioned on rs1000669403)			NR [5925277] (imputed)	N
2022-10-03	34568709	Santoro N	2021-08-18	J Endocr Soc	www.ncbi.nlm.nih.gov/pubmed/34568709	Genome-wide Association Study of Lipid Traits in Youth With Type 2 Diabetes.	HDL cholesterol levels in type 2 diabetes	1,037 youth cases		16q13	16	56956804		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		11940.0	5119.0	rs247617-?	rs247617	0	247617.0	regulatory_region_variant	1.0	NR	5e-09	8.301029995663981				Illumina [17642824] (imputed)	N
2022-10-03	34568709	Santoro N	2021-08-18	J Endocr Soc	www.ncbi.nlm.nih.gov/pubmed/34568709	Genome-wide Association Study of Lipid Traits in Youth With Type 2 Diabetes.	Triglyceride levels in type 2 diabetes	1,037 youth cases		3p14.1	3	67766957		SUCLG2-AS1			ENSG00000241316			rs148323096-?	rs148323096	0	148323096.0	intron_variant	0.0	NR	2e-08	7.698970004336019				Illumina [17642824] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals												chr1:63038303-?	chr1:63038303	0			1.0	NR	1e-21	21.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		1q42.13	1	230160042		GALNT2			ENSG00000143641			rs10127775-?	rs10127775	0	10127775.0	intron_variant	0.0	NR	5e-08	7.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		2p24.1	2	21008652		APOB			ENSG00000084674			rs676210-?	rs676210	0	676210.0	missense_variant	0.0	NR	7e-13	12.154901959985745				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals												chr2:27748992-?	chr2:27748992	0			1.0	NR	3.0000000000000003e-31	30.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		2q37.1	2	232655544		EFHD1			ENSG00000115468			rs13395911-?	rs13395911	0	13395911.0	intron_variant	0.0	NR	8e-09	8.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		4q13.2	4	68579342		UGT2B17 - UGT2B15	ENSG00000197888	ENSG00000277132		2929.0	67255.0	rs370026722-?	rs370026722	0	370026722.0	upstream_gene_variant	1.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		4q21.3	4	87098315		AFF1			ENSG00000172493			rs3775217-?	rs3775217	0	3775217.0	intron_variant	0.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		6p21.1	6	43837765		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		51278.0	7113.0	rs10223666-?	rs10223666	0	10223666.0	intron_variant	1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		6q25.3	6	160564494		LPA			ENSG00000198670			rs118039278-?	rs118039278	0	118039278.0	intron_variant	0.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		7q11.23	7	73619229		MLXIPL			ENSG00000009950			rs34062580-?	rs34062580	0	34062580.0	intron_variant	0.0	NR	7.999999999999999e-26	25.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		8p23.1	8	11525150		BLK			ENSG00000136573			rs2252797-?	rs2252797	0	2252797.0	intron_variant	0.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		8p21.3	8	19962922		LPL			ENSG00000175445			rs12679834-?	rs12679834	0	12679834.0	intron_variant	0.0	NR	4e-51	50.39794000867204				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals												chr8:126504383-?	chr8:126504383	0			1.0	NR	1e-33	33.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		11q12.2	11	61824890		FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs174566-?	rs174566	0	174566.0	intron_variant	0.0	NR	8e-20	19.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		11q23.3	11	116778201		ZPR1			ENSG00000109917			rs964184-?	rs964184	0	964184.0	3_prime_UTR_variant	0.0	NR	3e-80	79.52287874528034				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		17q21.31	17	43848758		CD300LG			ENSG00000161649			rs72836561-?	rs72836561	0	72836561.0	missense_variant	0.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		19p13.2	19	8364439		ANGPTL4			ENSG00000167772			rs116843064-?	rs116843064	0	116843064.0	missense_variant	0.0	NR	1e-21	21.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		19p13.11	19	19259532		HAPLN4			ENSG00000187664			rs756350040-?	rs756350040	1	150641967.0	intron_variant	0.0	NR	3e-11	10.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in type 2 diabetes	21,176 European ancestry individuals		19q13.32	19	44912383		APOE - APOC1	ENSG00000130203	ENSG00000130208		2990.0	1864.0	rs445925-?	rs445925	0	445925.0	non_coding_transcript_exon_variant	1.0	NR	1.0000000000000001e-23	23.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q13	2	111169802		MIR4435-2HG			ENSG00000172965			rs6708784-?	rs6708784	0	6708784.0	intron_variant	0.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q14.1	2	113111413		IL1RN			ENSG00000136689			rs56341434-?	rs56341434	0	56341434.0	intron_variant	0.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q14.2	2	119005157		MARCO - C1QL2	ENSG00000019169	ENSG00000144119		10497.0	151086.0	rs73948265-?	rs73948265	0	73948265.0	regulatory_region_variant	1.0	NR	1e-11	11.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q14.2	2	120551655		LINC01101 - Y_RNA	ENSG00000280409	ENSG00000264495		85437.0	99618.0	rs954244-?	rs954244	0	954244.0	downstream_gene_variant	1.0	NR	4e-11	10.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q24.3	2	164672366		COBLL1			ENSG00000082438			rs13389219-?	rs13389219	0	13389219.0	intron_variant	0.0	NR	4.999999999999999e-69	68.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q31.1	2	170772553		EIF2S2P4 - Y_RNA	ENSG00000128692	ENSG00000264495		19765.0	10614.0	rs12472667-?	rs12472667	0	12472667.0	intron_variant	1.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q33.1	2	201325945		FLACC1			ENSG00000155749			rs1918881-?	rs1918881	0	1918881.0	intron_variant	0.0	NR	8e-09	8.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q33.2	2	202562837		BMPR2			ENSG00000204217			rs547796478-?	rs547796478	0	547796478.0	3_prime_UTR_variant	0.0	NR	4e-12	11.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q35	2	218835276		PRKAG3 - RPL23AP31	ENSG00000115592	ENSG00000232625		3190.0	6323.0	rs78058190-?	rs78058190	0	78058190.0	upstream_gene_variant	1.0	NR	7.999999999999999e-50	49.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q36.3	2	226235259		NYAP2 - MIR5702	ENSG00000144460	ENSG00000263363		581241.0	423451.0	rs2943647-?	rs2943647	0	2943647.0	intergenic_variant	1.0	NR	4e-77	76.39794000867204				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q36.3	2	229263488		PID1			ENSG00000153823			rs7596814-?	rs7596814	0	7596814.0	intron_variant	0.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2q37.3	2	241456259		FARP2			ENSG00000006607			rs4675812-?	rs4675812	0	4675812.0	intron_variant	0.0	NR	8e-14	13.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p26.1	3	4714654		ITPR1			ENSG00000150995			rs9829279-?	rs9829279	0	9829279.0	intron_variant	0.0	NR	3e-12	11.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p25.2	3	12351626		PPARG			ENSG00000132170			rs1801282-?	rs1801282	0	1801282.0	missense_variant	0.0	NR	2e-20	19.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr3:15807354-?	chr3:15807354	0			1.0	NR	4e-10	9.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p24.3	3	23351175		UBE2E2			ENSG00000182247			rs12489408-?	rs12489408	0	12489408.0	intron_variant	0.0	NR	3e-09	8.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p13	3	69815539		MITF			ENSG00000187098			rs11916348-?	rs11916348	0	11916348.0	intron_variant	0.0	NR	5e-08	7.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p12.1	3	86988393		VGLL3			ENSG00000206538			rs13066793-?	rs13066793	0	13066793.0	intron_variant	0.0	NR	1e-11	11.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr3:123022312-?	chr3:123022312	0			1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q21.3	3	127587619		TPRA1			ENSG00000163870			rs79983121-?	rs79983121	0	79983121.0	intron_variant	0.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q22.3	3	136286950		PCCB			ENSG00000114054			rs7653249-?	rs7653249	0	7653249.0	intron_variant	0.0	NR	2e-31	30.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q23	3	142950251		PAQR9			ENSG00000188582			rs11391636-?	rs11391636	0	11391636.0	3_prime_UTR_variant	0.0	NR	3e-12	11.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q25.1	3	150348753		LINC01214 - TSC22D2	ENSG00000289524	ENSG00000196428		52148.0	59545.0	rs62271373-?	rs62271373	0	62271373.0	regulatory_region_variant	1.0	NR	2.0000000000000002e-24	23.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q25.31	3	157077736		LEKR1 - LINC00880	ENSG00000197980	ENSG00000243629		31607.0	3931.0	rs9854955-?	rs9854955	0	9854955.0	upstream_gene_variant	1.0	NR	4e-19	18.39794000867204				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q26.2	3	170970407		KLF7P1 - RNU1-70P	ENSG00000240704	ENSG00000199488		16510.0	24463.0	rs576198199-?	rs576198199	0	576198199.0	intron_variant	1.0	NR	1e-14	14.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q26.31	3	171858646		TMEM212, TMEM212-AS1			ENSG00000186329, ENSG00000234717			rs35240776-?	rs35240776	0	35240776.0	3_prime_UTR_variant	0.0	NR	4e-10	9.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p24.2	3	24478792		THRB			ENSG00000151090			rs6792725-?	rs6792725	0	6792725.0	intron_variant	0.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr3:37099025-?	chr3:37099025	0			1.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p21.31	3	46884049		PTH1R			ENSG00000160801			rs11926707-?	rs11926707	0	11926707.0	intron_variant	0.0	NR	3e-09	8.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p21.31	3	49847480		TRAIP			ENSG00000183763			rs13316065-?	rs13316065	0	13316065.0	intron_variant	0.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3p21.1	3	52312224		GLYCTK-AS1 - DNAH1	ENSG00000242797	ENSG00000114841		13157.0	4095.0	rs17052061-?	rs17052061	0	17052061.0	upstream_gene_variant	1.0	NR	1.0000000000000001e-29	29.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q26.31	3	172576710		LINC02068			ENSG00000223387			rs79287178-?	rs79287178	0	79287178.0	intron_variant	0.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q27.3	3	187910218		BCL6 - LINC01991	ENSG00000113916	ENSG00000224187		164493.0	48557.0	rs7631606-?	rs7631606	0	7631606.0	regulatory_region_variant	1.0	NR	3e-08	7.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q28	3	188749374		LPP			ENSG00000145012			rs1568669-?	rs1568669	0	1568669.0	intron_variant	0.0	NR	5e-08	7.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		3q29	3	196460737		UBXN7-AS1 - RNF168	ENSG00000225822	ENSG00000163961		28207.0	8046.0	rs2342371-?	rs2342371	0	2342371.0	intergenic_variant	1.0	NR	9e-11	10.045757490560677				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4p16.3	4	958159		TMEM175			ENSG00000127419			rs34311866-?	rs34311866	0	34311866.0	missense_variant	0.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4p16.3	4	3442204		HGFAC			ENSG00000109758			rs13108218-?	rs13108218	0	13108218.0	intron_variant	0.0	NR	2e-46	45.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4p16.2	4	4988571		RN7SKP113 - CYTL1	ENSG00000200761	ENSG00000170891		67507.0	26015.0	rs4450871-?	rs4450871	0	4450871.0	intergenic_variant	1.0	NR	2e-13	12.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4p15.31	4	17921191		LCORL			ENSG00000178177			rs548236486-?	rs548236486	1	199551309.0	intron_variant	0.0	NR	7e-20	19.154901959985743				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr4:26050450-?	chr4:26050450	0			1.0	NR	3e-28	27.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4p14	4	39682597		SMIM14-DT - UBE2K	ENSG00000255458	ENSG00000078140		15718.0	15512.0	rs7676961-?	rs7676961	0	7676961.0	TF_binding_site_variant	1.0	NR	8e-11	10.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q12	4	54643022		LINC02260 - KIT	ENSG00000250456	ENSG00000157404		35891.0	14245.0	rs7684939-?	rs7684939	0	7684939.0	intergenic_variant	1.0	NR	7e-13	12.154901959985745				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q13.2	4	68501108		TMPRSS11E - UGT2B29P	ENSG00000087128	ENSG00000250566		3504.0	8333.0	rs202059056-?	rs202059056	0	202059056.0	downstream_gene_variant	1.0	NR	2e-12	11.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q21.1	4	76451770		SHROOM3			ENSG00000138771			rs1398018-?	rs1398018	0	1398018.0	intron_variant	0.0	NR	1e-11	11.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q21.3	4	86009938		MAPK10			ENSG00000109339			rs7439032-?	rs7439032	0	7439032.0	intron_variant	0.0	NR	2e-12	11.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q21.3	4	87064014		AFF1			ENSG00000172493			rs3775228-?	rs3775228	0	3775228.0	intron_variant	0.0	NR	1e-61	61.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q22.1	4	88798217		FAM13A			ENSG00000138640			rs1377290-?	rs1377290	0	1377290.0	intron_variant	0.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q23	4	99126007		ADH4			ENSG00000198099			rs5860563-?	rs5860563	0	5860563.0	intron_variant	0.0	NR	4e-10	9.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q23	4	99587399		MTTP			ENSG00000138823			rs2035816-?	rs2035816	0	2035816.0	intron_variant	0.0	NR	6e-11	10.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q24	4	102267552		SLC39A8			ENSG00000138821			rs13107325-?	rs13107325	0	13107325.0	missense_variant	0.0	NR	2e-10	9.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q25	4	109603883		MCUB			ENSG00000005059			rs547113723-?	rs547113723	0	547113723.0	intron_variant	0.0	NR	6e-27	26.22184874961636				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q28.1	4	123895285		LINC01091			ENSG00000249464			rs28613054-?	rs28613054	0	28613054.0	intron_variant	0.0	NR	6e-10	9.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q31.3	4	153302896		TRIM2			ENSG00000109654			rs17369400-?	rs17369400	0	17369400.0	intron_variant	0.0	NR	3e-08	7.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q31.3	4	154568456		FGB			ENSG00000171564			rs6054-?	rs6054	0	6054.0	missense_variant	0.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		4q32.1	4	156774240		PDGFC			ENSG00000145431			rs983473-?	rs983473	0	983473.0	intron_variant	0.0	NR	1e-11	11.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5p13.1	5	40833385		RPL37			ENSG00000145592			rs29761-?	rs29761	0	29761.0	intron_variant	0.0	NR	9e-09	8.045757490560675				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q11.2	5	54014309		ARL15			ENSG00000185305			rs7735249-?	rs7735249	0	7735249.0	intron_variant	0.0	NR	5e-13	12.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q11.2	5	56561199		C5orf67			ENSG00000225940			rs11429307-?	rs11429307	0	11429307.0	intron_variant	0.0	NR	1e-61	61.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q11.2	5	58314242		PGAM1P1 - PLK2	ENSG00000248271	ENSG00000145632		152490.0	139740.0	rs37538-?	rs37538	0	37538.0	intergenic_variant	1.0	NR	4e-11	10.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q13.1	5	68418419		PIK3R1 - VWA8P1	ENSG00000145675	ENSG00000250289		116598.0	436491.0	rs4976033-?	rs4976033	0	4976033.0	regulatory_region_variant	1.0	NR	1e-19	19.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q14.1	5	79137332		DMGDH			ENSG00000132837			rs181193678-?	rs181193678	0	181193678.0	intron_variant	0.0	NR	9e-11	10.045757490560677				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q14.3	5	83515065		VCAN			ENSG00000038427			rs34580448-?	rs34580448	0	34580448.0	intron_variant	0.0	NR	5e-10	9.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q14.3	5	90959868		ADGRV1			ENSG00000164199			rs7704653-?	rs7704653	0	7704653.0	intron_variant	0.0	NR	6e-09	8.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q23.1	5	119377762		TNFAIP8			ENSG00000145779			rs5870855-?	rs5870855	0	5870855.0	intron_variant	0.0	NR	2e-19	18.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q31.1	5	131595845		RAPGEF6			ENSG00000158987			rs150930807-?	rs150930807	0	150930807.0	intron_variant	0.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr5:132426851-?	chr5:132426851	0			1.0	NR	1e-17	17.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q31.3	5	140719011		VTRNA1-2			ENSG00000202111			rs12188417-?	rs12188417	0	12188417.0	non_coding_transcript_exon_variant	0.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q31.3	5	141509809		PCDHGA5, PCDHGA11, PCDHGA2, PCDHGA6, PCDHGA9, PCDHGB1, PCDHGA7, PCDHGC5, PCDHGB4, PCDHGB2, PCDHGC4, PCDHGC3, PCDHGA12, PCDHGB7, PCDHGB6, PCDHGA3, PCDHGA10, PCDHGA1, PCDHGB3, PCDHGA8, PCDHGB5, PCDHGA4			ENSG00000253485, ENSG00000253873, ENSG00000081853, ENSG00000253731, ENSG00000261934, ENSG00000254221, ENSG00000253537, ENSG00000240764, ENSG00000253953, ENSG00000253910, ENSG00000242419, ENSG00000240184, ENSG00000253159, ENSG00000254122, ENSG00000253305, ENSG00000254245, ENSG00000253846, ENSG00000204956, ENSG00000262209, ENSG00000253767, ENSG00000276547, ENSG00000262576			rs13163163-?	rs13163163	0	13163163.0	intron_variant	0.0	NR	7e-10	9.154901959985745				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q32	5	149966412		SLC26A2			ENSG00000155850			rs245051-?	rs245051	0	245051.0	intron_variant	0.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q33.3	5	156968992		TIMD4 - HAVCR1	ENSG00000145850	ENSG00000113249		5766.0	60421.0	rs12657266-?	rs12657266	0	12657266.0	intergenic_variant	1.0	NR	6e-59	58.22184874961636				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q33.3	5	158576012		LINC02227 - EBF1	ENSG00000276778	ENSG00000164330		166239.0	119904.0	rs2963468-?	rs2963468	0	2963468.0	intron_variant	1.0	NR	1e-20	20.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr5:176740565-?	chr5:176740565	0			1.0	NR	2e-10	9.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		5q35.3	5	181281936		TRIM52-AS1 - RNU6-705P	ENSG00000248275	ENSG00000222533		9629.0	20031.0	rs2545075-?	rs2545075	0	2545075.0	intron_variant	1.0	NR	3e-08	7.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6p24.3	6	7247111		RREB1			ENSG00000124782			rs35742417-?	rs35742417	0	35742417.0	missense_variant	0.0	NR	4e-10	9.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6p22.3	6	20501964		Y_RNA - CDKAL1	ENSG00000264495	ENSG00000145996		1688.0	32493.0	rs62398908-?	rs62398908	0	62398908.0	downstream_gene_variant	1.0	NR	6e-12	11.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6p22.1	6	29639324		SUMO2P1 - MOG	ENSG00000228130	ENSG00000236561		2981.0	17678.0	rs3131856-?	rs3131856	0	3131856.0	upstream_gene_variant	1.0	NR	4e-20	19.39794000867204				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6p21.31	6	34210076		KRT18P9 - CYCSP55	ENSG00000271231	ENSG00000214810		18997.0	9363.0	rs185139895-?	rs185139895	0	185139895.0	intergenic_variant	1.0	NR	5e-16	15.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6p21.2	6	36679011		CDKN1A			ENSG00000124762			rs3176320-?	rs3176320	0	3176320.0	intron_variant	0.0	NR	7e-09	8.154901959985743				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6p21.1	6	43790159		VEGFA - LINC02537	ENSG00000112715	ENSG00000283215		3672.0	54719.0	rs998584-?	rs998584	0	998584.0	downstream_gene_variant	1.0	NR	1e-89	89.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6p12.2	6	52765471		GSTA12P			ENSG00000217228			rs6458869-?	rs6458869	0	6458869.0	intron_variant	0.0	NR	6e-16	15.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q13	6	71812618		RNU4-66P - RIMS1	ENSG00000202069	ENSG00000079841		160007.0	73932.0	rs138191773-?	rs138191773	0	138191773.0	intergenic_variant	1.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q16.3	6	100178468		PRDX2P4 - SIM1	ENSG00000213177	ENSG00000112246		41805.0	206541.0	rs732194-?	rs732194	0	732194.0	downstream_gene_variant	1.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q21	6	107115962		BEND3 - RNU6-1299P	ENSG00000178409	ENSG00000252125		447.0	17109.0	rs62427982-?	rs62427982	0	62427982.0	upstream_gene_variant	1.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q21	6	108867818		ARMC2			ENSG00000118690			rs9480889-?	rs9480889	0	9480889.0	intron_variant	0.0	NR	3e-09	8.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q22.33	6	127113961		RPS4XP9 - RSPO3	ENSG00000217404	ENSG00000146374		430114.0	4710.0	rs6916318-?	rs6916318	0	6916318.0	intron_variant	1.0	NR	4e-40	39.39794000867204				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q23.1	6	130033710		L3MBTL3			ENSG00000198945			rs9388766-?	rs9388766	0	9388766.0	intron_variant	0.0	NR	3e-15	14.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q23.2	6	133495050		EYA4			ENSG00000112319			rs667890-?	rs667890	0	667890.0	intron_variant	0.0	NR	6e-11	10.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q24.1	6	139514286		LINC01625 - ATP5PBP6	ENSG00000238099	ENSG00000219806		39628.0	100152.0	rs71562509-?	rs71562509	0	71562509.0	intron_variant	1.0	NR	3e-37	36.52287874528034				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q24.1	6	140258674		MIR3668 - MIR4465	ENSG00000263514	ENSG00000264390		53348.0	425140.0	rs9403164-?	rs9403164	0	9403164.0	intron_variant	1.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q25.2	6	153091342		RGS17			ENSG00000091844			rs3910737-?	rs3910737	0	3910737.0	intron_variant	0.0	NR	4e-08	7.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q25.3	6	160591981		LPA			ENSG00000198670			rs140570886-?	rs140570886	0	140570886.0	intron_variant	0.0	NR	1.9999999999999998e-42	41.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		6q26	6	163711969		QKI - RN7SL366P	ENSG00000112531	ENSG00000266128		133377.0	128592.0	rs4709746-?	rs4709746	0	4709746.0	intron_variant	1.0	NR	4e-12	11.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7p22.3	7	971165		COX19			ENSG00000240230			rs71538127-?	rs71538127	0	71538127.0	intron_variant	0.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7p22.1	7	5527965		ACTB			ENSG00000075624			rs852424-?	rs852424	0	852424.0	splice_region_variant	0.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7p21.2	7	15873963		RPL36AP26 - CRPPA	ENSG00000235828	ENSG00000214960		172211.0	213562.0	rs38205-?	rs38205	0	38205.0	intergenic_variant	1.0	NR	1e-12	12.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7p21.1	7	17247645		AHR			ENSG00000106546			rs6968865-?	rs6968865	0	6968865.0	5_prime_UTR_variant	0.0	NR	3e-18	17.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7p21.1	7	17902243		SNX13			ENSG00000071189			rs781006834-?	rs781006834	1	71010277.0	intron_variant	0.0	NR	3e-14	13.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p36.22	1	10736809		CASZ1			ENSG00000130940			rs880315-?	rs880315	0	880315.0	intron_variant	0.0	NR	8e-09	8.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p36.12	1	23458472		ASAP3, ASAP3			ENSG00000088280, ENSG00000282854			rs534417-?	rs534417	0	534417.0	intron_variant	0.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p36.11	1	26695422		ARID1A			ENSG00000117713			rs114165349-?	rs114165349	0	114165349.0	intron_variant	0.0	NR	2.0000000000000003e-34	33.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p34.3	1	39476571		MACF1			ENSG00000127603			rs371894931-?	rs371894931	0	371894931.0	intron_variant	0.0	NR	9.999999999999999e-26	25.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p32.3	1	50925897		FAF1			ENSG00000185104			rs12085666-?	rs12085666	0	12085666.0	intron_variant	0.0	NR	7e-15	14.154901959985745				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p32.3	1	54411430		SSBP3			ENSG00000157216			rs213494-?	rs213494	0	213494.0	intron_variant	0.0	NR	1e-13	13.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p31.3	1	61217884		NFIA			ENSG00000162599			rs9970076-?	rs9970076	0	9970076.0	intron_variant	0.0	NR	3e-11	10.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p31.3	1	62454337		DOCK7			ENSG00000116641			rs636523-?	rs636523	0	636523.0	non_coding_transcript_exon_variant	0.0	NR	9e-298	297.0457574905607				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p22.1	1	93381096		DR1 - Y_RNA	ENSG00000117505	ENSG00000264495		11603.0	4615.0	rs771481-?	rs771481	0	771481.0	upstream_gene_variant	1.0	NR	3e-11	10.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11p15.3	11	13339977		ARNTL			ENSG00000133794			rs6486122-?	rs6486122	0	6486122.0	intron_variant	0.0	NR	2e-20	19.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11p14.3	11	26052428		LINC02699 - ANO3	ENSG00000254456	ENSG00000134343		270411.0	136414.0	rs2349805-?	rs2349805	0	2349805.0	downstream_gene_variant	1.0	NR	4e-08	7.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11p14.1	11	27673288		BDNF, BDNF-AS			ENSG00000176697, ENSG00000245573			rs11030107-?	rs11030107	0	11030107.0	intron_variant	0.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11p11.2	11	47253513		NR1H3			ENSG00000025434			rs10838681-?	rs10838681	0	10838681.0	intron_variant	0.0	NR	7e-28	27.154901959985743				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q12.1	11	55857419		OR9M1P			ENSG00000186124			rs556240673-?	rs556240673	0	556240673.0	non_coding_transcript_exon_variant	0.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q12.1	11	57375151		P2RX3 - PRG3	ENSG00000109991	ENSG00000156575		2755.0	1618.0	rs118188894-?	rs118188894	0	118188894.0	downstream_gene_variant	1.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q12.1	11	58016169		CYCSP26 - OR9Q1	ENSG00000254601	ENSG00000186509		10464.0	7712.0	rs115006552-?	rs115006552	0	115006552.0	intergenic_variant	1.0	NR	9e-09	8.045757490560675				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q12.2	11	61146661		VPS37C			ENSG00000167987			rs628963-?	rs628963	0	628963.0	intron_variant	0.0	NR	8e-09	8.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q12.2	11	61820833		FADS2, FADS1			ENSG00000134824, ENSG00000149485			rs174564-?	rs174564	0	174564.0	intron_variant	0.0	NR	5e-106	105.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q12.3	11	62610749		EML3			ENSG00000149499			rs11231161-?	rs11231161	0	11231161.0	intron_variant	0.0	NR	1e-13	13.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q13.1	11	64250633		PPP1R14B-AS1 - PLCB3	ENSG00000256940	ENSG00000149782		2415.0	897.0	rs71468663-?	rs71468663	0	71468663.0	upstream_gene_variant	1.0	NR	2.9999999999999998e-40	39.52287874528034				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr11:64809581-?	chr11:64809581	0			1.0	NR	3e-16	15.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q13.1	11	65706327		RN7SL309P - KAT5	ENSG00000239356	ENSG00000172977		10490.0	5669.0	rs10750766-?	rs10750766	0	10750766.0	regulatory_region_variant	1.0	NR	2e-18	17.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q13.3	11	68794860		CPT1A			ENSG00000110090			rs2229738-?	rs2229738	0	2229738.0	missense_variant	0.0	NR	4e-13	12.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q14.1	11	78329213		GAB2			ENSG00000033327			rs7117238-?	rs7117238	0	7117238.0	intron_variant	0.0	NR	3e-09	8.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q23.1	11	111760274		PPP2R1B			ENSG00000137713			rs1788955-?	rs1788955	0	1788955.0	intron_variant	0.0	NR	6e-13	12.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11q23.3	11	116780399		ZPR1			ENSG00000109917			rs11604424-?	rs11604424	0	11604424.0	intron_variant	0.0	NR	2.0000000000000002e-307	306.69897000433605				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12p13.32	12	4275678		CCND2, CCND2-AS1			ENSG00000118971, ENSG00000255920			rs76895963-?	rs76895963	0	76895963.0	non_coding_transcript_exon_variant	0.0	NR	6e-24	23.22184874961636				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12p13.31	12	6630331		LPAR5			ENSG00000184574			rs35104374-?	rs35104374	0	35104374.0	intron_variant	0.0	NR	3e-11	10.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12p13.2	12	11638751		LINC01252 - ETV6	ENSG00000247157	ENSG00000139083		48382.0	10923.0	rs12824533-?	rs12824533	0	12824533.0	intergenic_variant	1.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12p12.2	12	20317265		LINC02468 - PDE3A-AS1	ENSG00000256499	ENSG00000256879		181102.0	44467.0	rs11045171-?	rs11045171	0	11045171.0	intergenic_variant	1.0	NR	1.0000000000000001e-23	23.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12p12.1	12	21190952		SLCO1B1			ENSG00000134538			rs67981690-?	rs67981690	0	67981690.0	intron_variant	0.0	NR	3e-23	22.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12p12.1	12	22624480		ETNK1-DT			ENSG00000257023			rs771115929-?	rs771115929	0	771115929.0	intron_variant	0.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12p11.23	12	26310241		SSPN - ITPR2	ENSG00000123096	ENSG00000123104		10951.0	25111.0	rs11048457-?	rs11048457	0	11048457.0	intron_variant	1.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12p11.1	12	34123149		ALG10 - TUBB8P4	ENSG00000139133	ENSG00000250788		93455.0	41624.0	rs11494834-?	rs11494834	0	11494834.0	regulatory_region_variant	1.0	NR	9e-10	9.045757490560677				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9p24.3	9	1033773		H3P29 - LINC01230	ENSG00000228783	ENSG00000281769		21974.0	11852.0	rs1567353-?	rs1567353	0	1567353.0	intergenic_variant	1.0	NR	6e-14	13.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9p22.3	9	15304784		TTC39B			ENSG00000155158			rs686030-?	rs686030	0	686030.0	intron_variant	0.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9p22.2	9	16903368		BNC2 - RN7SL720P	ENSG00000173068	ENSG00000241152		32525.0	150533.0	rs10738466-?	rs10738466	0	10738466.0	intergenic_variant	1.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9q21.32	9	83968161		HNRNPK			ENSG00000165119			rs696825-?	rs696825	0	696825.0	3_prime_UTR_variant	0.0	NR	1e-17	17.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9q22.2	9	89584356		SEMA4D - GADD45G	ENSG00000187764	ENSG00000130222		86226.0	20656.0	rs10908900-?	rs10908900	0	10908900.0	intron_variant	1.0	NR	7e-15	14.154901959985745				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9q22.33	9	99400288		STX17-DT			ENSG00000255145			rs62565259-?	rs62565259	0	62565259.0	intron_variant	0.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9q31.1	9	104903697		ABCA1			ENSG00000165029			rs1800978-?	rs1800978	0	1800978.0	5_prime_UTR_variant	0.0	NR	3e-17	16.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9q31.3	9	109478856		PTPN3			ENSG00000070159			rs77824033-?	rs77824033	0	77824033.0	intron_variant	0.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr9:123376295-?	chr9:123376295	0			1.0	NR	3e-08	7.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9q34.2	9	133264505		ABO, ABO			ENSG00000175164, ENSG00000281879			rs782134971-?	rs782134971	1	60937319.0	intron_variant	0.0	NR	1e-15	15.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		9q34.3	9	136476890		SEC16A			ENSG00000148396			rs11999525-?	rs11999525	0	11999525.0	synonymous_variant	0.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10p15.1	10	5225228		AKR1C4 - LINC02561	ENSG00000198610	ENSG00000224034		6279.0	40805.0	rs140107293-?	rs140107293	0	140107293.0	intergenic_variant	1.0	NR	2e-16	15.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q11.23	10	50814012		A1CF, ASAH2B			ENSG00000148584, ENSG00000204147			rs41274050-?	rs41274050	0	41274050.0	missense_variant	0.0	NR	2e-27	26.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q21.2	10	59709332		SLC16A9			ENSG00000165449			rs1171615-?	rs1171615	0	1171615.0	intron_variant	0.0	NR	4e-13	12.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q21.3	10	63364338		JMJD1C			ENSG00000171988			rs10822163-?	rs10822163	0	10822163.0	intron_variant	0.0	NR	1e-52	52.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q22.1	10	72954419		PLA2G12B			ENSG00000138308			rs3829126-?	rs3829126	0	3829126.0	intron_variant	0.0	NR	1e-11	11.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr10:81073027-?	chr10:81073027	0			1.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q23.33	10	93079885		CYP26A1 - NIP7P1	ENSG00000095596	ENSG00000232805		2000.0	26987.0	rs2068888-?	rs2068888	0	2068888.0	downstream_gene_variant	1.0	NR	3e-51	50.52287874528034				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q24.2	10	98012647		CRTAC1			ENSG00000095713			rs563296-?	rs563296	0	563296.0	intron_variant	0.0	NR	9e-15	14.045757490560677				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q24.31	10	100164661		ERLIN1			ENSG00000107566			rs10883451-?	rs10883451	0	10883451.0	intron_variant	0.0	NR	8e-11	10.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q24.32	10	102186723		NOLC1 - ELOVL3	ENSG00000166197	ENSG00000119915		22852.0	39576.0	rs75398587-?	rs75398587	0	75398587.0	intergenic_variant	1.0	NR	5e-11	10.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q25.2	10	112403562		ACSL5			ENSG00000197142			rs12221085-?	rs12221085	0	12221085.0	intron_variant	0.0	NR	4e-15	14.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q25.3	10	114045297		ADRB1			ENSG00000043591			rs1801253-?	rs1801253	0	1801253.0	missense_variant	0.0	NR	2e-17	16.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		10q26.12	10	121240386		LINC01153 - RN7SKP167	ENSG00000227143	ENSG00000222979		54420.0	170530.0	rs12245393-?	rs12245393	0	12245393.0	intergenic_variant	1.0	NR	9e-09	8.045757490560675				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		11p15.4	11	10652192		IRAG1			ENSG00000072952			rs4909945-?	rs4909945	0	4909945.0	missense_variant	0.0	NR	3e-09	8.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p21.3	1	98013425		MIR137HG			ENSG00000225206			rs1938566-?	rs1938566	0	1938566.0	intron_variant	0.0	NR	5e-12	11.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p13.3	1	109275908		CELSR2 - PSRC1	ENSG00000143126	ENSG00000134222		157.0	3648.0	rs646776-?	rs646776	0	646776.0	downstream_gene_variant	1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1p12	1	117605762		VPS25P1 - TENT5C	ENSG00000226755	ENSG00000183508		55840.0	286.0	rs41276588-?	rs41276588	0	41276588.0	non_coding_transcript_exon_variant	1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q21.2	1	149895680		BOLA1			ENSG00000178096			rs113011970-?	rs113011970	0	113011970.0	intron_variant	0.0	NR	2e-13	12.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q21.3	1	151067100		CDC42SE1, MLLT11			ENSG00000197622, ENSG00000213190			rs147779327-?	rs147779327	0	147779327.0	intron_variant	0.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q21.3	1	154287174		HAX1 - RNU6-239P	ENSG00000143575	ENSG00000212292		11299.0	8329.0	rs1760801-?	rs1760801	0	1760801.0	upstream_gene_variant	1.0	NR	8e-18	17.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q24.3	1	172391024		DNM3, PIGC			ENSG00000197959, ENSG00000135845			rs2227198-?	rs2227198	0	2227198.0	intron_variant	0.0	NR	1e-11	11.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q25.2	1	178533543		TEX35			ENSG00000240021			rs10631642-?	rs10631642	0	10631642.0	intron_variant	0.0	NR	3e-08	7.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q32.1	1	205101445		RBBP5			ENSG00000117222			rs11240358-?	rs11240358	0	11240358.0	intron_variant	0.0	NR	2e-10	9.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q41	1	219470307		LYPLAL1-AS1 - ZC3H11B	ENSG00000228536	ENSG00000215817		10938.0	137703.0	rs2605098-?	rs2605098	0	2605098.0	intergenic_variant	1.0	NR	2e-16	15.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q41	1	220827800		RNU6ATAC35P - LINC01352	ENSG00000221571	ENSG00000238078		1737.0	1455.0	rs61830291-?	rs61830291	0	61830291.0	intron_variant	1.0	NR	2e-17	16.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q42.13	1	227869167		PRSS38 - WNT9A	ENSG00000185888	ENSG00000143816		22697.0	49489.0	rs6690181-?	rs6690181	0	6690181.0	regulatory_region_variant	1.0	NR	2e-10	9.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		1q42.13	1	230161390		GALNT2			ENSG00000143641			rs2281721-?	rs2281721	0	2281721.0	intron_variant	0.0	NR	6e-120	119.22184874961636				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p25.3	2	3594771		RPS7 - COLEC11	ENSG00000171863	ENSG00000118004		13851.0	61.0	rs3820897-?	rs3820897	0	3820897.0	upstream_gene_variant	1.0	NR	2e-12	11.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p24.1	2	21008652		APOB			ENSG00000084674			rs676210-?	rs676210	0	676210.0	missense_variant	0.0	NR	2.0000000000000003e-187	186.698970004336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p23.3	2	25370049		ARNILA			ENSG00000235072			rs11903847-?	rs11903847	0	11903847.0	non_coding_transcript_exon_variant	0.0	NR	7e-09	8.154901959985743				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p23.3	2	25842723		ASXL2			ENSG00000143970			rs13392329-?	rs13392329	0	13392329.0	intron_variant	0.0	NR	7e-10	9.154901959985745				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p23.3	2	27525757		GCKR - C2orf16	ENSG00000084734	ENSG00000221843		2073.0	11629.0	rs1260333-?	rs1260333	0	1260333.0	downstream_gene_variant	1.0	NR	2.0000000000000002e-307	306.69897000433605				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p22.2	2	36847870		STRN			ENSG00000115808			rs1861435-?	rs1861435	0	1861435.0	3_prime_UTR_variant	0.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p21	2	43253178		THADA			ENSG00000115970			rs7595299-?	rs7595299	0	7595299.0	intron_variant	0.0	NR	4e-10	9.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p16.3	2	48735152		LHCGR, STON1-GTF2A1L			ENSG00000138039, ENSG00000068781			rs17326656-?	rs17326656	0	17326656.0	intron_variant	0.0	NR	9e-14	13.045757490560677				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr2:50728781-?	chr2:50728781	0			1.0	NR	3e-08	7.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p14	2	65056838		CEP68			ENSG00000011523			rs74181299-?	rs74181299	0	74181299.0	intron_variant	0.0	NR	5e-17	16.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p13.3	2	70061395		PCBP1-AS1			ENSG00000179818			rs534372768-?	rs534372768	1	371158717.0	intron_variant	0.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		2p11.2	2	85571593		VAMP8			ENSG00000118640			rs539482903-?	rs539482903	1	4019541.0	intron_variant	0.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7p15.2	7	25952704		MIR148A - NFE2L3	ENSG00000199085	ENSG00000050344		2718.0	199494.0	rs10642257-?	rs10642257	0	10642257.0	upstream_gene_variant	1.0	NR	1e-36	36.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7p14.3	7	29279633		CHN2			ENSG00000106069			rs11980456-?	rs11980456	0	11980456.0	intron_variant	0.0	NR	5e-08	7.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7p13	7	44157984		GCK			ENSG00000106633			rs2070971-?	rs2070971	0	2070971.0	intron_variant	0.0	NR	9e-20	19.045757490560675				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q11.23	7	73642420		MLXIPL - VPS37D	ENSG00000009950	ENSG00000176428		17877.0	25411.0	rs6957745-?	rs6957745	0	6957745.0	intergenic_variant	1.0	NR	2.0000000000000002e-307	306.69897000433605				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q11.23	7	75985688		POR			ENSG00000127948			rs1057868-?	rs1057868	0	1057868.0	missense_variant	0.0	NR	7e-10	9.154901959985745				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q22.3	7	106991668		PIK3CG - PRKAR2B	ENSG00000105851	ENSG00000005249		82688.0	53037.0	rs12530679-?	rs12530679	0	12530679.0	intergenic_variant	1.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q31.2	7	116845966		CAPZA2			ENSG00000198898			rs41785-?	rs41785	0	41785.0	intron_variant	0.0	NR	4e-12	11.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q31.2	7	117336776		CFTR			ENSG00000001626			rs6977665-?	rs6977665	0	6977665.0	intron_variant	0.0	NR	7e-09	8.154901959985743				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q31.31	7	121309488		CPED1 - WNT16	ENSG00000106034	ENSG00000002745		12046.0	15879.0	rs10277699-?	rs10277699	0	10277699.0	non_coding_transcript_exon_variant	1.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q32.2	7	130408807		CEP41			ENSG00000106477			rs200356336-?	rs200356336	0	200356336.0	intron_variant	0.0	NR	5e-08	7.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q32.2	7	130744427		KLF14 - H4P1	ENSG00000266265	ENSG00000240680		10220.0	78778.0	rs13234269-?	rs13234269	0	13234269.0	intergenic_variant	1.0	NR	2e-58	57.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		7q36.1	7	150513060		STRADBP1			ENSG00000213205			rs7784108-?	rs7784108	0	7784108.0	non_coding_transcript_exon_variant	0.0	NR	1e-15	15.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8p23.1	8	10786591		PINX1			ENSG00000284764			rs7821812-?	rs7821812	0	7821812.0	intron_variant	0.0	NR	1e-44	44.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8p22	8	18056461		ASAH1			ENSG00000104763			rs7508-?	rs7508	0	7508.0	3_prime_UTR_variant	0.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8p21.3	8	20010025		LPL - RPL30P9	ENSG00000175445	ENSG00000242709		42766.0	103318.0	rs34345068-?	rs34345068	0	34345068.0	intergenic_variant	1.0	NR	2.0000000000000002e-307	306.69897000433605				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8p21.2	8	25607154		CDCA2 - EBF2	ENSG00000184661	ENSG00000221818		99243.0	234571.0	rs73221948-?	rs73221948	0	73221948.0	intron_variant	1.0	NR	3e-11	10.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8q12.1	8	58476006		UBXN2B - CYP7A1	ENSG00000215114	ENSG00000167910		24505.0	14172.0	rs2081687-?	rs2081687	0	2081687.0	intergenic_variant	1.0	NR	1.0000000000000001e-29	29.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8q12.3	8	63665348		RN7SKP135 - LINC01414	ENSG00000252358	ENSG00000253554		55748.0	21831.0	rs56065444-?	rs56065444	0	56065444.0	intron_variant	1.0	NR	5e-09	8.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8q13.3	8	70805871		XKR9 - EYA1	ENSG00000221947	ENSG00000104313		15500.0	391562.0	rs62508819-?	rs62508819	0	62508819.0	intron_variant	1.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8q13.3	8	71547654		EYA1			ENSG00000104313			rs13269725-?	rs13269725	0	13269725.0	non_coding_transcript_exon_variant	0.0	NR	2e-19	18.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr8:106443129-?	chr8:106443129	0			1.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8q23.3	8	115658120		TRPS1			ENSG00000104447			rs3808477-?	rs3808477	0	3808477.0	intron_variant	0.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr8:126504383-?	chr8:126504383	0			1.0	NR	2.0000000000000002e-307	306.69897000433605				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8q24.21	8	128555815		LINC00824			ENSG00000254275			rs1561928-?	rs1561928	0	1561928.0	intron_variant	0.0	NR	7e-09	8.154901959985743				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		8q24.3	8	143224428		GPIHBP1 - ZFP41	ENSG00000277494	ENSG00000181638		7258.0	22393.0	rs11434143-?	rs11434143	0	11434143.0	intergenic_variant	1.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		14q24.1	14	68823599		ZFP36L1 - MAGOH3P	ENSG00000185650	ENSG00000270975		27346.0	38163.0	rs7142589-?	rs7142589	0	7142589.0	intergenic_variant	1.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		14q32.2	14	100239451		YY1			ENSG00000100811			rs765286940-?	rs765286940	1	76675246.0	inframe_insertion	0.0	NR	5e-10	9.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q15.1	15	40104990		BMF			ENSG00000104081			rs34245505-?	rs34245505	0	34245505.0	intron_variant	0.0	NR	6e-10	9.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q15.3	15	43735687		CATSPER2P1			ENSG00000205771			rs139974673-?	rs139974673	0	139974673.0	intron_variant	0.0	NR	7e-101	100.15490195998576				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr15:51921464-?	chr15:51921464	0			1.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q21.3	15	58431227		ALDH1A2, LIPC			ENSG00000128918, ENSG00000166035			rs1077835-?	rs1077835	0	1077835.0	intron_variant	0.0	NR	3e-85	84.52287874528034				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q22.2	15	61668103		RORA - LINC02349	ENSG00000069667	ENSG00000259284		438801.0	61662.0	rs12440800-?	rs12440800	0	12440800.0	intron_variant	1.0	NR	6e-14	13.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q22.31	15	63501039		LINC02568 - USP3	ENSG00000259459	ENSG00000140455		62719.0	3472.0	rs11635675-?	rs11635675	0	11635675.0	non_coding_transcript_exon_variant	1.0	NR	2e-33	32.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q22.31	15	64737757		OAZ2 - RBPMS2	ENSG00000180304	ENSG00000166831		34476.0	2134.0	rs10162671-?	rs10162671	0	10162671.0	downstream_gene_variant	1.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q22.31	15	66592637		LINC01169			ENSG00000259471			rs4776304-?	rs4776304	0	4776304.0	intron_variant	0.0	NR	8e-12	11.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q24.1	15	73325897		HCN4			ENSG00000138622			rs3826043-?	rs3826043	0	3826043.0	intron_variant	0.0	NR	8e-09	8.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		15q26.3	15	101528455		PCSK6 - SNRPCP18	ENSG00000140479	ENSG00000259464		3253.0	34081.0	rs1037117-?	rs1037117	0	1037117.0	upstream_gene_variant	1.0	NR	2e-17	16.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16p13.3	16	900007		LMF1			ENSG00000103227			rs12924608-?	rs12924608	0	12924608.0	non_coding_transcript_exon_variant	0.0	NR	3e-11	10.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16p13.3	16	2420719		ABCA17P			ENSG00000238098			rs11866534-?	rs11866534	0	11866534.0	intron_variant	0.0	NR	2e-10	9.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16p13.3	16	4438190		DNAJA3, DNAJA3			ENSG00000276726, ENSG00000103423			rs28577186-?	rs28577186	0	28577186.0	intron_variant	0.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16p13.13	16	11698844		TXNDC11			ENSG00000153066			rs933574-?	rs933574	0	933574.0	intron_variant	0.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16p13.11	16	15056648		PDXDC1			ENSG00000179889			rs12928099-?	rs12928099	0	12928099.0	intron_variant	0.0	NR	1e-35	35.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16p11.2	16	29983601		TAOK2			ENSG00000149930			rs3814883-?	rs3814883	0	3814883.0	synonymous_variant	0.0	NR	8e-13	12.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16p11.2	16	31042719		STX4			ENSG00000103496			rs2288004-?	rs2288004	0	2288004.0	non_coding_transcript_exon_variant	0.0	NR	4e-12	11.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16q13	16	56959974		HERPUD1 - CETP	ENSG00000051108	ENSG00000087237		15110.0	1949.0	rs821840-?	rs821840	0	821840.0	upstream_gene_variant	1.0	NR	3e-52	51.52287874528034				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16q22.1	16	69716946		NQO1			ENSG00000181019			rs2917677-?	rs2917677	0	2917677.0	intron_variant	0.0	NR	1e-16	16.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16q22.2	16	72041694		DHODH - TXNL4B	ENSG00000102967	ENSG00000140830		14030.0	2595.0	rs12924886-?	rs12924886	0	12924886.0	downstream_gene_variant	1.0	NR	3e-27	26.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr16:79754433-?	chr16:79754433	0			1.0	NR	9e-09	8.045757490560675				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16q23.2	16	81501185		CMIP			ENSG00000153815			rs2925979-?	rs2925979	0	2925979.0	intron_variant	0.0	NR	2e-44	43.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16q24.1	16	85116557		CIBAR2 - LINC02139	ENSG00000153789	ENSG00000278214		4085.0	20593.0	rs79311290-?	rs79311290	0	79311290.0	upstream_gene_variant	1.0	NR	4e-10	9.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		16q24.2	16	87970486		BANP			ENSG00000172530			rs12926107-?	rs12926107	0	12926107.0	intron_variant	0.0	NR	6e-10	9.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17p13.3	17	1715069		MIR22HG, MIR22HG			ENSG00000186594, ENSG00000282800			rs11078597-?	rs11078597	0	11078597.0	intron_variant	0.0	NR	7e-12	11.154901959985745				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17p13.2	17	4789345		GLTPD2			ENSG00000182327			rs79202680-?	rs79202680	0	79202680.0	intron_variant	0.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17p13.1	17	7166093		RPL7AP64 - ASGR1	ENSG00000213876	ENSG00000141505		24501.0	7338.0	rs186021206-?	rs186021206	0	186021206.0	intergenic_variant	1.0	NR	6e-15	14.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17p11.2	17	17581340		PEMT			ENSG00000133027			rs7224725-?	rs7224725	0	7224725.0	intron_variant	0.0	NR	7e-19	18.154901959985743				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q11.2	17	28367840		VTN, SARM1			ENSG00000109072, ENSG00000004139			rs704-?	rs704	0	704.0	missense_variant	0.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q21.31	17	43848758		CD300LG			ENSG00000161649			rs72836561-?	rs72836561	0	72836561.0	missense_variant	0.0	NR	4e-120	119.39794000867204				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q21.32	17	48120393		SNX11			ENSG00000002919			rs10775406-?	rs10775406	0	10775406.0	intron_variant	0.0	NR	8e-15	14.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q21.33	17	49329709		ZNF652			ENSG00000198740			rs12185242-?	rs12185242	0	12185242.0	intron_variant	0.0	NR	2e-19	18.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q21.33	17	50547162		SPATA20			ENSG00000006282			rs9890200-?	rs9890200	0	9890200.0	5_prime_UTR_variant	0.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr17:57925487-?	chr17:57925487	0			1.0	NR	2e-10	9.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q24.2	17	66214462		APOH			ENSG00000091583			rs1801689-?	rs1801689	0	1801689.0	missense_variant	0.0	NR	3e-26	25.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q24.2	17	67858691		BPTF			ENSG00000171634			rs62084237-?	rs62084237	0	62084237.0	intron_variant	0.0	NR	5e-20	19.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q24.2	17	68827664		LINC01482 - ABCA8	ENSG00000267659	ENSG00000141338		63782.0	39625.0	rs112001035-?	rs112001035	0	112001035.0	intergenic_variant	1.0	NR	4e-08	7.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr17:68465984-?	chr17:68465984	0			1.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr17:73315397-?	chr17:73315397	0			1.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q25.1	17	76285310		QRICH2			ENSG00000129646			rs77244849-?	rs77244849	0	77244849.0	intron_variant	0.0	NR	9e-13	12.045757490560677				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		17q25.3	17	78410089		PGS1			ENSG00000087157			rs4969145-?	rs4969145	0	4969145.0	intron_variant	0.0	NR	3e-17	16.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		18p11.32	18	289209		THOC1-DT - COLEC12	ENSG00000263884	ENSG00000158270		18931.0	27528.0	rs6506033-?	rs6506033	0	6506033.0	regulatory_region_variant	1.0	NR	1e-11	11.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		18p11.32	18	2846814		SMCHD1 - EMILIN2	ENSG00000101596	ENSG00000132205		41797.0	192.0	rs11664106-?	rs11664106	0	11664106.0	non_coding_transcript_exon_variant	1.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		18q11.2	18	22331727		GATA6 - CTAGE1	ENSG00000141448	ENSG00000282841		129199.0	81872.0	rs867939-?	rs867939	0	867939.0	regulatory_region_variant	1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		18q11.2	18	23522877		NPC1, RMC1			ENSG00000141458, ENSG00000141452			rs563297725-?	rs563297725	0	563297725.0	3_prime_UTR_variant	0.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		18q21.31	18	58451126		MIR3591, MIR122, MIR122HG			ENSG00000207778, ENSG00000284440, ENSG00000267391			rs41292412-?	rs41292412	0	41292412.0	mature_miRNA_variant	0.0	NR	4e-11	10.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		18q21.32	18	60191596		RNU4-17P - MC4R	ENSG00000202468	ENSG00000166603		27889.0	179466.0	rs8089364-?	rs8089364	0	8089364.0	upstream_gene_variant	1.0	NR	2e-11	10.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		18q21.33	18	63178651		BCL2			ENSG00000171791			rs12454712-?	rs12454712	0	12454712.0	intron_variant	0.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q11	12	37502486		AK6P1 - ZNF970P	ENSG00000256614	ENSG00000258368		3252528.0	73101.0	rs4002684-?	rs4002684	0	4002684.0	intergenic_variant	1.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q12	12	45591489		U6 - ARID2	ENSG00000266784	ENSG00000189079		36830.0	138217.0	rs73108788-?	rs73108788	0	73108788.0	intron_variant	1.0	NR	6e-10	9.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q13.11	12	46786225		SLC38A4			ENSG00000139209			rs79295634-?	rs79295634	0	79295634.0	intron_variant	0.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q13.13	12	53636378		ATP5MC2			ENSG00000135390			rs139413460-?	rs139413460	0	139413460.0	intron_variant	0.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q13.13	12	54030947		HOXC4			ENSG00000198353			rs4759319-?	rs4759319	0	4759319.0	intron_variant	0.0	NR	8e-09	8.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q13.3	12	56519080		HSPD1P4 - RBMS2	ENSG00000257576	ENSG00000076067		6377.0	2740.0	rs2694917-?	rs2694917	0	2694917.0	upstream_gene_variant	1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q13.3	12	57388110		R3HDM2			ENSG00000179912			rs2122982-?	rs2122982	0	2122982.0	intron_variant	0.0	NR	2.9999999999999998e-36	35.52287874528034				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q14.1	12	62273946		TAFA2, USP15			ENSG00000198673, ENSG00000135655			rs7296326-?	rs7296326	0	7296326.0	intron_variant	0.0	NR	5e-11	10.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q14.3	12	65508485		MSRB3 - LINC02454	ENSG00000174099	ENSG00000256268		17055.0	80626.0	rs145775785-?	rs145775785	0	145775785.0	intron_variant	1.0	NR	5e-08	7.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr12:67705947-?	chr12:67705947	0			1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q15	12	69362511		YEATS4			ENSG00000127337			rs548240-?	rs548240	0	548240.0	intron_variant	0.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr12:107209957-?	chr12:107209957	0			1.0	NR	8e-17	16.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q24.11	12	109223867		ACACB			ENSG00000076555			rs149793040-?	rs149793040	0	149793040.0	missense_variant	0.0	NR	4.9999999999999996e-26	25.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q24.12	12	111569952		ATXN2			ENSG00000204842			rs653178-?	rs653178	0	653178.0	intron_variant	0.0	NR	3e-08	7.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q24.31	12	122146934		MLXIP, MLXIP			ENSG00000175727, ENSG00000281178			rs1043771-?	rs1043771	0	1043771.0	3_prime_UTR_variant	0.0	NR	8e-09	8.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q24.31	12	124022084		RFLNA			ENSG00000178882			rs10773049-?	rs10773049	0	10773049.0	intron_variant	0.0	NR	2.9999999999999998e-40	39.52287874528034				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		12q24.31	12	124831485		SCARB1			ENSG00000073060			rs11057839-?	rs11057839	0	11057839.0	intron_variant	0.0	NR	6e-10	9.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		13q12.13	13	25234148		LINC01076 - MTMR6	ENSG00000225105	ENSG00000139505		23853.0	12074.0	rs9551188-?	rs9551188	0	9551188.0	regulatory_region_variant	1.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		13q12.3	13	30415655		LINC00426 - LINC01058	ENSG00000238121	ENSG00000225039		38510.0	2684.0	rs2094711-?	rs2094711	0	2094711.0	intron_variant	1.0	NR	4e-12	11.397940008672036				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		13q14.2	13	50081853		DLEU2			ENSG00000231607			rs41284816-?	rs41284816	0	41284816.0	non_coding_transcript_exon_variant	0.0	NR	3e-11	10.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr13:71839454-?	chr13:71839454	0			1.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		13q32.1	13	94600877		TGDS - GPR180	ENSG00000088451	ENSG00000152749		4635.0	980.0	rs9561643-?	rs9561643	0	9561643.0	upstream_gene_variant	1.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		13q34	13	113841051		GAS6-AS1, GAS6			ENSG00000233695, ENSG00000183087			rs7140110-?	rs7140110	0	7140110.0	non_coding_transcript_exon_variant	0.0	NR	2e-31	30.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		14q22.1	14	53344948		DDHD1-DT - RPS3AP46	ENSG00000258731	ENSG00000226132		187420.0	267776.0	rs1255334-?	rs1255334	0	1255334.0	intron_variant	1.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		14q23.2	14	63765800		SYNE2			ENSG00000054654			rs774893527-?	rs774893527	0	774893527.0	intron_variant	0.0	NR	8e-16	15.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19p13.3	19	4149054		Metazoa_SRP - CREB3L3	ENSG00000276525	ENSG00000060566		21322.0	4577.0	rs350883-?	rs350883	0	350883.0	upstream_gene_variant	1.0	NR	2e-14	13.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19p13.3	19	4965393		UHRF1 - KDM4B	ENSG00000276043	ENSG00000127663		3239.0	3720.0	rs34232444-?	rs34232444	0	34232444.0	upstream_gene_variant	1.0	NR	3e-10	9.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19p13.2	19	8364439		ANGPTL4			ENSG00000167772			rs116843064-?	rs116843064	0	116843064.0	missense_variant	0.0	NR	7.999999999999999e-192	191.09691001300808				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19p13.11	19	19268740		TM6SF2			ENSG00000213996			rs58542926-?	rs58542926	0	58542926.0	missense_variant	0.0	NR	8.000000000000001e-159	158.09691001300806				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.11	19	33403940		PEPD			ENSG00000124299			rs10422861-?	rs10422861	0	10422861.0	intron_variant	0.0	NR	4e-19	18.39794000867204				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.11	19	35060524		HPN-AS1, HPN			ENSG00000227392, ENSG00000105707			rs58895965-?	rs58895965	0	58895965.0	intron_variant	0.0	NR	2e-21	20.69897000433602				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr19:36028980-?	chr19:36028980	0			1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.2	19	38459753		RYR1			ENSG00000196218			rs73930587-?	rs73930587	0	73930587.0	intron_variant	0.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.2	19	41248525		AXL			ENSG00000167601			rs35538872-?	rs35538872	0	35538872.0	missense_variant	0.0	NR	1e-11	11.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.32	19	44913484		APOE - APOC1	ENSG00000130203	ENSG00000130208		4091.0	763.0	rs438811-?	rs438811	0	438811.0	non_coding_transcript_exon_variant	1.0	NR	1e-282	282.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.33	19	47858667		CRX - TPRX2P	ENSG00000105392	ENSG00000259009		15337.0	1446.0	rs62128824-?	rs62128824	0	62128824.0	upstream_gene_variant	1.0	NR	6e-11	10.221848749616356				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.33	19	48756272		FGF21			ENSG00000105550			rs838133-?	rs838133	0	838133.0	synonymous_variant	0.0	NR	8.000000000000001e-29	28.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.33	19	49513502		FCGRT			ENSG00000104870			rs142385484-?	rs142385484	0	142385484.0	non_coding_transcript_exon_variant	0.0	NR	8e-19	18.096910013008056				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.42	19	55580109		ZNF579			ENSG00000218891			rs12610512-?	rs12610512	0	12610512.0	intron_variant	0.0	NR	4e-18	17.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		19q13.43	19	56977055		MIMT1 - RPL7AP69	ENSG00000268654	ENSG00000268483		128499.0	88279.0	rs8102873-?	rs8102873	0	8102873.0	intergenic_variant	1.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20p13	20	590823		CSNK2A1 - TCF15	ENSG00000101266	ENSG00000125878		46988.0	13434.0	rs144033177-?	rs144033177	0	144033177.0	intergenic_variant	1.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q11.21	20	32765979		DNMT3B			ENSG00000088305			rs6058874-?	rs6058874	0	6058874.0	intron_variant	0.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q11.22	20	33600336		CBFA2T2			ENSG00000078699			rs149142833-?	rs149142833	0	149142833.0	5_prime_UTR_variant	0.0	NR	4e-09	8.397940008672037				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q11.22	20	35530220		C20orf173 - ERGIC3	ENSG00000125975	ENSG00000125991		568.0	11818.0	rs150122702-?	rs150122702	1	3055800.0	upstream_gene_variant	1.0	NR	2e-08	7.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q12	20	39941338		HSPE1P1 - LINC01370	ENSG00000234878	ENSG00000237767		8099.0	62878.0	rs2870132-?	rs2870132	0	2870132.0	regulatory_region_variant	1.0	NR	5e-09	8.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q12	20	40551182		LINC01370 - MAFB	ENSG00000237767	ENSG00000204103		539859.0	134666.0	rs1883711-?	rs1883711	0	1883711.0	regulatory_region_variant	1.0	NR	3e-23	22.522878745280337				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals												chr20:39822353-?	chr20:39822353	0			1.0	NR	5e-11	10.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q13.12	20	45923216		PLTP - PCIF1	ENSG00000100979	ENSG00000100982		11061.0	11467.0	rs6073958-?	rs6073958	0	6073958.0	downstream_gene_variant	1.0	NR	5e-108	107.30102999566398				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q13.2	20	52619074		LINC01524			ENSG00000234948			rs6068280-?	rs6068280	0	6068280.0	intron_variant	0.0	NR	5e-08	7.301029995663981				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q13.31	20	57561898		PCK1			ENSG00000124253			rs2236744-?	rs2236744	0	2236744.0	non_coding_transcript_exon_variant	0.0	NR	9e-15	14.045757490560677				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		20q13.33	20	64080106		OPRL1, OPRL1			ENSG00000277044, ENSG00000125510			rs8126001-?	rs8126001	0	8126001.0	5_prime_UTR_variant	0.0	NR	1e-14	14.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		21q22.2	21	39272244		BRWD1			ENSG00000185658			rs8134638-?	rs8134638	0	8134638.0	intron_variant	0.0	NR	3e-11	10.522878745280336				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		22q11.23	22	24002918		GSTT4, GSTT4			ENSG00000281748, ENSG00000276950			rs9608229-?	rs9608229	0	9608229.0	intron_variant	0.0	NR	1e-10	10.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		22q12.1	22	28411637		TTC28			ENSG00000100154			rs134551-?	rs134551	0	134551.0	intron_variant	0.0	NR	9e-09	8.045757490560675				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		22q12.3	22	35646939		MB - APOL6	ENSG00000198125	ENSG00000221963		8988.0	1507.0	rs9610329-?	rs9610329	0	9610329.0	upstream_gene_variant	1.0	NR	2e-09	8.698970004336019				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		22q13.1	22	38181508		PLA2G6			ENSG00000184381			rs2277844-?	rs2277844	0	2277844.0	intron_variant	0.0	NR	3.9999999999999996e-26	25.39794000867204				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		22q13.31	22	46223522		PPARA			ENSG00000186951			rs6008191-?	rs6008191	0	6008191.0	intron_variant	0.0	NR	1e-13	13.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		22q13.33	22	49674346		MIR3667HG - RN7SKP252	ENSG00000188511	ENSG00000223142		16804.0	64331.0	rs1807675-?	rs1807675	0	1807675.0	intergenic_variant	1.0	NR	1e-09	9.0				Affymetrix [NR] (imputed)	N
2023-01-17	36269708	Selvaraj MS	2022-10-21	PLoS One	www.ncbi.nlm.nih.gov/pubmed/36269708	Genome-wide discovery for diabetes-dependent triglycerides-associated loci.	Triglyceride levels in non-type 2 diabetes	402,944 European ancestry individuals		22q13.33	22	50218683		TUBGCP6			ENSG00000128159			rs11912397-?	rs11912397	0	11912397.0	intron_variant	0.0	NR	1e-08	8.0				Affymetrix [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Kidney disese (macroalbuminuria or end-stage renal disease) in diabetes	6,705 European ancestry cases, 15,430 European ancestry controls		2q36.3	2	227256385		MFF-DT, COL4A3			ENSG00000236432, ENSG00000169031			rs55703767-T	rs55703767	0	55703767.0	missense_variant	0.0	0.208	4e-11	10.397940008672036		0.82	[0.77-0.87]	Illumina [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Kidney disese (macroalbuminuria or end-stage renal disease) in diabetes	6,705 European ancestry cases, 15,430 European ancestry controls		4q13.3	4	70493059		MUC7 - AMTN	ENSG00000171195	ENSG00000187689		10062.0	25510.0	rs191449639-A	rs191449639	0	191449639.0	intergenic_variant	1.0	0.005	1e-08	8.0		32.42	[9.77-107.59]	Illumina [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Kidney disease (end stage renal disease vs macroalbuminuria) in diabetes	2,640 European ancestry cases, 3,502 European ancestry controls		8q24.21	8	127087785		PCAT1, CASC19, PRNCR1			ENSG00000253438, ENSG00000254166, ENSG00000282961			rs551191707-CA	rs551191707	1	57532727.0	non_coding_transcript_exon_variant	0.0	0.122	4e-08	7.397940008672037		1.69	[1.4-2.04]	Illumina [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Kidney disease (end stage renal disease or macroalbuminuria or microalbuminuria) in diabetes	11,380 European ancestry cases, 15,405 European ancestry controls		2q36.3	2	227256385		MFF-DT, COL4A3			ENSG00000236432, ENSG00000169031			rs55703767-T	rs55703767	0	55703767.0	missense_variant	0.0	0.207	2e-09	8.698970004336019		0.86	[0.82-0.9]	Illumina [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Microalbuminuria in diabetes	4,779 European ancestry cases, 15,331 European ancestry controls		3p25.2	3	11869161		FANCD2P2			ENSG00000230342			rs142823282-A	rs142823282	0	142823282.0	intron_variant	0.0	0.983	8e-10	9.096910013008056		0.15	[0.08-0.27]	Illumina [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Microalbuminuria in diabetes	4,779 European ancestry cases, 15,331 European ancestry controls		7q22.1	7	100130923		MBLAC1 - RPL7P60	ENSG00000214309	ENSG00000214142		2428.0	8706.0	rs77273076-T	rs77273076	0	77273076.0	upstream_gene_variant	1.0	0.008	1e-08	8.0		9.16	[4.29-19.56]	Illumina [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Microalbuminuria in diabetes	4,779 European ancestry cases, 15,331 European ancestry controls		11p15.1	11	16916299		PLEKHA7			ENSG00000166689			rs183937294-T	rs183937294	0	183937294.0	intron_variant	0.0	0.993	2e-08	7.698970004336019		0.06	[0.02-0.16]	Illumina [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in diabetes	4,122 European ancestry cases, 13,972 European ancestry controls		5q34	5	167551225		TENM2			ENSG00000145934			rs72831309-A	rs72831309	0	72831309.0	intron_variant	0.0	0.039	1e-08	8.0		2.08	[1.62-2.67]	Illumina [NR] (imputed)	N
2022-09-02	35763030	Sandholm N	2022-06-28	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/35763030	Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease.	Kidney disease (reduced eGFR and albuminuria or end stage renal disease) in diabetes	4,122 European ancestry cases, 13,972 European ancestry controls		2q36.3	2	227256385		MFF-DT, COL4A3			ENSG00000236432, ENSG00000169031			rs55703767-T	rs55703767	0	55703767.0	missense_variant	0.0	0.21	5e-08	7.301029995663981		0.81	[0.75-0.88]	Illumina [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	Fasting proinsulin levels in prediabetes	451 Han Chinese ancestry individuals		13q22.2	13	75107716		RIOK3P1 - RNU6-38P	ENSG00000225944	ENSG00000206812		277636.0	1871.0	rs9600432-?	rs9600432	0	9600432.0	upstream_gene_variant	1.0	NR	1e-06	6.0				NR [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	Fasting proinsulin levels in prediabetes	451 Han Chinese ancestry individuals		3q29	3	197482798		DLG1-AS1 - LINC02012	ENSG00000227375	ENSG00000272989		179043.0	22464.0	rs78022276-?	rs78022276	0	78022276.0	regulatory_region_variant	1.0	NR	3e-06	5.522878745280337				NR [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	Fasting proinsulin levels in prediabetes	451 Han Chinese ancestry individuals		10q25.1	10	106889263		SORCS1			ENSG00000108018			rs58879794-?	rs58879794	0	58879794.0	intron_variant	0.0	NR	4e-06	5.3979400086720375				NR [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	Fasting insulin levels in prediabetes	451 Han Chinese ancestry individuals		12q13.13	12	52548843		KRT71			ENSG00000139648			rs3803084-?	rs3803084	0	3803084.0	intron_variant	0.0	NR	1e-06	6.0				NR [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	2-hour postprandial proinsulin levels in prediabetes	451 Han Chinese ancestry individuals		19p13.2	19	8487389		HNRNPM			ENSG00000099783			rs2277987-?	rs2277987	0	2277987.0	non_coding_transcript_exon_variant	0.0	NR	6e-08	7.221848749616356				NR [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	2-hour postprandial proinsulin levels in prediabetes	451 Han Chinese ancestry individuals		4p16.3	4	192200		ZNF718			ENSG00000250312			rs4690234-?	rs4690234	0	4690234.0	intron_variant	0.0	NR	2e-08	7.698970004336019				NR [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	2-hour postprandial insulin levels in prediabetes	451 Han Chinese ancestry individuals		9q34.2	9	133266456		ABO, ABO			ENSG00000175164, ENSG00000281879			rs977371848-?	rs977371848	1	2519093.0	intron_variant	0.0	NR	2e-07	6.698970004336019				NR [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	2-hour postprandial insulin levels in prediabetes	451 Han Chinese ancestry individuals		10q23.1	10	85558056		RNU6-325P - GRID1-AS1	ENSG00000223064	ENSG00000234942		20573.0	19675.0	rs375709957-?	rs375709957	0	375709957.0	upstream_gene_variant	1.0	NR	2e-06	5.698970004336019				NR [NR] (imputed)	N
2023-06-05	35971929	Lin L	2022-08-16	Endokrynol Pol	www.ncbi.nlm.nih.gov/pubmed/35971929	Genome-wide association study of fasting proinsulin, fasting insulin, 2-hour postprandial proinsulin, and 2-hour postprandial insulin in Chinese Han people.	2-hour postprandial insulin levels in prediabetes	451 Han Chinese ancestry individuals		1p31.3	1	64315831		UBE2U - RNU7-62P	ENSG00000177414	ENSG00000238653		48463.0	68567.0	rs11585260-?	rs11585260	0	11585260.0	regulatory_region_variant	1.0	NR	5e-06	5.301029995663981				NR [NR] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to metfomin (Fasting glucose levels adjusted for baseline glucose levels)	807 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		2p23.2	2	28307503		BABAM2			ENSG00000158019			rs111770298-G	rs111770298	0	111770298.0	non_coding_transcript_exon_variant	0.0	NR	2e-08	7.698970004336019		0.8	unit increase	Illumina [12657451] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to metfomin (Fasting glucose levels adjusted for baseline glucose levels)	807 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		3p14.3	3	55883717		ERC2			ENSG00000187672			rs149403252-T	rs149403252	0	149403252.0	intron_variant	0.0	NR	2e-09	8.698970004336019		1.3	unit decrease	Illumina [12657451] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to metfomin (Fasting glucose levels adjusted for baseline glucose levels)	807 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		16q23.3	16	82250950		RN7SKP190 - CDH13	ENSG00000251888	ENSG00000140945		58160.0	376015.0	rs117207651-C	rs117207651	0	117207651.0	intergenic_variant	1.0	NR	5e-08	7.301029995663981		1.0	unit decrease	Illumina [12657451] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to metfomin (Glucose levels at 60 minutes adjusted for baseline glucose levels)	794 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		1q25.3	1	182077342		ZNF648 - LINC01344	ENSG00000179930	ENSG00000228918		15630.0	18996.0	rs12062755-A	rs12062755	0	12062755.0	intergenic_variant	1.0	NR	4e-08	7.397940008672037		0.4	unit increase	Illumina [12547822] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Fasting glucose	851 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		11p11.2	11	46677574		ARHGAP1			ENSG00000175220			rs8914-A	rs8914	0	8914.0	3_prime_UTR_variant	0.0	NR	7e-06	5.154901959985743		0.3	unit decrease	Illumina [12901357] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to glipizide (Glucose levels at 60 minutes adjusted for baseline glucose levels)	830 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		3p14.1	3	64193613		PRICKLE2-AS3, PRICKLE2			ENSG00000226017, ENSG00000163637			rs146209333-C	rs146209333	0	146209333.0	intron_variant	0.0	NR	3e-08	7.522878745280337		0.9	unit decrease	Illumina [12705251] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to metfomin (Insulin levels at 60 minutes)	776 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		10q25.3	10	113583078		HABP2			ENSG00000148702			rs111406936-T	rs111406936	0	111406936.0	intron_variant	0.0	NR	6e-09	8.221848749616356		1.5	unit decrease	Illumina [12483998] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to glipizide (Insulin levels at 30 minutes)	807 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		1q42.12	1	225964122		LEFTY2 - NDUFA3P3	ENSG00000143768	ENSG00000213032		22739.0	57.0	rs2749695-A	rs2749695	0	2749695.0	upstream_gene_variant	1.0	NR	3e-08	7.522878745280337		0.3	unit increase	Illumina [12534687] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to glipizide (Time to glucose trough)	550 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		4q35.2	4	187296094		LINC02374 - LINC02514	ENSG00000249747	ENSG00000250042		86748.0	74554.0	rs150628520-G	rs150628520	0	150628520.0	intergenic_variant	1.0	NR	1e-08	8.0		1.7	unit increase	Illumina [10786001] (imputed)	N
2023-05-31	37233759	Li JH	2023-05-26	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/37233759	Genome-wide association analysis identifies ancestry-specific genetic variation associated with acute response to metformin and glipizide in SUGAR-MGH.	Response to glipizide (Time to glucose trough)	550 Black, European, Hispanic, Asian or unknown ancestry individuals at risk of type 2 diabetes		18q21.31	18	56245092		LINC01539 - TXNL1	ENSG00000267712	ENSG00000091164		107556.0	352117.0	rs9954585-T	rs9954585	0	9954585.0	intergenic_variant	1.0	NR	7e-09	8.154901959985743		1.5	unit decrease	Illumina [10786001] (imputed)	N
2023-08-23	37601966	Walters RG	2023-07-20	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/37601966	Genotyping and population characteristics of the China Kadoorie Biobank.	Non-insulin-dependent diabetes mellitus (Union E11)	4,528 Chinese ancestry cases, 72,650 Chinese ancestry controls		3q27.2	3	185757918		IGF2BP2			ENSG00000073792			rs11925694-G	rs11925694	0	11925694.0	intron_variant	0.0	0.37605	4e-08	7.397940008672037		1.138	[1.086-1.192]	Affymetrix [8996068] (imputed)	N
2023-08-23	37601966	Walters RG	2023-07-20	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/37601966	Genotyping and population characteristics of the China Kadoorie Biobank.	Non-insulin-dependent diabetes mellitus (Union E11)	4,528 Chinese ancestry cases, 72,650 Chinese ancestry controls		6p22.3	6	20682933		CDKAL1			ENSG00000145996			rs9350271-A	rs9350271	0	9350271.0	intron_variant	0.0	0.39371	7e-10	9.154901959985745		1.155	[1.103-1.209]	Affymetrix [8996068] (imputed)	N
2023-08-23	37601966	Walters RG	2023-07-20	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/37601966	Genotyping and population characteristics of the China Kadoorie Biobank.	Non-insulin-dependent diabetes mellitus (Union E11)	4,528 Chinese ancestry cases, 72,650 Chinese ancestry controls		7q32.1	7	128204004		SND1 - MIR129-1	ENSG00000197157	ENSG00000207705		111395.0	3868.0	rs4731415-A	rs4731415	0	4731415.0	upstream_gene_variant	1.0	0.11687	2e-10	9.69897000433602		1.247	[1.165-1.335]	Affymetrix [8996068] (imputed)	N
2023-08-23	37601966	Walters RG	2023-07-20	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/37601966	Genotyping and population characteristics of the China Kadoorie Biobank.	Non-insulin-dependent diabetes mellitus (Union E11)	4,528 Chinese ancestry cases, 72,650 Chinese ancestry controls		9p21.3	9	22134069		CDKN2B-AS1 - DMRTA1	ENSG00000240498	ENSG00000176399		5966.0	312755.0	rs10811660-A	rs10811660	0	10811660.0	intergenic_variant	1.0	0.45471	6e-15	14.221848749616356		0.836	[0.8-0.875]	Affymetrix [8996068] (imputed)	N
2023-08-23	37601966	Walters RG	2023-07-20	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/37601966	Genotyping and population characteristics of the China Kadoorie Biobank.	Non-insulin-dependent diabetes mellitus (Union E11)	4,528 Chinese ancestry cases, 72,650 Chinese ancestry controls		10q23.33	10	92454823		IDE			ENSG00000119912			rs11187007-A	rs11187007	0	11187007.0	3_prime_UTR_variant	0.0	0.28802	1e-09	9.0		1.167	[1.11-1.228]	Affymetrix [8996068] (imputed)	N
2023-08-23	37601966	Walters RG	2023-07-20	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/37601966	Genotyping and population characteristics of the China Kadoorie Biobank.	Non-insulin-dependent diabetes mellitus (Union E11)	4,528 Chinese ancestry cases, 72,650 Chinese ancestry controls		11p15.4	11	2837316		KCNQ1, KCNQ1			ENSG00000282076, ENSG00000053918			rs2237897-T	rs2237897	0	2237897.0	intron_variant	0.0	0.33746	1e-14	14.0		0.817	[0.776-0.86]	Affymetrix [8996068] (imputed)	N
2023-08-23	37601966	Walters RG	2023-07-20	Cell Genom	www.ncbi.nlm.nih.gov/pubmed/37601966	Genotyping and population characteristics of the China Kadoorie Biobank.	Non-insulin-dependent diabetes mellitus (Union E11)	4,528 Chinese ancestry cases, 72,650 Chinese ancestry controls		Xq28	X	153642698		DUSP9			ENSG00000130829			rs2301142-G	rs2301142	0	2301142.0	intron_variant	0.0	0.3979	5e-09	8.301029995663981		0.887	[0.852-0.923]	Affymetrix [8996068] (imputed)	N
2023-07-12	36907892	Rudman N	2023-03-13	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/36907892	Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes.	Plasma protein N-glycan peak 29 levels in type 1 diabetes	1,074 child cases	190 child cases, 265 unaffected sibling controls	2q21.2	2	134256545		MGAT5			ENSG00000152127			rs2460382-G	rs2460382	0	2460382.0	intron_variant	0.0	0.21	3e-11	10.522878745280336		0.01	[0.0061-0.0139] unit increase	Illumina [108428]	N
2023-07-12	36907892	Rudman N	2023-03-13	Diabetologia	www.ncbi.nlm.nih.gov/pubmed/36907892	Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes.	Plasma protein N-glycan peak 6 levels in type 1 diabetes	1,074 child cases	190 child cases, 265 unaffected sibling controls	22q13.1	22	39447404		TAB1 - MGAT3	ENSG00000100324	ENSG00000128268		10344.0	9608.0	rs5757678-G	rs5757678	0	5757678.0	intergenic_variant	1.0	0.27	1e-11	11.0		0.08	[0.056-0.104] unit increase	Illumina [108428]	N
2023-06-26	36791419	Westerman KE	2023-02-15	Diabetes	www.ncbi.nlm.nih.gov/pubmed/36791419	Investigating gene-diet interactions impacting the association between macronutrient intake and glycemic traits.	HbA1c levels x carbohydrate intake interaction (2df)	4,328 African American individuals, 35 American Indian ancestry individuals, 122 Asian ancestry individuals, 18,214 European ancestry individuals, 7,084 Hispanic or Latin American individuals		4q21.1	4	77979164		HMGB1P44 - HNRNPA1P56	ENSG00000248956	ENSG00000248640		14653.0	8696.0	rs79762542-G	rs79762542	0	79762542.0	intergenic_variant	1.0	0.03	5e-08	7.301029995663981				NR [NR]	N
2023-06-26	36791419	Westerman KE	2023-02-15	Diabetes	www.ncbi.nlm.nih.gov/pubmed/36791419	Investigating gene-diet interactions impacting the association between macronutrient intake and glycemic traits.	Fasting glucose levels x carbohydrate intake interaction (2df)	4,328 African American individuals, 35 American Indian ancestry individuals, 122 Asian ancestry individuals, 18,214 European ancestry individuals, 7,084 Hispanic or Latin American individuals		3p13	3	71275429		FOXP1			ENSG00000114861			rs1288694-C	rs1288694	0	1288694.0	intron_variant	0.0	0.61	5e-08	7.301029995663981				NR [NR]	N
2023-06-26	36791419	Westerman KE	2023-02-15	Diabetes	www.ncbi.nlm.nih.gov/pubmed/36791419	Investigating gene-diet interactions impacting the association between macronutrient intake and glycemic traits.	Fasting insulin levels x carbohydrate intake interaction (2df)	4,328 African American individuals, 35 American Indian ancestry individuals, 122 Asian ancestry individuals, 18,214 European ancestry individuals, 7,084 Hispanic or Latin American individuals		Xq28	X	155084576		MTCP1, BRCC3			ENSG00000214827, ENSG00000185515			rs782681704-G	rs782681704	0	782681704.0	intron_variant	0.0	0.01	5e-08	7.301029995663981				NR [NR]	N
